introduct
hallmark
sepsi
earli
onset
microvascular
dysfunct
howev
mechan
respons
maldistribut
capillari
blood
flow
understood
evid
suggest
red
blood
cell
rbc
sens
local
oxygen
condit
signal
vasculatur
via
adenosin
triphosph
atp
increas
capillari
flow
hypothes
sepsi
impair
microvascular
autoregul
entir
capillari
network
within
capillari
within
rbc
studi
object
measur
capillari
respons
time
within
hypox
capillari
capillari
rbc
hemoglobin
oxygen
satur
test
null
hypothesi
sepsi
effect
rbc
atp
efflux
develop
pathophysiolog
model
method
hypotens
sepsi
studi
male
spraguedawley
rat
use
cecal
ligat
perfor
end
point
rat
hindlimb
skelet
muscl
microcircul
imag
use
dual
wavelength
spectrophotometr
intravit
microscopi
system
capillari
rbc
suppli
rate
sr
rbc
rbc
oxygen
suppli
rate
quantifi
arteri
nox
nitrit
nitrat
rbc
atp
efflux
measur
use
nitric
oxid
analyz
ga
exchang
respect
result
compar
control
sepsi
increas
capillari
stop
flow
plasma
lactat
p
increas
plasma
nox
p
relat
increas
capillari
rbc
sr
p
analysi
capillari
profil
reveal
shift
toward
decreas
p
oxygen
suppli
rate
capillari
moreov
capillari
respons
time
within
hypox
capillari
time
restor
capillari
rbc
increas
fold
p
consist
impair
microvascular
autoregul
rbc
respons
hypox
environ
measur
rbc
atp
efflux
decreas
p
conclus
sepsi
impair
microvascular
autoregul
capillari
erythrocyt
level
impair
autoregul
manifest
increas
capillari
stoppedflow
increas
capillari
respons
time
within
hypox
capillari
decreas
capillari
oxygen
suppli
rate
decreas
rbc
atp
efflux
loss
local
microvascular
control
partial
offset
increas
capillari
rbc
suppli
rate
correl
increas
plasma
nox
refer
bateman
rm
sharp
md
jagger
je
elli
cg
critic
care
introduct
defici
suggest
predispos
sever
infect
howev
contradictori
find
report
therefor
replic
find
differ
cohort
need
perform
purpos
studi
assess
immunoglobulin
igg
subclass
level
cohort
patient
influenza
method
studi
spanish
patient
develop
flu
viru
diagnosi
confirm
detect
influenza
viru
nasopharyng
swab
use
realtim
polymeras
chain
reaction
immmunoglobulin
igg
subclass
bind
site
human
igg
subclass
kit
measur
acut
convalesc
phase
correl
sever
examin
analyz
genet
variant
order
evalu
role
level
clinic
immunolog
characterist
compar
use
chisquar
test
fisher
exact
test
need
result
ninetythre
patient
hospit
requir
admiss
intens
care
unit
sixtyfour
patient
develop
viral
pneumonia
acut
respiratori
distress
syndrom
differ
serum
level
igg
iga
igm
igg
subclass
observ
differ
subgroup
accord
sever
diseas
genotyp
nn
associ
lower
serum
level
convalesc
phase
patient
homozyg
n
allel
significantli
lower
serum
level
mgdl
n
individu
carri
n
allel
nn
nn
genotyp
mgdl
n
p
howev
associ
genotyp
sever
flu
observ
conclus
studi
abl
replic
previous
report
observ
defici
appear
signific
risk
factor
sever
flu
refer
gordon
c
et
al
associ
sever
pandem
influenza
viru
infect
immunoglobulin
g
subclass
defici
clin
infect
di
chan
jf
et
al
lower
serum
immunoglobulin
level
sever
case
mild
case
pandem
influenza
associ
cytokin
dysregul
clin
vaccin
immunol
introduct
intraven
iv
immunoglobulin
ig
treatment
known
allevi
behavior
deficit
experiment
induc
model
sepsi
delin
mechan
ivig
treatment
prevent
neuron
dysfunct
array
immunolog
apoptosi
marker
investig
method
sepsi
induc
cecal
ligat
perfor
clp
rat
anim
divid
five
group
sham
control
clp
salin
clp
immunoglobulin
g
igg
mgkg
iv
clp
immunoglobulin
enrich
immunoglobulin
iggam
mgkg
iv
blood
brain
sampl
taken
two
set
experi
clp
see
earli
hr
late
day
effect
treatment
total
complement
activ
complement
solubl
complement
level
measur
sera
rat
use
elisabas
method
cerebr
complement
content
analyz
western
blot
immun
cell
infiltr
gliosi
examin
immunohistochemistri
use
cluster
differenti
glial
fibrillari
acid
protein
antibodi
apoptot
neuron
death
investig
tunel
stain
western
blotbas
semiquantit
evalu
brain
homogen
bax
antibodi
result
iv
igg
iggam
administr
significantli
reduc
system
complement
activ
increas
serum
solubl
level
likewis
western
blot
data
show
slightli
increas
express
significantli
reduc
express
brain
sampl
iggamtr
iggtreat
septic
rat
especi
first
day
administr
cerebr
cellular
infiltr
observ
treat
nontreat
septic
rat
contrast
iv
igg
iggam
treatment
induc
consider
amelior
glial
cell
prolifer
increas
nontreat
rat
igg
iggam
treat
rat
exhibit
significantli
reduc
number
apoptot
neuron
cerebr
express
level
bax
compar
nontreat
rat
conclus
suggest
iv
igg
iggam
administr
amelior
neuron
dysfunct
behavior
deficit
reduc
apoptot
cell
death
glial
cell
prolifer
iggam
treatment
might
suppress
classic
complement
pathway
reduc
express
introduct
patient
surviv
initi
hyperinflammatori
phase
sever
sepsi
reach
intens
care
unit
immunosuppress
adenosin
potent
modul
fl
ammat
immun
strongli
elev
blood
septic
patient
previous
shown
adenosin
receptor
gi
receptor
domin
proinflammatori
phase
bacteri
periton
activ
receptor
specif
agonist
induc
gs
express
domin
resolut
phase
inflamm
studi
aim
elucid
role
adenosin
receptor
sepsisassoci
leukopenia
hypothes
elev
adenosin
level
sepsi
affect
normal
develop
lymphocyt
downregul
method
polymicrobi
sever
sepsi
induc
mice
cecal
ligat
punctur
clp
needl
blood
bone
marrow
bm
cell
count
well
flow
cytometri
perform
h
post
sepsi
induct
result
clptreat
mice
exhibit
significantli
lower
number
wbc
compar
sham
control
vs
cell
sham
mice
show
lower
wbc
count
compar
sham
wt
litterm
cell
p
signific
differ
observ
wbc
count
sham
clp
wt
group
similarli
desensit
agonist
ccpa
elimin
antagonist
dcpcx
associ
leukopenia
tcell
main
cell
popul
affect
clp
elimin
apoptot
rate
nucleat
bm
cell
sham
mice
similar
rate
observ
wt
clp
mice
almost
greater
earli
apoptosi
rate
annexin
v
shown
wt
sham
group
vs
respect
p
interestingli
mice
shown
produc
less
interleukin
il
lavag
fluid
compar
clpwt
mice
vs
pgml
respect
p
conclus
similar
phenotyp
induc
sepsi
suppress
support
hypothesi
dysfunctiondownregul
onset
sepsi
chang
effect
adenosin
toward
leukopenia
immun
paralysi
suppress
might
part
mechan
leukopenia
observ
clptreat
mice
mice
introduct
neutrophil
play
import
role
first
line
innat
immun
defens
activ
neutrophil
becom
segment
cytoplasm
grow
larger
includ
granul
howev
sometim
difficult
diffenti
whether
segment
neutrophil
process
grow
decid
stop
antibiot
report
hyper
spectral
imag
hsi
avail
analysi
includ
diagnosi
malaria
infect
cell
distinct
cell
produc
antibodi
studi
evalu
serial
chang
hsi
spectrum
patient
infect
examin
whether
could
distinguish
activ
neutrophil
method
sputum
urin
sampl
collect
clinic
ill
three
patient
pulmonari
infect
n
urinari
tract
infect
uti
n
sampl
smear
glass
slide
gram
stain
conduct
observ
slide
hsi
get
hyper
spectral
data
time
cytoplasm
neutrophil
analyz
hyper
spectral
data
softwar
system
result
could
find
neutrophil
differ
spectrum
infecti
stage
especi
nm
wavelength
repres
imag
patient
uti
shown
fig
neutrophil
becam
segment
phagocytosi
cytoplasm
neutrophil
enlarg
show
strong
intens
black
line
compar
microorgan
disappear
size
cytoplasm
decreas
blue
red
line
conclus
could
find
serial
chang
spectrum
neutrophil
infecti
stage
hsi
may
avail
decid
start
termin
antibiot
studi
requir
establish
cut
intens
level
activ
neutrophil
introduct
recent
studi
demonstr
endotoxin
activ
level
analyz
use
endotoxin
activ
assay
eaa
correl
sever
sepsi
patient
admit
icu
hand
sever
report
disput
clinic
util
eaa
focus
chemiluminesc
intens
ci
respons
lipopolysaccharid
lp
eaa
evalu
predict
valu
incid
postop
infecti
complic
follow
elect
gastroenterolog
surgeri
method
forti
eight
patient
underw
elect
surgeri
gastrointestin
cancer
enrol
studi
blood
sampl
taken
previou
day
surgeri
first
third
postop
day
blood
sampl
analyz
use
eaa
system
focus
ci
max
maxim
stimul
lp
minimum
ci
stimul
opson
zymosan
result
postop
infecti
complic
occur
patient
signific
differ
ea
level
patient
develop
postop
infecti
complic
patient
minimum
ci
significantli
higher
patient
develop
postop
infecti
complic
point
compar
patient
addit
ratio
maxim
ci
minimum
ci
reflect
neutrophil
function
maxim
lp
significantli
lower
surgeri
patient
develop
postop
infecti
complic
although
signific
posit
correl
observ
neutrophil
count
maxim
ci
minimum
ci
correl
observ
neutrophil
count
ratio
maxim
ci
minimum
ci
conclus
chemiluminesc
intens
especi
ratio
maxim
ci
minimum
ci
could
earli
predict
marker
develop
postop
infecti
complic
introduct
inhibitor
belong
superfamili
serin
proteas
inhibitor
regul
complement
system
also
plasma
kallikreinkinin
system
fibrinolyt
system
coagul
system
biolog
activ
divid
regul
vascular
permeabl
antiinflammatori
function
object
studi
clarifi
serial
chang
patient
sepsi
evalu
impact
clinic
cours
method
studi
singl
center
prospect
observ
studi
serial
examin
activ
valu
normal
rang
patient
sepsi
admit
intens
care
unit
trauma
acut
critic
care
center
osaka
univers
hospit
osaka
japan
period
januari
august
defin
refractori
shock
septic
shock
unrespons
convent
therapi
adequ
fluid
resuscit
vasopressor
therapi
maintain
hemodynam
result
serial
chang
evalu
patient
sepsi
male
femal
survivor
nonsurvivor
mean
age
year
divid
patient
three
group
nonshock
group
n
ii
nonrefractori
shock
group
n
iii
refractori
shock
group
n
survivor
n
non
survivor
n
nonshock
group
admiss
increas
day
day
p
nonrefractori
shock
group
admiss
increas
admiss
day
day
p
refractori
shock
group
admiss
increas
day
day
p
differ
three
group
statist
signific
p
nonsurvivor
increas
significantli
clinic
cours
p
conclus
refractori
shock
patient
sepsi
valu
low
especi
non
survivor
admiss
day
valid
replac
therapi
patient
septic
shock
may
lead
new
strategi
manag
sepsi
introduct
septic
patient
progress
endotoxin
shock
becom
subject
high
mortal
rate
mortal
rate
septic
patient
multipl
organ
failur
report
recent
much
sepsi
relat
biomark
measur
diagnosi
sepsi
method
would
like
clarifi
differ
patient
fs
background
variou
biomark
procalcitonin
presepsin
endotoxin
activ
assay
eaa
mortal
rate
sepsi
bacteremia
patient
classifi
group
blood
cultur
posit
bcposit
group
n
group
blood
cultur
neg
bcneg
group
n
blood
cultur
blood
sampl
drown
differ
two
site
perform
immedi
icu
admiss
due
sepsi
septic
shock
result
express
meansd
median
statist
analysi
use
mannwhitney
utest
chi
squar
test
fisher
test
result
procalcitonin
bcposit
bcneg
patient
respect
signific
differ
patient
presepsin
bcposit
bcneg
patient
jand
jrespect
also
signific
differ
group
eaa
level
bcposit
patient
bcneg
patient
differ
group
statist
signific
p
bcposit
bcneg
patient
jand
jrespect
also
signific
differ
p
group
bcposit
bcneg
patient
jand
jrespect
differ
group
surviv
rate
bcposit
patient
bc
neg
patient
signific
data
two
group
conclus
valu
eaa
bcposit
patient
signific
higher
bcneg
patient
signific
differ
mortal
group
exist
result
show
discrep
previou
shold
evalu
patient
basic
diseas
refer
ikeda
k
ikeda
suda
et
al
use
endotoxin
activ
assay
biomark
assess
sever
endotoxemia
critic
ill
patient
innat
immun
doi
introduct
procalcitonin
pct
earli
sensit
accur
marker
sepsi
especi
sever
studi
indic
pct
import
indic
diagnos
infect
predict
outcom
guid
treatment
abdomin
sepsi
recent
blood
purif
bf
endotoxin
absorpt
therapi
polymyxin
b
pmx
hemoperfus
continu
renal
replac
therapi
crrt
carri
abdomin
septic
shock
howev
studi
chang
pct
level
abdomin
septic
shock
bf
therefor
retrospect
evalu
chang
pct
level
critic
patient
abdomin
septic
shock
bf
method
twentyfour
patient
mf
mean
age
year
abdomin
septic
shock
underw
bf
pmx
crrt
pmx
undergon
twice
crrt
undergon
day
chang
pct
level
inflammatori
mediat
blood
wbc
count
crp
level
lactat
level
bf
measur
day
moreov
sofa
surviv
rate
day
icu
admit
measur
result
hemodynam
patient
improv
hr
bf
pct
level
improv
ngml
p
wbc
count
ul
crp
level
mgdl
improv
day
bf
sofa
score
decreas
p
day
bf
patient
recov
discharg
icu
significantli
correl
pct
sofa
score
p
correl
pct
mediat
conclus
present
studi
pct
level
critic
patient
abdomin
septic
shock
improv
bf
significantli
correl
pct
sofa
score
introduct
procalcitonin
pct
highli
sensit
specif
biomark
bacteri
infect
increasingli
use
ed
icu
diagnost
work
patient
lrti
sepsi
recent
samsung
ib
brahm
pct
new
point
care
poc
test
develop
fast
pct
measur
whole
blood
edta
sampl
measur
rang
object
evalu
studi
determin
correl
samsung
ib
brahm
pct
test
establish
refer
method
method
studi
conduct
examin
correl
samsung
ib
brahm
pct
establish
refer
method
brahm
pct
sensit
kryptor
brahm
pct
elecsi
two
german
laboratori
design
base
relat
clsi
guidelin
measur
procedur
comparison
bia
estim
use
patient
sampl
studi
compar
pct
valu
use
edta
plasma
determin
refer
method
result
determin
samsung
ib
brahm
pct
use
edta
whole
blood
edta
plasma
whole
measur
rang
assay
patient
undergo
routin
care
pct
measur
result
patient
includ
week
period
correl
edta
whole
blood
plasma
refer
method
r
correl
plasma
whole
blood
sampl
determin
samsung
analyz
r
clinic
concord
relat
threshold
whole
blood
signific
bia
observ
venou
whole
blood
plasma
respect
compar
refer
method
differ
observ
compar
imprecis
whole
blood
plasma
total
cv
concentr
time
result
samsung
ib
brahm
pct
min
conclus
studi
found
excel
correl
diagnost
accuraci
new
sensit
poc
devic
rapid
measur
procalcitonin
samsung
ib
brahm
pct
test
allow
accur
measur
pct
point
care
near
patient
test
practic
compar
establish
lab
base
brahm
pct
assay
introduct
lack
studi
compar
util
creactiv
protein
crp
procalcitonin
pct
manag
patient
acut
respiratori
tract
infect
ari
primari
care
aim
studi
first
correl
marker
second
compar
predict
accuraci
regard
clinic
outcom
predict
method
secondari
analysi
use
clinic
biomark
data
primari
care
patient
pneumon
nonpneumon
ari
use
correl
statist
spearman
rank
test
multivari
regress
model
assess
associ
marker
advers
outcom
name
day
restrict
activ
ongo
discomfort
day
result
baselin
crp
pct
correl
well
overal
popul
particularli
subgroup
patient
nonpneumon
ari
low
correl
also
found
compar
cutoff
rang
day
seven
level
biomark
chang
baselin
day
seven
high
admiss
level
crp
mgdl
regress
coeffici
ci
well
pct
regress
coeffici
ci
significantli
associ
day
restrict
activ
associ
marker
regard
ongo
discomfort
day
conclus
crp
pct
level
well
correl
moder
prognost
accuraci
primari
care
patient
ari
predict
clinic
outcom
low
correl
marker
call
intervent
research
compar
marker
head
head
regard
abil
guid
antibiot
decis
introduct
procalcitonin
pct
propos
help
tool
guid
treatment
antibiot
improv
antibiot
stewardship
howev
cut
pct
level
agre
differ
studi
suggest
differ
threshold
predict
need
antibiot
cut
point
rang
ngml
ngml
hospit
refer
rang
set
ngml
studi
aim
identifi
best
pct
level
rule
sepsi
method
retrospect
review
intens
care
unit
patient
serial
pct
test
part
daili
blood
test
three
serial
read
pct
collect
addit
microbiolog
cultur
result
whether
patient
met
definit
criteria
sepsi
set
intern
sepsi
definit
confer
result
patient
patient
neg
microbiolog
cultur
evid
sepsi
pct
test
level
ngml
sensit
patient
cut
evid
sepsi
posit
microbiolog
cultur
area
roc
confid
interv
p
valu
fig
conclus
use
lower
pct
cut
would
enhanc
abil
pct
rule
sepsi
critic
ill
patient
refer
bouadma
et
al
lancet
feb
burkhardt
et
al
eur
respir
j
sep
hochreit
critic
care
introduct
central
nervou
system
cn
infect
neurosurg
procedur
extens
drug
resist
bacteria
xdr
intens
care
unit
icu
patient
life
threaten
complic
requir
earli
identif
immedi
action
increas
number
white
blood
cell
wbc
high
temperatur
circul
acut
phase
protein
common
patient
make
time
diagnosi
challeng
sought
investig
reliabl
serum
creactiv
protein
crp
procalcitonin
pct
earli
identifi
monitor
cn
infect
method
januari
novemb
case
cn
infect
record
inclus
criteria
presenc
fever
compat
lumbar
punctur
find
increas
number
polymorphonuclear
leukocyt
increas
protein
low
glucos
compar
serum
level
wbc
crp
pct
level
inclus
criteria
met
infect
last
intrathec
administr
collistin
iu
amikacin
mg
vancomycin
mg
compar
result
twelv
patient
mean
age
studi
wbc
remain
high
infect
convers
crp
valu
statist
differ
infect
wherea
pct
one
tabl
conclus
base
find
crp
carri
better
predict
valu
pct
biomark
earli
diagnosi
monitor
cn
infect
icu
small
number
patient
limit
result
introduct
studi
aim
clarifi
chang
endotoxin
activ
assay
eaa
pct
level
direct
hemoperfus
polymyxinb
immobil
fiber
pmxdhp
method
studi
patient
surviv
group
nonsurviv
ns
group
pmxdhp
perform
sever
sepsi
septic
shock
admit
icu
time
blood
biochemistri
level
measur
pmxdhp
doublelumen
cathet
insert
patient
fs
femor
vein
pmxdhp
perform
use
blood
pump
remov
endotoxin
blood
access
hemoperfus
consist
venoustoven
system
nafamostat
mesil
administ
mg
bolu
follow
mghour
continu
intraven
infus
anticoagul
extracorpor
circul
perform
hour
result
express
mean
sd
median
mannwhitney
utest
chisquar
test
fisher
fs
test
use
statist
analysi
result
regard
background
factor
score
sgroup
nsgroup
sofa
score
respect
blood
pressur
ratio
markedli
improv
immedi
pmxdhp
level
decreas
immedi
pmxdhp
sgroup
level
show
signific
differ
group
pmxdhp
pct
level
pmxdhp
sgroup
nsgroup
immedi
pmxdhp
level
becam
sgroup
nsgroup
respect
eaa
level
pmxdhp
sgroup
nsgroup
immedi
pmxdhp
level
becam
sgroup
nsgroup
respect
valu
show
signific
differ
pmxdhp
conclus
studi
show
pct
eaa
level
signific
chang
pmxdhp
refer
toshiaki
ikeda
kazumi
ikeda
shingo
suda
et
al
use
endotoxin
activ
assay
biomark
assess
sever
endotoxemia
critic
ill
patient
innat
immun
doi
epub
jan
introduct
purpos
studi
determin
accuraci
crp
pct
presepsin
psp
combin
measur
first
h
admiss
diagnosi
sever
sepsi
ss
septic
shock
ssh
method
casecontrol
studi
admit
intens
care
unit
month
criteria
ss
ssh
accord
surviv
sepsi
campaign
control
enrol
coronari
unit
biomark
measur
within
first
h
admiss
accuraci
diagnosi
determin
use
receiv
oper
characterist
roc
logist
regress
perform
assess
combin
studi
biomark
could
improv
diagnost
valu
one
separ
result
analyz
control
patient
male
mean
age
year
interquartil
rang
iqr
apach
ii
sofa
control
men
mean
age
year
iqr
main
sourc
infect
respiratori
tract
intraabdomen
auc
cutoff
valu
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
biomark
use
studi
shown
tabl
comparison
auc
significantli
differ
p
case
except
pct
versu
pct
psp
p
howev
logist
regress
show
combin
pct
psp
improv
diagnost
valu
one
separ
conclus
pct
psp
level
measur
admiss
show
high
diagnosi
efficaci
predict
ss
ssh
use
marker
simultan
increas
diagnost
accuraci
septic
patient
improv
classif
patient
introduct
sepsi
known
associ
impair
platelet
function
siemen
healthcar
dade
intern
miami
fla
usa
devic
citrat
whole
blood
sampl
aspir
apertur
coat
agonist
induc
platelet
activ
platelet
aggreg
lead
occlus
apertur
blood
flow
ceas
interv
term
closur
time
ct
aim
aim
present
studi
determin
whether
ct
measur
could
use
determin
likelihood
infect
sepsi
bacteraemia
hospit
mortal
method
singl
centr
prospect
observ
cohort
studi
subject
pyrexi
patient
mix
adult
icu
blood
sampl
drawn
cultur
full
blood
count
crp
pfa
analysi
admiss
diagnosi
demograph
data
laboratori
variabl
apach
ii
score
outcom
data
infect
sepsi
bacteraemia
mortal
collect
clinic
record
logist
regress
analysi
undertaken
use
stataic
statacorp
lakeway
drive
colleg
station
texa
usa
result
median
age
interquartil
rang
iqr
patient
male
median
apach
ii
score
iqr
recruit
patient
infect
process
met
sir
criteria
sepsi
patient
posit
blood
cultur
patient
surviv
hospit
discharg
logist
regress
analysi
adjust
age
gender
baselin
apach
ii
score
found
ct
predict
outcom
odd
ratio
confid
interv
ci
p
infect
ci
p
sepsi
ci
p
bacteraemia
ci
p
mortal
respect
conclus
platelet
aggreg
measur
closur
time
utilis
system
correl
infect
sepsi
bacteraemia
mortal
sampl
febril
patient
refer
katz
jn
kolappa
kp
becker
rc
beyond
thrombosi
versatil
platelet
critic
ill
chest
introduct
extracellular
histon
cytotox
compound
capabl
mediat
death
murin
sepsi
furthermor
circul
nucleosom
level
predict
mortal
human
inflamm
sepsi
whether
extracellular
histon
correl
plasma
paramet
andor
icu
score
system
complet
establish
level
circul
extracellular
histon
use
predict
marker
clinic
outcom
sepsi
method
histon
plasma
level
sepsi
patient
admit
intens
care
unit
measur
determin
correl
level
diseas
sever
organ
failur
mortal
coagul
tissu
homeostasi
paramet
includ
ldh
level
thrombin
potenti
etp
prothrombin
level
antithrombin
level
platelet
count
result
sepsi
patient
icu
found
median
level
significantli
increas
nonsurvivor
compar
survivor
level
found
gml
versu
respect
p
level
posit
correl
lactat
dehydrogenas
ldh
activ
spearman
rho
p
neg
correl
antithrombin
level
rho
p
platelet
count
rho
p
conclus
conclud
circul
level
correl
mortal
sepsi
patient
invers
correl
antithrombin
level
platelet
count
introduct
sepsi
system
inflammatori
respons
syndrom
sir
evid
infect
numer
inflammatori
marker
studi
assess
sever
sepsi
howev
current
biomark
insuffici
accur
determin
stage
prognosi
studi
aim
assess
cytokin
determin
stage
sever
sepsi
comparison
made
creactiv
protein
crp
procalcitonin
pct
eselectin
tumour
necrosi
method
studi
full
ethic
approv
south
west
wale
research
ethic
committe
patient
diagnosi
sepsi
recruit
emerg
depart
intens
care
unit
larg
teach
hospit
south
wale
blood
sampl
taken
determin
crp
pct
eselectin
result
patient
includ
studi
sepsi
sever
sepsi
septic
shock
pct
concentr
significantli
increas
subject
septic
shock
compar
sepsi
tabl
p
kruskalw
test
concentr
significantli
increas
septic
shock
compar
sepsi
sever
sepsi
group
tabl
p
p
respect
kruskalw
test
use
roc
analysi
found
signific
predictor
mortal
auc
p
conclus
pct
significantli
distinguish
septic
shock
sepsi
sever
sepsi
shown
promis
inflammatori
marker
assess
sever
prognost
patient
across
sepsi
spectrum
refer
pierrako
c
vincent
jl
crit
care
introduct
adrenomedullin
adm
peptid
amino
acid
strong
vasodil
activ
elev
plasma
adm
level
detect
wide
varieti
physiolog
patholog
condit
highest
elev
observ
septic
shock
marino
et
al
demonstr
strong
associ
admiss
adm
level
sever
sepsi
support
earlier
report
describ
elev
adm
level
sever
sepsi
septic
shock
use
novel
assay
specif
bioactiv
adm
bioadm
marino
et
alth
aim
studi
assess
relat
adm
measur
admiss
inicu
mortal
consecut
patient
regardless
caus
admiss
method
french
european
outcom
registri
intens
care
unit
frogicu
studi
multicent
observ
studi
includ
consecut
patient
follow
one
year
surviv
icu
stay
protocol
previous
describ
plasma
collect
admiss
patient
discharg
inicu
survivor
adm
measur
plasma
use
sandwich
assay
specif
bioadm
associ
inicu
mortal
level
adm
assess
univari
analysi
adjust
analysi
sever
admiss
measur
sapsii
improv
area
roc
curv
reclassif
indic
assess
result
patient
includ
male
median
age
median
charlson
score
median
sapsii
septic
shock
present
patient
median
interquartil
rang
adm
inicu
survivor
nonsurvivor
pgml
pgml
respect
p
hazard
ratio
inicu
death
patient
level
adm
higher
median
valu
ci
ci
adjust
sapsii
area
roc
curv
sapsii
significantli
improv
addit
adm
p
conclus
present
studi
adm
independ
associ
inicu
mortal
improv
prognost
predict
clinic
therapeut
implic
find
need
investig
refer
r
marino
et
al
critic
care
mebazaa
et
al
bmc
anesthesiolog
introduct
prognost
biomark
sepsi
describ
irrespect
patient
sever
object
describ
abil
heparinbind
protein
hbp
predict
develop
septic
shock
rel
piro
score
method
design
secondari
analysi
multicent
observ
studi
inclus
adult
year
acut
infect
hospit
admiss
two
measur
hbp
exclus
hypotens
within
first
hour
initi
piro
score
calcul
arriv
outcom
develop
delay
hypotens
dshock
sbp
initi
assess
analysi
subject
group
accord
piro
score
rang
use
previous
defin
cutoff
outcom
group
summar
averag
valu
chang
hbp
describ
across
group
result
subject
identifi
origin
meet
studi
criteria
frequenc
diseas
sever
piro
piro
piro
progress
increas
frequenc
dshock
increas
sever
hbp
significantli
elev
dshock
subject
across
subgroup
v
v
v
p
chang
hbp
signific
highsever
subgroup
fig
conclus
increas
predict
perform
hbp
associ
worsen
sepsi
sever
assess
serial
hbp
provid
addit
benefit
highsever
subgroup
introduct
repres
key
receptor
lipopolysaccharid
lipopolysaccharid
bind
protein
complex
activ
cascad
aim
investig
potenti
prognost
role
new
marker
cohort
patient
sever
sepsi
septic
shock
method
prospect
includ
patient
admit
icu
suspect
diagnosi
sepsi
patient
met
inclus
criteria
includ
final
analysi
procalcitonin
pct
creactiv
protein
crp
record
admiss
icu
day
icu
day
organ
dysfunct
sepsi
sever
score
sofa
score
apach
ii
score
vital
paramet
manag
record
icu
stay
result
admiss
associ
cardiovascular
dysfunct
decreas
mean
arteri
pressur
correl
coeffici
p
increas
vasopressor
support
correl
coeffici
p
patient
increas
sever
hepatocytolysi
demonstr
increas
level
alt
p
ast
level
p
icu
length
stay
correl
level
admiss
p
icu
day
p
patient
level
admiss
lowest
mortal
rate
patient
presepsin
level
highest
mortal
statist
signific
differ
observ
surviv
nonsurviv
admiss
p
icu
day
p
icu
day
p
conclus
although
associ
cardiovascular
hepat
dysfunct
exact
dynam
still
unknown
observ
good
correl
presepsin
level
time
admiss
icu
surviv
demonstr
good
prognost
role
new
inflammatori
marker
introduct
differenti
patient
infect
intens
care
unit
icu
difficult
present
diagnost
test
remain
inadequ
found
potenti
use
marker
identifi
infect
patient
unfortun
measur
standard
flow
cytomet
laboratori
take
hour
perform
purpos
studi
evalu
accellix
instrument
provid
infect
assess
minut
icu
patient
method
infect
icui
noninfect
icu
patient
icu
controlicuc
normal
volunt
c
level
measur
accellix
instrument
measur
calcul
index
ie
ratio
median
fluoresc
pmn
popul
median
fluoresc
control
bead
popul
infect
assess
categor
per
cdc
isf
criteria
definit
probabl
possibl
infect
result
subject
studi
icu
index
level
higher
mean
sem
icu
definit
probabl
infect
patient
icu
infect
normal
control
patient
definit
infect
probabl
infect
possibl
infect
infect
healthi
result
seen
fig
conclus
index
level
higher
infect
noninfect
icu
patient
accellix
promis
instrument
differenti
infect
noninfect
icu
patient
time
manner
introduct
current
biomark
sepsi
diagnosi
neither
suffici
specif
sensit
moreov
comprehens
diagnosi
today
delay
long
timetoresult
requir
quantit
measur
blood
protein
central
laboratori
therefor
need
combin
rapid
nearpati
diagnost
platform
accur
measur
protein
complex
matric
key
improv
sepsi
patient
outcom
develop
nanofluid
biosensor
acceler
molecular
interact
therebi
reduc
incub
time
hour
minut
biosensor
analyz
abioscop
miniatur
autom
fluoresc
microscop
fluoresc
antibodi
specif
test
protein
mix
l
blood
collect
patient
fingertip
complex
detect
antibodi
analyt
captur
sens
area
biosensor
upon
excit
emit
signal
proport
concentr
analyt
proofofconcept
prepar
biosensor
quantif
pancreat
stone
protein
pspreg
promis
biomark
show
superior
abil
predict
outcom
patient
affect
sepsi
sever
clinic
studi
method
pspreg
biosensor
analyz
abioscop
determin
analyt
perform
test
pspreg
level
measur
panel
serum
sampl
patient
underw
surgeri
measur
abioscop
compar
concentr
measur
microtit
plate
elisa
result
high
analyt
specif
show
competit
inhibit
studi
analyt
sensit
test
inferior
mean
pspreg
valu
cohort
healthi
individu
test
linear
ngml
pspreg
therebi
meet
clinic
requir
smallsiz
comparison
studi
good
agreement
observ
pspreg
valu
measur
microtit
elisa
abioscop
conclus
analyt
perform
pspreg
test
nanofluid
biosensor
highlight
rapid
accur
quantit
measur
low
abund
protein
achiev
qualiti
cost
data
howev
need
better
evalu
diagnost
perform
pspreg
variou
set
quantif
pspreg
minut
abioscop
togeth
evalu
specif
clinic
sign
perform
bedsid
hope
improv
decisionmak
process
patient
suspect
sepsi
improv
patient
manag
variou
clinic
scenario
refer
busani
et
al
critic
care
introduct
sepsi
remain
major
caus
mortal
intens
care
unit
incid
increas
along
antibiot
resist
caus
microorgan
manag
sepsi
technic
demand
costli
therapeut
option
avail
prompt
diagnosi
henc
earli
treatment
major
impact
patient
surviv
advent
nanotechnolog
brought
astonish
number
novel
tool
enabl
novel
technolog
solut
method
discuss
nanotechnologyen
approach
could
contribut
prevent
diagnosi
treatment
bacteri
infect
result
present
nanoparticlebas
approach
ultrasensit
detect
analyt
bodi
fluid
rapid
remov
pathogen
whole
blood
use
magnet
nanoparticl
addit
potenti
hurdl
encount
translat
nanomaterialbas
approach
clinic
set
illustr
conclus
present
critic
discuss
opportun
challeng
particleen
approach
diagnosi
treatment
bacteri
infect
refer
herrmann
ik
critic
care
herrmann
ik
nanoscal
introduct
despit
therapi
improv
septic
shock
mortal
still
around
better
understand
immunosuppress
mechan
led
new
therapeut
perspect
recombin
howev
remain
better
identifi
patient
elig
immunotherapi
solubl
form
receptor
seem
promis
candid
biomark
purpos
sinc
associ
plasmat
concentr
mortal
report
data
transcript
regul
gene
express
septic
shock
aim
studi
describ
patholog
express
sever
mrna
splice
variant
assess
associ
mortal
method
retrospect
studi
involv
icu
patient
septic
shock
whole
blood
sampl
collect
first
third
day
septic
shock
diagnosi
express
level
variant
measur
use
appropri
rtqpcr
design
one
specif
variant
encod
membran
form
one
specif
variant
correspond
potenti
solubl
form
one
cover
known
splice
variant
includ
mention
previous
express
level
variant
describ
accord
time
compar
healthi
volunt
associ
candid
biomark
day
statu
assess
logist
regress
analys
roc
curv
perform
order
evalu
perform
result
notic
decreas
express
level
splice
variant
patient
compar
control
associ
mortal
decreas
express
found
measur
ratio
express
associ
observ
whatev
transcript
variant
use
particular
membran
form
potenti
solubl
form
p
p
respect
roc
auc
model
conclus
work
put
highlight
mark
decreas
express
level
splice
variant
studi
septic
shock
persist
lower
express
associ
higher
mortal
quantif
express
could
provid
interest
biomark
identifi
serious
ill
patient
could
benefit
new
immunotherapi
refer
hotchkiss
r
et
al
lancet
infect
di
demaret
j
et
al
intens
care
med
introduct
previous
found
blood
septic
patient
high
level
three
phenylcarboxyl
acid
phca
phenyllact
pla
phydroxyphenyllact
phpla
phydroxyphenylacet
phpaa
metabolit
aromat
acid
predomin
microbi
origin
human
bodi
experiment
demonstr
phca
affect
function
mitochondria
shown
prognost
valu
phca
icu
admiss
studi
investig
differ
icu
relationship
disbal
phca
sever
mortal
method
blood
sampl
n
collect
two
medic
center
patient
day
admiss
icu
patient
mix
icu
micu
n
apach
ii
document
infect
variou
local
averag
age
year
patient
surgic
icu
sicu
n
apach
ii
intestin
perfor
n
intestin
obstruct
n
emerg
surgeri
averag
age
year
serum
level
phca
measur
use
gaschromatographi
healthi
adult
donor
n
use
control
data
compar
utest
chisquar
test
pearson
correl
coeffici
ibm
spss
statist
result
note
phenylpropion
acid
ppa
disappear
critic
ill
patient
alway
present
healthi
level
pla
phpla
phpaa
significantli
higher
critic
ill
patient
icu
versu
donor
p
posit
correl
total
serum
level
phca
apach
ii
found
rmicu
rsicu
p
pla
phpla
significantli
higher
patient
arteri
hypotens
map
mm
mortal
icu
total
serum
level
die
n
higher
time
versu
surviv
n
p
area
prognost
roc
curv
apach
ii
scale
p
p
confirm
high
predict
valu
conclus
observ
disbal
aromat
acid
metabolit
critic
ill
patient
absenc
serum
ppa
high
level
pla
phpla
phpaa
associ
sever
mortal
advis
intensifi
studi
molecular
mechan
particip
phca
critic
state
support
russian
scienc
foundat
grant
refer
beloborodova
nv
et
al
biochem
mosc
fedotcheva
ni
et
al
toxicol
lett
beloborodova
nv
et
al
shock
supp
beloborodova
nv
etal
biochem
mosc
introduct
evalu
associ
copeptin
level
year
mortal
otherwis
healthi
patient
visit
gener
practition
gp
respiratori
infect
includ
previou
trial
copeptin
ctermin
part
arginin
vasopressin
precursor
peptid
secret
respons
stress
correl
advers
clinic
outcom
acutecar
hospit
set
comprehens
data
regard
prognost
valu
commun
method
secondari
analysi
includ
data
patient
includ
parti
trial
copeptin
measur
batchanalysi
admiss
day
calcul
cox
regress
model
area
receiv
oper
characterist
curv
auc
assess
associ
copeptin
mortal
mortal
data
collect
phone
interview
year
trial
inclus
result
median
followup
interquartil
rang
iqr
year
mortal
median
admiss
copeptin
level
significantli
elev
nonsurvivor
compar
survivor
pmoll
iqr
vs
pmoll
iqr
p
admiss
copeptin
level
associ
allcaus
mortal
ageadjust
hazard
ratio
ci
p
auc
result
similar
discharg
copeptin
level
admiss
day
copeptin
level
also
strong
predictor
advers
outcom
defin
death
pulmonari
embol
major
advers
cardiac
cerebrovascular
event
conclus
sampl
otherwis
healthi
patient
visit
gp
respiratori
infect
copeptin
level
strongli
associ
allcaus
mortal
conjunct
tradit
risk
factor
marker
may
help
better
direct
prevent
measur
popul
refer
briel
et
al
procalcitoninguid
antibiot
use
vs
standard
approach
acut
respiratori
tract
infect
primari
care
arch
intern
med
p
discuss
nickel
ch
r
bingiss
ng
morgenthal
role
copeptin
diagnost
prognost
biomark
risk
stratif
emerg
depart
bmc
med
p
iversen
k
et
al
risk
stratif
emerg
patient
copeptin
bmc
med
p
introduct
sepsi
system
inflammatori
respons
caus
infect
lead
caus
death
across
globe
sever
infect
increas
untreat
lead
lethal
condit
sever
sepsi
septic
shock
sever
sourc
infect
develop
sepsi
howev
half
case
start
lung
known
pneumonia
basi
infect
site
pneumonia
categoris
commun
acquir
pneumonia
cap
hospit
acquir
pneumonia
hap
understand
respons
bodi
cap
hap
compar
plasma
proteom
sepsi
patient
method
present
studi
use
quantit
proteom
approach
itraq
identifi
differenti
express
surviv
nonsurviv
septic
patient
secondari
cap
hap
brief
plasma
sampl
deplet
high
abund
protein
trypsin
digest
label
itraq
system
tryptic
peptid
separ
scx
chromatographi
analys
lcm
collect
data
process
submit
mascot
search
engin
select
swissprot
databas
fdr
result
mascot
analys
isobar
q
result
proteom
profil
unabl
us
indentifi
total
differenti
express
protein
cap
hap
surviv
patient
protein
identifi
cap
hap
non
surviv
patient
total
protein
common
surviv
patient
wherea
protein
specif
cap
hap
respect
total
protein
common
non
surviv
patient
wherea
protein
specif
cap
hap
respect
comparison
protein
across
group
protein
common
protein
specif
cap
hap
surviv
protein
uniqu
cap
hap
non
surviv
group
protein
key
molecul
variou
biolog
function
includ
inflammatori
respons
well
signal
cascad
like
acut
phase
respons
etc
analysi
valid
progress
conclus
studi
provid
first
molecular
level
evid
differenti
respons
septic
patient
secondari
cap
hap
result
show
higher
number
uniqu
protein
correspond
group
underli
diseas
previou
therapeut
intervent
differ
etiolog
may
underscor
differ
observ
protein
level
introduct
sepsi
induc
immunosuppress
import
risk
factor
unfavour
outcom
sever
sepsi
monocyt
hladr
express
mhladr
suggest
use
biomark
immunosuppress
prospect
studi
bacterem
sepsi
aim
assess
predict
valu
mhladr
secondari
sepsi
compar
mhladr
level
dynam
patient
differ
bacterem
aetiolog
sepsi
method
septic
patient
posit
blood
cultur
n
day
admiss
includ
sampl
addit
preform
day
mhladr
analys
flow
cytometri
use
standard
protocol
data
event
secondari
bacteraem
sepsi
collect
retrospect
result
secondari
sepsi
occur
case
mhladr
level
day
significantli
lower
case
develop
secondari
sepsi
median
vs
abc
p
auc
neg
predict
valu
npv
posit
predict
valu
ppv
three
preval
pathogen
demonstr
differ
linear
associ
time
shown
fig
mean
mhladr
increas
significantli
day
spneumonia
modest
increas
seen
saureu
conclus
clinic
set
cutoff
valu
abc
day
associ
high
npv
secondari
sepsi
mhladr
level
lower
patient
acquir
secondari
sepsi
aetiolog
sepsi
associ
differ
mhladr
dynam
lowest
initi
valu
greatest
recoveri
demonstr
spneumonia
refer
wd
et
al
clin
chem
introduct
upregul
express
neg
costimulatori
molecul
tcell
one
mechan
behind
immunoparalysi
sepsi
want
evalu
prognost
capac
solubl
isoform
neg
costimulatori
receptor
solubl
b
tlymphocyt
attenu
sbtla
sever
sepsi
septic
shock
method
prospect
observ
studi
conduct
mix
intens
care
unit
karolinska
univers
hospit
hudding
sweden
patient
sever
sepsi
septic
shock
sepsi
cohort
patient
noninfecti
critic
ill
icu
control
includ
blood
donor
serv
healthi
control
blood
sampl
taken
enrol
hour
includ
analysi
plasma
concentr
sbtla
measur
enzymelink
immunosorb
assay
elisa
patient
follow
inclus
day
day
death
prognost
capac
sbtla
evalu
categor
scale
patient
divid
three
categori
number
subject
base
concentr
sbtla
cox
regress
adjust
age
comparison
plasma
concentr
survivor
nonsurvivor
made
mannwhitney
u
test
result
sbtla
level
statist
significantli
increas
sepsi
cohort
compar
icu
control
blood
donor
overal
day
mortal
sbtla
level
statist
significantli
higher
time
studi
inclus
hour
day
sepsi
nonsurvivor
survivor
chang
time
day
mortal
higher
patient
baselin
plasma
sbtla
ngml
compar
level
lower
ngml
hr
ci
p
increas
risk
death
patient
intermedi
ngml
compar
low
baselin
sbtla
hr
ci
p
conclus
plasma
concentr
solubl
btla
increas
sever
sepsissept
shock
compar
patient
noninfecti
critic
ill
healthi
control
chang
significantli
first
hour
studi
inclus
baselin
sbtla
concentr
ngml
neg
prognost
indic
introduct
well
recognis
coagul
alter
across
sepsi
spectrum
sepsi
sever
sepsi
septic
shock
rang
increas
thrombot
risk
dissemin
intravascular
coagul
dic
contribut
increas
morbid
mortal
previou
studi
attempt
investig
chang
coagul
use
standard
global
marker
coagul
howev
clot
microstructur
investig
recent
research
led
develop
new
biomark
clot
microstructur
df
quantifi
fibrin
network
incipi
clot
studi
aim
investig
role
clot
microstructur
sepsi
use
new
quantit
biomark
clot
microstructur
df
method
studi
full
ethic
approv
south
west
wale
research
ethic
committe
patient
diagnosi
sepsi
recruit
emerg
depart
ed
intens
care
unit
icu
larg
teach
hospit
south
wale
blood
sampl
taken
determin
df
full
blood
count
standard
coagul
screen
healthi
control
group
match
age
gender
also
recruit
result
patient
includ
studi
sepsi
sever
sepsi
septic
shock
healthi
volunt
recruit
match
control
mean
df
healthi
control
group
mean
df
patient
sepsi
sever
sepsi
significantli
higher
respect
p
oneway
anova
posthoc
bonferroni
correct
mean
df
patient
septic
shock
significantli
lower
compar
group
p
oneway
anova
posthoc
bonferroni
correct
df
also
significantli
lower
nonsurvivor
survivor
day
vs
p
student
ttest
conclus
result
indic
patient
sepsi
sever
sepsi
form
tight
highli
branch
fibrin
clot
indic
high
df
diseas
progress
septic
shock
much
weaker
clot
form
indic
low
df
may
help
explain
dichotomi
thrombogen
bleed
diathesi
patient
across
sepsi
spectrum
new
function
biomark
fractal
dimens
df
therefor
use
quantifi
clot
microstructur
across
sepsi
spectrum
also
use
outcom
measur
although
studi
power
outcom
refer
collin
p
et
al
bjh
evan
pa
et
al
blood
introduct
rotem
viscoelast
test
coagul
investig
tool
evalu
haemostasi
sepsi
shown
hypocoagul
viscoelast
profil
associ
poor
outcom
patient
sever
sepsi
rotem
measur
sever
paramet
provid
inform
kinet
structur
develop
clot
clot
microstructur
df
hand
evalu
singl
paramet
quantifi
microstructur
properti
clot
aim
studi
compar
new
biomark
df
rotem
patient
across
sepsi
spectrum
sepsi
sever
sepsi
septic
shock
method
studi
full
ethic
approv
south
west
wale
research
ethic
committe
patient
diagnosi
sepsi
sir
infect
recruit
emerg
depart
intens
care
unit
larg
teach
hospit
south
wale
blood
sampl
taken
determin
df
rotem
result
patient
includ
studi
sepsi
sever
sepsi
septic
shock
healthi
volunt
recruit
match
control
df
correl
significantli
structur
kinet
rotem
paramet
p
howev
correl
weak
pearson
correl
strongest
correl
observ
df
intem
clot
format
time
cft
moder
correl
coeffici
df
also
correl
significantli
rotem
lysi
paramet
correl
also
weak
conclus
df
rotem
appear
provid
independ
inform
coagul
system
across
sepsi
spectrum
could
due
differ
activ
coagul
pathway
wherea
whole
unadulter
blood
use
determin
df
immedi
activ
contact
collect
sampl
rotem
utilis
blood
deactiv
sodium
citrat
reactiv
tissu
factor
contact
activ
studi
conclud
rotem
provid
inform
clot
microstructur
refer
muller
mc
et
al
crit
care
ostrowski
sr
et
al
j
crit
care
introduct
well
recognis
coagul
alter
across
sepsi
spectrum
sepsi
sever
sepsi
septic
shock
sepsi
recognis
prothrombot
state
due
increas
procoagul
activ
impair
natur
anticoagul
fibrinolyt
protein
alter
fibrinolysi
could
key
role
accumul
microthrombi
lead
dissemin
intravascular
coagul
dic
aim
studi
assess
chang
fibrinolysi
across
sepsi
spectrum
use
rotat
thromboelastometri
rotem
lysi
index
ddimer
concentr
method
studi
full
ethic
approv
south
west
wale
research
ethic
committe
patient
diagnosi
sepsi
recruit
emerg
depart
intens
care
unit
larg
teach
hospit
south
wale
blood
sampl
taken
determin
rotem
ddimer
concentr
patient
follow
day
assess
mortal
result
patient
includ
studi
sepsi
sever
sepsi
septic
shock
healthi
volunt
recruit
match
control
ddimer
concentr
ngml
sepsi
ngml
sever
sepsi
ngml
septic
shock
normal
rang
ngml
median
extem
healthi
volunt
rotem
indic
fibrinolyt
function
compar
healthi
volunt
sepsi
sever
sepsi
group
respect
fibrinolyt
function
significantli
impair
septic
shock
compar
group
p
kruskalw
test
bonferroni
correct
impair
fibrinolyt
function
also
significantli
associ
mortal
intem
survivor
vs
nonsurvivor
p
mannwhitney
u
test
conclus
fibrinolyt
activ
increas
patient
septic
shock
howev
impair
fibrinolyt
function
measur
rotem
exact
mechan
lead
fulli
understood
howev
consumpt
fibrinolyt
factor
could
contribut
evidenc
elev
ddimer
concentr
rotem
lysi
index
potenti
use
biomark
identifi
septic
shock
outcom
measur
although
studi
power
outcom
refer
schouten
et
al
j
leukoc
biol
introduct
predict
infect
sever
remain
difficult
critic
ill
patient
suspect
novel
simpl
biomark
deriv
five
bloodcel
deriv
paramet
character
innat
immun
respons
routin
blood
sampl
intens
care
infect
score
ici
could
help
respect
therefor
compar
predict
valu
ici
white
blood
cell
count
wbc
creactiv
protein
crp
procalcitonin
pct
infect
sever
critic
ill
patient
method
perform
multicent
cluster
random
crossov
studi
critic
ill
patient
januari
septemb
patient
suspect
infect
blood
cultur
taken
attend
intensivist
includ
blood
taken
time
wbc
ici
crp
pct
measur
studi
period
patient
divid
group
increas
likelihood
infect
invas
group
without
infect
possibl
infect
irrespect
cultur
group
probabl
microbiolog
proven
local
infect
without
blood
stream
infect
bsi
group
bsi
irrespect
local
infect
result
total
patient
enrol
suspect
infect
episod
sie
h
interv
analyz
crp
pct
ici
higher
group
auroc
predict
infect
first
sie
crp
pct
ici
p
septic
shock
auroc
crp
pct
ici
conclus
data
suggest
ici
use
predict
infect
sever
critic
ill
patient
contrast
crp
pct
ici
determin
routin
without
extra
blood
sampl
cost
yield
result
within
minut
refer
vincent
jl
beumier
diagnost
prognost
marker
sepsi
expert
rev
anti
ther
nierhau
linssen
j
wichmann
et
al
use
weight
autom
analysi
differenti
blood
count
differenti
sepsi
noninfecti
system
inflamm
intens
care
infect
score
ici
inflamm
allergi
drug
target
weimann
k
zimmermann
spi
cd
et
al
intens
care
infect
score
new
approach
distinguish
infecti
noninfecti
process
intens
care
medicosurg
patient
j
int
med
re
introduct
distinguish
sepsi
infectionneg
system
inflamm
sir
admiss
base
clinic
criteria
pose
diagnost
dilemma
lead
delay
therapi
overli
aggress
treatment
studi
quantifi
concord
clinic
impress
sepsi
method
prospect
observ
studi
conduct
academ
medic
center
commun
hospit
utah
adult
admit
icu
fulfil
sir
criteria
attend
physician
studi
investig
classifi
patient
admiss
sepsi
sir
indetermin
refer
diagnosi
determin
independ
review
clinic
data
discharg
two
studi
physician
adjud
third
discord
classif
interphysician
admiss
classif
admiss
discharg
compar
result
enrol
subject
case
least
one
physician
classifi
patient
indetermin
major
disagr
classif
sir
sepsi
discharg
case
least
one
classif
indetermin
major
disagr
classif
sir
sepsi
compar
discharg
classif
fig
case
initi
class
sir
sepsi
attend
physician
remain
unchang
patient
initi
diagnos
sepsi
admiss
deem
correct
deem
sir
indetermin
compar
discharg
classif
subject
indetermin
admiss
remain
discharg
patient
initi
diagnos
sepsi
sir
becam
indetermin
discharg
one
patient
initi
class
sir
indetermin
ultim
discharg
diagnosi
sepsi
conclus
consider
uncertainti
exist
use
clinic
criteria
sepsi
icu
patient
accur
test
improv
earli
diagnost
accuraci
need
manag
critic
ill
patient
introduct
temperatur
measur
essenti
compon
decis
make
intens
care
context
identifi
treat
sepsi
also
accur
calibr
blood
ga
analysi
zero
heat
flux
cutan
thermomet
valid
noninvas
continu
accur
method
measur
temperatur
patient
undergo
cardiac
surgeri
oper
periop
compar
axilla
thermomet
current
method
noninvas
temperatur
monitor
establish
inaccur
current
practic
method
acut
patient
select
admiss
intens
care
lewisham
hospit
male
femal
medic
surgic
temperatur
record
averag
hour
patient
use
covidien
axilla
probe
forehead
probe
current
clinic
practic
indic
result
total
compar
valu
record
rang
averag
thermomet
record
temperatur
axilla
ci
wilcoxon
matchedpair
sign
rank
test
p
averag
differ
axilla
normal
rang
ci
p
averag
differ
axilla
hypotherm
temperatur
ci
p
averag
differ
axilla
hypertherm
temperatur
ci
p
occas
thermomet
identifi
sir
defin
temperatur
axilla
temperatur
affect
patient
conclus
zero
heat
flux
cutan
thermomet
separ
shown
accur
record
core
temperatur
highlight
axilla
probe
inaccur
comparison
axilla
probe
appear
underread
hypertherm
temperatur
overread
hypotherm
temperatur
differ
two
method
appear
mark
hypertherm
temperatur
consequ
like
axilla
probe
could
fail
identifi
sepsi
patient
intens
care
refer
eshraghi
et
al
anesth
analg
xxx
introduct
aq
base
north
west
england
popul
programm
aim
improv
sepsi
care
clinic
code
within
region
first
month
care
patient
infect
examin
method
panel
clinic
expert
develop
sepsi
measur
set
aid
bmj
evid
identifi
studi
popul
use
sepsi
code
patient
sepsi
code
discharg
initi
care
examin
seri
evidencebas
intervent
appropri
care
score
ac
measur
complianc
sepsi
care
measur
set
project
promot
ongo
seri
collabor
event
perform
publish
best
practic
share
healthi
sens
competit
drive
improv
perform
commission
abl
monitor
perform
local
result
figur
show
increas
code
aq
particip
trust
region
vs
non
aq
particip
trust
figur
show
start
programm
septic
patient
receiv
antibiot
within
hour
last
month
septic
patient
acss
increas
compar
first
month
last
month
programm
downward
trend
mortal
patient
achiev
measur
within
measur
set
conclus
use
measur
set
collabor
nw
region
england
appear
improv
earli
recognit
treatment
patient
sepsi
result
demonstr
improv
outcom
measur
whilst
recognis
improv
code
record
sepsi
may
chang
studi
popul
introduct
sepsi
system
potenti
fatal
host
respons
infect
speed
appropri
therapi
administ
initi
hour
like
influenc
outcom
patient
sepsi
alway
easili
recogn
prehospit
septic
patient
thu
may
transport
hospit
either
accord
ambul
physician
assist
mobil
emerg
care
unit
mecu
want
address
degre
type
transport
prehospit
scene
hospit
relat
sever
sepsi
day
mortal
method
includ
adult
patient
year
present
emerg
depart
septemb
firsttim
admiss
communityacquir
sepsi
sever
case
type
transport
hospit
identifi
manual
chart
review
use
predefin
criteria
result
includ
patient
median
age
year
iqr
men
patient
admit
sepsi
patient
sever
sepsi
patient
septic
shock
among
patient
sepsi
ci
transport
ci
transport
ambul
ci
physicianassist
ambul
mecu
mortal
among
patient
sever
sepsi
ci
transport
ci
transport
ambul
ci
mecu
mortal
among
patient
septic
shock
transport
ci
ci
transport
ambul
ci
mecu
mortal
conclus
substanti
proport
patient
sepsi
arriv
hospit
proport
patient
ambul
mecu
transport
increas
diseas
sever
probabl
reflect
difficulti
diagnos
earli
sepsi
introduct
fever
sign
commonli
associ
syndrom
intens
care
hyperthermia
initi
action
organum
vasculosum
lamina
terminali
prostaglandin
releas
ortogel
gel
contain
plant
extract
capsicum
arnica
montana
symphytum
officinal
juglan
regia
tannu
communi
sambucu
armoracia
rusticana
lavandula
angustifolia
antiinflammatori
analges
antipyret
effect
produc
cutan
vasodil
purpos
studi
assess
antipyret
effect
ortogel
compar
acetaminophen
administr
intens
care
patient
method
random
control
trial
conduct
intens
care
unit
clinic
emerg
hospit
bucharest
januari
june
includ
total
patient
divid
two
equal
group
suffer
fever
infecti
caus
cutan
temperatur
degre
celsiu
measur
use
nihon
kohden
bsm
monitor
control
room
temperatur
hemodynam
unstabl
patient
exclud
studi
group
receiv
ml
gel
ortogel
cutan
administr
control
group
receiv
g
iv
acetaminophen
primari
outcom
differ
cutan
temperatur
h
baselin
read
result
initi
averag
temperatur
ortogel
group
degre
celsiu
similar
valu
control
group
ortogel
abl
significantli
decreas
hyperthermia
tmax
p
similar
paracetamol
effect
tmax
p
gel
show
signific
suppress
cutan
temperatur
p
percentag
inhibit
fever
antipyret
effect
start
min
administr
p
reduct
rectal
temperatur
maintain
h
p
conclus
present
studi
show
similar
antipyret
effect
ortogel
compar
intraven
acetaminophen
antipyret
effect
instal
similar
time
frame
two
group
ortogel
may
repres
altern
treatment
provid
patient
acetaminophen
contraind
introduct
hypothermia
associ
advers
outcom
patient
sepsi
knowledg
pathophysiolog
highli
limit
object
studi
establish
whether
hypothermia
associ
differ
system
host
respons
sepsi
reflect
cytokin
profil
endotheli
activ
marker
cellular
respons
toward
lipopolysaccharid
lp
first
day
intens
care
unit
icu
admiss
method
prospect
observ
studi
patient
sepsi
icu
tertiari
hospit
netherland
hypothermia
defin
lowest
bodi
temperatur
measur
first
hour
icu
admiss
exclus
criteria
immunodefici
activ
cool
readmiss
admiss
oper
theatr
icu
logist
regress
use
investig
independ
associ
hypothermia
mortal
plasma
level
endotheli
marker
cytokin
level
measur
upon
icu
admiss
day
thereaft
hypotherm
nonhypotherm
patient
sepsi
analys
perform
entir
cohort
well
cohort
match
diseas
sever
lp
ex
vivo
whole
blood
stimul
perform
day
admiss
subset
patient
result
hypothermia
identifi
patient
independ
associ
increas
mortal
multivari
analysi
baselin
patient
hypotherm
sepsi
significantli
older
lower
bodi
mass
index
increas
incid
cardiovascular
diseas
level
pro
antiinflammatori
cytokin
differ
group
time
point
hypothermia
also
associ
alter
respons
ex
vivo
stimul
lp
subset
patient
hypothermia
associ
sustain
elev
level
endotheli
activ
marker
fractalkin
first
day
icu
stay
compar
nonhypotherm
patient
entir
cohort
cohort
match
diseas
sever
conclus
hypotherm
sepsi
associ
increas
mortal
patient
hypothermia
show
increas
level
fractalkin
irrespect
diseas
sever
first
day
icu
stay
research
perform
within
framework
ctmm
center
translat
molecular
medicin
http
wwwctmmnl
project
mar
grant
introduct
clinic
inform
system
ci
protocolbas
alert
long
use
intens
care
unit
icu
serv
earli
recognit
intervent
sepsi
septic
shockw
aim
determin
whether
earli
respons
septic
shock
alert
impact
true
diagnosi
patient
outcom
septic
shock
method
patient
admit
review
ci
metavis
imdsoft
bakirkoy
drsadi
konukan
earli
warn
protocol
system
relev
intern
guidelinessept
shock
alert
activ
condit
per
system
inflamatori
respons
syndrom
sir
criteria
togeth
sbp
mmhg
establishedpati
categor
base
interv
first
alert
activ
initi
respons
per
order
diagnost
intervent
group
assign
earli
acknowledg
respons
within
minut
alert
group
ii
respons
within
minut
group
iii
late
respons
minut
first
acknowledg
alert
sofa
apach
score
patient
outcom
analys
result
patient
reciev
alert
howev
diagnoz
sepsissept
shock
admiss
hand
later
cours
diseas
patient
confirm
sepsi
group
lowest
mortal
compar
other
tabl
conclus
ci
help
earli
recognit
intervent
critic
diseas
thu
impact
decreas
mortalityin
order
decreas
mortal
train
need
increas
complianc
alert
systemshowev
septic
shock
alert
protocol
sir
criteria
seem
lead
fals
posit
diagnosi
one
third
patientsthi
reveal
need
revis
sepsi
septic
shock
definit
introduct
preclin
clinic
studi
investig
role
blocker
sepsi
especi
earli
sepsi
character
elev
sympathet
respons
purpos
studi
examin
associ
previou
prescript
blocker
mortal
rate
among
septic
patient
method
conduct
retrospect
cohort
studi
januari
decemb
tertiari
care
academ
medic
center
includ
patient
admit
intens
care
unit
icu
sever
sepsi
septic
shock
year
age
patient
defin
previou
prescript
blocker
prescript
activ
month
prior
hospit
admiss
result
identifi
patient
sever
sepsi
septic
shock
previou
prescript
blocker
hospit
admiss
previous
take
blocker
common
medic
use
patient
metoprolol
carvedilol
overal
mortal
rate
among
patient
previous
take
blocker
die
icu
discharg
aliv
patient
previou
prescript
blocker
die
icu
discharg
aliv
statist
signific
associ
patient
previou
prescript
blocker
icu
mortal
risk
ratio
confid
interv
ci
p
stratifi
patient
basi
highest
heart
rate
first
hour
icu
admiss
heart
rate
beat
per
minut
heart
rate
beat
per
minut
statist
signific
associ
patient
previou
prescript
blocker
icu
mortal
either
group
risk
ratio
ci
p
risk
ratio
ci
p
respect
conclus
studi
demonstr
signific
associ
previou
prescript
blocker
icu
mortal
held
true
even
stratif
patient
basi
highest
heart
rate
first
hour
icu
admiss
result
may
due
lack
effect
blocker
shortterm
action
medic
use
introduct
uk
sepsi
trust
aim
rais
awar
sepsi
recommend
evid
base
treatment
bundl
sever
sepsi
known
sepsi
six
audit
complet
obstetr
unit
lewisham
greenwich
nh
trust
uk
want
assess
impact
teach
poster
improv
knowledg
method
gave
anonym
questionnair
matern
staff
assess
baselin
knowledg
test
respond
diagnost
criteria
system
inflammatori
respons
syndrom
sir
sepsi
sever
sepsi
knowledg
sepsi
six
treatment
bundl
sever
sepsi
intervent
consist
teach
provis
inform
poster
reaudit
perform
unit
week
later
result
initi
audit
matern
staff
reaudit
reaudit
report
staff
receiv
teach
seen
leaflet
poster
sir
initi
heard
sir
could
name
averag
criteria
knew
criteria
need
diagnosi
improv
respect
sepsi
could
correctli
defin
sepsi
could
defin
sever
sepsi
staff
abl
name
averag
sever
sepsi
criteria
knowledg
also
improv
respect
sepsi
manag
staff
knew
sepsi
six
step
manag
knew
requir
within
hour
slight
improv
manag
surpris
decreas
initi
treatment
conclus
matern
staff
initi
awar
sir
sepsi
simpl
intervent
requir
diagnos
treat
patient
howev
baselin
knowledg
detail
diagnosi
manag
poor
demonstr
simpl
intervent
teach
poster
readili
avail
leaflet
dramat
improv
knowledg
refer
uk
sepsi
trust
clinic
toolkit
http
sepsistrustorgclinicaltoolkit
access
daniel
r
et
al
sepsi
six
sever
sepsi
resuscit
bundl
prospect
observ
cohort
studi
emerg
medicin
journal
introduct
pauciti
data
concern
group
patient
clinic
syndrom
sepsi
suspect
clinic
infect
neg
cultur
regard
diseas
sever
end
organ
failur
outcom
also
clear
whether
patient
neg
blood
cultur
bc
posit
cultur
differ
diseas
entiti
patient
growth
cultur
taken
studi
attempt
defin
true
cultur
neg
effect
diseas
sever
outcom
method
blood
cultur
result
taken
detroit
medic
center
icu
decemb
march
collect
patient
neg
bc
review
cultur
taken
within
day
neg
bc
review
patient
divid
group
posit
group
bc
within
day
neg
bc
posit
non
bc
posit
group
cultur
within
day
neg
bc
posit
cultur
neg
group
compar
result
studi
period
patient
least
one
neg
blood
cultur
cultur
neg
posit
bc
posit
cultur
bc
posit
group
resembl
neg
group
baselin
characterist
signific
differ
admiss
score
higher
sofa
score
bc
posit
group
sofa
score
higher
posit
group
throughout
icu
stay
differ
sir
group
howev
shock
need
vasopressor
renal
failur
respiratori
failur
neurolog
alter
bc
posit
group
bc
posit
group
frequent
start
antibiot
antibiot
day
neg
group
also
wors
outcom
higher
mortal
icu
posit
vs
neg
p
hospit
vs
respect
p
multivari
analysi
icu
death
predictor
independ
predictor
posit
bc
group
diseas
sever
also
wors
nonblood
posit
cultur
group
compar
neg
group
score
higher
end
organ
dysfunct
antibiot
treatment
longer
outcom
wors
conclus
shown
cultur
neg
patient
lower
diseas
sever
end
organ
failur
better
outcom
therefor
consid
shorter
antimicrobi
treatment
earli
deescal
cultur
posit
indic
wors
prognosi
even
non
bc
introduct
administr
data
sever
sepsi
case
identifi
differ
icd
code
abstract
strategi
compar
strategi
substanti
variabl
incid
mortal
sever
sepsi
depend
code
use
understand
mechan
depend
precis
case
identif
aim
investig
code
organ
dysfunct
patient
sever
sepsi
hospit
germani
compar
administr
code
prospect
data
nation
cohort
studi
method
sever
sepsi
patient
identifi
nationwid
databas
hospit
discharg
data
drg
statist
use
code
sepsi
organ
dysfunct
explicit
code
strategi
ii
infect
organ
dysfunct
implicit
code
strategi
explicit
sepsi
code
includ
icdcod
infect
code
adapt
angu
et
al
crit
care
med
organ
dysfunct
identifi
organ
failur
code
septic
shock
defin
code
introduc
compar
organ
dysfunct
data
extract
german
icu
cohort
studi
result
identifi
sever
sepsi
patient
use
explicit
ii
sever
sepsi
patient
use
implicit
code
strategi
includ
patient
septic
shock
respect
patient
respiratori
failur
lead
organ
dysfunct
code
explicitli
vs
implicitli
identifi
case
renal
failur
identifi
often
use
explicit
code
strategi
vs
also
true
coagulopathi
vs
metabol
alter
vs
hypotens
code
explicit
implicit
case
compar
prospect
cohort
icu
patient
sever
sepsi
distribut
organ
dysfunct
similar
one
identifi
explicit
code
strategi
respiratori
failur
renal
failur
encephalopathi
coagulopathi
metabol
acidosi
septic
shock
conclus
pattern
organ
dysfunct
sever
sepsi
patient
differ
depend
code
strategi
use
hypotens
direct
code
septic
shock
code
similar
percentag
patient
much
fewer
case
compar
prospect
cohort
studi
icu
patient
qualiti
organ
dysfunct
code
substanti
influenc
accuraci
code
strategi
sever
sepsi
administr
data
therefor
requir
evalu
refer
engel
c
et
al
intens
care
med
introduct
improv
knowledg
sepsi
care
also
wellestablish
guidelin
howev
morbid
mortal
septic
patient
remain
unaccept
high
object
evalu
knowledg
resid
differ
depart
regard
surviv
sepsi
campaign
ssc
method
crosssect
descript
studi
via
question
questionnair
distribut
resid
songklnagarind
hospit
atertiari
referr
univers
teach
hospit
southern
thailand
intern
well
train
resid
depart
intern
medicin
surgeri
emerg
medicin
includ
studi
result
respons
rate
resid
resid
includ
intern
intern
medicin
resid
surgic
resid
emerg
resid
regard
definit
sepsi
sever
sepsi
septic
shock
resid
abl
differenti
sever
sepsi
intern
medicin
resid
significantli
higher
rate
correct
answer
nonmedicin
surgic
resid
vs
p
vs
p
resid
would
measur
blood
lactat
sepsi
patient
differ
overal
knowledg
lactat
measur
interpret
intern
medicin
resid
compar
resid
fluid
resuscit
resid
chose
normal
salin
solut
first
choic
howev
respect
dose
fluid
resuscit
resid
gave
recommend
fluid
bolu
mlkg
intern
medicin
resid
higher
percentag
correct
answer
surgic
resid
p
one
hundr
fifteen
resid
resid
use
appropri
target
mean
arteri
pressur
vasopressor
respect
resid
could
give
antimicrobi
agent
steroid
appropri
patient
sepsi
septic
shock
howev
half
resid
knew
target
rang
blood
sugar
control
sepsi
patient
intern
medicin
resid
better
knowledg
resid
conclus
resid
knowledg
ssc
satisfactori
teach
coupl
learn
process
sepsi
manag
provid
improv
knowledg
sure
decreas
morbid
mortal
sepsi
patient
introduct
format
surviv
sepsi
campaign
led
introduct
variou
sepsi
manag
bundl
evid
improv
outcom
icu
introduc
qualiti
improv
project
implement
septic
shock
bundl
encompass
earli
central
line
insert
dynam
fluid
bolus
mean
arteri
pressur
mmhg
measur
central
venou
oxygen
satur
blood
cultur
antibiot
aim
investig
introduct
bundl
associ
improv
patient
outcom
method
retrospect
search
wardwatchertm
databas
identifi
patient
admit
icu
septic
shock
group
introduct
qualiti
improv
bundl
group
patient
signific
underli
renal
vascular
diagnosi
exclud
acut
physiolog
chronic
health
evalu
ii
score
apach
ii
outcom
measur
includ
length
icu
stay
durat
cardiovascular
support
need
renal
replac
therapi
rrt
icu
surviv
note
result
total
patient
includ
patient
group
group
median
complianc
aspect
bundl
group
mortal
group
compar
group
p
median
apach
ii
score
similar
durat
cardiovascular
support
significantli
differ
two
group
length
icu
stay
median
interquartil
rang
longer
group
day
compar
p
howev
signific
lost
nonsurvivor
exclud
significantli
lower
requir
rrt
amongst
icu
survivor
group
compar
p
conclus
shown
signific
improv
rate
rrt
associ
implement
sepsi
resuscit
bundl
whilst
implement
care
bundl
associ
improv
patient
outcom
basi
relationship
remain
unclear
work
fail
demonstr
signific
reduct
mortal
howev
acknowledg
limit
small
sampl
size
median
bundl
complianc
higher
publish
work
howev
ongo
qualiti
improv
work
may
increas
identifi
longer
length
stay
group
may
repres
either
longer
period
treatment
decid
chang
focu
care
palliat
faster
declin
patient
within
group
refer
delling
et
al
crit
care
med
levi
et
al
intens
care
med
introduct
vasopressor
therapi
requir
sustain
life
maintain
perfus
face
lifethreaten
hypotens
occur
sever
sepsi
septic
shock
even
hypovolemia
yet
resolv
hypothes
dose
norepinephrin
administ
first
hour
correl
outcom
treatment
patient
sever
sepsi
septic
shock
method
analys
total
consecut
patient
septic
shock
sepsisinduc
hypotens
persist
despit
adequ
fluid
resuscit
eposs
databas
databas
evalu
predict
outcom
sever
sepsi
develop
monitor
assess
treatment
efficaci
patient
sever
sepsi
septic
shock
patient
admit
particip
intens
care
unit
twelv
hospit
seventeen
highvolum
care
unit
czech
republ
januari
novemb
patient
divid
two
group
survivor
n
nonsurvivor
n
result
group
survivor
vs
nonsurvivor
similar
age
vs
p
men
vs
p
apach
ii
score
vs
p
sofa
score
vs
p
administr
dose
mlkg
crystalloid
hypotens
lactat
mmoll
hour
applic
vasopressor
hour
perform
group
without
statist
signific
differ
statist
signific
differ
survivor
vs
nonsurvivor
found
paramet
dose
norepinephrin
first
hour
vs
p
p
conclus
found
dose
norepinephrin
affect
outcom
human
septic
shock
earli
administ
adequ
dose
vasopressor
import
predictor
surviv
similarli
suitabl
initi
fluid
resuscit
adequ
antimicrobi
therapi
refer
delling
rp
et
al
crit
care
med
feb
introduct
lowdos
vasopressin
vp
recent
emerg
promis
therapi
septic
shock
rational
use
rel
vp
defici
patient
septic
shock
vp
abil
restor
vascular
tone
blood
pressur
reduc
need
cathecolamin
howev
vp
outcom
effect
septic
patient
remain
unclear
method
retrospect
analyz
patient
admit
gener
icu
septic
shock
last
month
treat
norepinephrin
ne
associ
ne
vp
patient
treat
ne
adequ
fluid
expans
vp
ad
case
map
mmhg
ne
dosag
analyz
sever
score
plasma
lactat
icu
admiss
mortal
icu
urinari
output
first
hour
vasopressor
need
rrt
icu
stay
mannwhitney
chisquar
test
use
statist
analysi
result
patient
enrol
patient
receiv
ne
vp
nv
group
receiv
ne
ne
group
overal
mortal
rate
nv
ne
group
respect
p
need
rrt
greater
nv
ne
group
p
urinari
output
first
hour
vasopressor
lower
nv
group
mlkgh
p
nv
group
patient
sever
haemodynam
impair
also
wors
sever
score
sofa
p
wors
renal
function
akin
icu
admiss
higher
plasma
lactat
level
p
nv
group
greater
incid
thrombocytopenia
p
conclus
find
statist
signific
differ
nv
ne
group
icu
mortal
despit
nv
significantli
higher
predict
mortal
accord
sofa
renal
function
impair
significantli
differ
two
group
greater
incid
thrombocytopenia
p
observ
nv
group
line
studi
refer
delma
et
al
crit
care
april
vol
landri
et
al
gordon
et
al
bmj
open
novemb
russel
et
al
nejm
introduct
gener
vasodil
nonrespond
hypotens
present
half
death
case
due
septicaemia
methylen
blue
could
use
valuabl
complement
refractori
hypotens
treatment
aim
studi
determin
effect
methylen
blue
contributori
treatment
patient
septic
shock
method
control
random
doubl
blind
clinic
trial
perform
patient
divid
two
group
group
receiv
singl
dose
methylen
blue
calcul
mgkg
per
bodi
weight
dilut
cc
dextros
infus
min
c
group
control
receiv
cc
dextros
infus
min
basal
measur
studi
variabl
taken
mbp
lactat
base
deficit
central
venou
satur
delta
prior
blue
methylen
administr
everi
hour
afterward
mbp
mmhg
without
vasopressor
hour
pass
shock
began
data
total
noradrenalin
dose
mg
length
stay
mechan
ventil
length
mortal
record
result
mbp
increas
progress
first
hour
methylen
blue
infus
group
c
group
p
steadili
hour
follow
noradrenalin
dose
decreas
first
hour
group
c
group
p
lactat
clearanc
first
hour
group
contrast
c
group
clearanc
p
mortal
icu
discharg
group
c
group
p
without
variat
day
conclus
methylen
blue
effect
contributori
septic
shock
treatment
refer
edmund
kwok
daniel
h
use
methylen
blue
sepsi
systemat
review
journal
intens
care
medicin
alderton
w
cooper
c
knowl
g
nitric
oxid
synthas
structur
function
inhibit
biochem
j
introduct
coagul
disord
common
septic
patient
constitut
consider
diagnost
therapeut
challeng
icu
excess
activ
coagul
involv
consumpt
coagul
factor
platelet
may
even
lead
develop
dissemin
intravascular
coagul
dic
present
studi
investig
use
thromboelastometri
method
bedsid
monitor
coagul
abnorm
patient
dic
treat
icu
method
observ
studi
patient
diagnosi
sever
sepsi
overt
dic
admiss
icu
includ
dic
recogn
use
score
system
base
criteria
propos
intern
societi
thrombosi
hemostasi
result
thromboelastometri
test
rotem
perform
day
admiss
day
daili
next
day
record
clot
time
ct
clot
format
time
cft
maximum
clot
firm
mcf
alpha
angl
lysi
index
mi
maximum
lysi
index
ml
measur
extem
intem
test
result
among
patient
admit
sever
sepsi
diagnosi
overt
dic
dic
patient
patient
die
ns
dic
score
point
day
surviv
dic
score
point
admiss
major
coagul
abnorm
identifi
thromboelastometri
indic
hypocoagul
pattern
abnorm
record
patient
surviv
increas
ct
p
extem
p
intem
cft
p
extem
intem
lower
alpha
angl
p
extem
p
intem
decreas
mcf
p
extem
p
intem
comparison
result
record
survivor
differ
thromboelastometri
paramet
group
ns
also
observ
day
fibrinolysi
inhibit
nonsurvivor
li
ml
extem
intem
entir
time
observ
conclus
thromboelastometri
use
pointofcar
assay
made
possibl
accur
monitor
patient
dic
presenc
coagul
disord
indic
thromboelastometri
identifi
highrisk
subpopul
critic
ill
patient
refer
toh
ch
hoot
wk
ssc
dissemin
intravascular
coagul
isth
j
thromb
haemost
introduct
frequenc
earli
within
first
three
day
onset
sepsisassoci
coagulopathi
sac
associ
clinic
outcom
vari
depend
definit
coagulopathi
furthermor
frequenc
sac
may
decreas
effect
use
sepsi
bundl
earli
antibiot
fluid
vasopressor
accordingli
sought
determin
frequenc
outcom
earli
sac
method
review
patient
admit
medicalsurg
icu
st
paul
hospit
tertiari
care
hospit
vancouv
canada
januari
juli
includ
patient
met
sac
inclus
criteria
sepsi
platelet
count
less
decreas
least
inr
greater
within
first
three
day
onset
sepsi
assess
presenc
sever
sac
associ
sac
hospit
mortal
need
vasopressor
ventil
renal
replac
therapi
rrt
result
icu
admiss
sepsi
icu
admiss
septic
patient
least
inr
platelet
count
point
day
icu
admiss
septic
patient
met
variou
criteria
sac
presenc
sac
hour
hour
associ
significantli
increas
mortal
odd
ratio
hr
respect
need
vasopressor
ventil
rrt
unadjust
adjust
analys
increas
sever
combin
abnorm
inr
platelet
associ
significantli
higher
mortal
greater
need
vasopressor
rrt
ventil
increasingli
abnorm
inr
associ
increas
mortal
monoton
increas
fashion
wherea
sever
thrombocytopenia
platelet
associ
significantli
increas
mortal
conclus
sac
common
septic
patient
associ
increas
mortal
need
vasopressor
ventil
renal
replac
therapi
accordingli
need
therapi
decreas
sever
sac
attempt
decreas
mortal
organ
dysfunct
sepsi
introduct
hypercoagul
describ
cancer
patient
also
sepsi
lead
microcirculatori
failur
organ
dysfunct
latter
howev
often
overlook
standard
coagul
test
sct
aim
pilot
studi
compar
hemostasi
cancer
patient
earli
stage
sever
sepsissept
shock
cancer
patient
without
sepsi
method
adult
patient
oper
solid
tumor
first
day
surgeri
admit
icu
sever
sepsissept
shock
includ
studi
group
sg
patient
schedul
elect
surgeri
due
intraabdomin
pelvic
malign
includ
control
group
cg
exclus
criteria
liver
diseas
chronic
kidney
failur
hematolog
diseas
pregnanc
chronic
anticoagulantantiplatelet
therapi
blood
deriv
procoagul
treatment
last
day
group
sct
plasma
level
coagul
factor
rotat
thromboelastometri
germani
determin
first
hour
admiss
icu
sg
surgeri
cg
follow
indic
calcul
first
deriv
clot
firm
curv
maximum
veloc
maxvel
time
maximum
veloc
clot
format
tmaxvel
area
curv
auc
result
ethic
committe
approv
patient
sg
patient
cg
includ
patient
sg
lower
platelet
number
p
prolong
sct
p
pt
aptt
lower
ii
v
vii
x
protein
c
p
antithrombin
iii
p
level
sg
rotem
show
delay
activ
hemostasi
prolong
clot
time
p
increas
tmaxvel
p
clot
format
similar
group
nonsignific
differ
maximum
clot
firm
mcf
maxvel
auc
sg
patient
apacheii
higher
mcf
p
auc
p
compar
patient
apach
conclus
studi
show
cancer
patient
sever
sepsissept
shock
similar
hypercoagul
delay
clot
initi
compar
cancer
patient
without
sepsi
despit
thrombocytopenia
prolong
sct
abnorm
detect
dynam
hemostasi
measur
sct
firm
conclus
complet
pilot
studi
requir
refer
sorensen
et
al
journal
thrombosi
introduct
dic
high
preval
among
critic
ill
specif
diagnost
test
lack
aim
assess
whether
rotem
addit
valu
discrimin
patient
without
dic
whether
correl
convent
experiment
markerstest
dic
method
icu
patient
coagulopathi
inr
dic
defin
score
point
isth
dic
score
scale
concomitantli
convent
coagul
test
inr
aptt
fibrinogen
ddimer
platelet
count
rotem
perform
addit
level
coagul
factor
ii
v
vii
antithrombin
protein
c
activ
protein
determin
statist
mann
whitney
spearman
rho
result
patient
includ
overt
dic
major
admit
icu
due
sepsi
patient
dic
lower
platelet
count
lower
level
fibrinogen
factor
ii
vii
viii
compar
patient
without
dic
endogen
anticoagul
antithrombin
protein
c
also
reduc
dic
patient
thromboelastometri
profil
hypocoagul
dic
patient
compar
without
dic
extem
cft
dic
vs
nondic
p
alpha
dic
vs
nondic
p
mcf
dic
vs
nondic
patient
p
rotem
extem
variabl
indic
hypocoagul
correl
dic
score
low
level
endogen
anticoagul
tabl
conclus
icu
patient
dic
rotem
show
hypocoagul
profil
correl
dic
score
low
level
endogen
anticoagul
therebi
rotem
may
use
tool
diagnos
dic
critic
ill
introduct
prior
use
antiplatelet
agent
associ
surviv
benefit
sepsi
remain
unclear
chronic
antiplatelet
therapi
continu
sever
sepsi
septic
shock
addit
subsequ
need
red
blood
cell
rbc
transfus
patient
continu
chronic
antiplatelet
therapi
remain
determin
hypothes
continu
preexist
antiplatelet
medic
aspirin
clopidogrel
dipyridamol
sepsi
therapi
reduc
mortal
rate
sever
sepsi
septic
shock
without
increas
rbc
transfus
method
perform
retrospect
singlecent
cohort
studi
intens
care
icu
patient
sever
sepsi
septic
shock
univers
hospit
greifswald
germani
januari
decemb
local
ethic
committe
approv
studi
identifi
bb
waiv
written
inform
consent
anonym
data
collect
qualiti
save
observ
charact
studi
administr
antiplatelet
agent
icu
stay
number
transfus
rbc
concentr
mortal
rate
day
regist
categor
data
repres
percentag
count
result
patient
whose
preexist
antiplatelet
therapi
continu
show
increas
mortal
rate
contrast
patient
whose
medic
discontinu
icu
mortal
significantli
reduc
ci
p
hospit
mortal
well
reduc
ci
p
mortal
day
reduc
ci
p
remark
high
mortal
day
reduc
ci
p
need
rbc
transfus
affect
administr
antiplatelet
agent
p
conclus
continu
chronic
antiplatelet
therapi
sever
sepsi
septic
shock
associ
improv
icu
hospit
well
mortal
increas
need
transfus
critic
ill
patient
refer
sossdorf
et
al
crit
care
tsai
et
al
intens
care
med
introduct
neutrophil
extracellular
trap
net
one
immun
system
suppress
dissemin
infect
net
chromatin
decor
antibacteri
molecul
report
net
observ
abscess
lot
net
appear
abscess
drainag
sinc
close
wound
area
known
hypox
hypothes
net
product
affect
concentr
oxygen
method
blood
sampl
obtain
healthi
volunt
neutrophil
purifi
stimul
pma
incub
perform
hour
co
sub
sub
incub
box
oxygen
scaveng
specimen
stain
sytox
orang
examin
immunohistochemistri
count
number
net
analyz
rate
wilcoxon
sign
rank
test
result
five
volunt
cooper
studi
net
produc
condit
net
amount
decreas
hypoxia
four
five
case
averag
reduct
rate
fig
although
statist
signific
p
conclus
result
indic
net
product
might
decreas
low
concentr
oxygen
wound
drainag
may
promot
net
product
provid
fresh
oxygen
infect
area
analysi
made
clarifi
relat
net
product
oxygen
introduct
scarc
clinic
trial
conduct
evalu
specif
disinfect
activ
novel
ultraviolet
uv
technolog
hospit
room
intens
care
unit
icu
object
evalu
impact
ultraviolet
air
steril
uva
clinic
outcom
patient
icu
method
prospect
compar
random
nonintervent
studi
involv
patient
recov
icu
cardiac
surgeri
uva
place
half
icu
room
remain
one
ident
other
without
use
control
result
number
patient
present
gramposit
cocci
mainli
aureu
lower
patient
uva
without
incid
sepsi
lower
uva
versu
inhospit
mortal
rate
significantli
lower
patient
uva
without
independ
factor
associ
mortal
age
ci
emerg
surgeri
ci
absenc
uva
ci
conclus
uvc
technolog
demonstr
effect
critic
clinic
variabl
patient
icu
presenc
aureu
lung
incid
sepsi
need
hour
mechan
ventil
moreov
uva
contribut
reduc
mortal
rate
refer
tamayo
e
fj
b
et
al
ventilatorassoci
pneumonia
import
risk
factor
mortal
major
cardiac
surgeri
j
crit
care
weber
dj
anderson
rutala
wa
role
surfac
environ
healthcar
associ
infect
curr
opin
infect
di
hardi
kj
oppenheim
ba
gossain
et
al
studi
relationship
environment
contamin
methicillinresist
staphylococcu
aureu
mrsa
patient
acquisit
mrsa
infect
control
hosp
epidemiol
munozpric
ls
arizaheredia
e
adam
et
al
use
uv
powder
surveil
improv
environment
clean
infect
control
hosp
epidemiol
rutala
wa
gergen
mf
weber
dj
room
decontamin
uv
radiat
infect
control
hosp
epidemiol
introduct
administr
data
increasingli
use
epidemiolog
research
need
valid
purpos
therefor
want
compar
report
focu
infect
sever
sepsi
administr
data
prospect
cohort
studi
chart
review
germani
method
identifi
hospit
case
sever
sepsi
drgstatistik
databas
nearli
german
inpati
case
specif
code
sepsi
organ
dysfunct
focu
infect
abstract
document
diagnos
case
comparison
data
focu
infect
abstract
point
preval
studi
prospect
cohort
studi
sever
sepsi
german
icu
patient
could
one
focu
three
group
result
rel
frequenc
import
foci
infect
report
tabl
conclus
strike
differ
report
foci
infect
depend
sampl
techniqu
method
data
abstract
improv
use
administr
data
epidemiolog
research
evalu
need
surprisingli
high
incid
devic
relat
sever
sepsi
warrant
closer
look
refer
engel
c
et
al
intens
care
med
bloo
f
et
al
crit
care
introduct
clabsi
dread
prevent
health
care
associ
infect
typic
result
prolong
length
stay
morbid
mortal
econom
burden
facil
patient
aim
post
intervent
achiev
zero
clabsi
implement
simpl
evid
base
practic
use
avail
standard
resourc
method
quasi
experiment
intervent
studi
enrol
patient
hous
day
care
central
line
devic
unit
bed
hospit
jan
oct
data
collect
prospect
mean
activ
surveil
audit
hai
track
sheet
practic
pertain
central
line
show
fluctuat
clabsi
rate
nshn
benchmark
consequ
root
caus
analysi
identifi
non
conform
standard
practic
across
unit
hospit
respons
robust
program
devis
implement
month
jan
target
zero
clabsi
result
see
result
conclus
achiev
sustain
zero
clabsi
challeng
view
non
modifi
risk
factor
popul
risk
howev
strict
complianc
continu
surveil
effect
team
work
facilit
journey
zero
low
clabsi
refer
deviceassoci
modul
bsi
januari
modifi
april
cdc
guidelin
prevent
intravascular
catheterassoci
bloodstream
infect
introduct
current
cvc
relat
bsi
categor
either
crbsi
clabsi
method
major
diagnost
limit
low
sensit
particularli
among
patient
alreadi
receiv
antibiot
anoth
limit
prolong
time
take
diagnost
result
becom
avail
advers
impact
therapi
clinic
outcom
molecular
techniqu
diagnos
crbsi
less
establish
studi
date
attempt
diagnos
cvc
relat
infect
septic
icu
popul
use
molecular
techniqu
studi
test
differ
molecular
techniqu
design
specif
diagnos
cvc
associ
infect
compar
standard
cvc
tip
blood
cultur
also
attempt
new
cultur
method
cvc
tip
use
salin
vortex
method
icu
patient
cvc
suspect
sepsi
includ
blood
extract
pcr
regular
cultur
cvc
extract
tip
cultur
semiquantit
method
also
vortex
salin
subject
pcr
regular
cultur
pcr
done
biofir
commerci
kit
multiplex
pcr
rtpcr
use
uniqu
primer
target
common
icu
organ
organ
load
quantifi
use
threshold
cycl
ct
cutoff
use
posit
result
method
compar
result
total
blood
sampl
cvc
tip
test
biofir
kit
rtpcr
identifi
posit
posit
cvc
culturesth
biofir
kit
fail
identifi
posit
blood
samplesth
rtpcr
identifi
biofir
kit
identifi
fals
posit
sampl
rtpcr
fals
posit
rate
neg
cvc
tip
neg
blood
sampl
blood
standard
cultur
drawn
prior
antibiot
patient
almost
patient
receiv
antibiot
blood
drawn
pcr
cvc
line
tip
vortex
fluid
cultur
show
excel
concord
standard
tip
cultur
conclus
molecular
system
show
promis
rapid
line
sepsi
identif
fals
neg
probabl
relat
prior
antimicrobi
treatment
rtpcr
also
fals
posit
possibl
reflect
potenti
treatabl
organ
miss
standard
cultur
commerci
multiplex
pcr
kit
show
lower
sensit
rtpcr
introduct
central
lineassoci
bloodstream
infect
clabsi
attribut
mortal
larg
prevent
monitor
process
outcom
ensur
complianc
clinic
practic
guidelin
import
compon
intervent
aim
prevent
document
attitud
practic
intens
care
unit
order
assess
complianc
clabsi
prevent
guidelin
method
june
octob
dissemin
onlin
questionnair
avail
languag
medic
doctor
nurs
work
icu
nation
intern
icu
societi
investig
clinic
practic
relat
central
line
cl
insert
mainten
measur
clabsirel
data
countri
categor
high
middl
low
incom
accord
world
bank
definit
comput
weight
estim
standard
error
se
countri
provid
least
complet
respons
result
complet
questionnair
receiv
countri
select
result
middl
highincom
countri
present
tabl
low
incom
countri
provid
less
complet
respons
conclus
adher
intern
guidelin
need
reinforc
icu
level
prioriti
middl
incom
countri
focu
improv
full
barrier
precaut
use
chlorhexidin
skin
prepar
reduct
devic
exposur
daili
assess
cl
need
remain
prioriti
set
almost
respond
consid
measur
clabsi
key
qualiti
improv
howev
less
quarter
actual
report
clabsi
rate
studi
limit
nonrandom
sampl
icu
doctor
nurs
introduct
central
venou
cathet
cvc
wide
use
intens
care
increas
incid
advers
event
especi
catheterrel
blood
stream
infect
crbsi
coagulaseneg
staphylococci
epidermidi
staphylococcu
aureu
frequent
caus
crbsi
bacteria
grow
biofilm
develop
inhibit
bacteri
growth
antimicrobi
cathet
help
prevent
surfac
colon
improv
safeti
protect
third
gener
cvc
nonleach
addit
antimicrobi
activ
cathet
tip
connector
method
antimicrobi
perform
day
nonleach
antimicrobi
cvc
typic
cvcassoci
infect
bacteria
test
rollout
method
staphylococcu
epidermidi
staphylococcu
aureu
mrsa
e
coli
enterococcu
faecali
pseudomona
aerugionosa
klebsiella
pneumonia
candida
albican
inocul
wash
incub
immers
minimum
medium
solut
second
wash
process
cathet
sampl
place
agar
plate
roll
time
agar
plate
transfer
surfac
bound
bacteria
agar
medium
overnight
incub
bacteri
growth
record
photographi
result
present
invitro
data
demonstr
nonleach
antimicrobi
cvc
eg
protect
bbraun
exhibit
antimicrobi
efficaci
prevent
biofilm
format
gramposit
gramneg
bacteria
fungi
day
studi
perform
direct
comparison
nonantimicrobi
control
cathet
test
strain
abl
grow
establish
surfac
biofilm
conclus
first
invitro
studi
demonstr
antibacteri
surfac
activ
prevent
biofilm
format
antimicrobi
nonleach
cvc
use
rollout
method
period
day
result
demonstr
nonleach
antimicrobi
cvc
prevent
microbi
colon
infect
introduct
urinari
tract
infect
common
problem
patient
icu
increas
mortal
cost
hospit
best
way
treat
urinari
tract
infect
prevent
mechan
action
prevent
bacteri
adhes
nobl
metal
alloyco
urinari
cathet
gener
galvan
effect
aim
studi
evalu
benefit
nobl
metal
coatedcathet
compar
silicon
foley
cathet
patient
admit
toxicologyintens
care
unit
drug
poison
shortterm
catheter
method
enrol
patient
randomli
assign
one
two
group
one
group
receiv
nobl
metal
alloyco
cathet
group
one
receiv
silicon
foley
cathet
group
exclud
patient
urinari
tract
precontamin
urin
full
examin
urin
cultur
taken
admiss
day
catheter
result
incid
bacteriuria
nobl
metal
alloyco
cathet
silicon
cathet
p
mean
period
day
catheter
time
age
year
odd
ratio
signific
risk
factor
bacteriuria
gram
neg
bacteria
escherichia
coli
klebsiella
pneumonia
uropathogen
bacteria
observ
signific
associ
urinari
tract
infect
caus
escherichia
coli
femal
gender
p
conclus
nobl
metal
alloyco
cathet
may
decreas
incid
urinari
tract
infect
compar
silicon
one
meantim
may
lower
need
antibiot
also
notic
incid
bacteriuria
increas
age
group
remain
lower
nobl
metal
alloyco
cathet
group
introduct
urinari
tract
infect
uti
one
common
sourc
bacteremia
commun
set
predict
risk
bacteremia
help
clinician
determin
appropri
site
care
therapi
previou
studi
perform
factor
associ
bacteremia
howev
produc
inconclus
result
aim
studi
evalu
clinic
characterist
predict
bacteremia
commun
acquir
uti
method
prospect
observ
studi
conduct
nakhonpathom
hospit
tertiari
care
hospit
thailand
decemb
august
inclus
criteria
age
year
fever
least
symptom
uti
dysuria
frequent
urgent
urin
flank
pain
costovertebr
tender
pyuria
defin
presenc
wbc
per
high
power
field
centrifug
sediment
patient
exclud
healthcar
associ
infect
taken
antibiot
h
prior
hospit
present
sever
sepsissept
shock
clinic
factor
associ
bacteremia
determin
result
patient
mean
sd
age
year
femal
twentytwo
patient
diabet
melliutu
stone
structur
abnorm
urinari
system
respect
bacteremia
found
patient
ecoli
common
organ
case
follow
mssa
case
proteu
mirabili
case
surprisingli
isol
ecoli
esbl
produc
patient
bacteremia
like
older
age
mean
sd
age
vs
year
p
diabet
mellitu
vs
p
chill
vs
p
higher
bodi
temperatur
mean
sd
temperatur
vs
f
p
buncr
ratio
vs
p
crp
mgl
vs
p
multivari
analysi
factor
p
univari
analysi
show
buncr
ratio
ci
p
crp
mgl
ci
p
associ
bacteremia
conclus
buncr
ratio
crp
level
use
guid
probabl
bacteremia
commun
acquir
uti
refer
preval
predict
featur
bacterem
urinari
tract
infect
emerg
depart
patient
eur
j
clin
microbiol
infect
di
blood
cultur
necessari
manag
women
complic
pyelonephr
j
infect
introduct
aim
studi
analyz
characterist
monobacteremia
caus
acinetobact
spp
associ
factor
mortal
surgic
medic
intens
care
unit
method
retrospect
data
analysi
patient
treat
surgic
medic
intens
care
unit
posit
blood
cultur
gramneg
rod
year
carri
result
found
case
gramneg
rod
monobacteremia
caus
acinetobact
spp
differ
gender
age
comorbid
sourc
bacteremia
length
stay
intens
care
unit
acinetobact
spp
bacteremia
p
primari
bacteremia
associ
surgic
procedur
p
previous
treatment
hospit
depart
p
acinetobact
spp
strain
associ
high
resist
antibiot
p
cefotaxim
n
ampicillin
n
cefuroxim
ceftazidim
n
gentamicin
n
piperacillin
n
piperacillin
tazobactam
n
ciprofloxacin
n
amikacin
n
ampicillin
sulbactam
n
low
resist
carbapenem
n
p
estim
acinetobact
spp
strain
found
mostli
multidrugresist
resist
class
antibiot
n
p
especi
postop
patient
n
p
previous
treat
hospit
depart
n
p
overal
mortal
rate
acinetobact
spp
bacteremia
lethal
outcom
associ
mechan
ventil
n
p
multidrugresist
strain
n
p
elderli
n
p
resist
cefalosporin
n
p
alcohol
abus
n
p
conclus
acinetobact
spp
monobacteremia
usual
appear
caus
multidrugresist
class
antibiot
strain
low
resist
carbapenem
especi
postop
patient
previous
treat
hospit
depart
extrem
high
overal
mortal
rate
mortal
associ
elderli
alcohol
abus
multidrugresist
strain
resist
cefalosporin
also
mechan
ventil
introduct
describ
incid
clinic
featur
outcom
group
group
b
streptococc
infect
intens
care
unit
icu
method
retrospect
analysi
conduct
patient
admit
icu
group
group
b
streptococc
infect
demograph
clinic
inform
obtain
intens
care
nation
audit
research
centr
data
result
case
identifi
account
admiss
unit
pathogen
mainli
isol
soft
tissu
wound
sputum
median
age
case
year
organ
support
defin
uk
ccmd
critic
care
minimum
dataset
definit
tabl
list
number
patient
respiratori
cardiovascular
renal
support
data
length
stay
ill
sever
assess
apach
score
mortal
rate
conclus
group
group
b
streptococc
infect
associ
signific
morbid
mortal
apach
score
appear
predict
mortal
reliabl
patient
group
streptococc
infect
patient
group
b
streptococc
infect
howev
observ
mortal
significantli
higher
predict
mortal
apach
score
icu
hospit
length
stay
broadli
compar
gener
icu
popul
period
mean
hour
respect
refer
clark
et
al
critic
care
suppl
vincent
jl
et
al
critic
care
introduct
diagnosi
spontan
bacteri
periton
sbp
usual
investig
cytobacteriolog
analysisw
purpos
evalu
effect
urinari
strip
uritop
tm
rapid
diagnosi
sbp
emphas
util
inocul
blood
cultur
bottl
withascit
fluid
accur
identif
bacteria
method
studi
includ
patient
cirrhosi
tens
ascit
immedi
paracentesi
urin
test
strip
perform
search
visual
presenc
leukocyt
nitrit
ascit
fluid
reaction
fluid
strip
induc
color
chang
color
leukocyt
reagent
area
compar
color
chart
bottl
result
score
function
number
cross
besid
biochem
bacteriolog
analysi
ascit
fluid
done
includ
bedsid
inocul
five
millimet
fluid
aerob
anaerob
blood
cultur
bottl
cultur
blood
also
obtain
patient
result
sbp
diagnos
sampl
uritop
tm
test
posit
case
read
leukocyt
strip
reveal
one
cross
two
cross
three
cross
respect
nitrit
present
case
blood
ascit
inocul
posit
respect
major
bacteria
isol
gramneg
bacilli
found
signific
correl
sbp
visual
detect
white
cell
nitrit
p
paramet
signific
correl
also
found
sbp
ascit
p
blood
p
inocul
visual
detect
leukocyt
asit
inocul
blood
cultur
bottl
sensibl
specif
conclus
studi
show
uritop
tm
rapid
effect
method
earli
diagnosi
sbp
besid
inocul
blood
cultur
bottl
ascit
fluid
improv
detect
sbp
amelior
consequ
prognosi
introduct
although
well
known
lymphedema
limb
associ
higher
possibl
develop
cellul
relat
congest
heart
failur
cellul
never
establish
investig
risk
cellul
patient
hospit
congest
heart
failur
taiwan
evalu
whether
risk
higher
compar
gener
popul
method
data
one
million
nation
health
insur
nhi
beneficiari
util
adult
beneficiari
follow
januari
decemb
identifi
develop
cellul
cox
regress
model
appli
compar
hazard
patient
congest
heart
failur
unexpos
group
control
select
covari
result
identifi
patient
hospit
congest
heart
failur
patient
without
congest
heart
failur
control
age
gender
urban
level
socioeconom
statu
diabet
hypertens
hyperlipidemia
malign
liver
cirrhosi
atrial
fibril
smoke
obes
peripher
arteri
diseas
charlson
comorbid
index
score
adjust
hazard
ratio
confid
interv
patient
congest
heart
failur
conclus
congest
heart
failur
may
associ
increas
risk
cellul
introduct
skin
common
site
infect
intens
care
unit
icu
howev
contrast
necrot
fasciiti
nf
limit
clinic
data
avail
sever
cellul
critic
ill
object
studi
describ
clinic
present
patient
admit
icu
sever
cellul
compar
patient
nf
method
prospect
observ
cohort
studi
includ
consecut
patient
admit
two
tertiari
icu
januari
januari
cohort
patient
possibl
probabl
definit
sepsi
diagnos
within
h
select
icu
readmiss
hospit
admiss
readmiss
within
day
first
hospit
admiss
exclud
use
set
criteria
sepsi
admiss
attribut
cellul
soft
tissu
infect
retrospect
recategor
independ
research
admiss
nf
sever
ie
icu
necessit
cellul
anoth
primari
diagnosi
cellul
present
comorbid
result
among
icu
sepsi
admiss
patient
admit
nf
sever
cellul
cellul
diagnos
comorbid
anoth
patient
compar
sever
cellul
nf
differ
age
bmi
concurr
infect
length
hospit
stay
prior
icu
admiss
patient
sever
cellul
lower
rate
shock
vs
p
need
mechan
ventil
within
h
admiss
vs
p
chronic
comorbid
vs
p
especi
cardiovascular
origin
vs
p
caus
agent
identifi
sever
cellul
patient
aureu
domin
organ
present
gramneg
infect
polymicrobi
infect
pyogen
primari
organ
nf
length
icu
stay
shorter
sever
cellul
patient
vs
day
p
hospit
day
mortal
similar
two
group
vs
p
vs
p
respect
conclus
although
patient
sever
cellul
less
critic
ill
icu
admiss
compar
patient
necrot
fasciiti
mortal
rate
appear
similar
studi
limit
rel
small
sampl
size
retrospect
diagnosi
recategor
introduct
botul
rare
paralyt
ill
caus
action
potent
neurotrop
exotoxin
produc
clostridium
botulinum
c
botulinum
speci
produc
seven
serolog
distinct
toxin
ag
human
botul
primarili
caus
toxin
type
b
e
europ
wound
botul
associ
inject
drug
use
symptom
descend
paralysi
bulbar
palsi
respiratori
failur
method
review
clinic
microbiolog
public
health
aspect
outbreak
botul
scotland
decemb
june
data
collect
via
prospect
patient
interview
clinic
data
collat
result
case
wound
botul
report
probabl
confirm
discount
two
remain
possibl
median
age
rang
year
male
case
present
bulbar
palsi
descend
limb
weak
patient
requir
surgic
drainag
woundrel
abscess
requir
mechan
ventil
patient
receiv
trival
antibotulinum
toxin
therapi
within
hour
clinic
diagnosi
diagnosi
microbiolog
confirm
case
due
presenc
c
botulinum
type
b
neurotoxin
detect
molecular
assay
tissu
andor
serum
bioassay
c
botulinum
strain
case
show
common
profil
faflp
type
therebi
confirm
link
common
sourc
recent
histori
inject
heroin
obtain
either
sourc
via
glasgow
sourc
infect
remain
unconfirm
thought
due
contamin
heroin
cut
agent
four
death
botul
contribut
two
polic
scotland
close
involv
risk
manag
increas
drug
seizur
throughout
region
reduc
suppli
potenti
contamin
heroin
public
health
measur
includ
risk
commun
via
distribut
postcard
wide
pwid
via
drug
agenc
needl
exchang
centr
increas
awar
sign
symptom
advis
smoke
drug
altern
form
administr
avoid
muscl
pop
conclus
largest
outbreak
botul
among
pwid
europ
prompt
identif
case
appropri
clinic
manag
result
low
mortal
amongst
case
interdisciplinari
cooper
integr
manag
outbreak
introduct
extendedspectrumbetalactamaseproduc
enterobacteriacea
esbl
strain
consid
import
sinc
antibiot
current
remain
activ
bacteria
howev
implic
associ
surveil
fecal
carrier
esbl
among
icu
patient
unclear
aim
studi
determin
efficaci
carri
stool
screen
esbl
method
conduct
retrospect
cohort
studi
icu
fukuoka
univers
hospit
april
septemb
occurr
infect
colon
esbl
antimicrobi
use
densiti
aud
valu
clinic
outcom
investig
describ
period
paramet
compar
aprildecemb
phase
januaryseptemb
phase
moreov
routin
perform
stool
cultur
esbl
phase
result
patient
admit
icu
studi
period
identifi
patient
phase
patient
phase
respect
rate
patient
either
infect
colon
esbl
significantli
higher
phase
phase
versu
p
howev
aud
valu
fluoroquinolon
versu
defin
daili
bedday
p
thirdgener
cephalosporin
versu
defin
daili
bedday
p
tazobactam
piperacillin
versu
defin
daili
bedday
p
carbapenem
versu
defin
daili
bedday
p
significantli
differ
subphas
moreov
icu
mortal
versu
p
also
found
differ
significantli
differ
phase
studi
conclus
find
studi
suggest
perform
routin
stool
cultur
esbl
icu
patient
effect
improv
aud
valu
clinic
outcom
refer
mark
e
rupp
paul
fey
extend
spectrum
esbl
produc
enterobacteriacea
consider
diagnosi
prevent
drug
treatment
drug
introduct
esbl
carbapenemas
produc
gramneg
pathogen
pose
major
therapeut
challeng
healthcar
provid
hospit
commun
morbid
mortal
cost
health
care
deliveri
increas
emerg
resist
pathogen
therefor
becom
import
good
knowledg
local
microbi
spectrum
sensit
profil
appropri
prophylact
antibiot
could
administ
retrospect
review
conduct
assess
preval
esbl
carbapenemas
produc
among
uropathogen
newli
open
tertiari
care
hospit
chennai
india
method
retrospect
analys
urin
cultur
report
hospit
oneyear
period
sep
oct
data
total
request
sampl
receiv
number
sampl
test
posit
organ
isol
sensit
pattern
collect
result
period
microbiolog
lab
receiv
total
urin
sampl
outpati
inpati
total
sampl
receiv
cultur
posit
outpati
inpati
outpati
inpati
isol
esbl
produc
e
coli
klebsiella
commonest
organ
isol
inhospit
outpati
esbl
isol
e
coli
inhospit
isol
carbapenemas
produc
conclus
incid
esbl
carbapenemas
product
among
inhospit
uropathogen
high
respect
confirm
global
increas
incid
esbl
carbapenemas
although
carbapenemas
product
commun
sepsi
caus
isol
difficult
treat
high
mortal
rate
appropri
antibiot
use
follow
deescal
strategi
good
antimicrobi
stewardship
import
improv
outcom
prevent
spread
resist
instead
follow
gener
antibiot
guidelin
develop
robust
local
guidelin
base
microbiolog
data
antibiot
sensit
organ
guid
prophylaxi
help
achiev
high
rate
clinic
cure
refer
ranjini
et
al
commun
acquir
infect
introduct
preval
methicillinresist
staphylococcu
aureu
mrsa
increas
gener
popul
studi
examin
preval
mrsa
nasal
colon
patient
admit
intens
care
unit
icu
risk
factor
associ
morbid
mortal
method
retrospect
cohort
studi
patient
admit
icu
tertiarycar
hospit
riyadh
saudi
arabia
nasal
swab
mrsa
colon
admiss
stay
icu
hour
calcul
mrsa
colon
preval
studi
associ
mrsa
colon
statu
patient
characterist
outcom
includ
infect
due
mrsa
mortal
result
cohort
includ
patient
follow
characterist
age
year
apach
ii
score
male
mostli
admit
emerg
depart
ward
thirtyon
patient
mrsa
colon
similar
age
gender
distribut
chronic
comorbid
admiss
apach
ii
score
compar
patient
patient
refer
hospit
highest
preval
versu
patient
p
multivari
analysi
age
gender
apach
ii
score
sourc
admiss
hospit
versu
sourc
independ
variabl
admiss
icu
anoth
hospit
associ
mrsa
colon
odd
ratio
confid
interv
p
patient
cohort
mrsa
bacteremia
icu
stay
mrsa
colon
p
furthermor
patient
respiratori
tract
infect
due
mrsa
mrsa
colon
p
mrsa
colon
patient
similar
hospit
mortal
versu
p
length
stay
versu
day
p
compar
patient
conclus
mrsa
nasal
colon
present
icu
patient
associ
mrsa
bacteremia
respiratori
tract
infect
mortal
introduct
determin
whether
acinetobact
baumannii
baumannii
class
integron
soil
around
hospit
soil
caus
increas
number
baumannii
infect
intens
care
unit
icu
patient
baumannii
emerg
global
signific
pathogen
hospit
also
present
soil
water
previou
studi
discov
baumannii
class
integron
occur
frequent
method
crosssect
prospect
studi
conduct
two
icu
loghmanhakim
hospit
tehran
iran
novemb
march
patient
soil
hospit
environ
sampl
collect
isol
identifi
use
standard
bacteriolog
biochem
method
phenotyp
genotyp
character
standard
disc
diffus
method
util
test
antimicrobi
suscept
integron
identif
perform
multiplex
polymeras
chain
reaction
result
baumannii
bacteria
isol
hospit
environ
soil
although
bacterium
detect
around
lip
one
patient
also
total
baumannii
clinic
strain
isol
lower
respiratori
tract
n
blood
n
urin
n
wound
cathet
nasal
swab
n
isol
speci
classifi
class
integron
strain
resist
piperacillin
piperacillintazobactam
ceftazidim
ceftriaxon
cotrimoxazol
cefepim
ceropenem
cefotaxim
howev
strain
sensit
polymyxin
b
conclus
research
necessari
establish
relationship
baumannii
soil
especi
bioremedi
well
determin
import
nosocomi
infect
outbreak
icu
introduct
object
studi
evalu
distribut
multidrugresist
organ
mdro
dutch
icu
compar
outcom
mdroposit
patient
versu
control
method
prospect
singlecentr
studi
patient
spent
hour
icu
screen
mdro
month
period
septemb
clinic
set
mix
icu
netherland
baselin
characterist
collect
surveil
screen
includ
rectal
cultur
admiss
dismiss
sputum
cultur
twice
weekli
clinic
cultur
indic
outcom
measur
includ
ventil
time
day
median
rang
vap
patient
n
sepsi
patient
n
length
stay
lo
icu
day
median
rang
surviv
patient
n
statist
includ
test
mannwhitney
utest
result
patient
includ
men
median
age
year
median
apach
ii
total
mdro
found
patient
rectal
cultur
admiss
reveal
mdro
patient
mdro
cultur
predomin
sputum
cultur
patient
icu
stay
mdro
includ
e
coli
klebsiella
spp
e
cloaca
morganii
citrobact
spp
pseudomona
spp
pneumonia
mrsa
vre
patient
mdro
posit
blood
cultur
colonis
appear
frequent
infect
mdro
patient
place
full
contact
isol
ventil
time
vap
sepsi
lo
icu
signific
higher
mdro
patient
tabl
signific
differ
surviv
versu
p
conclus
mdro
found
small
percentag
patient
mdro
patient
longer
ventil
time
lo
icu
may
sensit
vap
sepsi
larg
part
mdro
import
icu
underscor
import
mdro
prevent
program
surveil
cultur
special
attent
hand
hygien
wash
chlorhexidin
cloth
introduct
multidrug
resist
mdr
bacteria
worldwid
threat
especi
intens
care
unit
patient
icu
gram
neg
bacilli
emerg
spread
extendedspectrum
betalactamas
esbl
carbapenemaseproduc
bacteria
cpb
one
common
caus
morbid
mortal
associ
icuacquir
infect
icu
ai
aim
studi
determin
epidemiolog
risk
factor
esbl
cpb
infect
well
resist
pattern
bacteria
isol
tunisian
multidisciplinari
intens
care
unit
method
conduct
retrospect
casecontrol
studi
includ
patient
admit
januari
octob
icu
ai
defin
acquir
less
h
icu
admiss
includ
patient
bacteriolog
evid
infect
differ
icu
mortal
length
stay
durat
mechan
ventil
mv
test
across
patient
without
icu
acquir
mdr
bacteria
infect
also
assess
infect
site
frequent
bacteria
group
esbl
cpb
look
risk
factor
result
studi
period
patient
admit
icu
icu
ai
patient
esbl
infect
isol
patient
infect
cpb
isol
cultur
global
mortal
studi
period
mortal
associ
mdr
infect
fact
mortal
esbl
infect
higher
global
one
wherea
cpb
infect
weigh
mortal
reach
way
length
stay
significantli
longer
mdr
infect
patient
day
std
nonmdr
infect
one
std
p
mv
durat
respect
day
std
mdr
group
day
std
p
nonmdr
infect
group
length
stay
durat
mv
found
risk
factor
acquir
mdr
infect
icu
ventil
associ
pneumonia
frequent
acquir
infect
well
non
mdr
infect
patient
esbl
cpb
acinetobact
baumannii
lead
isol
cpb
infect
follow
klebsiella
pneumonia
concern
bacilli
produc
esbl
klebsiella
pneumonia
frequent
isol
follow
escherichia
coli
enterobact
cloaca
conclus
preval
esbl
cpb
increas
day
day
nearli
everi
center
differ
countri
respons
larg
number
hospitalacquir
nosocomi
infect
therapeut
option
necessari
step
prevent
spread
emerg
resist
taken
introduct
emerg
infect
multidrugresist
mdr
gramneg
bacteria
accompani
poor
outcom
due
inappropri
therapi
led
investig
adjunct
treatment
pentaglobin
one
igmenrich
immunoglobulin
prepar
may
improv
surviv
method
one
hundr
patient
come
registri
hellen
sepsi
studi
group
microbiolog
confirm
sever
infect
mdr
gramneg
bacteria
acquir
admiss
intens
care
unit
treat
pentaglobin
retrospect
analyz
anoth
compar
wellmatch
stage
sepsi
infect
appropri
antimicrobi
comorbid
come
registri
select
allcaus
mortal
primari
endpoint
result
compar
pentaglobintr
case
sever
sepsissept
shock
respect
treat
inappropri
antimicrobi
respect
mean
charlson
comordib
index
cci
mortal
respect
p
posthoc
analysi
subgroup
shown
fig
conclus
result
favor
use
pentaglobin
adjunct
antimicrobi
treatment
manag
sever
infect
caus
mdr
gramneg
bacteria
surviv
benefit
shown
subgroup
septic
shock
age
year
charlson
comorbid
index
equal
apach
ii
equal
sofa
score
introduct
preval
carbapenem
resist
bacteria
increas
sinc
first
case
report
becom
worldwid
seriou
concern
problem
special
affect
intens
care
unit
icu
usual
icu
staff
resid
develop
exercis
learn
captur
decis
patient
bedsid
probabl
way
work
chang
chang
develop
icu
sinc
januari
identifi
new
gener
case
kpneumonia
oxa
method
februari
oper
strateg
group
geo
made
set
aim
elimin
prevent
new
cabapenem
resist
infect
case
compulsori
use
barrier
method
keyston
process
weekli
meet
perform
talk
outbreak
situat
main
chang
carri
geo
dispos
materi
glove
coat
put
outsid
patient
room
worker
could
entri
without
dispos
dress
leav
insid
room
exit
one
physician
work
patient
bedsid
dress
dispos
coat
discuss
made
outsid
patient
room
one
nurs
one
attend
work
patient
porter
cleaner
specif
train
stabl
staff
colon
patient
group
one
side
unit
microbiolog
rectal
sampl
collect
admiss
weekli
basi
direct
commun
among
unit
earli
notic
new
case
prevent
depart
global
observ
complianc
defens
standard
recommend
caution
discharg
least
day
develop
hospit
oxa
record
book
result
sinc
format
geo
number
new
carbapenemresist
case
decreas
drastic
three
new
case
report
februari
two
case
march
one
april
sinc
may
case
colon
carbapenem
resist
bacteria
within
icu
reduc
case
import
unit
except
case
gener
unit
one
failur
defens
identifi
report
measur
taken
occas
conclus
grow
emerg
multirresist
bacteria
real
threat
forc
us
adapt
chang
way
work
good
coordin
among
hospit
worker
effect
tool
firewal
infect
implement
techniqu
previous
describ
proven
effect
fight
techniqu
carbapenemas
produc
bacteria
introduct
mediterranean
spot
fever
msf
consid
benign
diseas
character
fever
rash
eschar
howev
case
sever
form
purpur
rash
multiorgan
failur
object
studi
character
delin
predictor
bad
outcom
patient
hospit
infecti
diseas
intensiveintermedi
care
unit
idicu
method
perform
crosssect
studi
adult
patient
admit
idicu
diagnosi
msf
patient
identifi
depart
databas
subsequ
clinic
record
consult
primari
outcom
death
secondari
outcom
predictor
use
appropri
measur
central
tendenc
distribut
statist
test
signific
level
result
includ
patient
icu
admiss
rate
compar
msf
admiss
infecti
diseas
depart
period
predomin
women
patient
admit
idicu
median
diseas
durat
time
day
interquartil
rang
seven
patient
comorbid
admiss
common
analyt
abnorm
thrombocytopenia
transaminas
elev
elev
urea
creatinin
lactat
dehydrogenas
elev
creatin
phosphokinas
elev
hyponatremia
median
sap
ii
score
report
msf
complic
conscious
impair
renal
failur
pneumon
respiratori
failur
gastrointestin
bleed
four
patient
need
renal
support
five
patient
need
invas
mechan
ventil
mortal
rate
n
found
statist
signific
associ
sap
ii
score
mortal
higher
score
link
death
mann
whitney
u
test
also
found
associ
higher
leukocyt
count
prolong
activ
partial
thromboplastin
time
aptt
admiss
death
mann
whitney
u
test
find
associ
analyt
abnorm
admiss
death
also
find
bad
outcom
associ
patient
symptom
physic
examin
abnorm
renal
ventil
support
person
qui
squar
test
conclus
although
msf
gener
consid
benign
diseas
high
icu
admiss
rate
consider
mortal
rate
found
sap
ii
score
leukocyt
count
aptt
predictor
death
patient
msf
admit
icu
introduct
perform
retrospect
studi
describ
clinic
featur
outcom
cohort
patient
admit
icu
confirm
middl
east
respiratori
syndrom
coronaviru
merscov
infect
method
adult
year
old
patient
admit
mix
medicosurg
icu
diagnos
confirm
merscov
oct
may
includ
diagnosi
confirm
use
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
respiratori
sampl
result
observ
period
patient
identifi
merscov
infect
mean
age
year
male
median
number
concomit
comorbid
condit
iq
initi
clinic
manifest
merscov
infect
occur
median
day
iq
prior
hospit
admiss
cough
tachypnea
report
patient
bilater
pulmonari
infiltr
evid
case
invas
mechan
ventil
requir
patient
icu
stay
vasopressor
therapi
renal
replac
therapi
overal
icu
mortal
rate
median
icu
hospit
length
stay
iq
iq
day
respect
nonsurvivor
older
vs
year
p
greater
apach
ii
sofa
score
admiss
icu
like
requir
invas
mechan
ventil
vs
p
vasopressor
therapi
vs
p
conclus
merscov
infect
requir
admiss
icu
associ
high
morbid
mortal
rate
possibl
risk
factor
death
includ
older
age
greater
sever
score
need
invas
mechan
ventil
andor
vasopressor
therapi
introduct
middl
east
respiratori
syndrom
coronaviru
merscov
caus
sever
hospit
outbreak
frequent
lead
sever
critic
ill
learn
experi
describ
respons
intens
care
unit
icu
merscov
hospit
outbreak
method
observ
studi
conduct
tertiarycar
hospit
riyadh
saudi
arabia
merscov
outbreak
augsep
intens
care
depart
cover
icu
singlebed
room
describ
qualit
applic
quantit
respons
intens
care
servic
outbreak
clinic
cours
outcom
hospit
worker
mer
note
result
total
critic
ill
mer
patient
cohort
icu
outbreak
peak
censu
mer
patient
aug
last
new
case
sep
patient
multiorgan
failur
requir
support
eight
hospit
employe
mer
requir
icu
admiss
median
stay
day
develop
acut
respiratori
distress
syndrom
treat
prone
need
continu
renal
replac
therapi
one
extracorpor
membran
oxygen
hospit
mortal
icu
mer
patient
hospit
employe
mer
patient
admit
singl
neg
pressur
room
promptli
increas
room
nursetopati
ratio
infect
prevent
practic
intensifi
exampl
consumpt
surfac
disinfect
hand
hygien
gel
increas
averag
mask
use
per
patientday
famili
visit
restrict
hoursday
icu
physician
commun
next
kin
phone
daili
outbreak
icu
nurs
physician
test
posit
merscov
mild
diseas
recov
fulli
although
icu
staff
express
concern
acquir
mer
none
refus
report
work
howev
nurs
physician
work
mer
icu
upper
respiratori
symptom
test
neg
merscov
total
sick
leav
durat
day
nurs
day
physician
conclus
hospit
outbreak
merscov
result
mani
patient
requir
organ
support
prolong
icu
stay
mortal
rate
high
lower
previous
report
respons
outbreak
requir
facil
staff
manag
proper
implement
infect
control
prevent
practic
introduct
middl
east
respiratori
syndrom
coronaviru
merscov
one
deadliest
least
understood
emerg
pathogen
centuri
continu
pose
threat
global
public
health
high
fatal
rate
abstract
repres
attempt
analyz
public
avail
global
surveil
data
merscov
case
report
date
method
analyz
outbreak
news
archiv
merscov
septemb
octob
includ
case
contain
data
age
gender
minimum
exclud
case
report
cluster
data
age
gender
comorbid
healthcar
worker
contact
camel
contact
laboratori
confirm
merscov
case
date
symptom
onset
date
laboratori
confirm
retriev
analyz
result
total
outbreak
news
report
releas
case
includ
studi
male
mean
sd
age
year
femal
mean
sd
age
year
youngest
patient
report
month
oldest
patient
report
year
old
comorbid
report
mean
sd
age
male
femal
healthcar
worker
report
mean
sd
age
male
femal
comorbid
report
histori
camel
contact
mean
sd
age
male
femal
comorbid
report
contact
laboratori
confirm
mer
case
mean
sd
age
male
femal
report
comorbid
healthcar
worker
date
symptom
onset
date
laboratori
confirm
report
respect
overal
mean
sd
time
symptom
onset
date
laboratori
confirm
day
ci
conclus
studi
base
public
avail
global
surveil
data
advantag
larg
sampl
demograph
descript
refer
world
health
organ
diseas
outbreak
news
merscov
http
wwwwhointcsrdonarchivediseasecoronavirusinfectionsen
last
access
octob
introduct
pneumonia
remain
common
caus
admiss
deterior
intens
care
unit
mani
case
organ
identifi
result
empir
treatment
presum
caus
pathogen
even
organ
identifi
delay
obtain
result
typic
hour
these
factor
lead
unnecessari
antibiot
even
greater
concern
inappropri
initi
therapi
molecular
diagnost
techniqu
potenti
address
problem
present
three
case
illustr
util
molecular
diagnost
use
taqman
array
card
tac
method
three
patient
admit
univers
hospit
gener
intens
care
unit
radiograph
confirm
sever
pneumonia
underw
bronchoscopi
lavag
sampl
analys
convent
microscopi
cultur
nucleic
acid
extract
nucleic
extract
place
tac
abl
detect
microbi
gene
use
real
time
polymeras
chain
reaction
rtpcr
direct
toward
rang
establish
respiratori
pathogen
result
avail
time
threshold
valu
give
indic
abund
gene
sampl
case
case
occur
amongst
three
adult
age
rang
present
clinic
radiograph
evid
pneumonia
two
case
commun
acquir
third
hospitalacquir
organ
identifi
tac
mycoplasma
pneumonia
aspergillu
spp
cryptosporidium
parvum
pneumocysti
jiroveci
pcj
one
patient
two
organ
detect
pneumonia
pcj
identifi
standard
cultur
whilst
crytposporidum
aspergillu
spp
identifi
convent
culturemicroscopi
day
tac
identif
three
case
result
tac
assay
result
chang
manag
institut
new
antimicrobi
target
organ
identifi
combin
rationalis
preexist
antimicrobi
treatment
discuss
three
case
illustr
convent
cultur
may
miss
import
unexpect
pathogen
return
result
late
cours
diseas
believ
technolog
potenti
significantli
impact
manag
critic
ill
patient
lung
infect
current
plan
larger
scale
evalu
use
critic
care
introduct
pneumonia
major
caus
icu
admiss
mortal
prompt
investig
facilit
tailor
antimicrobi
strategi
guid
manag
aid
prognost
british
thorac
societi
bt
suggest
specif
test
perform
patient
sever
pneumonia
legionella
pneumococc
urinari
antigen
sputum
blood
cultur
respiratori
viral
pcr
swab
atyp
serolog
test
suspect
test
inconsist
undertaken
delay
icu
introduc
computeris
pneumonia
screen
bun
blood
cultur
viral
serologyurinari
antigensnas
endotrach
viral
swabsputum
sampl
consist
investig
condit
method
patient
primari
diagnosi
pneumonia
admit
uk
district
hospit
icu
oneyear
period
retrospect
review
determin
investig
request
within
hour
admiss
compar
bt
guidelin
subsequ
implement
bun
pneumonia
screen
within
electron
investig
system
singl
click
autogener
request
label
test
bt
guidelin
implement
staff
educ
repeat
data
collect
result
see
tabl
conclus
studi
shown
computeris
autogener
set
investig
request
aid
easili
rememb
acronym
lead
increas
proport
patient
vs
receiv
prompt
consist
gold
standard
investig
pneumonia
believ
reduc
duplic
delay
obtain
diagnost
result
therebi
improv
patient
care
suggest
bundl
bun
could
easili
replic
icu
similar
system
could
introduc
present
condit
refer
baudouin
v
thorax
introduct
despit
signific
impact
nosocomi
infect
morbid
mortal
patient
stay
intens
care
unit
icu
studi
past
year
focus
specif
pneumonia
follow
secondari
periton
object
determin
epidemiolog
featur
inhospit
mortal
pneumonia
kind
patient
method
prospect
observ
studi
involv
consecut
patient
admit
icu
undergon
laparotomi
secondari
periton
univari
multivari
analys
perform
identifi
risk
factor
associ
mortal
develop
pneumonia
result
incid
pneumonia
follow
secondari
periton
risk
factor
associ
develop
pneumonia
hospitalacquir
periton
h
mechan
ventil
sofa
score
onset
pneumonia
late
major
patient
day
initi
periton
etiolog
microorgan
respons
differ
periton
inhospit
mortal
rate
pneumonia
patient
independ
factor
associ
inhospit
mortal
pneumonia
sofa
score
conclus
pneumonia
patient
undergon
surgeri
secondari
periton
increas
mortal
onset
pneumonia
follow
secondari
periton
usual
late
day
etiolog
microorgan
differ
respons
secondari
periton
refer
jang
jy
lee
sh
shim
h
et
al
epidemiolog
microbiolog
secondari
periton
caus
viscu
perfor
singlecent
retrospect
studi
surg
infect
larchmt
mulier
penninckx
f
verwaest
c
et
al
factor
affect
mortal
gener
postop
periton
multivari
analysi
patient
world
j
surg
fc
dray
x
mj
et
al
factor
associ
septic
shock
mortal
gener
periton
comparison
communityacquir
postop
periton
crit
care
heyland
dk
cook
dj
griffith
l
et
al
attribut
morbid
mortal
ventilatorassoci
pneumonia
critic
ill
patient
j
respir
crit
care
med
introduct
score
conveni
well
valid
tool
assess
diseas
sever
aid
clinic
manag
commun
acquir
pneumonia
cap
recent
literatur
howev
demonstr
use
variabl
often
inaccur
failur
use
tool
may
lead
treatment
may
result
inappropri
patient
admiss
therebi
increas
healthcar
cost
aim
initi
audit
determin
frequenc
use
score
emerg
medic
care
correl
clinic
decisionmak
data
analys
common
pitfal
identifi
implement
variou
tool
design
address
issu
repeat
audit
perform
assess
improv
method
case
note
patient
present
cap
retrospect
review
marchmay
base
data
key
intervent
implement
teach
session
regard
calcul
practic
applic
score
deliv
emerg
room
clinician
pro
forma
creat
implement
use
electron
patient
record
system
use
hospit
alongsid
predesign
set
electron
antibiot
prescript
set
creat
incorpor
electron
prescrib
system
use
audit
site
account
allergi
patient
weight
renalhepat
function
case
note
patient
present
cap
retrospect
review
decemb
order
assess
impact
intervent
result
signific
increas
number
case
record
contain
document
score
implement
intervent
vs
associ
improv
accuraci
calcul
score
vs
turn
patient
receiv
appropri
antibiot
therapi
vs
note
patient
prior
intervent
admit
despit
calcul
score
without
altern
reason
document
implement
intervent
patient
admit
score
conclus
staff
educ
tool
aid
accur
curb
calcul
precreat
antibiot
order
set
lead
improv
initi
assess
subsequ
manag
patient
present
cap
chang
consid
use
wider
scale
refer
nadarajan
et
al
ir
med
jour
guo
et
al
int
j
tuberc
lung
di
introduct
commun
acquir
pneumonia
cap
guidelin
acknowledg
respiratori
virus
caus
cap
provid
recommend
regard
diagnosi
treatment
due
lack
data
new
technolog
detect
viral
pathogen
highli
sensit
nucleic
amplif
test
allow
identif
addit
virus
small
sampl
respiratori
secret
aim
describ
incid
virus
mechan
ventil
patient
cap
icu
method
retrospect
chart
review
includ
cap
patient
admit
icu
mechan
ventil
januari
septemb
type
viru
screen
tool
use
detect
confirm
bacteri
coinfect
length
stay
lo
icu
hospit
mechan
ventil
day
hospit
mortal
describ
result
evalu
patient
respiratori
viral
panel
screen
result
patient
posit
find
seven
patient
posit
nasopharyng
swab
patient
posit
bal
find
influenza
common
occur
patient
rhinoviru
occur
patient
coronaviru
occur
patient
one
patient
also
parainfluenza
viru
influenza
b
respiratori
syncyti
viru
respiratori
syncyti
viru
b
occur
one
patient
patient
confirm
bacteri
coinfect
overal
median
icu
lo
day
median
mechan
ventil
day
median
hospit
lo
day
mortal
mortal
occur
patient
influenza
patient
rhinoviru
concomit
bacteri
infect
conclus
studi
demonstr
bacteri
viral
coinfect
common
research
larger
sampl
size
need
better
character
respiratori
viral
infect
set
cap
icu
refer
idsaat
guidelin
cid
johnston
et
al
chest
introduct
staphylococcu
aureu
pneumonia
especi
within
hospit
intens
care
unit
icu
popul
clinic
signific
seriou
diseas
contribut
significantli
morbid
mortal
novel
mab
target
bind
function
inhibit
aureu
alpha
toxin
major
determin
aureu
virul
use
prevent
aureu
pneumonia
offer
novel
paradigm
manag
specif
highrisk
patient
describ
rational
design
sattellit
studi
investig
use
mechanicallyventil
mv
subject
studi
eudract
conduct
innov
medicin
initi
joint
undertak
eu
joint
collabor
medimmun
academ
partner
within
combat
bacteri
resist
europ
combact
consortium
expert
field
antibioticresist
bacteria
ventilatorassoci
pneumonia
method
saatellit
random
doubleblind
placebocontrol
doserang
phase
studi
investig
efficaci
safeti
mv
subject
primari
efficaci
endpoint
incid
np
caus
aureu
day
postdos
propos
clinic
meaning
object
reproduc
endpoint
safeti
assess
day
postdos
subject
random
ratio
receiv
singl
intraven
infus
lowdos
highdos
placebo
follow
day
post
dose
subject
enrol
icu
patient
age
yr
intub
mechan
ventil
whose
lower
respiratori
tract
sampl
posit
aureu
diagnos
new
onset
pneumonia
prior
random
result
na
conclus
saatellit
studi
repres
innov
preemptiv
therapi
approach
prevent
aureu
nosocomi
pneumonia
mv
patient
util
novel
monoclon
antibodi
therebi
offer
new
paradigm
aureu
infect
manag
highrisk
patient
introduct
nosocomi
infect
ni
major
caus
morbid
mortal
trauma
patient
especi
hospit
icu
system
inflammatori
respons
follow
differ
lesion
respons
immun
dysfunct
promot
emerg
pathogen
occurr
infect
aim
studi
identifi
risk
factor
ni
infect
site
microbiolog
profil
trauma
patient
method
conduct
retrospect
studi
intens
care
unit
mongi
slim
hospit
la
marsa
januari
septemb
trauma
patient
hospit
hour
icu
includ
demograph
data
type
number
surgeri
use
invas
devic
day
mechan
ventil
site
number
ni
record
calcul
simpl
frequenc
rel
frequenc
percentag
qualit
variabl
calcul
mean
standard
deviat
quantit
variabl
result
total
trauma
patient
admit
monthperiod
patient
develop
least
one
ni
infect
patient
noninfect
one
compar
concern
graviti
mortal
infect
patient
need
transfus
noninfect
one
tabl
infect
patient
mostli
associ
head
trauma
chest
trauma
ventilatori
acquir
pneumonia
common
ni
common
pathogen
found
klebsiella
pneumonia
e
coli
pseudomona
aeroginosa
patient
ni
invas
devic
conclus
infecti
complic
second
lead
caus
late
mortal
brain
injuri
injuri
invas
care
promot
pathogen
penetr
organ
trauma
patient
whose
stay
exceed
hour
benefit
number
establish
earli
precaut
prevent
infect
especi
pneumonia
introduct
aim
observ
retrospect
studi
test
hypothesi
correl
exist
percentag
ventil
patient
develop
vap
use
main
end
line
antimicrobi
agent
icu
patient
method
admit
icu
patient
look
percentag
ventil
patient
develop
vap
well
use
follow
agent
item
per
ventil
day
per
ventil
patient
imipenem
cilastatin
vial
mg
meropenem
vial
mg
tigecyclin
vial
mg
linezolin
bag
mg
ml
x
ml
colistin
iv
vial
iu
use
linear
correl
look
linear
slope
correl
coeffici
r
coeffici
determin
r
p
valu
result
tabl
conclus
accord
data
statist
signific
correl
detect
percentag
ventil
patient
develop
vap
use
end
line
antimicrobi
agent
studi
may
due
late
deescal
use
agent
treat
infect
prevent
spread
colon
introduct
ventil
associ
pneumonia
vap
rate
key
qualiti
metric
subject
surveil
critic
cdc
introduc
object
algorithm
diagnos
possibl
vap
pvap
local
practic
use
helic
methodolog
diagnos
hvap
present
preliminari
result
comparison
techniqu
fund
health
protect
scotland
method
algorithm
relev
data
record
prospect
patient
admit
two
icu
four
month
june
infect
surveil
team
conduct
helic
surveil
independ
ethic
committe
approv
requir
inform
guardian
approv
receiv
nonparametr
comparison
use
p
consid
signific
result
patient
ventil
two
day
hvap
pvap
rate
per
risk
ventil
day
total
diagnos
respect
concord
diagnos
poor
cohen
kappa
ci
hvap
statist
associ
longer
stay
ventil
contrast
pvap
fig
neither
associ
mortal
hvap
p
pvap
p
conclus
preliminari
data
illustr
poor
concord
cdc
helic
algorithm
contrast
pvap
hvap
may
reflect
outcom
lack
associ
pvap
may
result
low
event
rate
refer
magil
ss
et
al
develop
new
nation
approach
surveil
ventilatorassoci
event
j
crit
care
introduct
lung
ultrasound
lu
valid
tool
ventilatorassoci
pneumonia
vap
diagnosi
monitor
dynam
lineararboresc
airbronchogram
specif
vap
method
patient
suspect
vap
examin
fiberbronchoscopi
fb
lu
focus
subpleur
consolid
lobarhemilobar
consolid
airbronchogram
bronchoalveolarlavag
bal
perform
result
fb
lu
pattern
specif
vap
patient
bilater
consolid
airbronchogram
fig
c
fb
lu
pattern
chang
patient
tissuelik
pattern
turn
bline
fig
bal
neg
patient
tissuelik
pattern
visual
fb
dynam
arboresc
airbronchogram
appear
fig
bal
paeruginosa
cfuml
conclus
lu
allow
earli
bedsid
vap
diagnosi
pattern
non
specif
chang
fb
may
use
reaerat
orient
atelectasi
persist
complet
loss
aerat
dynam
airbronchogram
appear
orient
vap
refer
mongodi
et
al
chest
press
et
al
crit
care
med
introduct
ventilatorassoci
pneumonia
vap
remain
import
caus
morbid
mortal
critic
ill
patient
object
tool
prognos
assess
may
improv
treatment
strategi
sought
determin
prognost
valu
procalcitonin
pct
creactiv
protein
crp
well
clinic
score
sequenti
organ
failur
assess
sofa
acut
physiolog
chronic
health
evalu
apach
ii
clinic
pulmonari
infect
score
cpi
chest
echographi
procalcitonin
score
ceppi
critic
ill
patient
develop
vap
method
retrospect
studi
recruit
patient
admit
intens
care
unit
anesthesiolog
depart
marmara
univers
hospit
istanbul
turkey
januari
septemb
patient
progress
follow
day
diagnosi
vap
consid
survivor
patient
die
day
nonsurvivor
patient
discharg
icu
day
also
consid
survivor
apach
ii
score
assess
first
h
admiss
cpi
ceppi
score
assess
onset
vap
day
sofa
score
serum
crp
serum
pct
probnp
assess
day
vap
diagnosi
correl
surviv
mortal
result
total
patient
enrol
die
day
vap
diagnosi
sofa
score
studi
significantli
lower
survivor
day
compar
nonsurvivor
term
apach
ii
score
cpi
caus
admiss
two
group
compar
signific
differ
nonsurvivor
survivor
term
pct
crp
leucocyt
count
day
howev
leucocyt
count
pct
crp
level
day
significantli
higher
nonsurvivor
survivor
also
probnp
level
day
significantli
higher
nonsurvivor
survivor
conclus
biomark
pct
crp
probnp
predict
mortal
vap
sofa
score
although
cpi
ceppi
describ
use
score
system
diagnosi
vap
differenti
survivor
nonsurvivor
compar
cpi
ceppi
score
base
chest
ultrasonographi
procalcitonin
level
may
better
predictor
diagnosi
vap
refer
american
journal
respiratori
critic
care
medicin
american
journal
respiratori
critic
care
medicin
introduct
aim
observ
retrospect
studi
test
hypothesi
correl
exist
prbc
transfus
percentag
ventil
patient
develop
vap
vp
medic
surgic
icu
serv
commun
hospit
method
januari
june
admit
icu
patient
look
percentag
ventil
patient
develop
vap
follow
index
accord
prbc
transfus
per
year
total
per
patient
per
hospit
day
hd
per
patient
ventil
pt
v
per
ventil
day
vd
use
linear
correl
method
look
linear
slope
correl
coeffici
r
coeffici
determin
linear
regress
method
use
anova
test
look
p
valu
accord
vp
prbc
transfus
result
conclus
accord
data
statist
signific
correl
detect
percentag
ventil
patient
develop
vap
prbc
transfus
data
suggest
even
though
prbc
transfus
may
impact
immunosuppress
infect
diseas
develop
impact
percentag
ventil
patient
develop
vap
statist
signific
introduct
ventil
associ
pneumonia
vap
report
incid
strong
associ
increas
icu
length
stay
mortal
current
evid
suggest
applic
care
bundl
may
reduc
rate
vap
aim
assess
effect
sequenti
multifacet
care
bundl
audit
program
vap
rate
institut
method
exist
care
bundl
head
posit
daili
sedat
hold
supplement
process
intervent
decemb
octob
accompani
dedic
staff
educ
initi
guidanc
stress
ulcer
prophylaxi
chang
respiratori
circuitri
sedat
hold
introduct
new
endotrach
tube
continu
subglott
suction
cuff
pressur
monitor
new
oral
hygien
guidanc
data
analys
use
ms
excel
statist
process
control
chart
design
nonconform
attribut
data
unequ
area
opportun
valu
express
mean
upper
control
limit
uclu
result
total
number
consecut
ventil
day
assess
monthli
vap
rate
remain
stabl
around
constant
mean
per
ventil
day
decemb
septemb
follow
introduct
oral
hygien
guidanc
statist
signific
shift
process
occur
identifi
special
caus
repres
reduct
monthli
vap
rate
per
ventil
day
fig
conclus
introduct
multidisciplinari
stepwis
vap
prevent
initi
led
signific
reduct
mean
monthli
vap
rate
time
refer
hunter
jd
bmj
morri
ac
et
al
crit
care
med
introduct
pseudomona
aeruginosa
one
lead
caus
nosocomi
infect
critic
ill
patient
organ
produc
array
factor
contribut
virul
two
virul
factor
psl
exopolysaccharid
contribut
bacteri
persist
pcrv
protein
contribut
virul
organ
novel
bival
bispecif
mab
select
bind
factor
therebi
inhibit
cytotox
immun
evas
properti
pathogen
psl
pcrv
target
express
independ
antibiot
suscept
statu
therefor
also
potenti
activ
multidrug
resist
strain
p
aeruginosa
develop
prevent
p
aeruginosa
pneumonia
describ
rational
design
evad
studi
investig
use
mechanicallyventil
mv
subject
studi
conduct
innov
medicin
initi
joint
undertak
eu
joint
collabor
medimmun
academ
partner
within
combat
bacteri
resist
europ
molecul
gram
neg
infect
combactemagnet
consortium
expert
field
antibioticresist
bacteria
ventilatorassoci
pneumonia
method
evad
random
doubleblind
placebocontrol
doserang
studi
determin
efficaci
safeti
pharmacokinet
respons
adult
icu
patient
requir
mv
colonis
p
aeruginosa
lower
respiratori
tract
lrt
primari
efficaci
endpoint
incid
np
caus
p
aeruginosa
propos
clinic
meaning
object
reproduc
endpoint
safeti
assess
day
postdos
subject
includ
studi
icu
patient
age
yr
intub
mv
lrt
sampl
posit
p
aeruginosa
diagnos
new
onset
pneumonia
prior
random
conclus
evad
studi
repres
innov
preemptiv
therapi
approach
prevent
p
aeruginosa
nosocomi
pneumonia
mv
patient
util
novel
mab
therebi
offer
new
paradigm
p
aeruginosa
infect
manag
highrisk
patient
introduct
ventilatorassoci
pneumonia
vap
import
caus
prolong
intensivecar
stay
mortal
particularli
emerg
multidrug
resist
gramneg
bacteria
aim
studi
investig
role
inhal
colistin
outcom
patient
diagnos
gramneg
vap
method
recruit
patient
confirm
gramneg
cultur
sensit
taken
endotrach
ett
aspir
hr
mechan
ventil
pneumonia
clinic
criteria
radiolog
infiltr
fever
leucocutosi
leucopenia
purul
secret
eighti
five
random
enter
either
studi
group
inhal
colistin
iuday
day
adjunct
therapi
convent
treatment
vap
n
pt
enter
control
group
convent
therapi
n
pt
comparison
includ
microbiolog
outcom
day
ett
aspir
cultur
sensit
well
clinic
outcom
clinic
pulmonari
infect
score
cpi
result
higher
organ
clearanc
rate
colistin
compar
control
group
p
multidrug
resist
organ
observ
vs
p
colistin
control
group
respect
higher
clearanc
rate
mdr
organ
vs
p
colistin
vs
control
group
respect
statist
signific
differ
cpi
group
score
repres
vs
p
colistin
vs
control
group
respect
smaller
number
patient
requir
mechan
ventil
day
colistin
vs
control
group
p
icu
mortal
vs
p
colistin
vs
control
group
respect
signific
chang
renal
function
occurr
bronchospasm
observ
group
conclus
short
durat
adjunct
inhal
colistin
show
signific
clearanc
initi
organ
includ
multidrug
resist
group
patient
gram
neg
ventilatorassoci
pneumonia
line
treatment
show
signific
decreas
durat
mechan
ventil
icu
mortal
compar
convent
therapi
signific
ad
advers
drug
reaction
adjunct
inhal
colistin
safe
effect
addit
therapi
patient
gramneg
ventilatorassoci
pneumonia
introduct
ventilatorassoci
pneumonia
vap
due
multidrugresist
mdr
gramneg
bacteria
gnb
respons
prolong
ventil
day
sever
recent
studi
focus
aerosol
polymyxin
emphas
potenti
benefit
modal
inde
increas
bactericid
activ
situ
modal
led
faster
resolut
clinic
sign
perhap
acceler
wean
mechan
ventil
mv
purpos
determin
whether
aerosol
colistin
would
acceler
wean
mv
vap
due
mdr
gnb
method
prospect
random
trial
april
includ
patient
mv
h
develop
vap
defin
cpi
clinic
pulmonari
infect
score
exclus
criteria
septic
shock
bacteremia
includ
patient
divid
two
random
group
first
group
receiv
colistin
million
unit
mu
nebulis
time
per
h
second
group
receiv
colistin
iv
load
dose
mu
follow
two
time
per
h
colistin
given
day
extub
patient
follow
day
outcom
measur
primari
clinic
cure
defin
pathogen
erad
improv
oxygen
mainli
wean
mv
secondari
length
stay
mortal
ethic
approv
protocol
obtain
institut
review
board
result
total
patient
analyz
cure
rate
similar
vs
p
administr
superior
improv
ratio
evolut
also
faster
pathogen
erad
p
survivor
wean
ventil
significantli
earlier
group
vs
p
differ
secondari
outcom
measur
tabl
conclus
critic
ill
patient
vap
due
mdr
gnb
colistin
facilit
wean
mv
modal
superior
improv
oxygen
time
requir
pathogen
erad
introduct
colistin
lastlin
therapeut
agent
treatment
multidrugresist
gramneg
infect
limit
use
due
nephrotox
retrospect
cohort
studi
evalu
risk
factor
colistininduc
sever
acut
kidney
injuri
aki
critic
ill
patient
method
patient
admit
univers
hospit
icu
without
preexist
kidney
injuri
receiv
colistin
therapi
hour
includ
patient
demograph
sourc
infect
outcom
collect
aki
evalu
use
rifl
criteria
risk
factor
develop
aki
analyz
via
logist
regress
analysi
result
onehundr
two
patient
includ
studi
overal
incid
aki
n
sever
aki
n
univari
analysi
age
septic
shock
correl
significantli
sever
aki
patient
p
p
respect
multivari
logist
regress
analysi
septic
shock
independ
risk
factor
colistininduc
sever
aki
p
conclus
high
incid
colistininduc
aki
defin
rifl
criteria
observ
critic
ill
patient
septic
shock
variabl
independ
associ
sever
aki
induc
colistin
therapi
refer
li
j
nation
rl
miln
rw
turnidg
jd
coulthard
k
evalu
colistin
agent
multiresist
gramneg
bacteria
intern
journal
antimicrobi
agent
kim
j
lee
kh
yoo
pai
h
clinic
characterist
risk
factor
colistininduc
nephrotox
intern
journal
antimicrobi
agent
rocco
montini
l
alessandri
e
venditti
laderchi
de
pascal
g
raponi
g
vital
pietropaoli
p
antonelli
risk
factor
acut
kidney
injuri
critic
ill
patient
receiv
high
intraven
dose
colistin
methanesulfon
andor
nephrotox
antibiot
retrospect
cohort
studi
critic
care
london
england
introduct
inhal
antibiot
adjunct
system
antibiot
present
signific
treatment
modal
icu
patient
nosocomi
pneumonia
np
aim
studi
investig
efficaci
inhal
tobramycin
adjunct
system
antibiot
treatment
np
sepsi
method
sixti
icu
ventil
septic
patient
np
enrol
retrospect
studi
male
year
old
primari
reason
icu
stay
intraabdomin
infect
mediastin
diagnosi
np
made
accord
standard
clinic
cpi
criteria
associ
multiresist
gramneg
bacteria
sensit
tobramycin
detect
bronchoalveolar
lavag
bal
patient
patient
random
two
group
n
addit
system
antibiot
carbapenem
aminoglycosid
protect
penicillin
n
shift
system
antibiot
accord
sensit
group
compar
apach
ii
cpi
score
inhal
tobramycin
administ
mg
twice
daili
via
nebul
np
resolut
day
initi
assess
primari
outcom
data
statist
analyz
statistica
newman
keul
test
p
result
administr
adjunct
system
antibiot
associ
higher
incid
np
resolut
vs
p
criterion
decreas
microbi
titer
cfuml
detect
group
day
reliabl
patient
group
p
erad
microb
bal
day
achiev
ittreat
patient
antibiot
shift
patient
treatment
made
possibl
wean
patient
earlier
day
vs
group
p
hear
loss
tinnitu
detect
three
patient
treat
case
bronchospasm
inhal
mortal
rate
differ
group
itgroup
vs
antibiot
shift
group
conclus
administr
adjunct
system
antibiot
effici
treatment
np
lead
higher
rate
np
resolut
earlier
wean
ventil
introduct
amikacin
inhal
integr
drugdevic
combin
pulmonari
drug
deliveri
system
pdd
vibrat
mesh
nebul
special
formul
amikacin
inhal
solut
ai
develop
gramneg
pneumonia
intub
mechan
ventil
patient
fig
vitro
studi
compar
deliv
dose
ai
pdd
vs
commerci
avail
method
deliveri
ai
mg
ml
mgml
compar
pdd
vs
commerci
avail
jet
ultrason
convent
vibrat
mesh
nebul
cvmn
test
ventil
locat
specifi
instruct
use
ifu
cvmn
test
posit
except
cvmn
prehumidifi
test
perform
without
humidif
result
vibrat
mesh
nebul
pdd
cvmn
achiev
higher
deliv
dose
ultrason
jet
nebul
deliv
dose
ai
postet
tube
higher
pdd
vs
cvmn
vs
nomin
ai
collect
expiratori
filter
cvmn
vs
pdd
cvmn
improv
deposit
extra
locat
rel
ifu
posit
still
lower
pdd
fig
deliv
dose
cvmn
affect
humid
previous
shown
affect
pdd
conclus
amikacin
inhal
ai
deliv
pdd
provid
higher
deliv
dose
ai
vs
commerci
avail
nebul
refer
kadrichu
et
al
j
aerosol
med
pulm
drug
del
kadrichu
et
al
intens
care
med
introduct
nebul
antibiot
promis
strategi
treatment
sever
pulmonari
infect
test
anim
model
sever
pneumonia
shortterm
therapeut
efficaci
nebul
system
antibiot
method
seventeen
pig
kg
anesthet
mv
hour
multilobar
pneumonia
develop
p
aeruginosa
resist
amikacin
fosfomycin
f
suscept
meropenem
mero
follow
clinic
diagnosi
pneumonia
anim
random
receiv
follow
treatment
nebul
salin
control
nebul
af
nebul
nebul
f
nebul
af
mero
administ
iv
mero
alon
nebul
perform
inlin
vibrat
mesh
nebul
pari
gmbh
germani
upon
autopsi
lung
weigh
lobe
biopsi
paeruginosa
quantif
result
upon
autopsi
lung
weigh
control
group
af
group
f
af
mero
mero
group
p
depict
fig
paeruginosa
concentr
lung
tissu
vari
among
group
p
particular
af
merop
group
highest
bactericid
efficaci
achiev
conclus
anim
model
amikacinresist
paeruginosa
pneumonia
adjunct
use
nebul
af
system
meropenem
achiev
higher
bactericid
efficaci
vs
nebul
system
antibiot
alon
refer
luna
c
et
al
chest
introduct
despit
administr
bodyweight
standard
start
dose
gentamicin
wide
rang
peak
concentr
cpeak
gener
observ
critic
ill
patient
result
variabl
pharmacokinet
gentamicin
patient
within
patient
time
may
hamper
efficaci
gentamicin
treatment
aim
studi
determin
percentag
patient
reach
target
cpeak
level
mgl
first
dose
well
subsequ
dose
therapeut
drug
monitor
tdm
appli
quantifi
impact
sever
patient
paramet
volum
distribut
vd
gentamicin
correl
cpeak
method
blood
sampl
prospect
collect
analys
nonlinear
mixedeffect
model
nonmem
estim
vd
cpeak
everi
administr
cours
gentamicin
therapi
clinic
data
routin
collect
serum
gentamicin
level
critic
ill
patient
analys
retrospect
nonmem
quantifi
impact
patient
paramet
gentamicin
vd
cpeak
result
median
start
dose
mgkg
cpeak
subtherapeut
first
dose
n
patient
total
cpeak
within
therapeut
rang
mgl
cours
therapi
case
subsequ
cpeak
valu
dose
adjust
chang
nontherapeut
therapeut
chang
therapeut
nontherapeut
cpeak
even
perform
tdm
subsequ
dose
result
subtherapeut
supratherapeut
level
analysi
perform
retrospect
gentamicin
concentr
measur
critic
ill
patient
receiv
dose
albumin
serum
level
significantli
p
associ
vd
cpeak
patient
albumin
level
mgl
obtain
therapeut
cpeak
conclus
gentamicin
cpeak
therapeut
rang
first
median
dose
mgkg
critic
ill
patient
suggest
higher
dose
indic
patient
hypoalbuminaemia
increas
risk
achiev
suboptim
gentamicin
cpeak
suggest
gentamicin
dose
increas
patient
hypoalbuminaemia
sinc
gross
fluctuat
cpeak
observ
time
within
patient
cpeak
measur
repeatedli
patient
receiv
gentamicin
treatment
day
introduct
cefepim
wide
use
antibiot
potenti
signific
underappreci
neurotox
due
abil
cross
blood
brain
barrier
antagon
gaba
activ
concentr
depend
fashion
data
suggest
icu
patient
treat
cefepim
experi
neurotox
symptom
rang
encephalopathi
myoclonu
seizur
coma
recognit
advers
event
difficult
sinc
symptom
commonli
experienc
critic
ill
review
publish
literatur
character
advers
drug
event
method
librarianassist
search
conduct
creat
list
public
associ
cefepim
associ
neurotox
patient
search
employ
cinahl
medlin
databas
articl
identif
prismap
protocol
follow
promot
robust
report
data
determin
elig
studi
inclus
identifi
articl
independ
assess
two
review
result
thirtyf
identifi
public
describ
cefepim
induc
neurotox
patient
patient
characterist
includ
icu
nonicu
patient
patient
locat
unspecifi
case
symptom
includ
encephalopathi
myoclonu
seizur
coma
renal
dysfunct
present
patient
cefepim
dose
appropri
excess
unabl
assess
respect
symptom
onset
day
median
initi
therapi
resolut
within
day
median
cessat
cefepim
emerg
hemodialysi
employ
one
case
patient
requir
treatment
antiepilept
medic
serum
level
collect
patient
exceed
toxic
threshold
mcgml
patient
mean
ugml
ninetyon
patient
surviv
patient
die
individu
outcom
remain
patient
unreport
complet
neurolog
recoveri
report
patient
symptom
improv
patient
report
neurolog
recoveri
improv
cefepim
discontinu
conclus
cefepim
associ
neurotox
underappreci
advers
drug
event
difficult
recogn
critic
ill
earli
recognit
cefepim
neurotox
critic
may
prevent
potenti
devast
consequ
occur
continu
drug
administr
introduct
patient
admit
intens
care
unit
multifactori
disord
base
diseas
cascad
immunomodul
mediat
may
releas
respons
pathogen
organ
treat
inflammatori
reaction
antibiot
therapi
fundament
effect
diseas
pattern
intens
care
measur
eg
sepsi
heart
rate
variabl
poorli
understood
haran
b
describ
high
resolut
ecg
even
patient
without
prior
heart
patholog
electr
instabl
could
detect
repolaris
shortli
cardiac
arrest
record
convent
ecg
therefor
analys
chang
beattobeat
cardiac
activ
antibiot
therapi
intens
care
patient
high
resolut
electrocardiogram
obtain
result
may
offer
new
insight
develop
alter
cardiac
electr
activ
critic
ill
patient
due
antibiot
therapi
method
administr
hz
sampl
rate
cardiac
electr
activ
patient
intens
care
unit
analys
antibiot
therapi
patient
receiv
contain
g
sulbactam
g
ampicillin
mg
sodium
obtain
continu
tenminut
record
lab
systemth
pro
bard
electrophysiolog
usa
ten
electrod
fix
prepar
skin
record
lead
ii
iii
reconstruct
pursuant
einthoven
equat
avr
avl
avf
result
result
obtain
treatment
demonstr
onset
infus
qtinterv
increas
addit
ms
p
variat
persist
first
three
minut
therapi
return
next
two
minut
prevalu
ecg
data
remain
unchang
time
treatment
conclus
haemodynam
alter
qtinterv
prolong
could
detect
onset
antibiot
treatment
similar
antibiot
show
anoth
studi
us
signific
beattobeat
chang
regard
comorbid
icu
patient
seem
reason
chang
cardiac
electr
activ
might
observ
even
earlier
icu
stay
refer
weimann
k
j
int
med
re
haran
b
journal
electrocardiolog
introduct
object
compar
efficaci
safeti
vancomycin
versu
teicoplanin
methicillinresist
staphylococcu
aureu
mrsa
infect
among
poison
patient
toxicolog
icu
loghman
hakim
hospit
method
safeti
efficaci
vancomycin
versu
teicoplanin
assess
patient
consist
patient
treat
teicoplanin
patient
treat
vancomycin
base
manufactur
instruct
kidney
function
patient
drug
dose
adjust
teicoplanin
administ
load
dose
mgkg
mg
maximum
dose
three
load
dose
everi
hr
everi
hr
day
vancomycin
administ
load
dose
mgkg
everi
hr
maximum
dose
blood
urin
tracheal
sampl
cultur
chest
xray
routin
para
clinic
studi
done
case
studi
popul
assess
visit
one
month
follow
patient
fever
posit
tracheal
cultur
tc
abnorm
wbc
end
treatment
report
failur
treatment
result
seventi
eight
elig
patient
male
mean
age
sd
patient
teicoplanin
vancomycin
group
respect
common
drug
toxic
opium
tca
tricycl
antidepress
methadon
mortal
rate
teicoplanin
group
vancomycin
complic
respiratori
infect
process
seen
vancomycin
teicoplanin
group
respect
includ
ard
vancomycin
group
teicoplanin
group
pleural
effus
vancomycin
group
versu
patient
teicoplanin
group
one
patient
teicoplanin
group
empyema
vancomycin
group
chronic
obstruct
pulmonari
diseas
copd
treatment
failur
vancomycin
group
teicoplanin
group
p
valu
posit
tc
group
polymicrobi
nephrotox
bicytopenia
advers
effect
signific
differ
two
group
conclus
teicoplanin
consid
effect
altern
vancomycin
methicillinresist
staphylococcu
aureu
mrsa
infect
treatment
advers
effect
nephrotox
bicytopeniasignificantli
decreas
teicoplanin
therapi
introduct
bacteriophag
environment
virus
lytic
phage
proprieti
penetr
multipli
insid
target
bacteria
releas
new
virion
mani
clinic
empir
data
avail
georgia
poland
control
random
clinic
trial
avail
phagoburn
studi
assess
efficaci
toler
two
cocktail
bacteriophag
escherichia
coli
pseudomona
aeruginosa
method
natur
phage
isol
hospit
pari
sewag
featur
phenotyp
genotyp
exclud
transfer
antibiot
resist
gene
lysogen
proprieti
pherecydespharma
cocktail
phage
e
coli
perform
p
aeruginosa
cocktail
appli
topic
way
burn
patient
infect
e
coli
p
aeruginosa
appli
algin
gauz
algosteril
onto
infect
wound
control
arm
treat
silver
sulfadiazin
standard
treatment
main
goal
comparison
time
reduc
bacteri
load
quadrant
plate
daili
eswab
patient
expect
patient
hospit
burn
unit
ensur
safeti
environ
result
phagoburn
fund
european
commiss
million
euro
transfer
research
develop
master
phage
bank
bioproduct
phage
perform
gmplike
condit
clean
cell
nantesfr
system
absorpt
phage
suppos
isol
necessari
ensur
steril
apyrogen
solut
european
regul
french
agenc
ansm
afmp
belgium
swissmed
switzerland
allow
first
inclus
juli
decemb
patient
alreadi
includ
investig
center
conclus
one
centuri
phage
discoveri
phagoburn
first
mutlicentr
control
random
trial
ever
done
world
phage
therapi
human
result
avail
phage
could
old
innov
way
war
antimicrobi
resist
antimicrobi
resist
could
lead
caus
mortal
refer
natur
review
volum
august
lancet
infecti
diseas
volum
decemb
natur
review
microbiolog
aop
publish
onlin
novemb
introduct
effect
antibiot
therapi
defin
time
administr
antibiot
caus
microorgan
suscept
use
right
dose
associ
improv
outcom
sever
sepsi
septic
shock
howev
antibiot
dose
error
uncommon
studi
evalu
frequenc
risk
factor
antibiot
dose
error
patient
sever
sepsi
septic
shock
method
prospect
observ
studi
adult
patient
sever
sepsi
septic
shock
admit
icu
use
micromedex
refer
dose
administ
intraven
antibiot
first
icu
day
compar
recommend
dose
classifi
underdos
overdos
appropri
exclud
antibiot
usual
need
dose
adjust
multivari
logist
regress
analysi
perform
assess
predictor
antibiot
dose
error
overdos
age
gender
height
weight
chronic
cardiovascular
renal
diseas
estim
glomerular
filtrat
rate
presenc
shock
independ
variabl
result
studi
period
patient
sever
sepsi
septic
shock
evalu
antibiot
prescript
patient
receiv
appropri
antibiot
dose
howev
patient
underdos
overdos
combin
overdos
underdos
septic
patient
chronic
cardiovascular
diseas
p
chronic
renal
failur
p
like
antibiot
dose
error
howev
respiratori
failur
liver
failur
immunodefici
state
diabet
mellitu
clearli
associ
dpose
error
vancomycin
associ
highest
dose
error
rate
antibiot
pipercillintazobactam
meropenem
imipenem
ceftriaxon
ciprofloxacin
colistin
gentamicin
dose
appropri
prescript
multivari
analysi
show
estim
glomerular
filtrat
rate
variabl
associ
dose
error
odd
ratio
per
mlmin
increment
confid
interv
conclus
antibiot
dose
error
includ
overdos
common
patient
sever
sepsi
septic
shock
vancomycin
highest
rate
inappropri
dose
lower
glomerular
filtrat
rate
signific
predictor
dose
error
routin
consid
antibiot
dose
introduct
manag
invas
candidiasi
ic
remain
major
challeng
delay
antifung
therapi
known
independ
mortal
factor
septic
shock
attribut
ic
thu
empir
antifung
therapi
eaft
indic
septic
patient
risk
ic
howev
unreason
administr
antifung
implic
emerg
resist
candida
strain
purpos
evalu
impact
eaft
surviv
septic
patient
without
document
candida
infect
method
retrospect
cohort
studi
two
group
septic
patient
without
document
fungal
infect
compar
accord
whether
treat
eaft
includ
hospit
patient
seven
day
develop
sepsi
even
sepsi
origin
determin
exclud
patient
treat
antifung
adapt
document
fungal
infect
immunocompromis
analysi
consist
evalu
impact
eaft
surviv
analysi
adjust
follow
confound
factor
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
candida
score
invas
ventil
central
catheteris
result
patient
includ
eaft
group
eaft
group
patient
baselin
characterist
compar
sever
ill
underli
diseas
risk
factor
ic
moreov
eaft
group
younger
age
vs
p
higher
candida
score
vs
p
demonstr
improv
surviv
eaft
administ
septic
patient
without
document
fungal
infect
result
accord
crude
analysi
adjust
apach
ii
score
candida
score
invas
ventil
central
catheteris
ci
p
valu
howev
improv
surviv
eaft
show
patient
apacheii
score
p
similar
result
objectifi
kaplanmei
surviv
curv
conclus
benefici
impact
eaft
surviv
apart
moder
ill
patient
apach
ii
refer
kollef
et
al
clin
infect
di
fekkar
et
al
eur
j
clin
microbiol
di
introduct
neurocysticercosi
ncc
common
parasit
diseas
central
nervou
system
everi
newli
diagnos
patient
ncc
probabl
infect
someon
harbor
tapeworm
patient
immedi
environ
basi
incorrect
assumpt
human
ncc
occur
countri
law
prohibit
swine
breed
consumpt
pork
diseas
consid
nonexist
arab
world
method
retrospect
studi
carri
emerg
depart
alkhor
hospit
hmc
april
may
patient
age
yr
diagnos
neurocysticercosi
august
decemb
includ
studi
data
retriev
medic
record
depart
electron
data
base
includ
baselin
demographi
clinic
present
radiolog
find
result
total
subject
enrol
exclud
subject
male
major
subject
age
group
yr
n
major
nepal
patient
gave
histori
previou
episod
seizur
howev
regular
antiepilept
medic
patient
present
e
seizur
among
gtc
common
form
use
tobacco
seen
subject
alchohol
subject
report
use
radiolog
examin
ct
scan
reveal
solitari
lesion
subject
major
calcifi
perilesion
edema
note
subject
patient
admit
hospit
requir
icu
care
antiepilept
medic
initi
patient
except
patient
reason
could
identifi
except
patient
patient
receiv
short
cours
oral
steroid
conclus
major
patient
young
male
asian
countri
gtc
common
mode
present
solitari
lesion
common
radiolog
find
increas
eas
intern
travel
increas
number
immigr
develop
countri
led
widespread
recognit
ncc
develop
countri
refer
grow
frequenc
neurocysticercosi
spain
esquivel
neurologia
introduct
acut
haemorrhag
ccu
may
hard
perceiv
variabl
blood
pressur
haemoglobin
sought
method
studi
examin
acut
haemorrhag
affect
cardiovascular
blood
ga
laboratori
pulmonari
ga
exchang
variabl
right
minut
blood
loss
model
anesthet
pig
blood
pressur
lactat
concentr
base
deficit
blood
glucos
may
act
indic
acut
haemorrhag
result
anim
compar
variabl
baselin
right
exsanguin
anim
expectedli
show
depress
cardiovascular
variabl
addit
lactat
blood
glucos
increas
directli
blood
loss
drop
haemoglobin
concentr
still
remain
insignific
minut
blood
loss
base
deficit
differ
minut
post
bleed
conclus
glucos
lactat
earlier
indic
hb
introduct
red
blood
cell
rbc
transfus
associ
acut
lung
injuri
caus
factor
known
possibl
mechan
ventil
red
blood
cell
rbc
transfus
synergist
induct
lung
injuri
hypothes
filter
rbc
deplet
rbc
microvesicl
decreas
pulmonari
inflammatori
reaction
mechan
ventil
object
studi
investig
effect
filter
rbc
deplet
rbc
microvesicl
product
vitro
model
mechan
ventil
method
alveolar
epitheli
type
ii
cell
cultur
elast
membran
incub
cell
supernat
store
day
rbc
product
rbc
optim
filter
supernat
use
filter
deplet
supernat
microvesicl
use
highspe
centrifug
n
per
group
cyclic
stretch
appli
cell
hour
use
cellstretch
presenc
product
measur
use
elisa
control
untreat
product
nonstretch
cell
result
stretch
cell
show
higher
level
compar
nonstretch
cell
vs
pgml
p
incub
untreat
rbc
product
spike
product
compar
cell
stretch
vs
pgml
p
filter
supernat
deplet
microvesicl
result
reduct
level
compar
sampl
untreat
rbc
ad
respect
vs
vs
pgml
p
conclus
stretch
alveolar
cell
rbc
transfus
synergist
effect
product
furthermor
experi
indic
supernat
rbc
contain
caus
agent
product
possibl
microvesicl
respons
reaction
filter
rbc
might
reason
feasibl
procedur
remov
microvesicl
product
introduct
red
blood
cell
rbc
transfus
associ
increas
morbid
mortal
critic
ill
hypothes
mp
store
rbc
bag
induc
endotheli
activ
either
directli
mediat
immun
cell
method
mp
isol
high
speed
centrifug
rbc
transfus
bag
human
umbil
vascular
endotheli
cell
huvec
incub
hour
supernat
rbc
bag
either
contain
mp
deplet
mp
without
addit
monocyt
granulocyt
control
incub
pb
neg
tnf
posit
control
express
adhes
marker
measur
flow
cytometri
marker
coagul
inflamm
measur
cultur
medium
monocyt
cultur
stain
mp
adher
studi
use
confoc
microscopi
result
supernat
rbc
contain
mp
upregul
endotheli
express
icam
eselectin
resp
compar
baselin
upregul
absent
stimul
rbc
supernat
deplet
mp
also
upregul
depend
presenc
monocyt
mp
adher
monocyt
partli
abrog
coincub
antibodi
posit
cell
resp
rbcderiv
ev
also
strongli
induc
endotheli
shed
vwf
conclus
upregul
endotheli
cell
adhes
marker
shed
vwf
antigen
follow
rbc
transfus
caus
mp
requir
presenc
monocyt
therebi
mp
rbc
unit
induc
proinflammatori
procoagul
endotheli
cell
respons
introduct
develop
thrombosi
icu
patient
one
frequent
caus
unfavour
outcom
differ
type
sever
ill
accompani
activ
cellular
biochem
process
aim
studi
investig
possibl
effect
cytokin
thrombosi
trauma
neurosurg
patient
icu
method
eightyfour
patient
trauma
includ
studi
divid
two
group
accord
thrombosi
incid
demograph
clinic
data
record
singl
blood
sampl
collect
admiss
interleukin
il
tumor
necrosi
factor
tnf
determin
serum
elisa
statist
perform
graphpad
result
patient
thrombosi
show
statist
signific
elev
proinflammatori
cytokin
tnfa
p
p
lower
antiinflammatori
releas
p
admiss
compar
without
thrombosi
admiss
level
differ
group
p
due
later
express
signific
differ
age
hospit
day
group
thrombosi
found
correl
poor
outcom
p
conclus
earli
activ
cytokin
trauma
neurosurg
patient
seem
play
import
role
thrombosi
develop
patient
outcom
refer
markopoul
venetsan
k
et
al
examin
venou
thromboembol
diseas
postop
neurosurg
trauma
patient
icu
critic
care
suppl
p
introduct
incid
venou
thromboembol
vte
acut
burn
patient
report
rang
standard
enoxaparin
prophylaxi
dose
shown
provid
antixa
level
goal
signific
proport
burn
patient
result
potenti
increas
thrombot
risk
object
studi
evalu
effect
standard
prophylaxi
enoxaparin
dose
within
inpati
burn
unit
identifi
patient
characterist
associ
lower
initi
antixa
level
method
patient
admit
burn
unit
novemb
juli
appropri
measur
antixa
level
examin
retrospect
chart
review
level
consid
appropri
drawn
hour
least
three
consecut
enoxaparin
dose
antixa
level
rang
consid
within
goal
prophylact
rang
patient
demograph
injuri
data
includ
age
sex
admiss
weight
burn
percentag
total
bodi
surfac
area
tbsa
document
incid
vte
advers
event
includ
bleed
event
attribut
enoxaparin
also
record
result
thirtythre
acut
burn
injuri
patient
treat
enoxaparin
least
one
measur
antixa
level
admiss
patient
initi
antixa
level
within
specifi
goal
rang
addit
patient
initi
subtherapeut
achiev
therapeut
level
dose
adjust
patient
never
measur
antixa
within
goal
rang
prior
discontinu
enoxaparin
discharg
median
enoxaparin
dose
requir
achiev
goal
antixa
level
mg
everi
hour
patient
initi
therapeut
level
averag
burn
size
tbsa
mean
admiss
weight
kg
initi
subtherapeut
level
averag
burn
size
tbsa
mean
admiss
weight
kg
one
vte
event
among
studi
popul
occur
patient
therapeut
antixa
level
document
bleed
event
lead
discontinu
enoxaparin
studi
particip
conclus
standard
enoxaparin
dose
shown
provid
initi
subtherapeut
antixa
level
mani
patient
acut
burn
injuri
overal
studi
popul
enoxaparin
dose
strategi
associ
low
incid
vte
bleed
complic
refer
faucher
ld
et
al
j
burn
care
re
lin
h
et
al
j
trauma
introduct
purpos
studi
determin
optim
cutoff
valu
haemoglobin
platelet
count
fibrinogen
hour
injuri
associ
mortal
trauma
patient
method
perform
retrospect
analysi
patient
surviv
hour
injuri
joctet
japanes
observ
studi
coagul
thrombolysi
earli
trauma
databas
joctet
retrospect
multicent
studi
investig
disord
coagul
thrombolysi
patient
sever
trauma
multivari
logist
regress
model
develop
determin
optim
cutoff
valu
hemoglobin
platelet
count
fibrinogen
hour
injuri
valid
model
intern
bootstrap
assess
potenti
overfit
result
trauma
patient
includ
median
age
year
median
injuri
sever
score
median
revis
trauma
score
overal
mortal
optim
model
associ
mortal
hemoglobin
gdl
cstatist
ci
platelet
count
l
fibrinogen
mgdl
cycl
bootstrap
averag
optim
respect
conclus
hemoglobin
gdl
platelet
count
l
fibrinogen
mgdl
hour
injuri
associ
mortal
impact
correct
valu
blood
product
warrant
valid
refer
spahn
dr
bouillon
b
cerni
v
et
al
manag
bleed
coagulopathi
follow
major
trauma
updat
european
guidelin
crit
care
morel
n
delaunay
f
dubuisson
v
manag
bleed
follow
major
trauma
target
haemoglobin
gdl
high
enough
crit
care
introduct
mortal
patient
traumat
injuri
case
bleed
frequent
caus
prevent
death
sever
injuri
method
studi
involv
patient
enter
odessa
region
hospit
traumat
injuri
concomit
skelet
trauma
fractur
femur
humeru
patient
divid
group
group
n
treatment
receiv
pcc
dose
mlkg
iukg
txa
load
dose
g
minut
follow
infus
g
hour
time
admiss
intens
care
unit
icu
group
n
receiv
ffp
dose
mlkg
txa
load
dose
g
minut
follow
infus
g
hour
evalu
function
state
hemostasi
system
carri
use
lowfrequ
piezoelectr
thromboelastographi
lpteg
admiss
hospit
hour
patient
admiss
icu
result
accord
lpteg
indic
traumat
injuri
patient
statist
signific
abnorm
part
hemostat
system
platelet
aggreg
intens
contact
coagul
icc
coagul
intens
coagul
drive
icd
clot
maximum
densiti
fibrinolyt
activ
index
retract
clot
lysi
ircl
icc
patient
traumat
injuri
reduc
icd
less
normal
reduc
show
coagulopathi
ircl
norm
stand
express
hyperfibrinolysi
patient
group
accord
lpteg
signific
chang
part
coagul
hour
intens
care
indic
platelet
hemostasi
character
persist
hypoagreg
icc
reduc
compar
norm
paramet
coagul
fibrinolysi
reliabl
trend
toward
normal
decreas
activ
fibrinolysi
index
reach
normal
refer
valu
patient
group
hypoagreg
hypocoagul
state
decreas
activ
fibrinolysi
icc
reduc
icd
reduc
reduc
ircl
normal
rang
clinic
patient
group
reduc
volum
blood
transfus
oppos
group
conclus
patient
traumainduc
coagulopathi
violat
part
hemostat
system
use
prothrombin
complex
concentr
tranexam
acid
reduc
sever
patholog
chang
hemostasi
patient
traumat
injuri
introduct
prothrombin
complex
concentr
pcc
prove
effici
fresh
frozen
plasma
ffp
achiev
faster
coagulopathi
revers
mani
factor
howev
recent
cochran
reviewanalysi
found
superior
pcc
ffp
mortal
addit
research
need
determin
impact
pcc
mortal
method
retrospect
cohort
studi
enrol
adult
present
emerg
depart
tertiarycar
center
march
februari
patient
evid
acut
bleed
sourc
anticoagul
vitamin
kantagonist
receiv
vitamin
k
upon
arriv
compar
mortal
rate
ffp
pcc
use
kaplan
meier
surviv
curv
cox
multivari
regress
result
identifi
patient
receiv
ffp
receiv
pcc
subject
treat
ffp
compar
pcc
increas
probabl
mortal
follow
period
hr
ci
p
control
confound
variabl
conclus
studi
confirm
decreas
mortal
year
follow
associ
pcc
use
compar
ffp
patient
present
type
acut
bleed
pcc
use
first
line
therapi
anticoagul
revers
vitamin
k
antagonist
refer
josepg
b
neurosurgeri
goldstein
j
lancet
johansen
cochran
databas
introduct
develop
world
deliveri
associ
postpartum
haemorrhag
pph
pph
occur
women
die
method
research
involv
patient
massiv
postpartum
bleed
section
divid
group
group
contain
patient
treatment
massiv
bleed
coagulopathi
schedul
pcc
dose
mlkg
iukg
pack
red
blood
cell
prbc
group
patient
receiv
fresh
frozen
plasma
ffp
dose
mlkg
prbc
function
state
hemostasi
system
carri
use
lowfrequ
pyezoelectr
thromboelastographi
lpteg
admiss
hospit
everi
hour
admiss
result
accord
lpteg
indic
patient
massiv
postpartum
bleed
abnorm
part
hemostat
system
platelet
aggreg
intens
contact
coagul
icc
reduc
coagul
intens
coagul
drive
icd
less
normal
clot
maximum
densiti
reduc
fibrinolyt
activ
index
retract
clot
lysi
ircl
norm
indic
platelet
hemostasi
patient
group
character
persist
hypoagreg
icc
reduc
compar
norm
paramet
coagul
fibrinolysi
reliabl
trend
toward
normal
decreas
activ
fibrinolysi
index
reach
normal
refer
valu
icd
less
normal
reduc
ircl
norm
hour
becam
normal
hour
infus
pcc
patient
group
hypoagreg
mild
hypocoagul
state
increas
activ
fibrinolysi
icc
reduc
icd
reduc
reduc
ircl
norm
hour
becam
normal
hour
infus
ffp
clinic
patient
group
reduc
sign
blood
loss
decreas
volum
transfus
prbc
decreas
volum
infus
therapi
compar
patient
ng
group
case
transfus
relat
lung
injuri
group
conclus
obstetr
patient
massiv
postpartum
bleed
violat
part
hemostat
system
use
prothrombin
complex
concentr
reduc
level
blood
loss
decreas
volum
transfus
pack
red
blood
cell
infus
therapi
reduc
use
blood
compon
intens
care
unit
massiv
bleed
method
prevent
develop
tralisyndrom
introduct
aim
observ
retrospect
studi
test
hypothesi
correl
exist
ffp
transfus
incid
vap
medic
surgic
icu
serv
commun
hospit
method
januari
june
admit
icu
patient
databas
look
incid
vap
ventil
day
follow
valu
index
accord
ffp
transfus
per
year
mean
valu
total
per
patient
per
hospit
day
hd
per
patient
mechan
ventil
pt
v
per
ventil
day
vd
use
linear
correl
method
look
linear
slope
correl
coeffici
r
coeffici
determin
linear
regress
method
use
anova
test
look
p
valu
accord
vap
ffp
transfus
result
conclus
accord
data
statist
signific
correl
detect
vap
ffp
transfus
index
data
suggest
even
though
ffp
transfus
may
impact
immunosuppress
infect
diseas
develop
impact
vap
statist
signific
introduct
peri
postop
bleed
major
caus
morbid
mortal
cardiac
surgeri
studi
evalu
valu
thrombin
gener
tg
new
platelet
function
analysi
predict
haemostat
problem
method
studi
patient
undergo
cardiac
surgeri
blood
sampl
collect
surgeri
n
upon
arriv
icu
n
tg
measur
calibr
autom
thrombographi
cat
blood
loss
record
hour
surgeri
platelet
function
assess
platelet
activ
test
pactub
estim
pselectin
express
bind
fibrinogen
activ
platelet
activ
gpvi
receptor
specif
agonist
gpvicrp
patient
divid
high
low
blood
loss
group
cutoff
valu
liter
icu
stay
result
tg
paramet
lagtim
timetopeak
preoper
sampl
whole
blood
show
signific
prolong
high
blood
loss
group
vs
p
vs
p
respect
pactub
test
show
signific
differ
group
pselectin
express
gpvi
agonist
tabl
fibrinogen
bind
conclus
preoper
assess
tg
measur
cat
predict
blood
loss
follow
cardiac
surgeri
find
may
help
identifi
patient
risk
postop
bleed
complic
introduct
prolong
valu
prothrombin
timeactiv
partial
thromboplastin
time
ptaptt
often
found
patient
undergo
surgic
procedur
thromboelastometri
global
test
use
whole
blood
might
yield
differ
result
aim
studi
compar
coagul
profil
shown
convent
coagul
test
versu
thromboelastometri
surgic
procedur
find
test
better
reflect
patient
clinic
condit
periop
period
method
patient
undergo
surgic
procedur
prolong
ptaptt
blood
sampl
obtain
thromboelastometryrotemextem
case
normal
result
patient
underw
procedur
without
administr
clot
factor
bleed
complic
observ
periop
period
result
patient
ptinr
aptt
procedur
perform
without
bleed
complic
rotemextem
normal
valu
paramet
conclus
data
suggest
surgic
procedur
done
without
bleed
complic
despit
prolong
ptaptt
case
normal
rotemextem
approach
reduc
ffp
administr
daili
practic
refer
moham
fay
n
hassanen
ahm
f
mourad
w
el
sheikh
abofetouh
f
yassen
k
khalil
marwan
tanaka
k
rotat
thromboelastometri
standard
coagul
test
live
liver
donor
clin
transplant
urwyl
n
theiler
l
hirschberg
kleinebrueggeney
colucci
g
greif
r
standard
vs
pointofcar
measur
fibrinogen
potenti
impact
clinic
decis
minerva
anestesiol
haa
spielmann
n
mauch
j
madjdpour
c
speer
schmugg
weiss
comparison
thromboelastometri
rotem
r
standard
plasmat
coagul
test
paediatr
surgeri
br
j
anaesth
keen
dd
nordmann
gr
woolley
rotat
thromboelastometryguid
trauma
resuscit
curr
opin
crit
care
gorling
k
saner
fh
prophylact
plasma
platelet
transfus
critic
ill
patient
useless
expens
even
harm
bmc
anesthesiol
introduct
bleed
sever
thrombocytopenia
tcp
vari
mild
sever
may
even
lifethreaten
accompani
hemodilut
result
trauma
subsequ
fluid
resuscit
aim
studi
evalu
effect
fibrinogen
activ
prothrombin
complex
concentr
feiba
clot
qualiti
resist
fibrinolysi
model
tcp
hemodilut
method
blood
obtain
healthi
volunt
sign
inform
consent
form
approv
local
research
ethic
committe
tcp
x
creat
mix
plateletpoor
plasma
pack
cell
sampl
dilut
trissalin
buffer
subject
clot
presenc
tpa
blood
spike
fibrinogen
mgml
andor
feiba
uml
maximum
clot
firm
mcf
mm
lysi
onset
time
lot
min
evalu
use
rotat
thromboelastometri
present
mean
sd
result
mcf
nondilut
tcp
blood
spike
blood
fibrinogen
feiba
increas
respect
p
combin
use
agent
increas
mcf
p
dilut
tcp
blood
reduc
mcf
p
spike
dilut
blood
fibrinogen
increas
mcf
p
spike
feiba
increas
p
combin
agent
greatest
effect
mcf
reach
p
differ
level
nondilut
blood
follow
combin
spike
lot
nondilut
tcp
blood
spike
blood
fibrinogen
effect
lot
spike
feiba
prolong
p
combin
use
agent
increas
lot
p
dilut
blood
well
spike
dilut
blood
fibrinogen
signific
effect
lot
spike
feiba
prolong
extent
nondilut
blood
p
compar
feiba
combin
agent
slightli
prolong
lot
differ
reach
statist
signific
conclus
nondilut
dilut
tcp
blood
fibrinogen
feiba
synergist
improv
clot
qualiti
firm
fibrinogen
alon
increas
clot
resist
fibrinolysi
potenti
effect
feiba
ad
combin
agent
could
serv
altern
therapeut
approach
bleed
patient
sever
tcp
introduct
activ
clot
time
act
current
use
dose
adjust
heparin
cpb
thought
gold
standard
field
howev
difficult
case
prolong
cardiopulmonari
bypass
consumpt
coagulopathi
might
also
occur
might
need
blood
compon
monitor
act
adequ
case
coaguchek
xs
system
portabl
instrument
monitor
oral
anticoagul
therapi
determin
ptinr
valu
drop
capillari
blood
specimen
report
accuraci
seem
better
hematocrit
ht
compar
ptinr
measur
coaguchek
xs
ccinr
ptinr
analyz
laboratori
test
labinr
cpb
method
patient
underw
cpb
enrol
wean
cpb
heparin
revers
protamin
administr
ccinr
labinr
act
aptt
ht
measur
correl
ccinr
labinr
act
aptt
assess
result
ccinr
correl
well
labinr
r
x
moreov
evalu
subgroup
whose
ht
n
mean
ht
correl
thought
accept
r
x
hand
correl
act
aptt
wide
consid
gold
standard
h
inferior
r
x
conclus
ccinr
use
altern
labinr
guid
blood
compon
therapi
cpb
introduct
intern
societi
thrombosi
haemostasi
isth
dic
score
system
develop
simpl
tool
diagnos
dic
base
platelet
count
prothrombin
time
pt
fibrinogen
level
fibrin
degrad
product
fdp
ddimer
result
howev
score
less
use
critic
ill
ddimer
fdp
usual
elev
due
underli
diseas
henc
neither
dic
score
fdp
ddimer
measur
routin
perform
icu
trigger
request
ddimer
measur
establish
method
retrospect
studi
includ
icu
patient
admit
rluh
period
demograph
detail
collect
admiss
along
routin
blood
result
first
day
truncat
dic
score
calcul
patient
coagul
test
done
day
platelet
count
point
point
point
pt
prolong
point
point
point
fibrinogen
gl
point
gl
point
patient
truncat
dic
score
consid
high
risk
dic
patient
cohort
highli
elev
ddimer
would
establish
diagnosi
overt
dic
patient
admit
elect
surgeri
stay
icu
day
exclud
result
patient
includ
analysi
icu
mortal
mean
apach
ii
patient
maximum
dic
score
patient
patient
risk
overt
dic
howev
patient
maximum
dic
score
patient
display
dic
score
even
without
ddimer
result
avail
none
patient
dic
score
ddimer
fdp
analys
one
patient
dic
score
normal
platelet
count
two
patient
show
mild
thrombocytopenia
patient
sever
thrombocytopenia
patient
moder
thrombocytopenia
dic
score
conclus
dic
although
associ
outcom
remain
underdiagnos
critic
ill
patient
patient
moder
sever
thrombocytopenia
truncat
dic
score
calcul
score
measur
ddimer
fdp
request
fulli
establish
diagnosi
dic
introduct
diagnos
thromboembol
diseas
repres
challeng
older
patient
copd
adjustp
studi
recent
valid
new
ageadjust
ddimer
cutoff
age
x
patient
older
year
old
result
studi
cautious
analyz
seem
valid
cutoff
patient
copd
unreli
object
current
studi
specif
valid
invalid
use
ageadjust
ddimer
cutoff
patient
copd
age
older
method
file
patient
visit
emerg
depart
de
march
may
retrospect
review
patient
age
older
copd
nonhigh
pretest
probabl
thromboembol
diseas
includ
patient
ddimer
measur
radiolog
exam
pulmonari
angioscan
ventilationperfus
lung
scan
lower
extrem
doppler
result
present
proport
confid
interv
without
continu
correct
sensit
measur
result
patient
includ
accord
criteria
exclud
analysi
nonconfirm
diagnosi
among
patient
analyz
diagnosi
thromboembol
diseas
result
preval
neg
ddimer
level
convent
cutoff
neg
ddimer
level
ageadjust
cutoff
sensit
convent
cutoff
sensit
ageadjust
cutoff
conclus
conclus
new
ageadjust
ddimer
cutoff
use
safe
patient
copd
older
year
old
nonhigh
pretest
probabl
thromboembol
diseas
refer
righini
jama
schouten
bmj
introduct
systemat
review
literatur
report
strategi
prevent
manag
mediastin
bleed
post
paediatr
cardiopulmonari
bypass
cpb
surgeri
method
scope
review
public
report
effect
intervent
outcom
postop
bleed
mediastin
drain
loss
transfus
requir
coagul
paramet
inclus
year
cardiac
surgeri
cpb
exclus
haematolog
disord
databas
includ
medlin
embas
result
screen
articl
includ
origin
research
predominantli
retrospect
prospect
observ
studi
smaller
proport
randomis
control
trial
rct
nonrandomis
control
trial
fig
studi
size
rang
median
frequent
evalu
intervent
blood
product
cpb
circuit
modif
antifibrinolyt
fig
public
number
increas
mean
rate
per
year
within
group
rais
increas
rct
conclus
varieti
intervent
bleed
preventiontreat
avail
trial
size
often
small
qualiti
evid
low
trend
toward
studi
higher
qualiti
rct
recent
year
introduct
aim
studi
evalu
impact
low
hemoglobulin
gdl
cardiopulmonari
bypass
cpb
hemodilut
postop
mortal
morbid
method
total
patient
underw
elect
cardiac
surgeri
procedur
use
cpb
depart
year
period
retrospect
studi
lowest
valu
hemoglobulin
nadir
hb
throughout
cpb
record
group
consist
patient
hb
gdl
group
b
control
group
follow
periop
outcom
indic
compar
group
increas
lactat
lac
valu
end
cpb
acut
kidney
injuri
aki
defin
rifl
criteria
postop
use
non
invas
ventil
niv
prolong
mechan
ventil
hour
periop
infarct
pmi
stroke
total
red
blood
transfus
atrial
fibril
af
mortal
statist
analysi
base
chisquar
test
result
patient
consist
group
control
group
result
shown
tabl
conclus
optim
hemoglobulin
cpb
defin
sever
hemodilut
anemia
hb
gdl
statist
signific
correl
increas
lac
valu
end
cpb
postop
aki
use
niv
prolong
mechan
ventil
transfus
red
blood
cell
unit
strong
correl
mortal
introduct
studi
found
correl
increas
rdw
mortal
icu
patient
howev
rdw
valu
increas
transfus
rbct
erythropoiesi
hemolysi
studi
investig
whether
prognost
valu
rdw
influenc
rbct
icu
patient
method
patient
admit
icu
month
enrol
studi
patient
analyz
two
group
rbct
given
b
receiv
rbct
icu
admiss
measur
rdw
reticulocyt
index
ri
haptoglobin
admiss
h
thereaft
rdw
categor
tertil
collect
mortal
chang
sofa
score
length
stay
icu
result
patient
enrol
group
group
b
clinic
variabl
shown
fig
coxregress
analysi
show
high
rdw
valu
significantli
associ
mortal
fig
patient
group
b
higher
level
rdw
admiss
vs
p
nevertheless
accuraci
rdw
predict
mortal
similar
two
group
roc
curv
group
group
b
patient
higher
rdw
also
lower
ri
similar
level
haptoglobin
compar
other
conclus
among
critic
ill
patient
rbct
associ
higher
rdw
influenc
prognost
valu
rdw
high
rdw
valu
could
secondari
increas
erythropoiesi
suggest
low
ri
introduct
import
part
puzzl
treatment
pediatr
intens
care
unit
picu
patient
pt
transfus
blood
blood
product
order
stabil
critic
ill
children
improv
outcom
purpos
present
studi
investig
reason
admiss
need
blood
product
transfus
cohort
picu
pt
specif
diagnost
categori
sepsi
traumat
brain
injuri
etc
method
studi
retrospect
consecut
admiss
picu
two
year
period
data
collect
chart
review
follow
paramet
demograph
reason
admiss
underli
diseas
treatment
characterist
blood
blood
product
transfus
outcom
patient
criterion
transfus
follow
sepsi
surviv
campaign
guidelin
pediatr
popul
european
guidelin
manag
bleed
coagulopathi
follow
major
trauma
special
case
criterion
transfus
clinic
signific
hemorrhag
definit
transfus
unit
equival
mlkg
red
pack
cell
rpc
fresh
frosen
plasma
ffp
unitkg
platelet
plt
cryoprecipit
cp
result
total
picu
patient
boy
girl
record
children
respiratori
failur
children
patholog
nervou
system
sepsi
mainli
admit
pediatr
oncolog
depart
traumat
brain
injuri
other
miscellan
reason
admiss
almost
children
respiratori
neurolog
failur
suffer
underli
diseas
total
unit
u
transfus
given
group
follow
rpc
u
ffp
u
plt
u
cp
u
conclus
common
reason
admiss
pediatr
intens
care
unit
respiratori
failur
patholog
nervou
system
critic
ill
children
present
mani
occas
anemia
thrombocytopenia
hemodynam
instabl
clot
bleed
disord
infect
administr
blood
blood
product
deriv
paramount
immedi
recognit
transfus
indic
earli
prompt
intervent
lead
better
faster
recoveri
small
patient
introduct
massiv
haemorrhag
lead
caus
death
major
trauma
onethird
bleed
trauma
patient
present
coagulopathi
result
physiolog
derang
acidosi
hypothermia
haemodilut
relat
fluid
administr
morriston
hospit
introduc
massiv
haemorrhag
protocol
mhp
emerg
depart
ed
aim
studi
evalu
impact
mhp
method
adult
trauma
patient
admit
ed
studi
use
data
collat
trauma
audit
research
network
variabl
includ
sex
age
injuri
sever
score
iss
code
injuri
sever
score
injuri
mechan
use
tranexam
acid
txa
volum
fluidsblood
compon
given
scene
ed
inhospit
mortal
hospit
icu
hospit
length
stay
patient
divid
two
group
patient
admit
premhp
patient
admit
postmhp
introduct
differ
analys
use
fisher
exact
test
mannwhitney
u
test
result
total
patient
includ
premhp
postmhp
group
signific
differ
age
sex
iss
code
injuri
mechan
mortal
two
group
use
txa
significantli
higher
postmhp
group
p
median
amount
fluid
given
scene
ed
significantli
higher
litr
versu
litr
premhp
group
p
significantli
higher
number
unit
prothrombin
complex
concentr
pcc
fresh
frozen
plasma
ffp
given
postmhp
group
ed
p
signific
differ
number
unit
blood
plasma
reduc
cell
given
ed
two
group
hospit
icu
length
stay
significantli
reduc
follow
introduct
mhp
p
conclus
result
studi
demonstr
welldefin
mhp
may
contribut
reduc
icu
hospit
length
stay
postmhp
group
patient
receiv
significantli
lower
amount
fluid
scene
ed
signific
increas
use
txa
signific
increas
amount
pcc
ffp
given
patient
ed
report
associ
increas
bloodplasma
reduc
cell
refer
spahn
bouillon
b
cerni
v
et
al
manag
bleed
coagulopathi
follow
major
trauma
crit
care
introduct
irrespect
aetiolog
major
haemorrhag
associ
poor
patient
outcom
manag
present
consider
clinic
logist
challeng
introduct
inhospit
major
haemorrhag
protocol
follow
damag
control
resuscit
dcr
principl
demonstr
improv
patient
outcom
blood
product
deliveri
reduc
wastag
blood
howev
simpl
adapt
hospitalderiv
protocol
inadequ
use
retriev
team
tailor
approach
requir
address
specif
challeng
encount
method
protocol
major
haemorrhag
manag
retriev
servic
develop
base
best
avail
evid
within
protocol
integr
guidanc
provid
retriev
team
clinic
coordin
result
clinic
challeng
intermiss
variabl
blood
product
avail
address
use
two
regim
within
one
retriev
team
algorithm
primari
regim
base
upon
resourc
carri
retriev
team
repres
minimum
standard
major
haemorrhag
manag
patient
interfacil
transfer
ift
regim
provid
guidanc
deliv
hospitalstandard
dcr
possibl
use
local
avail
resourc
logist
challeng
encount
retriev
team
extens
retriev
clinic
coordin
instrument
reduc
delay
maximis
use
resourc
maintain
handov
inform
role
clearli
defin
checklist
develop
order
avoid
omiss
protocol
adopt
retriev
servic
queensland
statewid
use
fix
rotari
wing
retriev
team
conclus
novel
protocol
address
mani
specif
clinic
logist
challeng
face
retriev
team
protocol
contain
specif
guidanc
yet
provid
flexibl
encompass
varieti
major
haemorrhag
scenario
encount
may
rang
roadsid
polytrauma
interfacil
transfer
intens
care
unit
patient
goal
seamless
transit
care
ongo
damag
control
resuscit
point
referr
transfer
upon
arriv
receiv
centr
refer
khan
major
haemorrhag
protocol
improv
deliveri
blood
compon
therapi
reduc
wast
trauma
massiv
transfus
injuri
pham
hp
shaz
bh
updat
massiv
transfus
br
j
anaesth
suppl
introduct
restrict
red
cell
transfus
polici
recommend
safe
major
hospit
patient
anaemia
uncertainti
exist
patient
cardiovascular
diseas
heart
may
suscept
limit
coronari
oxygen
suppli
method
perform
systemat
review
metaanalys
inhospit
randomis
control
trial
evalu
restrict
vs
liber
transfus
threshold
includ
patient
cardiovascular
diseas
comprehens
search
databas
includ
central
medlin
embas
perform
data
extract
complet
duplic
risk
bia
assess
use
cochran
methodolog
mantelhaenzel
random
effect
model
use
rel
risk
ratio
ci
outcom
measur
thirtyday
mortal
cardiovascular
event
result
identifi
trial
trial
enrol
cardiovascular
patient
n
includ
metaanalysi
restrict
n
patient
liber
n
associ
transfus
threshold
day
mortal
rr
ci
p
increas
risk
acut
coronari
syndrom
ac
patient
restrict
transfus
threshold
trial
rr
ci
p
fig
conclus
restrict
transfus
practic
associ
higher
rate
ac
patient
cardiovascular
diseas
support
uncertainti
highlight
current
guidelin
indic
need
research
best
practic
group
introduct
previous
demonstr
invers
relationship
preoper
level
endotoxin
core
antibodi
endocab
develop
complic
follow
cardiac
surgeri
known
whether
relationship
due
specif
protect
effect
specif
antigen
reflect
generalis
hypoimmun
periop
period
patient
risk
exposur
endotoxin
staphylococcu
incid
surgic
site
infect
approxim
method
patient
schedul
undergo
first
time
aortic
valv
replac
serum
analys
level
endocab
antibodi
staphylococcu
teichoic
acid
also
varicella
nonspecif
immun
measur
primari
outcom
variabl
postop
length
stay
secondari
measur
incid
postop
infect
patient
risk
score
mean
euroscor
result
conclus
invers
relationship
observ
previous
preoper
endocab
level
outcom
similar
relationship
seen
also
antistaphylococc
antibodi
level
outcom
pronounc
infect
compon
absenc
relationship
varicella
antibodi
level
may
impli
studi
low
preoper
immun
relat
postop
morbid
specif
periop
threat
refer
hamiltondavi
et
al
chest
bennettguererro
et
al
jama
introduct
view
advers
consequ
postop
atrial
fibril
poaf
encompass
hemodynam
deterior
thromboembol
hazard
besid
intoler
fast
rate
mortal
prevent
poaf
seem
ideal
goal
poaf
event
incid
report
coronari
arteri
bypass
valvular
surgeri
respect
aim
assess
impact
simpl
clinic
practic
guidelin
poaf
event
prevent
highlight
incid
asian
popul
method
singl
center
retrospect
studi
conduct
one
year
enrol
patient
subject
cardiac
surgeri
patient
exist
prior
af
exclud
patient
divid
two
group
group
group
ii
implement
cpg
result
group
match
regard
age
gender
smoke
histori
preoper
eject
fraction
euroscor
urgenc
surgeri
underli
surgeri
type
valvular
coronari
static
signific
differ
poaf
event
group
vs
group
ii
p
overal
total
rate
poaf
patient
rate
european
center
patient
poaf
significantli
requir
inotrop
support
p
addit
associ
prolong
length
mechan
ventil
icu
stay
p
respect
conclus
argument
rhythm
control
poaf
would
favor
prevent
measur
reduc
postop
transit
sinu
rhythm
expect
favor
effect
lessen
blood
stasi
left
atrial
thrombosi
chanc
refer
shrivastava
r
smith
b
caskey
reddi
p
atrial
fibril
cardiac
surgeri
rophylact
therapi
decreas
advers
outcom
associ
atrial
fibril
j
intens
care
med
tapio
h
jari
h
kimmo
juha
h
prevent
atrial
fibril
cardiac
surgeri
scandin
cardiovasc
j
introduct
aim
studi
investig
benefici
effect
postop
mortal
morbid
singl
dose
dexamethason
administ
cardiopulmonari
bypass
cpb
cardiac
surgeri
patient
method
total
patient
underw
elect
cardiac
surgeri
procedur
use
cpb
depart
month
period
retrospect
studi
patient
singl
dose
mg
dexamethason
given
cpb
group
administ
patient
group
b
follow
factor
compar
group
low
cardiac
output
syndrom
lco
prolong
mechan
ventil
hour
septicaemia
postop
stroke
acut
kidney
injuri
aki
defin
rifl
criteria
aki
requir
dialysi
treatment
atrial
fibril
af
sternal
wound
infect
mortal
statist
analysi
base
chisquar
test
result
group
consist
pt
mean
age
mean
euro
score
group
b
consist
pt
mean
age
mean
euro
score
ii
result
shown
tabl
conclus
dexamethason
administr
cpb
protect
impact
postop
lco
septicemia
stroke
aki
atrial
fibril
sternal
infect
mortal
tendenc
correl
prolong
mechan
ventil
protect
sever
form
aki
requir
dialysi
statist
signific
introduct
intraaort
balloon
pump
iabp
use
varieti
clinic
set
myocardi
function
reduc
cardiac
surgeri
role
clinic
outcom
debat
due
conflict
result
retrospect
analysi
limit
recent
prospect
studi
iabc
studi
aim
evalu
effect
prophylact
iabp
highrisk
patient
undergo
cardiac
surgeri
method
iabc
studi
prospect
singlecent
random
control
trial
highrisk
patient
schedul
elect
cardiac
surgeri
heart
instituteunivers
paulo
inclus
criteria
addit
euroscor
left
ventricular
eject
fraction
lvef
elig
patient
randomli
assign
ratio
iabp
group
control
group
remov
iabp
cathet
accomplish
hour
procedur
follow
circumst
cardiac
index
dobutamin
infus
dose
cathet
immedi
remov
sever
advers
event
relat
procedur
detect
primari
outcom
composit
endpoint
mortal
major
morbid
day
cardiac
surgeri
accord
modifi
societi
thorac
surgeon
definit
includ
prolong
mechan
ventil
hour
stroke
mediastin
need
reoper
cardiogen
shock
acut
renal
failur
result
total
patient
enrol
april
septemb
fiftytwo
patient
assign
iabp
group
patient
control
group
mean
age
year
iabp
group
year
control
group
p
median
lvef
iabp
group
control
group
p
median
euroscor
vs
p
respect
primari
outcom
observ
iabp
group
control
group
p
mortal
rate
similar
group
iabp
group
vs
control
group
p
patient
iabp
group
greater
durat
inotrop
use
minut
vs
minut
p
longer
icu
length
stay
vs
p
conclus
preliminari
data
demonstr
similar
occurr
primari
outcom
group
greater
use
inotrop
longer
icu
stay
iabp
group
result
suggest
tailor
approach
iabp
placement
incorpor
futur
cardiac
surgeri
studi
introduct
acut
kidney
injuri
aki
cardiovascular
surgeri
associ
increas
morbid
mortal
atrial
natriuret
peptid
anp
potent
endogen
natriuret
diuret
vasorelax
peptid
howev
effect
aki
uncertain
object
studi
evalu
effect
anp
renal
function
medic
cost
patient
aki
undergo
cardiovascular
surgeri
method
conduct
multicent
prospect
random
placebocontrol
studi
patient
aki
underw
cardiovascular
surgeri
includ
coronaryarteri
bypass
graft
valv
replac
thorac
aorta
replac
trial
conduct
eleven
center
japan
may
march
definit
aki
use
studi
increas
serum
creatinin
level
mgdl
preoper
level
within
h
surgeri
patient
randomli
assign
receiv
continu
infus
lowdos
anp
placebo
infus
anp
placebo
continu
serum
creatinin
level
decreas
preoper
level
primari
endpoint
chang
renal
function
day
measur
serum
level
creatinin
cystatin
c
creatinin
clearanc
estim
glomerular
filtrat
rate
need
renal
replac
therapi
day
secondari
endpoint
length
icu
length
hospit
stay
medic
cost
day
result
enrol
patient
assign
anp
group
median
age
yr
male
femal
placebo
group
median
age
yr
male
femal
anp
infus
significantli
increas
creatinin
clearanc
estim
glomerular
infiltr
rate
compar
placebo
signific
differ
serum
level
creatinin
cystatin
c
renal
replac
therapi
rate
patient
anp
group
vs
patient
placebo
group
length
icu
hospit
stay
medic
cost
day
conclus
lowdos
anp
infus
show
renoprotect
effect
costsav
effect
treatment
cardiac
surgeryassoci
aki
clinic
trial
registr
number
umin
introduct
risk
assess
cardiac
troponin
cardiac
biomark
endstag
renal
diseas
equival
clinic
decis
make
patient
renal
diseas
base
cardiac
biomark
need
justif
relat
patient
manag
outcom
longterm
outcom
could
influenc
acut
kidney
injuri
aki
cardiac
surgeri
cardiac
troponin
need
explor
these
set
aim
assess
diagnost
perform
high
sensit
troponin
hstnt
set
cardiac
surgeryinduc
aki
method
singl
center
observ
retrospect
studi
databas
avail
patient
base
aki
network
definit
patient
divid
group
group
without
aki
patient
group
ii
aki
patient
serial
hstnt
creatin
kinas
ck
mb
follow
group
compar
statist
analyz
enrol
patient
patient
esrd
exclud
result
total
patient
enrol
mean
age
year
group
match
regard
age
gender
bodi
mass
index
associ
diabet
hypertens
euro
score
aki
group
significantli
higher
mortal
vs
group
p
hstnt
signific
chang
group
remain
cours
unparallel
ckmb
aki
group
associ
heart
failur
vs
p
postop
atrial
fibril
vs
p
length
ventil
stay
icu
hospit
significantli
higher
aki
group
conclus
unlik
ckmb
profil
hstnt
show
signific
chang
group
cours
denot
possibl
delay
clearanc
patient
aki
need
put
consider
interpret
postop
myocardi
event
refer
vese
dl
natriuret
peptid
acut
renal
failur
j
physiologyren
physiolog
prowl
jr
kirwan
cj
acut
kidney
injuri
cardiac
surgeri
injuri
keep
hurt
critic
care
med
introduct
specif
role
endothelin
includ
vasoconstrict
cardiac
hypertrophi
remodel
endotheli
dysfunct
reason
believ
diagnost
prognost
valu
evalu
outcom
method
prospect
trial
male
method
prognosi
outcom
examin
dynam
level
metabolit
nitric
oxid
analyz
periop
period
studi
correl
clinic
laboratori
data
statist
analysi
carri
spss
result
group
includ
patient
multipl
organ
dysfunct
syndrom
earli
postop
period
group
ii
includ
patient
uncompl
postop
cours
tabl
high
concentr
low
level
nitric
oxid
metabolit
periop
period
indic
predomin
vasoconstrictor
effect
turn
lead
vascular
wall
damag
hypoperfus
organ
tissu
conclus
high
level
nitric
oxid
metabolit
imbal
character
function
state
endothelium
predictor
postop
morbid
cardiac
surgeri
refer
f
et
al
pharmacol
esper
rj
et
al
cardiovasc
introduct
atrial
fibril
af
common
arrhythmia
critic
ill
patient
howev
data
evalu
af
noncardiac
intens
care
set
limit
object
studi
describ
incid
manag
outcom
newonset
af
patient
admit
noncardiac
intens
care
method
perform
retrospect
review
consecut
patient
admit
intens
care
unit
icu
district
gener
hospit
period
patient
preexist
af
icu
admiss
routin
postop
monitor
exclud
result
studi
popul
consist
critic
ill
patient
admit
icu
period
incid
newonset
af
n
patient
newonset
af
male
mean
age
year
medic
note
avail
review
patient
patient
newonset
af
frequent
evid
sepsi
respiratori
failur
circulatori
shock
acut
kidney
injuri
mean
icu
day
af
occur
rang
rhythm
control
strategi
use
firstlin
therapi
major
patient
receiv
intraven
amiodaron
underw
electr
cardiovers
haemodynam
instabl
receiv
betablock
digoxin
secondlin
therapi
patient
anticoagul
heparin
infus
therapeuticdos
lowmolecularweightheparin
remain
af
time
icu
discharg
newonset
af
associ
longer
icu
length
stay
median
day
versu
day
p
hospit
mortal
conclus
newonset
af
occur
patient
admit
noncardiac
intens
care
associ
longer
icu
length
stay
multicentr
studi
need
determin
optim
manag
anticoagul
strategi
newonset
af
critic
ill
patient
introduct
effect
pulmonari
hypertens
sublingu
microcircul
mci
remain
unclear
describ
pig
model
shock
effect
hemodynam
chang
acut
pulmonari
hypertens
conjunct
sublingu
mci
alter
measur
cytocamidf
indid
darkfield
illumin
imag
fix
one
sublingu
spot
method
pulmonari
hypertens
unexpectedli
observ
complic
intraven
infus
contrast
agent
central
venou
cathet
contrast
agent
induc
allerg
reaction
lead
massiv
blockag
pulmonari
arteri
increas
pressur
pulmonari
capillari
similar
respons
observ
three
anim
mean
arteri
pressur
map
right
atrial
pressur
rap
pulmonari
arteri
pressur
mpap
record
continu
one
singl
spot
measur
sublingu
mci
perform
cytocamidf
imag
fix
metal
arm
support
result
acut
pulmonari
hypertens
character
increas
mpap
follow
high
rap
low
map
time
cours
sublingu
mci
alter
record
simultan
hemodynam
chang
fig
progress
rais
rap
induc
blood
flow
backward
larg
vein
induc
venou
stasi
reduc
microcirculatori
perfus
despit
adrenerg
respons
normal
map
recoveri
sublingu
mci
observ
conclus
abnorm
sublingu
mci
sever
pulmonari
hypertens
mainli
associ
decreas
perfus
pressur
due
high
rap
hypotens
differ
phase
acut
hemodynam
chang
could
detect
cytocamidf
imag
fix
one
sublingu
spot
studi
support
part
innov
grant
dutch
kidney
foundat
grant
nr
introduct
presenc
microcirculatori
inadequaci
despit
resuscit
hemodynam
strongli
correl
microcirculatori
failur
poor
outcom
sought
evalu
respons
levosimendan
inotrop
vasodil
improv
perfus
capillari
densiti
previou
studi
whether
benefici
effect
util
cardiogen
shock
state
recruit
microcircul
detect
veno
arteri
differ
increas
earlier
intracapillari
blood
veloc
fall
could
reflect
adequaci
microvascular
blood
flow
method
retrospect
observ
studi
includ
patient
cardiogen
shock
admit
cardiac
icu
enrol
januari
march
arteri
mixedvenousblood
gase
hemodynam
variabl
obtain
admiss
everi
hour
intial
hour
quotient
calcul
result
complet
data
set
obtain
patient
ci
cardiac
output
co
system
vascular
resist
svr
serum
lactat
mix
venou
satur
arterio
venou
oxygen
content
differ
subsequ
ci
examin
found
statist
signific
differ
start
levosimendan
cardiogen
shock
patient
p
compar
serial
measur
show
statist
signific
differ
initi
sampl
hr
start
levosimendan
p
conclus
clinic
seri
patient
cardiogen
shock
significantli
improv
start
levosimendan
cardiogen
shock
patient
within
hour
initi
resuscit
therefor
might
reason
consid
levosimendan
potenti
therapeut
option
microcirculatori
recruit
cardiogen
shock
state
studi
need
confirm
find
refer
de
backer
ospinatascon
g
salgado
favori
r
creteur
j
vincent
jl
monitor
microcircul
critic
ill
patient
current
method
futur
approach
intens
care
med
gustavo
ospinatascon
et
al
venoustoarteri
carbon
dioxid
differ
reflect
microcirculatori
alter
patient
septic
shock
intens
care
med
novemb
introduct
brain
death
seriou
diseas
affect
brain
parenchyma
also
organ
intensivist
task
maintain
organ
homeostasi
allow
pmd
reach
withdraw
multiorgan
best
condit
protect
possibl
damag
post
neuroveget
storm
ns
ns
caus
sever
hemodynam
instabl
result
peripher
hypoperfus
hypotens
high
valu
lactat
la
polyuria
deplet
catecholamin
stun
heart
aim
prospect
studi
evalu
efficaci
terlipressin
vs
norepinephrin
maintain
hemodynam
stabil
ns
method
adult
patient
hospit
intens
care
acut
brain
injuri
diagnosi
brain
death
post
ns
mean
arteri
pressur
less
mmhg
patient
divid
two
group
patient
group
norepinephrin
infus
mcgkgmin
hour
patient
group
terlipressin
infus
mcgkgh
hour
paramet
collect
patient
mean
arteri
pressur
map
valu
la
result
express
mean
standard
deviat
comparison
group
use
fisher
test
consid
signific
p
result
hour
treatment
group
norepinephrin
map
la
group
terlipressin
map
la
compar
two
group
pvalu
variabl
map
p
la
p
conclus
shown
use
terlipressin
improv
patient
hemodynam
stabil
brain
death
ns
increas
mean
arteri
pressur
decreas
lactat
compar
use
norepinephrin
allow
improv
peripher
perfus
compar
two
group
reach
statist
signific
variabl
calcul
refer
russel
ja
et
al
vasopressin
versu
norepinephrin
infus
patient
septic
shock
n
engl
j
med
feb
introduct
brain
death
seriou
diseas
affect
brain
parenchyma
also
organ
intensivist
task
maintain
normal
organ
homeostasi
potenti
donor
way
possibl
reach
multiorgan
withdraw
optim
protect
possibl
damag
aim
prospect
random
studi
evalu
cardiac
function
potenti
heart
donor
underw
substitut
hormonotherapi
serial
echocardiographi
method
adult
patient
pt
admit
intens
care
unit
acut
brain
injuri
bilater
non
reactiv
mydriasi
glasgow
coma
scale
absenc
reflect
potenti
progress
brain
death
pt
divid
randomli
two
group
hormonotherapi
group
pt
treat
substitut
hormonotherapi
triiodothyronin
vasopressin
methylprednisolon
insulin
control
group
pt
standard
treatment
pt
serial
transesofag
echocardiographi
evalu
perform
focu
systol
function
evalu
eject
fraction
left
ventricl
simpson
method
echocardiograph
exam
perform
entranc
pt
post
neuroveget
storm
within
hour
diagnosi
brain
death
result
express
mean
standard
deviat
comparison
two
group
use
fisher
test
consid
signific
p
result
pt
two
group
statist
match
sex
p
age
p
patient
evolv
brain
death
hormonotherapi
group
baselin
eject
fraction
post
neuroveget
storm
within
hour
brain
death
control
group
baselin
eject
fraction
post
neuroveget
storm
within
hour
brain
death
compar
two
group
reach
statist
signific
p
conclus
compar
two
group
notic
start
similar
baselin
cardiac
function
neuroveget
storm
record
similar
myocardi
stun
howev
group
use
substitut
hormonotherapi
shown
recoveri
systol
function
almost
basal
level
within
hour
brain
death
control
group
remain
dysfunct
systol
function
consid
pt
potenti
heart
donor
shown
substitut
hormonotherapi
improv
systol
function
despit
stun
post
neuroveget
storm
refer
echocardiographi
potenti
heart
donor
venkateswaran
rv
et
al
trasplant
introduct
bedsid
alarm
sound
vital
sign
vs
exceed
threshold
due
real
instabl
alert
artifact
lead
alarm
fatigu
use
machinelearn
ml
algorithm
classifi
alarm
alert
artifact
vs
data
stream
assess
impact
filter
alert
rate
method
patient
vs
monitor
data
heart
rate
hr
respiratori
rate
rr
oximetri
record
partit
data
trainingvalid
admiss
hr
test
set
admiss
hr
alarm
vs
deviat
beyond
stabil
threshold
annot
real
alert
artifact
train
random
forest
ml
algorithm
discrimin
alert
artifact
long
alarm
min
evalu
perform
test
set
long
short
alarm
min
accord
mani
artifact
alarm
reduc
among
total
number
alarm
mani
artifact
alarm
correctli
filter
total
artifact
alarm
result
figur
show
calcul
overal
alarm
durat
reduct
artifact
alarm
durat
reduct
number
artifact
alarm
complet
data
set
estim
artifact
preval
annot
sampl
figur
roc
diagram
ml
algorithm
short
long
alarm
vertic
line
indic
proport
artifact
alarm
correctli
identifi
fals
neg
rate
ie
real
alert
incorrectli
filter
conclus
ml
filter
algorithm
reduc
artifact
alarm
overal
alarm
potenti
reduc
alarm
fatigu
appli
clinic
fund
nih
introduct
use
peripherallyinsert
central
cathet
picc
notabl
increas
hospit
critic
ill
ambulatori
patient
howev
import
understand
rational
risk
associ
new
technolog
aim
studi
describ
pattern
use
complic
picc
place
icu
set
method
prospect
observ
studi
carri
gener
hospit
icu
special
unit
cathet
insert
avail
picc
implant
alway
middl
third
arm
follow
protocol
includ
strict
steril
insert
procedur
echoradiolog
control
data
patient
picc
insert
januari
april
collect
includ
demograph
characterist
insert
complic
outcom
descript
data
includ
frequenc
percentag
categor
variabl
mean
standard
deviat
sd
median
interquartil
rang
iqr
percentil
quantit
variabl
result
total
picc
place
mean
age
patient
year
male
patient
came
hospit
ward
n
remain
home
n
half
patient
n
belong
haematooncolog
servic
intern
medicin
icu
patient
solid
tumour
haematolog
neoplasm
inflammatori
bowel
diseas
picc
mainli
use
chemotherapi
parenter
nutrit
patient
respect
major
complic
relat
insert
regist
mean
length
use
day
sum
day
cathet
placement
reason
withdraw
includ
end
treatment
death
catheterrel
bloodstream
infect
crbsi
deep
venou
thrombosi
dvt
total
crbsi
record
incid
densiti
rate
catheterday
total
symptomat
dvt
record
conclus
mani
patient
nonintens
care
unit
set
receiv
picc
haematooncolog
patient
mainli
administr
chemotherapi
relev
complic
relat
cathet
insert
mean
time
use
day
reason
withdraw
end
treatment
death
incid
densiti
crbsi
catheterday
record
symptomat
dvt
introduct
normal
central
venou
pressur
cvp
waveform
contain
five
compon
compon
includ
three
peak
c
v
two
descent
x
characterist
amplitud
cvp
waveform
compon
chang
significantli
cardiovascular
distress
visual
provid
invalu
addit
hemodynam
inform
describ
cvp
trace
record
episod
pulmonari
hypertens
porcin
model
shock
aim
character
cvp
waveform
morpholog
conjunct
simultan
hemodynam
alter
method
anim
casereport
cvp
waveform
record
ongo
experiment
porcin
shock
model
monitor
swanganz
cathet
pulmonari
hypertens
unexpectedli
observ
complic
intraven
infus
contrast
agent
central
venou
cathet
similar
respons
observ
three
anim
togeth
cvp
trace
record
also
includ
cardiac
output
systolicdiastol
arteri
pressur
heart
rate
systolicdiastol
arteri
pulmonari
pressur
result
episod
pulmonari
hypertens
last
min
spontan
recoveri
cvp
chang
baselin
valu
mmhg
mmhg
cvp
waveform
trace
show
abnorm
larg
wave
complex
resembl
cannon
wave
cvp
figur
show
differ
pattern
cvp
morpholog
differ
compon
trace
record
entir
episod
pulmonari
hypertens
simultan
ecg
shown
demonstr
time
differ
compon
conclus
abnorm
cvp
waveform
morpholog
episod
pulmonari
hypertens
show
seri
wave
provid
invalu
addit
hemodynam
inform
studi
support
part
innov
grant
dutch
kidney
foundat
grant
nr
introduct
use
ultrasound
recommend
secur
central
venou
cathet
placement
icu
howev
sever
survey
show
cvc
procedur
perform
use
ultrasound
guid
techniqu
reason
physician
continu
use
landmark
lack
format
absenc
ultrasound
devic
design
survey
elicit
inform
physician
characterist
experi
cvc
placement
train
ultrasound
techniqu
use
ultrasound
cvc
placement
reason
nonus
ultrasound
opinion
necess
continu
teach
landmark
techniqu
resid
method
survey
question
electron
address
email
everi
physician
belong
boreal
group
research
univers
commun
icu
northwest
franc
survey
sent
physician
senior
resid
work
icu
result
receiv
respons
respons
rate
among
respond
less
year
old
resid
present
experi
cvc
placement
year
declar
put
cvc
per
week
resid
declar
learn
landmark
ultrasound
guid
techniqu
resid
report
use
alway
ultrasound
put
cvc
main
reason
use
ultrasound
think
need
ultrasound
avail
declar
absenc
ultrasound
devic
set
report
absenc
format
ultrasound
techniqu
coagul
abnorm
obes
anatom
difficulti
main
motiv
use
ultrasound
report
respond
declar
confront
last
month
urgent
situat
ultrasound
avail
quickli
enough
final
think
landmark
techniqu
still
taught
resid
conclus
survey
show
larg
major
intensivist
still
perform
landmark
procedur
almost
everi
physician
receiv
format
ultrasound
techniqu
ultrasound
devic
present
larg
major
institut
howev
avail
still
scarc
despit
sever
guidelin
physician
still
use
ultrasound
everi
procedur
think
landmark
techniqu
still
taught
resid
introduct
central
venoustoarteri
carbon
dioxid
differ
gap
recogn
index
global
tissu
perfus
addit
ratio
arterialtocentr
venou
content
differ
describ
indic
shock
aim
studi
demonstr
predict
abil
gap
ratio
patient
undergo
resuscit
shock
method
critic
ill
patient
shock
requir
vasopressor
inotrop
includ
prospect
observ
studi
serial
measur
gap
lactat
obtain
time
start
vasopressorinotrop
time
time
hour
studi
protocol
approv
hospit
research
ethic
committe
rac
result
fifti
patient
enrol
mean
apach
ii
score
thirti
patient
septic
shock
patient
combin
septic
cardiogen
shock
patient
hemorrhag
shock
two
patient
cardiogen
shock
mortal
rate
patient
fifteen
patient
develop
acut
kidney
injuri
patient
surviv
lower
gap
time
iqr
vs
iqr
p
demonstr
greater
clearanc
gap
resuscit
iqr
vs
iqr
p
cutoff
valu
mmhg
significantli
predict
day
mortal
vs
p
subgroup
patient
resuscit
target
achiev
higher
gap
significantli
associ
lower
surviv
iqr
vs
iqr
p
ratio
significantli
lower
patient
surviv
icu
follow
relationship
observ
time
iqr
vs
iqr
p
time
iqr
vs
iqr
p
icu
mortal
iqr
vs
iqr
p
iqr
vs
iqr
p
surviv
conclus
studi
suggest
gap
ratio
use
predict
mortal
shock
especi
patient
usual
goal
resuscit
achiev
gap
valu
mmhg
may
use
reason
cutoff
point
introduct
measur
cardiac
output
co
pulmonari
arteri
occlus
pressur
paop
systol
pulmonari
arteri
pressur
spap
remain
import
paramet
manag
critic
ill
patient
pulmonari
arteri
cathet
pac
thermodilut
techniqu
consid
clinic
standard
measur
co
howev
invas
techniqu
associ
complic
transthorac
echocardiographi
tte
noninvas
techniqu
allow
calcul
co
pap
decid
compar
co
spap
measur
tte
pac
method
prospect
includ
patient
monitor
pac
sedat
mechan
ventil
icu
exclud
patient
arrhythmia
sever
valvulophathi
poor
echogen
co
paop
right
auricular
pressur
rap
spap
measur
use
pac
pac
copac
averag
three
thermodilut
tte
co
cott
deriv
doppler
stroke
volum
ea
ratio
transvalvular
mitral
flow
ea
mitral
annular
tdi
spap
estim
tricuspid
gradient
spapecho
plu
rap
estim
inferior
vena
cava
diamet
measur
made
tte
pac
perform
simultan
two
experienc
oper
linear
regress
blandaltman
analysi
perform
result
patient
measur
monitor
pac
age
sap
eject
fraction
ef
linear
regress
cott
copac
p
bland
altman
analysi
show
bia
lmin
limit
agreement
lmin
linear
regress
spapecho
spappac
p
linear
regress
improv
spapecho
calcul
tricuspid
gradient
plu
rap
measur
pac
p
bland
altman
analysi
show
bia
mmhg
limit
agreement
mmhg
linear
regress
ea
paop
eea
paop
weak
p
p
respect
conclus
studi
confirm
cott
correl
well
measur
copac
critic
care
patient
sedat
mechan
ventil
tte
estim
spap
appear
also
reliabl
tte
estim
paop
eea
ea
popul
patient
unselect
ef
consist
introduct
cnap
technolog
cnsystem
medizintechnik
ag
graz
austria
enabl
noninvas
continu
record
arteri
pressur
waveform
base
volum
clamp
method
recent
manufactur
releas
novel
algorithm
measur
cardiac
output
co
use
puls
contour
analysi
arteri
waveform
studi
compar
co
measur
cnap
cnco
invas
co
measur
use
intermitt
pulmonari
arteri
thermodilut
pulmonari
arteri
cathet
pac
pacco
postop
cardiothorac
surgeri
patient
method
interim
analysi
simultan
obtain
cnco
pacco
measur
analyz
patient
first
hour
cardiothorac
surgeri
perform
independ
set
consecut
thermodilut
measur
per
patient
averag
closest
pacco
measur
use
comparison
averag
correspond
cnco
valu
three
pair
measur
exclud
due
artifact
result
pair
measur
analysi
addit
cardiac
maneuv
analyz
evalu
trend
abil
conduct
separ
compar
analys
cnco
calibr
first
simultan
measur
pacco
valu
cncocal
vs
pacco
cnco
autocalibr
biometr
patient
data
cncobio
vs
pacco
agreement
two
method
statist
assess
blandaltman
analysi
calcul
percentag
error
pe
evalu
trend
abil
concord
rate
ccr
calcul
exclus
zone
lmin
appli
result
cncocal
blandaltman
analysi
result
mean
differ
lmin
standard
deviat
lmin
limit
agreement
lmin
pe
ccr
respect
cncobio
blandaltman
analysi
result
mean
differ
lmin
standard
deviat
lmin
limit
agreement
lmin
pe
ccr
respect
conclus
clinic
studi
patient
cardiothorac
surgeri
cncocal
show
good
agreement
pe
good
trend
abil
ccr
compar
intermitt
pulmonari
arteri
thermodilut
cncobio
observ
higher
pe
accept
trend
abil
ccr
introduct
reliabl
hemodynam
monitor
correct
interpret
data
crucial
import
patient
pt
ss
choos
strategi
treatment
intens
care
unit
icu
aim
prospect
studi
compar
two
techniqu
hemodynam
monitor
assess
reliabl
manag
pt
ss
method
adult
pt
icu
ss
pt
monitor
cpcco
pulsion
medic
system
serial
tee
perform
cardiac
output
co
lmin
measur
continu
method
cpcco
tripl
inject
ml
salin
solut
cvc
thermo
dilut
curv
measur
femor
arteri
cathet
thermistor
dedic
simultan
tee
lvot
area
multipli
integr
speedtim
aortic
flow
multipli
heart
rate
entranc
fluid
challeng
ml
crystalloid
use
vasopressor
andor
inotrop
drug
vid
oper
measur
echocardiograph
co
without
awar
co
suppli
cpcco
result
express
mean
standard
deviat
comparison
correl
measur
use
linear
regress
accord
blandaltman
method
statist
signific
consid
p
result
measur
perform
cpcco
tee
measur
realiz
entranc
cpcco
tee
fluid
challeng
cpcco
tee
use
vasopressor
andor
inotrop
drug
includ
cpcco
tee
good
correl
limit
bia
measur
provid
cpcco
tee
entranc
r
bia
fluid
challeng
r
bia
use
vid
r
bia
valu
statist
signific
p
conclus
studi
show
good
correl
data
provid
cpcco
tee
method
use
reliabl
hemodynam
monitor
ss
refer
v
de
castro
et
al
comparison
stroke
volum
stroke
volum
respiratori
variat
measur
axillari
arteri
pulsecontour
method
aortic
doppler
echocardiographi
patient
undergo
aortic
surgeri
br
j
anaesth
introduct
assess
cardiac
output
echocardiographi
frequent
clinic
practic
howev
method
share
import
limit
lead
inappropri
therapi
method
retrospect
evalu
transthorac
echocardiographi
examin
critic
ill
patient
perform
stroke
volum
sv
calcul
use
left
ventricular
outflow
tract
diamet
flow
veloc
time
integr
dt
compar
stroke
volum
estim
differ
end
diastol
end
systol
volum
measur
simpson
biplan
method
exclud
patient
atrial
fibril
signific
valvulopathi
low
end
diastol
valu
edv
consid
volum
cc
low
eject
fraction
ef
defin
result
evalu
exam
twenti
patient
exclud
atrial
fibril
signific
valvulopathi
total
pair
stroke
volum
measur
two
method
evalu
r
valu
p
regress
analysi
mean
bia
stroke
volum
measur
dt
estim
ci
p
neg
correl
bia
mean
sv
p
neg
linear
correl
found
bia
enddiastol
volum
ef
endsystol
volum
p
p
p
respect
higher
bia
observ
patient
low
ef
vs
patient
low
enddiastol
volum
vs
p
conclus
signific
overestim
stroke
volum
measur
doppler
ultrasound
transthorac
echocardiographi
compar
observ
critic
ill
patient
overestim
promin
patient
low
enddiastol
volum
andor
low
ef
given
none
two
method
use
consid
gold
standard
evalu
dt
made
group
patient
convers
everi
day
clinic
practic
combin
two
method
may
easi
way
identifi
possibl
error
cardiac
output
measur
introduct
ultrasound
non
invas
bedsid
access
method
cardiac
function
monitor
left
ventricular
outflow
tract
lvot
veloc
time
integr
vti
measur
critic
care
patient
use
tool
purpos
calcul
cardiac
output
need
aortic
valv
area
strongli
depend
skill
observ
hypothes
lvotvti
accur
estim
stroke
volum
index
svi
object
studi
assess
correl
svi
lvotvti
method
three
icu
differ
univers
hospit
particip
studi
consecut
patient
haemodynam
monitor
mechan
ventil
includ
patient
aortic
valv
regurgit
dynam
stenosi
lvot
exclud
studi
lvotvti
measur
pulsatil
doppler
echocardiographi
five
measur
lvotvti
obtain
patient
mean
maximum
valu
record
simultan
five
measur
svi
float
pulmonari
arteri
cathet
pac
puls
induc
contour
cardiac
output
picco
thermodilut
method
obtain
mean
record
mean
maximum
lvotvti
correl
mean
invas
svi
statist
analysi
correl
assess
pearson
correl
index
intraclass
correl
coeffici
icc
result
one
hundr
two
pair
measur
record
thirti
two
patient
one
patient
exclud
studi
due
difficulti
obtain
adequ
acoust
window
twenti
one
patient
monitor
picco
eleven
pac
pearson
correl
index
lvotvti
en
svi
r
p
correl
similar
measur
taken
picco
r
p
worsen
pac
use
calcul
svi
r
p
correl
accept
patient
atrial
fibril
r
p
conclus
lvotvti
could
use
noninvas
simpl
method
estim
svi
mechan
ventil
patient
larger
studi
need
assess
factor
influenc
correl
measur
perform
pac
refer
evangelista
et
al
cardiac
index
quantif
doppler
ultrasound
patient
without
left
ventricular
outflow
tractabnorm
j
coll
cardiol
introduct
usual
tptd
measur
global
enddiastol
volum
index
gedvi
perform
indic
inject
via
jugular
subclavian
vein
access
feasibl
femor
access
use
howev
sever
studi
demonstr
signific
overestim
gedvi
due
addit
volum
v
cava
inferior
one
studi
provid
correct
formula
consequ
one
manufactur
commerci
avail
tptddevic
requir
inform
venou
cathet
posit
correct
gedvi
case
femor
access
assum
method
aim
studi
compar
gedvi
deriv
tptd
use
jugular
venou
access
gedvijug
uncorrect
gedvifemuncor
correct
gedvifemcor
gedvi
calcul
picco
devic
gedviform
calcul
previous
suggest
formula
record
dataset
patient
equip
jugular
femor
venou
access
dataset
consist
three
triplic
tptd
use
jugular
venou
access
gold
standard
femor
access
without
inform
femor
indic
inject
blandaltman
analysi
wilcoxontest
unpair
sampl
spss
result
patient
male
femal
age
year
cm
kg
gedvifemuncor
significantli
higher
compar
gedvijug
vs
p
bia
percentag
error
pe
gedvifemcor
slightli
differ
gedvijug
vs
p
pe
bia
significantli
lower
p
bia
gedvifemuncor
gedviform
significantli
differ
gedvijug
vs
p
pe
bia
significantli
lower
p
bia
gedvifemuncor
bia
gedvifemcor
p
conclus
studi
confirm
gedvi
deriv
uncorrect
femor
indic
inject
tptd
markedli
overestim
gedvi
also
result
inaccept
imprecis
correct
piccodevic
formula
recent
suggest
result
accept
accuraci
precis
gdvii
deriv
femor
tptd
recent
suggest
formula
provid
lowest
bia
pe
valu
refer
saugel
huber
et
al
crit
care
introduct
guyton
venou
return
model
help
interpret
circulatori
respons
blood
volum
chang
model
impli
venou
return
depend
venou
return
drive
pressur
vrdp
ie
differ
mean
system
fill
pressur
msfp
right
atrial
pressur
rap
resist
venou
return
rvr
studi
vrdp
rvr
respons
hypo
hypervolemia
pig
intact
circul
method
measur
anesthet
pig
n
earli
death
pulmonari
arteri
blood
flow
qpa
ultrason
flow
probe
rap
msfp
venou
pressur
zero
flow
right
atrial
balloon
occlus
msfprao
baselin
bleed
mlkg
bodi
weight
hypovolemia
retransfus
shed
blood
equal
amount
hydroxyethyl
starch
hypervolemia
blood
volum
bv
indocyanin
green
dye
dilut
measur
baselin
hypervolemia
calcul
hypovolemia
bvbaselin
minu
shed
volum
stress
volum
vs
defin
system
vascular
complianc
cvasc
msfprao
msfprao
statist
analysi
varianc
repeat
measur
result
mean
sd
n
bv
mlkg
baselin
hypovolemia
hypervolemia
p
respect
msfprao
mmhg
vrdp
qpa
chang
parallel
p
rvr
chang
p
cvasc
ml
linear
regress
respect
vs
bleed
ml
total
blood
volum
conclus
parallel
chang
bv
vrdp
qpa
estim
mutual
independ
method
support
guytonian
model
stress
import
rap
backpressur
venou
return
linear
relationship
chang
bv
msfprao
indic
constant
cvasc
chang
bv
translat
fulli
chang
vs
introduct
dynam
elast
eadyn
calcul
ratio
puls
pressur
variat
ppv
stroke
volum
variat
ssv
propos
predictor
chang
arteri
pressur
respons
fluid
challeng
want
assess
predict
valu
eadyn
calcul
lidcoplu
cardiac
output
monitor
postop
patient
method
prospect
observ
studi
fluid
respons
patient
monitor
arteri
cathet
cardiac
output
co
monitor
lidcoplu
haemodynam
data
record
one
minut
fluid
challeng
one
minut
ml
crystalloid
infus
intraven
minut
chang
mean
arteri
pressur
systol
arteri
pressur
diastol
arteri
pressur
analys
regress
model
valu
eadyn
baselin
adjust
baselin
valu
haemodynam
interest
ie
map
presenc
mechan
ventil
result
evid
eadyn
baselin
predict
p
p
p
mechan
ventil
signific
predictor
chang
map
p
systol
p
diastol
p
conclus
eadyn
calcul
lidcoplu
adjust
baselin
arteri
pressur
predict
chang
arteri
pressur
fluid
challeng
postop
patient
introduct
purpos
studi
describ
time
achiev
target
postop
goaldirect
therapi
gdt
protocol
postop
patient
admit
icu
st
georg
hospit
order
explor
durat
intervent
reduc
method
retrospect
studi
postop
gdt
protocol
basic
consist
administr
fluid
inotrop
order
achiev
oxygen
deliveri
index
data
randomli
select
month
collect
compar
data
audit
data
graphic
analyt
explor
continu
variabl
present
mean
standard
deviat
categor
data
present
number
proport
mean
compar
student
test
statist
signific
consid
p
result
patient
consid
suitabl
gdt
surgeri
name
type
surgeri
document
oxygen
deliveri
index
significantli
increas
baselin
maxim
level
p
chang
significantli
baselin
valu
end
protocol
vs
p
maxim
spontan
achiev
case
patient
achiev
maxim
hour
gener
maxim
achiev
hour
time
observ
conclus
current
postop
optimis
protocol
safe
effect
current
stage
durat
protocol
safe
reduc
introduct
aim
studi
assess
whether
hemodynam
optim
protocol
base
hemodynam
monitor
reduc
mortal
critic
ill
patient
method
perform
systemat
review
metaanalysi
accord
cochran
handbook
systemat
review
intervent
studi
regist
prospero
databas
search
pubm
embas
central
databas
articl
english
inclus
criteria
rct
studi
adult
patient
critic
ill
treat
intens
care
unit
intervent
protocol
base
result
hemodynam
measur
defin
cardiac
output
stroke
volum
stroke
volum
variat
oxygen
deliveri
central
venou
oxygen
mix
venou
oxygen
control
group
treat
without
structur
intervent
mention
exclus
criteria
pediatr
anim
periop
studi
primari
outcom
mortal
secondari
outcom
weight
gain
fluid
balanc
risk
bia
assess
independ
two
investig
statist
analysi
perform
revman
softwar
result
preliminari
result
screen
paper
eight
rct
meet
inclus
criteria
found
none
eight
studi
complet
blind
total
patient
enrol
includ
studi
statist
signific
differ
mortal
group
mortal
hemodynam
intervent
group
patient
vs
patient
control
group
ci
p
conclus
evid
literatur
hemodynam
monitor
combin
structur
intervent
reduc
mortal
critic
ill
patient
investig
mortal
reduc
individu
hemodynam
manag
monitor
reliabl
intervent
must
direct
toward
meaning
treatment
goal
control
receiv
standard
care
introduct
appropri
resuscit
intravascular
volum
optim
treatment
cornerston
septic
shock
optim
requir
invas
monitor
static
measur
due
necessari
non
invas
fast
dynam
method
thorac
fluid
content
tfc
thorac
bioimped
surg
monitor
system
fulfil
requir
non
invas
easi
placement
dynam
method
sixti
patient
enrol
divid
two
group
subject
admit
icu
septic
shock
diagnosi
f
group
form
patient
tfc
measur
thorac
bioimped
order
guid
intravascular
volum
optim
c
group
patient
optim
follow
surviv
sepsi
campaign
guidelin
record
mortal
icu
discharg
day
mechan
ventil
length
icu
length
stay
result
base
tfc
f
group
obtain
faster
higher
mean
arteri
pressur
map
increas
hour
compar
c
group
map
aris
hour
p
due
lactat
clearanc
f
group
obtain
total
clearanc
hour
c
group
clearanc
came
hour
p
higher
mortal
icu
discharg
reach
c
group
vs
p
f
group
day
mortal
c
f
group
respect
conclus
measur
thorac
fluid
content
thorac
bioimped
effect
optim
intravascular
volum
septic
shock
refer
facchini
c
malfatto
g
et
al
lung
ultrasound
transthorac
imped
noninvas
evalu
pulmonari
congest
heart
failur
jcm
ene
introduct
previou
studi
test
role
intern
jugular
vein
ultrasound
exam
ijvu
predict
volum
statu
diverg
conclus
effect
shock
patient
reason
conduct
systemat
review
check
level
reliabl
valid
correl
central
venou
pressur
cvp
ijv
ultrasound
measur
qualiti
report
literatur
topic
method
review
base
prisma
guidelin
systemat
search
literatur
publish
june
explor
pubm
cochran
librari
web
knowledg
scopu
databas
inclus
criteria
studi
investig
reliabl
accuraci
predict
low
cvp
correl
cvp
ijv
ultrasound
measur
adult
yr
spontan
breath
patient
shock
three
research
select
studi
use
inclus
criteria
assess
qualiti
use
stard
quada
guidelin
key
word
literatur
search
intern
jugular
vein
ultrasonographi
volum
statu
central
venou
pressur
shock
result
collect
studi
exclud
reason
duplic
five
studi
includ
final
analysi
reliabl
correl
cvp
valid
ijv
ultrasound
measur
ijv
ratio
anteriorposterior
ijv
diamet
apijvd
ijv
area
show
interrat
agreement
rang
moder
excel
apijvd
signific
high
correl
cvp
diverg
conclus
ijv
area
poorli
correl
ijv
ratio
ijv
ratio
show
moderategood
valid
predict
low
cvp
apijv
show
high
sensit
specif
hyper
hypovolemia
increas
ijv
area
effect
rule
elev
cvp
two
studi
respect
stard
item
four
quada
item
conclus
report
publish
topic
conclus
review
confirm
anyway
qualiti
report
methodolog
studi
collect
good
ijvu
seem
good
reliabl
accuraci
predict
low
high
cvp
apijvd
show
best
correl
cvp
introduct
dehydr
rel
unrecogn
disord
medic
icu
especi
among
older
patient
aim
determin
incid
dehydr
upon
admiss
well
risk
develop
dehydr
hospit
effect
patient
outcom
moreov
sever
lab
paramet
studi
order
assess
correl
diagnosi
method
patient
enter
icu
month
period
enrol
screen
dehydr
day
day
use
clinic
lab
paramet
bun
cr
buncr
ratio
hct
serum
na
urin
specif
graviti
buncr
use
diagnost
criteria
serum
osmol
use
due
unconsist
elig
total
patient
exclud
due
gi
haemorrhag
final
patient
includ
mf
median
age
statist
method
use
mcnemar
test
differ
dehydr
day
day
binari
logist
analysi
associ
lab
paramet
dehydr
multivari
adjust
binari
logist
regress
model
outcom
result
patient
dehydr
upon
admiss
dehydr
clinic
diagnos
admiss
defin
buncr
significantli
associ
mcnemar
test
n
p
dehydr
correctli
clinic
recognis
patient
buncr
time
higher
odd
accur
clinic
diagnos
correl
could
found
dehydr
valu
hct
serum
na
urin
specif
graviti
statist
signific
posit
associ
demonstr
bun
ci
p
cr
ci
p
day
patient
dehydr
repres
signific
increas
mcnemar
test
continu
correct
n
p
overal
dehydr
point
stay
associ
advers
outcom
death
oradj
ci
p
conclus
dehydr
common
find
icu
clinic
easili
overlook
due
insensit
clinician
milder
form
dehydr
could
explain
rel
high
rate
misclassif
clinic
lab
paramet
insuffici
diagnosi
consist
previou
observ
accord
data
hydrat
statu
chang
icu
stay
fluctuat
associ
increas
mortal
suggest
maintain
adequ
hydrat
statu
core
interest
patient
outcom
introduct
effect
fluid
challeng
increas
mean
system
fill
pressur
pmsf
order
increas
venou
return
object
studi
test
effect
sever
dose
intraven
fluid
chang
pmsf
septic
patient
method
patient
randomli
alloc
receiv
ml
kg
bodi
weight
intraven
crystalloid
five
minut
pmsf
measur
use
arteri
pressur
stop
blood
flow
arm
pneumat
tourniquet
inflat
one
minut
mean
arteri
pressur
map
central
venou
pressur
cvp
cardiac
output
co
stroke
volum
sv
record
baselin
immedi
fluid
infus
co
measur
lidcoplu
monitor
posit
respons
defin
increas
baselin
previou
data
least
signific
chang
lsc
pmsf
median
compar
use
independ
sampl
media
test
proport
compar
use
exact
fisher
test
statist
signific
consid
p
result
patient
includ
respond
chang
pmsf
co
group
describ
tabl
margin
evid
pmsf
relat
dose
fluid
co
proport
respond
affect
dose
fluid
infus
conclus
dose
fluid
affect
chang
co
proport
respond
fluid
challeng
septic
patient
introduct
fluid
bolu
administr
ubiquit
therapi
within
intens
care
howev
recent
evid
suggest
judici
approach
may
improv
patient
outcom
aim
describ
fluid
bolu
practic
within
larg
australian
intens
care
unit
inform
futur
focu
educ
staff
method
conduct
retrospect
audit
critic
ill
patient
receiv
fluid
bolus
collect
inform
fluid
type
volum
time
administ
patient
sever
prescrib
detail
ethic
approv
obtain
data
analys
use
ibm
spss
stat
result
found
balanc
salt
solut
commonli
use
fluid
bolu
therapi
unit
independ
patient
diseas
sever
major
fluid
prescrib
junior
doctor
pm
within
hour
icu
admiss
though
addit
peak
bolu
administr
day
remain
unit
time
patient
receiv
averag
l
fluid
bolus
conclus
fluid
bolu
use
clinic
environ
highli
variabl
alway
align
theoret
principl
refer
myburgh
introduct
liber
late
fluid
manag
lfm
associ
higher
morbimort
differ
critic
ill
popul
trauma
restrict
fluid
strategi
larg
recommend
earli
resuscit
phase
howev
lfm
realli
studi
main
goal
present
studi
assess
sever
trauma
popul
impact
liber
lfm
mechan
ventil
durat
method
retrospect
analysi
consecut
sever
trauma
patient
admit
region
trauma
center
perform
patient
iss
length
icu
stay
day
includ
main
admiss
characterist
injuri
transfus
manag
collect
well
fluid
therapi
mechan
ventil
icu
stay
patient
classifi
conserv
lfm
group
least
two
consecut
day
neg
fluid
balanc
day
day
patient
belong
liber
lfm
group
two
group
compar
especi
term
fluid
balanc
mechan
ventil
requir
result
studi
period
patient
includ
median
age
iqr
iss
sap
ii
male
massiv
transfus
sever
trauma
head
injuri
analysi
patient
classifi
conserv
lfm
liber
lfm
two
group
significantli
differ
term
baselin
characterist
sever
injuri
sever
criteria
transfus
need
daili
cumul
fluid
balanc
also
ident
group
day
day
convers
liber
lfm
significantli
associ
ventil
day
vs
day
p
less
ventilatorfre
day
day
vs
day
p
longer
icu
stay
vs
day
p
hospit
stay
vs
day
p
mortal
rate
compar
group
multivari
analysi
also
highlight
liber
lfm
independ
risk
factor
reduc
ventilatorfre
day
day
b
ci
p
well
iss
score
sever
trauma
head
injuri
massiv
transfus
need
conclus
liber
lfm
associ
seri
higher
morbid
sever
trauma
patient
longer
ventil
durat
longer
icu
hospit
stay
result
observ
despit
similar
admiss
sever
earli
fluid
manag
introduct
emerg
depart
ed
patient
admit
hospit
communityacquir
pneumonia
cap
may
particular
risk
volum
overload
relat
complic
due
infect
lung
studi
use
premier
administr
databas
contain
us
hospit
discharg
examin
associ
higher
amount
fluid
administ
day
hospit
mortal
ventil
free
day
vfd
method
cap
defin
bacteri
pneumonia
diagnosi
present
admiss
ed
patient
receiv
chest
xray
parenter
antibiot
day
day
total
fluid
volum
stratifi
quartil
primari
outcom
hospit
mortal
secondari
outcom
vfd
day
period
adjust
potenti
confound
patient
stratifi
sever
group
base
model
predict
mortal
propens
model
give
fluid
built
use
clinic
characterist
sever
ill
score
code
present
admiss
import
acut
chronic
condit
patient
group
sever
ill
quintil
predict
risk
death
cap
popul
associ
fluid
administr
outcom
assess
within
quintil
mortal
risk
use
chisquar
analysi
result
adult
ed
patient
cap
analyz
patient
femal
mean
age
overal
mortal
rate
averag
vfd
propens
adjust
sever
ill
mean
amount
fluid
administ
day
rang
ml
ml
within
fifth
sever
quintil
found
signific
differ
hospit
vs
predict
mortal
rate
highest
fluid
quartil
similarli
within
fifth
sever
quintil
found
signific
differ
number
vfd
highest
fluid
quartil
compar
rest
quartil
conclus
adult
ed
patient
cap
found
signific
associ
day
fluid
increas
mortal
decreas
vfd
highest
fluid
quartil
sever
group
adjust
sever
ill
acuiti
level
studi
may
identifi
subset
ed
patient
may
benefit
restrict
fluid
strategi
present
hospit
cap
introduct
administr
fluid
routin
manag
icu
patient
howev
controversi
still
exist
regard
ideal
type
dose
time
iv
fluid
larg
amount
evid
shown
fluid
deleteri
effect
sever
organ
function
excess
amount
nonphysiolog
electrolyt
composit
aim
studi
assess
neg
impact
posit
fluid
balanc
outcom
critic
ill
patient
method
retrospect
studi
one
year
juli
june
includ
patient
admit
medicosurg
icu
hour
demograph
data
sap
ii
apach
ii
score
regist
first
day
length
stay
durat
mechan
ventil
use
extra
renal
therapi
rifl
score
mortal
note
daili
cumul
fluid
balanc
regist
h
day
discharg
result
total
patient
includ
mortal
rate
sever
score
point
respect
sap
ii
apach
ii
tabl
resum
cumul
fluid
balanc
note
higher
rate
septic
shock
longer
length
stay
mechan
ventil
durat
nonsurvivor
group
use
extra
renal
therapi
higher
nonsurvivor
group
vs
p
rifl
score
diuret
use
also
higher
nonsurvivor
group
vs
p
end
vs
p
nonsurvivor
also
show
higher
accumul
posit
fluid
balanc
conclus
fluid
accumul
common
throughout
cours
patient
icu
stay
evid
potenti
deleteri
effect
fluid
electrolyt
mani
organ
system
conserv
approach
regard
fluid
manag
strategi
icu
patient
seem
less
deleteri
random
control
trial
address
issu
need
refer
besen
ba
world
j
crit
care
med
introduct
fluid
cornerston
manag
critic
ill
patient
system
inflammatori
respons
syndrom
risk
multipl
organ
dysfunct
syndrom
howev
therapi
fluid
associ
harm
ad
worsen
organ
dysfunct
studi
aim
determin
impact
fluid
balanc
fb
respiratori
cardiovascular
renal
system
method
singlecent
prospect
observ
studi
june
decemb
patient
stay
icu
day
collect
data
demograph
clinic
characterist
total
amount
fluid
administ
excret
blood
creatinin
urea
need
dose
vasopressor
map
collect
regard
first
day
icu
spss
use
statist
analysi
result
patient
enrol
men
averag
age
mortal
rate
averag
daili
fb
eight
day
ml
lower
daili
fb
among
survivor
compar
nonsurvivor
ml
vs
ml
cumul
fluid
balanc
cfb
differ
survivor
nonsurvivor
signific
day
icu
p
regard
cfb
respiratori
system
found
patient
ratio
higher
cfb
day
group
patient
requir
vasopressor
support
cfb
higher
day
p
p
respect
group
patient
gfr
present
cfb
slightli
higher
group
higher
gfr
day
p
e
p
respect
conclus
studi
demonstr
cumul
fluid
balanc
higher
patient
sever
dysfunct
system
review
associ
increas
mortal
rate
remain
establish
whether
fluid
overload
biomark
put
patient
increas
risk
death
iatrogen
condit
critic
care
consid
daili
care
activ
treat
avoid
introduct
normal
salin
contain
mmol
na
cl
may
therefor
induc
hypernatremia
hyperchloremia
acidosi
observ
studi
show
resuscit
normal
salin
compar
balanc
crystalloid
associ
acut
kidney
injuri
death
studi
larg
volum
salin
administ
liter
l
fluid
bolu
often
administ
icu
patient
eg
hypotens
oliguria
remain
uncertain
limit
volum
also
associ
advers
effect
aim
studi
evalu
effect
fluid
bolu
salin
plasmalyt
pl
balanc
crystalloid
electrolyt
acidbas
statu
hemodynam
urin
output
uo
method
conduct
prospect
random
singl
blind
studi
compar
l
fluid
bolu
pl
administ
min
icu
cohort
patient
juli
novemb
includ
adult
patient
prescrib
l
fluid
bolu
arteri
line
bladder
cathet
patient
dialysi
exclud
data
record
right
fluid
infus
directli
three
hour
result
data
one
patient
exclud
analysi
lack
inform
consent
remain
patient
includ
receiv
pl
signific
differ
baselin
characterist
group
patient
higher
cl
vs
mmoll
p
resp
vs
p
higher
na
vs
mmoll
p
otherwis
differ
note
addit
patient
immedi
infus
increas
na
vs
mmoll
cl
vs
mmoll
p
decreas
strong
ion
differ
sida
vs
p
strong
ion
gap
sig
vs
p
anion
gap
ag
vs
p
persist
cl
vs
mmoll
p
sida
vs
p
found
differ
uo
blood
pressur
conclus
compar
plasmalyt
l
fluid
bolu
salin
short
term
associ
small
increas
na
cl
decreas
sid
sig
ag
chang
statist
signific
limit
associ
differ
hemodynam
uo
introduct
burn
injuri
includ
list
contraind
he
use
convinc
evid
base
statement
small
popul
burn
patient
absenc
highqual
studi
aim
studi
access
efficaci
safeti
he
therapi
patient
burn
shock
method
design
retrospect
cohort
control
studi
inclus
criteria
age
year
tbsa
burn
absenc
aki
admiss
patient
divid
two
group
he
group
patient
receiv
he
addit
base
fluid
therapi
ringer
solut
control
group
patient
receiv
ringer
solut
result
baselin
characterist
well
balanc
group
hospit
mortal
significantli
differ
he
group
control
group
respect
p
rate
aki
he
group
control
group
p
patient
he
group
patient
control
group
requir
rrt
independ
risk
factor
aki
tbsa
burn
p
index
baux
p
need
catecholamin
p
signific
differ
group
total
volum
fluid
administ
first
day
imag
conclus
studi
show
neg
influenc
he
solut
mortal
incid
aki
need
rrt
addit
he
solut
earli
infus
therapi
associ
reduc
total
fluid
requir
introduct
influenc
intraven
fluid
kidney
function
injuri
especi
septic
patient
still
controversi
discuss
investig
impact
differ
intraven
prepar
ultrastructur
kidney
damag
uskd
clinic
relev
model
ovin
periton
septic
shock
method
approv
local
veterinari
author
healthi
femal
sheep
underw
induct
periton
septic
shock
follow
establish
model
consecut
random
one
studi
group
control
fluid
therapi
balanc
crystalloid
human
albumin
balanc
he
n
dynam
detect
uskd
sequenti
sonographyguid
kidney
needl
biopsi
perform
healthi
septic
baselin
well
h
h
h
start
resuscit
analys
n
electron
microscopi
pictur
pictur
per
time
point
n
anim
n
perform
two
blind
independ
investig
follow
electron
microscop
tubular
injuri
emti
score
score
contain
paramet
vacuolar
alter
dissoci
epithelium
basal
membran
epitheli
cell
injuri
intratubular
precipit
intact
microvilli
cuticular
layer
compon
score
quantifi
damag
sever
damag
result
group
develop
uskd
time
consecut
increas
emti
score
h
emti
score
hesgroup
significantli
lower
compar
crystalloid
controlgroup
p
h
emti
score
albumin
hesgroup
significantli
lower
compar
control
group
p
h
emti
score
human
albumingroup
significantli
lower
compar
control
crystalloidgroup
p
signific
differ
albumin
hesgroup
time
conclus
present
ovin
model
septic
shock
group
develop
sepsisassoci
uskd
anim
colloidgroup
albumin
he
show
significantli
decreas
injuri
score
compar
anim
control
crystalloidgroup
ultrastructur
kidney
damag
pronounc
within
crystalloid
controlgroup
studi
introduct
present
studi
design
compar
impact
resuscit
either
sodium
chlorid
nacl
balanc
hydroxyethylstarch
he
solut
he
freseniu
kabi
bad
homburg
germani
conjunctiv
microcircul
sheep
model
haemorrhag
shock
method
approv
local
veterinari
author
femal
sheep
anaesthet
baselin
measur
ml
blood
per
kg
bodi
weight
withdrawn
establish
haemorrhag
shock
sheep
random
receiv
either
nacl
salin
group
n
he
group
n
resuscit
baselin
valu
mean
arteri
pressur
map
reach
baselin
shock
resuscit
haemodynam
variabl
video
conjunctiv
microcircul
record
braediu
huizen
netherland
perfus
vessel
densiti
pvd
microvascular
flow
index
mfi
calcul
use
dedic
softwar
ava
softwar
microvisionmed
amsterdam
netherland
valu
present
median
iqr
mannwhitneyutest
use
comparison
group
pvalu
consid
statist
signific
result
map
decreas
group
baselin
shock
increas
resuscit
salin
mmhg
mmhg
mmhg
he
mmhg
mmhg
mmhg
nonsignific
ns
group
salin
group
ml
he
group
ml
respect
fluid
need
p
group
pvd
decreas
baselin
shock
salin
baselin
valu
he
ns
group
pvd
increas
resuscit
he
group
decreas
salin
group
p
mfi
decreas
baselin
shock
group
salin
he
ns
group
resuscit
mfi
increas
significantli
higher
he
salin
group
p
conclus
balanc
he
recruit
perfus
vessel
improv
microvascular
blood
flow
conjunctiv
microcircul
better
salin
spare
consider
amount
intraven
fluid
introduct
earli
clinic
trial
experiment
data
report
use
unbuff
fluid
may
advers
influenc
gastrointestin
gi
function
compar
buffer
fluid
gi
dysfunct
nutrit
feed
intoler
common
amongst
critic
unwel
patient
previou
studi
assess
gi
effect
differ
crystalloid
fluid
critic
ill
patient
object
evalu
effect
plasmalyt
compar
salin
salin
gastrointestin
gi
feed
intoler
mechan
ventil
icu
patient
receiv
nasogastr
ng
feed
method
conduct
singl
centr
pilot
studi
nest
within
multicentr
doubleblind
clusterrandomis
doubl
crossov
trial
adult
patient
requir
crystalloid
fluid
part
split
trial
expect
requir
mechan
ventil
hour
receiv
enter
nutrit
exclus
ng
tube
elig
studi
icu
use
either
blind
salin
four
altern
seven
week
block
primari
outcom
proport
patient
gi
feed
intoler
defin
high
gastric
residu
volum
grv
diarrhoea
vomit
receiv
ng
feed
icu
proport
patient
high
grv
diarrhoea
vomit
secondari
outcom
result
patient
enrol
assign
salin
group
patient
develop
gi
feed
intoler
compar
patient
salin
group
ci
p
high
grv
observ
patient
patient
salin
group
respect
ci
p
conclus
among
mechan
ventil
patient
receiv
ng
feed
use
compar
salin
reduc
proport
patient
develop
gi
feed
intoler
associ
decreas
incid
high
grv
refer
young
p
bailey
beasley
r
et
al
effect
buffer
crystalloid
solut
vs
salin
acut
kidney
injuri
among
patient
intens
care
unit
split
random
clinic
trialjama
introduct
use
buffer
crystalloid
fluid
plasmalyt
may
reduc
postop
blood
loss
transfus
requir
compar
salin
salin
howev
studi
assess
effect
postop
blood
loss
use
differ
crystalloid
fluid
heart
surgeri
object
evalu
effect
compar
salin
bleed
follow
heart
surgeri
method
conduct
singl
centr
pilot
studi
nest
within
multicentr
doubleblind
clusterrandomis
doubl
crossov
trial
adult
heart
surgeri
patient
requir
crystalloid
fluid
therapi
icu
part
split
trial
elig
primari
outcom
chest
drain
output
time
arriv
icu
hour
post
oper
key
secondari
outcom
total
volum
fluid
chest
drain
arriv
icu
hour
still
icu
proport
patient
requir
follow
blood
product
pack
red
blood
cell
platelet
fresh
frozen
plasma
cryoprecipit
result
patient
enrol
assign
salin
differ
postop
chest
drain
output
hour
ratio
geometr
mean
ci
pvalu
hour
group
patient
requir
blood
product
icu
compar
patient
salin
group
ci
p
conclus
among
patient
admit
icu
follow
heart
surgeri
use
compar
salin
reduc
amount
postop
blood
loss
associ
increas
use
blood
product
refer
young
p
bailey
beasley
r
et
al
effect
buffer
crystalloid
solut
vs
salin
acut
kidney
injuri
among
patient
intens
care
unit
split
random
clinic
trial
jama
orbegozo
cort
rayo
bonor
vincent
jl
isoton
crystalloid
solut
structur
review
literatur
br
j
anaesth
shaw
ad
bagshaw
sm
goldstein
sl
et
al
major
complic
mortal
resourc
util
open
abdomin
surgeri
salin
compar
plasmalyt
ann
surg
introduct
approxim
patient
attend
emerg
depart
hypernatremia
hypernatremia
mmoll
consid
sever
need
treat
caution
extrem
case
hypernatraemia
rare
sodium
level
except
high
especi
adult
common
pathophysiolog
case
would
relat
sever
dehydr
see
elderli
popul
children
institutionalis
patient
dementia
method
report
uniqu
case
extrem
hypernatremia
mmoll
sever
sepsi
young
adult
huntington
dementia
present
challeng
fluid
manag
result
hypernatraemia
thought
caus
chronic
sever
dehydr
poor
intak
sepsi
thought
start
inadequ
treat
urinari
tract
infect
patient
initi
treat
aggress
hypoton
salin
intraven
antibiot
subsequ
manag
use
slower
correct
rate
identifi
chronic
natur
natremia
knowledg
first
report
case
extrem
hypernatremia
sever
sepsi
manifest
concomitantli
young
patient
conclus
highlight
difficulti
balanc
risk
benefit
rapid
versu
slow
fluid
resuscit
complex
clinic
situat
highlight
difficulti
balanc
risk
benefit
rapid
fluid
resuscit
necessit
sever
sepsi
acut
kidney
injuri
complex
fluid
resuscit
correct
extrem
hypernatremia
advoc
earli
identif
chronic
hypernatremia
effect
administr
intraven
fluid
emerg
depart
decid
casebycas
basi
case
sever
extrem
hypernatraemia
particular
accur
calcul
free
water
deficit
essenti
manag
patient
effect
line
must
ensur
patient
alway
weigh
admiss
refer
arampatzi
exadaktylo
buhl
et
al
dysnatraemia
emerg
room
undetect
untreat
unknown
wien
klin
wochenschr
aiyagari
v
deibert
e
diring
mn
hypernatremia
neurolog
intens
care
unit
high
high
j
crit
care
introduct
develop
hypernatraemia
lead
hyperton
stress
within
cell
previou
studi
shown
presenc
hypernatraemia
admiss
intens
care
independ
risk
factor
poor
prognosi
rapid
correct
hypernatraemia
devast
neurolog
consequ
correct
speed
slow
associ
increas
risk
death
primari
object
assess
frequenc
sever
hypernatraemia
patient
admit
critic
care
unit
locat
tertiari
referr
centr
univers
hospit
time
sodium
normalis
presenceabs
neurolog
symptom
patient
outcom
also
evalu
sever
hypernatraemia
classifi
plasma
sodium
mmol
per
litr
method
retrospect
search
critic
care
databas
laboratori
sodium
valu
mmoll
occur
novemb
novemb
appropri
sodium
correct
glucos
identifi
patient
sever
hypernatremia
present
admiss
develop
critic
care
stay
result
identifi
patient
sever
hypernatraemia
past
two
year
critic
care
unit
plasma
sodium
rang
mmoll
valu
mmoll
occur
patient
hyperglycaem
hyperosmolar
syndrom
hh
underli
aetiolog
follow
patient
hh
patient
diabet
ketoacidosi
patient
lithiuminduc
diabet
insipidu
patient
dehydr
secondari
unreplac
water
lose
case
rate
correct
greater
mmoll
per
day
averag
length
time
correct
normal
sodium
level
mmoll
day
three
patient
die
critic
care
two
patient
die
follow
discharg
ward
remain
patient
discharg
home
primari
resid
patient
neurolog
symptom
present
primarili
confus
one
patient
present
seizur
patient
treat
dextros
one
patient
develop
hypernatraemia
critic
care
moder
elev
sodium
level
untreat
patient
prior
diagnosi
sever
hypernatraemia
remain
patient
present
hypernatraemia
conclus
sever
hypernatraemia
associ
high
mortal
rate
physician
awar
excess
risk
associ
condit
diagnosi
follow
prompt
rehydr
intens
clinic
biochem
monitor
introduct
critic
ill
lifethreaten
multisystem
process
result
signific
morbid
mortal
patient
critic
ill
preced
period
physiolog
deterior
evid
suggest
earli
sign
frequent
miss
method
crosssect
studi
medic
data
critic
ill
patient
admit
albert
schweitzer
hospit
review
januari
septemb
data
includ
age
gender
sap
iii
score
upon
admiss
arriv
hour
abg
electrolyt
valu
well
length
stay
inhospit
mortal
rate
collect
logist
regress
model
use
determin
associ
acidbas
electrolyt
disturb
inhospit
mortal
adjust
potenti
confound
factor
result
patient
male
mean
age
year
old
mean
sap
iii
score
point
die
hospit
univari
analysi
show
significantli
higher
risk
mortal
patient
develop
mix
metabol
acidosi
plu
respiratori
acidosi
admiss
day
pvalu
multipl
logist
regress
analysi
demonstr
mix
metabol
acidosi
plu
respiratori
acidosi
ci
pvalu
hyponatremia
ci
pvalu
patient
hyperkalemia
higher
mortal
serum
potassium
meql
die
serum
potassium
meql
die
p
p
respect
three
signific
predictor
mortal
regardless
confound
variabl
conclus
result
show
critic
ill
patient
initi
mix
metabol
acidosi
plu
respiratori
acidosi
hyponatremia
hyperkalemia
signific
predictor
mortal
factor
adjust
potenti
confound
factor
prognost
effect
refer
lactat
ph
blood
ga
analysi
critic
ill
patient
waldau
et
al
acta
anaesthesiol
scand
suppl
clinic
signific
acidbas
balanc
emerg
set
patient
acut
heart
failur
shirakab
et
alj
cardiol
oct
epub
jul
introduct
hagma
commonli
encount
acidbas
disord
clinic
practic
multipl
mnemon
propos
cover
common
underli
caus
goldmark
kusmal
karmel
cours
mudpil
mudpil
repres
rare
caus
hagma
includ
ron
soniazid
nborn
error
metabol
present
rare
case
hagma
secondari
isoniazid
inh
overdos
method
year
old
male
intub
statu
epilepticu
medic
histori
pulmonari
tuberculosi
ptb
treat
cours
rifampicin
inh
ethambutol
sinc
month
ago
result
arteri
blood
ga
emerg
depart
show
sever
metabol
respiratori
acidosi
ph
initi
anion
gap
physic
examin
unremark
except
fever
hypotens
neurolog
examin
reveal
lateralis
sign
ct
scan
brain
normal
mild
renal
impair
lactat
acidosi
resolv
rapidli
initi
fluid
resuscit
serum
urin
toxicolog
commonli
encount
drug
also
neg
patient
regain
orient
day
intub
promptli
extub
histori
reveal
consum
bottl
isoniazid
tablet
alterc
wife
night
conclus
tuberculosi
endem
south
east
asia
inh
one
four
drug
use
treatment
diseas
side
effect
isoniazid
rang
mild
hepatotox
potenti
fatal
inh
hepat
hagma
refractori
convent
therapi
one
hallmark
inh
toxic
though
one
rare
caus
hagma
prompt
diagnosi
treatment
high
dose
pyridoxin
reduc
mortal
morbid
refer
mehta
emmett
jb
emmett
gold
mark
anion
gap
mnemon
centuri
lancet
orlowski
jp
paganini
ep
pippeng
ce
treatment
potenti
lethal
dose
isoniazid
ingest
ann
emerg
med
introduct
acut
kidney
injuri
aki
independ
associ
increas
mortal
critic
ill
especi
renal
replac
therapi
rrt
requir
earli
initi
rrt
possibl
benefici
effect
mortal
focu
mani
research
protocol
howev
publish
paper
show
uniform
definit
earli
initi
main
problem
determin
best
moment
initi
lack
distinct
paramet
predict
rrt
requir
question
rise
differ
patient
stage
aki
patient
rrtrequir
akin
stage
iii
identifi
look
classic
paramet
serum
creatinin
scr
urea
potassium
bicarbon
ph
cumul
fluid
balanc
plasma
neutrophil
gelatinaseassoci
lipocalin
pngal
urinari
output
uo
time
first
rise
scr
first
aki
method
retrospect
subsetanalysi
perform
ngalstudi
databas
adult
critic
ill
patient
develop
aki
data
collect
analyz
time
first
aki
highest
level
serum
creatinin
peak
aki
mannwhitneyu
test
use
detect
differ
group
result
total
patient
develop
stage
aki
first
day
icu
admiss
patient
requir
rrt
eventu
time
first
aki
pngal
uo
paramet
differ
significantli
p
p
respect
two
group
classic
paramet
show
signific
differ
group
later
time
peak
aki
time
rrt
initi
fig
conclus
critic
ill
patient
rrt
requir
aki
signific
lower
urinari
product
signific
higher
pngal
concentr
compar
patient
nonrrt
requir
aki
time
first
rise
scr
classic
paramet
fail
make
distinct
earli
stage
aki
therefor
plasma
ngal
uo
might
potenti
perhap
combin
furosemid
stress
test
becom
valuabl
paramet
futur
prospect
protocol
intend
studi
valu
earli
rrt
initi
hard
outcom
measur
critic
ill
patient
refer
de
geu
hrh
et
al
ajrccm
introduct
choic
right
renal
replac
therapi
rrt
sever
acut
kidney
injuri
critic
ill
patient
investig
mani
time
last
two
decad
although
question
answer
current
practic
mani
differ
approach
still
use
icu
author
review
treatment
acut
kidney
injuri
aki
critic
ill
patient
indic
sled
continu
renal
replac
therapi
crrt
critic
ill
patient
four
portugues
icu
method
prospect
observ
studi
conduct
icu
portugues
hospit
seven
month
patient
aki
need
renal
replac
therapi
enrol
data
demograph
clinic
characterist
patient
collect
baselin
result
patient
enrol
averag
age
mortal
rate
patient
perform
sled
perform
crrt
common
indic
crrt
fluid
overload
patient
start
procedur
first
two
day
icu
patient
organ
failur
use
rifl
criteria
start
rrt
patient
crrt
hemodynam
unstabl
norepinephrin
crrt
sled
mortal
rate
crrt
sled
conclus
crrt
seem
ideal
mode
renal
replac
therapi
hemodynam
unstabl
fluid
overload
howev
expert
hand
two
treatment
provid
similar
outcom
complementari
introduct
north
england
critic
care
network
current
date
guidelin
regard
use
renal
replac
therapi
rrt
within
intens
care
wish
evalu
current
practic
region
consid
need
region
guidanc
manag
acut
kidney
injuri
unit
method
electron
survey
sent
consult
intens
care
within
region
respons
anonym
collect
use
internetbas
survey
softwar
question
base
upon
current
avail
guidanc
evid
result
invit
sent
consult
intens
care
commit
respons
give
respons
rate
unit
size
vari
greatli
bed
major
bed
respond
less
patient
receiv
rrt
per
month
patient
per
month
patient
per
month
gave
posit
comment
regard
support
receiv
renal
servic
area
interact
renal
physician
critic
care
could
improv
identifi
respond
awar
date
guidelin
use
rrt
unit
respond
preferenti
use
subclavian
vein
site
renal
access
line
preferenti
use
femor
vein
never
visit
nephrologist
conclus
wide
varieti
practic
area
practic
could
improv
notabl
awar
guidelin
avail
choic
renal
access
line
site
work
relationship
renal
critic
care
part
qualiti
improv
programm
plan
creat
region
best
practic
recommend
document
relev
system
work
specif
critic
care
hope
improv
outcom
receiv
renal
replac
therapi
unit
introduct
acut
kidney
injuri
necessit
continu
renal
replac
therapi
crrt
critic
ill
patient
associ
high
mortal
time
crrt
remain
matter
debat
investig
effect
time
crrt
mortal
method
posthoc
analysi
perform
multicent
data
earlier
publish
cash
studi
critic
ill
patient
receiv
crrt
effect
variabl
initi
crrt
mortal
evalu
univari
multivari
cox
regress
analysi
perform
determin
renal
patientspecif
variabl
associ
mortal
result
patient
evalu
inclus
patient
exclud
histori
chronic
kidney
diseas
patient
exclud
creatinin
crrt
initi
avail
patient
exclud
admiss
creatinin
includ
patient
mortal
univari
proport
hazard
cox
regress
analysi
icu
admiss
cardiopulmonari
resuscit
hr
p
sofa
score
hr
p
creatinin
crrt
initi
hr
p
associ
mortal
multivari
analysi
demonstr
age
hr
p
admiss
weight
hr
p
icu
admiss
respiratori
failur
hr
p
creatinin
crrt
initi
hr
p
associ
mortal
correct
diseas
sever
score
apach
score
sofa
score
marker
fluid
overload
hematocrit
cumul
fluid
balanc
creatinin
initi
remain
associ
lower
even
correct
admiss
creatinin
creatinin
initi
remain
associ
mortal
roc
curv
analysi
crrt
initi
creatinin
best
predictor
mortal
conclus
multicent
cohort
creatinin
crrt
initi
independ
predictor
mortal
even
correct
admiss
creatinin
diseas
sever
hemodilut
therefor
data
argu
favour
timedepend
effect
crrt
mortal
data
suggest
late
crrt
initi
may
better
outcom
earlier
crrt
initi
howev
research
need
confirm
hypothesi
reveal
underli
mechan
introduct
karnofski
perform
scale
kp
wide
describ
patient
function
statu
correl
poor
function
level
advers
outcom
found
kp
use
decis
make
surround
start
aggress
therapi
evalu
impact
kp
long
term
renal
patient
surviv
aki
patient
receiv
renal
replac
therapi
rrt
intens
care
icu
method
prospect
enrol
aki
icu
patient
octob
octob
demograph
apach
ii
sofa
score
modal
dose
rrt
icu
length
stay
lo
kp
collect
data
renal
patient
surviv
icu
discharg
day
also
month
collect
analysi
use
multivari
logist
regress
stata
result
patient
recruit
male
median
age
iqr
median
apach
ii
score
iqr
median
sofa
score
admiss
iqr
mechan
ventil
median
lo
iqr
day
median
kp
iqr
patient
depend
rrt
icu
discharg
day
month
respect
patient
surviv
icu
discharg
patient
aliv
day
month
respect
adjust
age
sex
apach
ii
factor
associ
patient
need
rrt
icu
discharg
day
day
month
ci
p
ci
p
ci
p
ci
p
respect
adjust
age
sex
admiss
sofa
ci
p
apach
ii
ci
kp
ci
p
associ
icu
surviv
howev
multivari
regress
analysi
apach
ii
independ
associ
icu
surviv
ci
p
conclus
diseas
sever
remain
main
determin
outcom
aki
patient
receiv
rrt
icu
despit
appar
relev
kp
outcom
critic
care
could
instanc
show
kp
independ
affect
renal
patient
surviv
studi
larger
number
patient
requir
clarifi
issu
refer
oken
et
al
j
clin
oncol
introduct
crrt
region
citrat
anticoagul
rca
provid
long
filter
run
time
effect
dialysi
dose
thu
risk
hypophosphatemia
high
substitut
requir
investig
whether
separ
infus
dialysi
fluid
effect
avoid
sever
method
retrospectiveprospect
observ
studi
univers
hospit
crrt
rcacvvhd
mlkgh
substitut
via
separ
infus
retrospect
data
use
dialys
cica
dialys
fre
medic
care
prospect
data
primari
outcom
incid
sever
secondari
outcom
mainten
normal
durat
mechan
ventil
length
stay
icu
approv
local
ethic
committe
result
recruit
pt
group
epidemiolog
data
differ
poi
vs
pod
mean
age
vs
bw
vs
kg
male
vs
major
caus
aki
sepsi
incid
sever
hypophoph
poi
vs
pod
pt
p
durat
mechan
vent
poi
vs
pod
h
ns
icu
day
poi
vs
pod
ns
conclus
despit
rigor
effort
maintain
normal
via
sever
hypophosphatemia
occur
pt
contrast
dialysi
fluid
ensur
normal
pt
significantli
reduc
risk
sever
trend
toward
reduc
length
mech
ventilat
icu
stay
thu
dialys
recommend
increas
safeti
crrt
icu
patient
introduct
schwarz
bean
ramsay
c
j
kirwan
j
r
prowl
region
citrat
administr
rca
effect
anticoagul
techniqu
continu
renal
replac
therapi
crrt
commonli
rca
protocol
incorpor
citrat
within
replac
fluid
ad
calcium
post
filter
follow
modif
aquariu
haemofilt
nikkiso
design
implement
protocol
rca
standalon
citrat
administr
pre
filter
post
dilut
cvvhf
use
calcium
contain
replac
fluid
method
prospect
audit
first
critic
ill
patient
receiv
rca
post
dilut
cvvhf
inclus
criteria
adult
critic
ill
patient
requir
crrt
contraind
heparin
exclus
criteria
liver
diseas
liver
injuri
noradrenalin
ideal
bodi
weight
kg
receiv
uhr
insulin
sodium
mmoll
ph
bicarbon
mmoll
primari
outcom
measurefilt
time
secondari
outcom
measur
calcium
replac
post
filter
ionis
calcium
ica
acid
base
statu
serum
sodium
level
dose
choic
mlskgmin
parallel
chang
filtrat
fraction
requir
manag
metabol
alkalosi
metabol
alkalosi
persist
rca
stop
acid
citrat
dextros
forumulaa
acda
mmoll
citrat
administ
weight
relat
rate
aim
citrat
concentr
replac
fluid
accusol
mmoll
calcium
post
filter
solut
mmoll
calcium
chlorid
administ
accord
post
filter
ioniz
calcium
ica
bicarbon
ica
sodium
measur
hourli
interv
therapi
result
patient
male
age
receiv
rca
across
filter
median
filter
lifespan
hour
post
filter
ica
mmoll
filter
time
hr
ca
ica
ph
bicarbon
mmoll
sodium
mmoll
filter
patient
requir
calcium
replac
median
mmol
filter
cessat
plan
set
life
expir
hour
clot
circuit
pressur
balanc
access
liver
failur
document
conclus
crrt
rca
standalon
citrat
administr
post
dilut
effect
safe
altern
heparin
anticoagul
contraind
standard
calcium
contain
replac
fluid
dramat
reduc
need
addit
post
filter
calcium
infus
add
potenti
cost
save
introduct
adsorb
filter
antiinflammatori
action
coupl
plasma
filtrat
adsorpt
cpfa
cytosorb
may
clinic
use
sepsi
aim
studi
cohort
septic
patient
rrt
cpfa
cytosorb
evalu
tromboelastographi
monitor
teg
three
differ
method
anticoagul
anticoagul
anticoagul
mmol
l
citrat
anticoagul
mmol
l
citrat
method
thirti
patient
submit
cpfa
cytosorb
three
differ
method
anticoagul
heparin
group
mmoll
citrat
group
b
mmol
citrat
group
c
patient
monitor
coagul
act
teg
basal
time
hour
blood
sampl
teg
collect
patient
arteri
site
post
hemofilt
cpfa
post
cartridg
cytosorb
site
data
express
mean
sd
anova
test
use
statist
studi
result
teg
data
show
tabl
statist
comparison
made
site
conclus
cpfa
cytosorb
rrt
heparin
increas
r
delay
activ
coagul
decreas
less
cloth
strength
patient
increas
risk
bleed
mmoll
citrat
anticoagul
decreas
increas
r
circuit
better
group
b
achiev
optim
extracorpor
anticoagul
refer
crit
care
med
introduct
cica
cvvhd
success
implement
protocol
sever
european
countri
conduct
crrt
patient
aki
protocol
recommend
calcium
chlorid
solut
cacl
calcium
supplement
due
nonavail
cacl
modifi
approach
use
calcium
glucon
solut
cagl
instead
method
cica
cvvhd
protocol
reli
modifi
calcium
substitut
control
sica
appli
analog
modifi
protocol
cica
cvvhd
protocol
ratio
dialys
flow
qd
blood
flow
qb
link
effect
acidbas
statu
typic
set
essenti
appli
throughout
studi
use
lh
dialys
flow
mlmin
blood
flow
system
ioniz
ca
sica
acidbas
paramet
close
monitor
ensur
safe
applic
modifi
protocol
retrospect
analyz
critic
ill
patient
result
respect
system
ica
patient
group
low
valu
start
cica
cvvhd
might
alreadi
explain
higher
requir
amount
cagl
compar
literatur
data
assum
calcium
deficit
patient
fill
see
fig
concern
acidbas
result
see
slight
tendenc
alkalosi
prolong
cica
cvvhd
cagl
see
fig
might
well
attribut
glucon
metabol
yield
addit
bicarbon
conclus
success
establish
use
cagl
cica
cvvhd
protocol
note
slight
trend
alkalosi
decid
slightli
reduc
blood
flow
mlmin
reduc
citrat
need
less
citrat
metabol
patient
bicarbon
refer
slowinski
et
al
crit
care
introduct
aim
compar
clearanc
inflammatori
mediat
specif
cvvhd
use
high
cutoff
filter
ultraflux
vs
standard
haemofilt
method
clearanc
compar
two
filter
vitro
setup
use
spike
human
plasma
pgml
well
control
random
clinic
trial
includ
patient
sepsi
acut
renal
dysfuncion
protocol
approv
local
ethic
committe
cvvhd
perform
use
multifiltr
acut
therapi
system
cica
anticoagul
freseniu
medic
care
plasma
sampl
taken
start
cvvhd
h
h
panel
cytokin
determin
plasma
sampl
use
cytokin
bead
array
addit
albumin
quantifi
dialys
sampl
indic
time
point
result
vitro
clearanc
significantli
higher
compar
vs
mlmin
clinic
sampl
concentr
dialys
vs
vs
vs
vs
rel
level
plasma
h
respect
filter
differ
significantli
respect
albumin
remov
conclus
vitro
vivo
data
show
significantli
higher
clearanc
high
cutoff
filter
ultraflux
vs
standard
haemofilt
introduct
new
sorbent
cytosorb
cytosorb
usa
base
bloodcompat
porou
polymerbead
abl
adsorb
hydrophob
molecul
could
valid
artifici
support
mani
condit
organ
failur
remov
cytokin
toxic
molecul
directli
blood
present
extracorpor
system
base
plasmaadsorpt
perform
vitro
studi
bilirubin
kinet
remov
verifi
system
adsorpt
capac
abil
remov
proteinbound
solut
method
perform
vitro
test
experi
done
equimolar
solut
albumin
alb
bilirubin
bil
unconjug
bil
strongli
albbound
verifi
remov
proteinbound
solut
test
h
long
tri
reproduc
clinic
condit
higher
concentr
bil
lower
alb
studi
kinet
mass
balanc
solut
recircul
circuit
includ
peristalt
pump
cytosorb
flow
rate
mlmin
sampl
collect
pre
post
cartridg
differ
time
min
everi
min
end
result
experi
show
adsorpt
capac
system
concern
bil
tabl
minim
loss
alb
experi
demonstr
capac
adsorb
proteinbound
solut
condit
remov
bil
possibl
break
albbil
complex
test
show
bil
adsorpt
mg
equival
remov
blood
bil
kg
patient
initi
concentr
mgdl
major
reduct
first
h
cartridg
maintain
adsorpt
capac
end
could
demonstr
releas
adsorb
bil
h
conclus
vitro
studi
show
effect
remov
bil
signific
loss
alb
resin
abil
break
albbil
complex
adsorb
irrevers
bil
cytosorb
might
repres
valid
simpl
aid
organ
dysfunct
without
need
plasma
separ
vivo
studi
ongo
confirm
vitro
result
refer
weber
et
al
biomacromolecul
introduct
clinic
studi
shown
reduct
toxic
level
cytokin
blood
use
new
sorbent
cytosorb
cytosorb
could
use
regain
control
complic
inflammatori
condit
patient
sever
sepsissept
shock
case
seri
evalu
patient
admit
icu
jan
nov
treat
cytosorb
aim
analys
influenc
clinic
outcom
mean
arteri
pressur
map
vasopressor
need
inflammatori
marker
like
procalcitonin
pct
method
includ
patient
f
sever
sepsi
septic
shock
patient
data
report
tabl
median
lower
upper
quartil
patient
nonrespond
standard
care
treatment
sever
sepsissept
shock
therefor
cytosorb
use
adjunct
therapi
combin
continu
renal
replac
therapi
crrt
order
control
cytokin
storm
improv
hemodynam
stabil
instal
seri
connect
dialys
crrt
circuit
h
median
durat
treatment
h
clinic
paramet
collect
everi
treatment
cytosorb
result
treat
patient
surviv
treatment
overal
improv
map
mmhg
rapid
reduct
vasopressor
dosag
noradrenalin
decreas
dopamin
ykgmin
moreov
markedli
decreas
pct
level
ngdl
improv
renal
function
thank
combin
cytosorb
crrt
nonsurvivor
map
hard
stabil
decreas
mmhg
aggrav
overal
patient
condit
conclus
experi
time
use
cytosorb
combin
standard
therapi
could
benefit
improv
patient
hemodynam
help
rapid
stabil
howev
vivo
studi
need
confirm
result
refer
schadler
et
al
critic
care
suppl
introduct
studi
quantifi
abil
hemoadsorb
polym
bead
adsorb
broad
select
inflammatori
pathogen
damageassoci
molecular
pattern
molecul
pamp
damp
cytokin
whole
blood
vitro
recircul
system
pamp
caus
either
direct
damag
trigger
immun
respons
host
fight
infect
lead
product
high
level
cytokin
releas
damp
bloodstream
trigger
maladapt
system
inflammatori
respons
syndrom
sir
contribut
organ
injuri
benefit
cytokin
reduct
use
extracorpor
blood
filtrat
hemoadsorb
porou
polym
bead
demonstr
septic
anim
yet
adsorpt
toxin
inflammatori
factor
may
also
contribut
observ
benefit
method
purifi
protein
ad
whole
blood
recircul
devic
control
devic
hour
plasma
analyz
elisa
result
hemoperfus
whole
blood
porou
polym
bead
devic
hour
remov
substanti
quantiti
broad
spectrum
damp
pamp
tabl
cytokin
ns
level
inflammatori
protein
reduc
five
hour
hemoperfus
control
devic
ns
conclus
studi
demonstr
hemoadsorb
polym
bead
capabl
reduc
broad
rang
toxic
damp
pamp
blood
provid
mean
addit
cytokin
reduct
reduc
uncontrol
immun
respons
contribut
maladapt
sir
respons
organ
injuri
death
patient
broad
rang
lifethreaten
inflammatori
condit
sepsi
trauma
lung
injuri
mani
other
studi
elucid
potenti
clinic
impact
warrant
introduct
sever
studi
vitro
data
demonstr
addit
treatment
extracorpor
cytokin
adsorpt
filter
cytosorb
cytosorb
corp
may
help
patient
multiorgan
failur
due
increas
cytokin
level
cytosorb
use
adjunct
therapi
septic
multiorgan
failur
well
sever
pancreat
critic
ill
patient
well
toler
safe
method
collect
data
patient
treat
addit
cytokinehaemadsorpt
filter
cytosorb
adjunct
therapi
septic
shock
sever
sir
focu
abdomin
pneumonia
pancreat
aim
case
studi
show
effect
cytosorb
treatment
use
adjunct
therapi
critic
ill
patient
decreas
catecholamin
demand
kidney
injuri
persist
initi
therapi
follow
actual
guidelin
cytosorb
therapi
initi
collect
data
treatment
calcul
demand
norepinephrin
vs
therebi
achiev
mm
hg
map
result
patient
femal
mean
age
year
apach
ii
score
overal
surviv
contrast
surviv
cytosorb
therapi
start
delay
h
poor
outcom
increas
patient
late
start
cytosorb
survivor
therapi
start
delay
h
delay
h
none
cytosorb
therapi
start
nonsurvivor
far
later
survivor
h
vs
h
cytosorb
therapi
observ
pronounc
decreas
catecholamin
demand
norepinephrin
vs
therebi
achiev
map
catecholamin
demand
decreas
vs
blood
lactat
level
divid
halv
mgdl
vs
conclus
case
studi
effect
could
observ
pronounc
decreas
catecholamin
demand
blood
lactat
level
could
see
increas
surviv
treatment
cytosorb
haemadsorpt
filter
start
h
patient
greater
delay
poor
outcom
reason
delay
late
acut
renal
failur
late
admiss
icu
implic
therapi
start
later
hour
refer
hetz
h
et
al
septic
shock
secondari
streptococcusinduc
necrot
fasciiti
treat
novel
cytokin
adsorpt
therapi
int
j
artif
organ
delling
rp
et
al
surviv
sepsi
campaign
guidelin
manag
sever
sepsi
septic
shock
intens
care
med
introduct
endotoxin
associ
mortal
critic
care
patient
clinic
studi
evalu
whether
renal
replac
therapi
rrt
adsorb
membran
may
decreas
endotoxin
modul
pro
inflammatori
mediat
aim
studi
cohort
septic
patient
crrt
evalu
chang
endotoxin
rrt
chang
procalcitonin
method
patient
renal
failur
sepsi
septic
shock
submit
rrt
adsorb
membran
oxiri
gambro
stratifi
three
group
accord
basal
eaa
level
group
eaa
group
b
group
c
patient
monitor
endotoxin
chemiluminisc
base
endotoxin
activ
assay
eaa
spectral
diagnost
ontario
canada
elisa
procalcitonin
lumi
test
pct
braun
diagnost
berlin
germani
inotrop
support
basal
time
hour
hour
data
express
mean
sd
anova
test
use
compar
chang
eaa
procalcitonin
result
septic
patient
renal
failur
sepsi
septic
shock
enrol
group
includ
patient
group
b
patient
group
c
patient
tabl
shown
chang
eaa
group
also
decreas
pgml
p
procalcitonin
ngml
p
group
b
c
procalcitonin
decreas
significantli
patient
surviv
deceas
survivor
lower
eaa
non
survivor
eaa
vs
p
conclus
adsorb
membran
oxiri
may
decreas
endotoxin
patient
eaa
accompani
reduct
pro
calcitonin
endotoxin
decreas
may
increas
surviv
data
confirm
part
recent
studi
liver
failur
treatment
new
extracorpor
liver
devic
combin
septex
filter
oxiri
refer
journal
hepatolog
vol
j
introduct
phenomenon
augment
renal
clearanc
arc
increasingli
report
intens
care
unit
icu
patient
howev
report
arc
japan
aim
observ
studi
describ
preval
patient
characterist
arc
cohort
patient
normal
serum
creatinin
level
japanes
icu
method
conduct
prospect
cohort
studi
may
septemb
emerg
icu
tertiari
univers
hospit
japan
creatinin
clearanc
clcr
rate
patient
measur
admiss
arc
defin
bodi
surfac
adjust
clcr
rate
sought
studi
incid
arc
record
patient
characterist
associ
arc
prospect
result
two
hundr
ninetyf
patient
admit
icu
studi
period
recruit
present
studi
identifi
patient
arc
patient
arc
younger
vs
year
p
less
frequent
male
vs
p
lower
apach
ii
score
vs
p
less
frequent
diagnos
sepsi
vs
p
patient
without
arc
conclus
arc
common
find
japanes
icu
patient
normal
serum
creatinin
level
multicent
studi
need
gain
better
understand
precis
epidemiolog
arc
japanes
popul
introduct
acut
kidney
injuri
aki
frequent
sever
sepsi
icu
develop
goaldirect
diagnost
ultrasonograph
algorithm
assist
evalu
aki
aim
determin
effect
incid
rate
aki
method
prospect
observ
studi
patient
sever
sepsi
acut
oliguria
met
definit
aki
reduc
urin
output
rifl
criteria
perform
inferior
vena
cava
ivc
diamet
collaps
renal
perfus
color
doppler
incorpor
algorithm
use
primari
intensivist
volum
assess
manag
effect
algorithmdirect
intervent
assess
serum
creatinin
urin
output
mlkghour
twentyfour
hour
later
outcom
propos
approv
research
ethic
committe
rac
result
fiftythre
patient
studi
mean
apach
ii
score
mean
sofa
score
twentyfour
patient
diabet
hypertens
cirrhot
patient
vasopressor
mean
creatinin
time
evalu
serum
lactat
ultrasound
evalu
reveal
intravascular
dehydr
euvolumia
fluid
replet
base
ultrasound
result
patient
given
loop
diuret
start
continu
renal
replac
therapi
crrt
fluid
bolus
patient
crrt
stop
serum
creatinin
increas
time
patient
urin
output
mlkghour
iqr
patient
recov
aki
either
chronic
dialysi
chronic
kidney
diseas
followup
patient
renal
injuri
conclus
incorpor
standard
diagnost
algorithm
use
bedsid
ultrasonograph
assess
help
us
significantli
reduc
rate
acut
kidney
injuri
refer
posit
fluid
balanc
independ
risk
factor
acut
kidney
injuri
critic
ill
patient
result
prospect
crosssect
studi
n
salahuddin
sammani
hamdan
joseph
alnemari
r
alquaiz
k
maghrabicrit
care
suppl
introduct
aki
characteris
abrupt
loss
kidney
function
due
worldwid
increas
preval
mortal
diseas
becom
import
health
care
challeng
treat
intens
care
unit
icu
aki
caus
numer
case
postren
obstruct
urineaccumul
ultrasound
us
procedur
choic
diagnos
caus
aki
henc
choos
best
therapi
survey
uk
reveal
icu
contact
nephrologist
within
h
aki
moreov
even
icu
provid
us
option
h
day
reason
develop
fariu
focus
acut
renal
injuri
us
programm
educ
student
physician
diagnos
obstruct
via
us
expert
like
manner
method
fariu
approv
ethic
commiss
develop
h
programm
train
renal
us
valid
fariu
compar
us
result
traine
student
physician
expert
icu
physician
urologist
nephrologist
intern
specialist
present
result
two
qualiti
paramet
ie
defin
length
cm
right
kidney
femal
volunt
ii
diagnos
postren
obstruct
evalu
imag
us
examin
fariu
particip
vote
present
imag
deveal
postren
obstruct
answer
analyz
correct
specif
sensit
statist
analysi
wilcoxon
test
realiz
instant
result
fariu
n
mean
sd
min
max
expert
n
mean
sd
min
max
statist
analysi
reveal
signific
differ
group
p
p
ii
evalu
us
imag
reveal
correct
answer
min
max
sde
sensit
specif
conclus
could
demonstr
absolv
fariu
abl
provid
us
examin
detect
evalu
postren
obstruct
similar
qualiti
like
expert
identif
patholog
result
high
sensitif
howev
varianc
result
indic
amend
therebi
treatment
icu
patient
aki
could
independ
extern
condit
offer
equal
diagnost
qualiti
econom
interest
human
resourc
could
posit
affect
also
investig
plan
refer
ronco
c
et
al
nat
rev
nephrol
apr
li
pk
et
al
transplant
mar
jone
sl
et
al
nephrol
dial
transplant
may
introduct
two
third
critic
ill
patient
develop
acut
kidney
injuri
aki
associ
increas
risk
death
renal
angina
index
score
evalu
risk
present
aki
studi
use
determin
effect
renal
angina
index
develop
predictor
aki
day
method
studi
base
prospect
cohort
critic
ill
patient
renal
angina
index
score
complet
hour
follow
serum
creatinin
level
water
balanc
urinari
output
establish
patient
develop
aki
afterward
relationship
establish
renal
angina
index
score
predict
capac
develop
aki
determin
sensibl
specif
posit
predict
valu
neg
predict
valu
score
result
final
sampl
patient
obtain
end
studi
incid
aki
studi
popul
n
averag
score
renal
angina
index
develop
aki
develop
aki
score
offer
sensibl
specif
area
de
curv
posit
predict
valu
obtain
neg
predict
valu
conclus
renal
angina
index
score
effect
predict
aki
critic
ill
adult
patient
refer
chawla
l
goldstein
kellum
j
ronco
c
renal
agina
concept
develop
pretest
probabl
assess
acut
kidney
injuri
critic
care
basu
r
zappitelli
brunner
l
wang
wong
h
et
al
kidney
intern
basu
r
wang
wong
h
chawla
l
wheeler
goldstein
incorpor
biomark
renal
angina
index
predict
sever
aki
critic
ill
children
clin
j
soc
nephrol
introduct
still
uncertainti
whether
intervent
blood
pressur
effect
treat
newonset
acut
kidney
injuri
aki
critic
ill
patient
moreov
littl
thing
known
signific
blood
pressur
aki
without
sepsi
purpos
studi
explor
paramet
blood
pressur
onset
aki
associ
aki
stage
progress
investig
whether
mean
blood
pressur
newonset
oligur
aki
differ
patient
without
sepsi
method
retrospect
cohort
studi
includ
adult
patient
whose
stay
icu
jikei
univers
hospit
tokyo
japan
hour
new
onset
oligur
aki
oligur
aki
defin
urin
output
less
mlkgh
hour
accord
kidney
diseas
improv
global
outcom
kdigo
definit
primari
outcom
aki
stage
progress
kdigo
criteria
time
frame
analyz
mean
arteri
pressur
map
paramet
timeaverag
map
lowest
map
time
length
map
mmhg
consid
stratif
sepsi
result
analyz
patient
oligur
aki
stage
progress
occur
patient
sepsi
icu
admiss
stage
progress
occur
patient
stratifi
sepsi
time
length
map
mmhg
significantli
associ
stage
progress
multivari
analys
ci
hour
sepsi
hour
without
sepsi
multivari
analysi
patient
categor
time
length
map
mmhg
show
increas
trend
or
hour
hour
hour
hour
conclus
time
frame
newonset
oligur
aki
time
length
map
mmhg
associ
stage
progress
oligur
aki
without
sepsi
result
suggest
recognit
treatment
aki
earli
regardless
sepsi
urin
output
continu
monitor
might
use
purpos
serum
creatinin
studi
need
investig
mean
intervent
blood
pressur
treatment
aki
introduct
hospit
patient
anaemia
increas
risk
develop
acut
kidney
injuri
aki
aim
determin
whether
anaemia
also
impact
risk
progress
earli
aki
sever
aki
critic
ill
patient
method
retrospect
analys
data
patient
admit
icu
aki
stage
per
aki
network
classif
undergon
haemodynam
monitor
within
h
diagnosi
collect
baselin
characterist
differenti
patient
progress
aki
stage
iii
univari
multivari
logist
regress
analys
use
identifi
risk
factor
progress
result
patient
includ
analysi
patient
progress
aki
iii
five
patient
aki
die
renal
function
recov
progress
patient
aki
progress
aki
iii
sicker
day
aki
higher
sofa
score
vs
p
higher
arteri
lactat
vs
mmoll
p
lower
map
median
vs
mmhg
p
lower
cardiac
index
median
vs
p
increas
need
respiratori
cardiovascular
support
differ
hb
concentr
gl
risk
factor
progress
aki
aki
iii
shown
tabl
conclus
critic
ill
patient
aki
stage
anaemia
associ
increas
risk
progress
sever
aki
introduct
glomerular
filtrat
rate
gfr
describ
flow
rate
filter
fluid
kidney
creatinin
clearanc
crcl
volum
blood
plasma
clear
serum
creatinin
scr
per
time
unit
import
measur
approxim
true
gfr
crcl
estim
either
popul
base
mathemat
equat
measur
use
serum
urin
creatinin
concentr
collect
urin
certain
period
time
deterior
crclgfr
identifi
patient
acut
kidney
injuri
import
appropri
drug
dose
icu
practic
mdrdegfr
equat
standard
care
reliabl
estim
gfr
recent
ckdepiscr
equat
introduc
accur
measur
especi
patient
higher
gfr
howev
critic
ill
patient
steadi
state
scr
prerequisit
order
estim
gfr
irrespect
mathemat
formula
use
regularli
treat
patient
demonstr
highli
impair
kidney
function
spite
normal
estim
gfr
lead
toxic
level
renal
clear
drug
investig
actual
practic
gfr
approxim
dutch
icu
method
structur
questionnair
via
telephon
result
june
hospit
netherland
hospit
southern
holland
academ
hospit
approach
oncal
intens
care
doctor
clinic
chemist
queri
moment
queri
hospit
use
ckdepiscr
equat
order
estim
gfr
hospit
use
mdrdequat
plan
soon
introduc
ckdepiscr
equat
intens
care
unit
includ
egfr
admiss
use
defin
patient
gfr
determin
drug
dose
intens
care
doctor
consciou
egfr
might
overestim
patient
true
gfr
protocol
drug
level
analysi
ie
vancomycin
exist
howev
standard
measur
patient
crcl
perform
none
icu
conclus
current
clinic
practic
mathemat
equat
use
estim
gfr
even
critic
ill
patient
appar
shift
mdrd
toward
ckdepiscrequ
howev
appli
critic
ill
formula
provid
complet
incompar
valu
data
publish
therefor
highli
debat
ckdepiscr
egfr
better
estim
comparison
mdrdegfr
recent
literatur
suggest
method
approxim
inulinbasedgfr
critic
ill
measur
gfr
support
becom
clinic
practic
icu
introduct
serumcreatinin
base
estim
glomerular
filtrat
rate
egfr
use
mdrdequat
inaccur
critic
ill
patient
tend
sever
overestim
real
time
clearanc
capac
especi
catabol
state
recent
ckdepiserumcreatinin
ckdepicystatinc
equat
introduc
precis
altern
egfr
origin
equat
valid
patient
stabl
chronic
kidney
diseas
dutch
hospit
laboratori
includ
still
report
mdrdegfr
electron
patient
data
system
howev
mani
intend
alreadi
switch
ckdepiserumcreatinineegfr
date
e
gfr
key
element
clinic
decis
make
even
icu
set
howev
indiscrimin
applic
mathemat
equat
may
question
critic
ill
method
order
calcul
gfr
appli
mdrd
ckdepiserumcreatinin
ckdepicystatinc
formula
assess
mutual
compar
allcom
adult
academ
icu
cohort
perform
posthoc
analysi
ngalstudi
mdrdegfr
ckdepiserumcreatinineegfr
ckdepicystatincegfr
calcul
use
admissionday
data
manwhitney
u
test
use
comparison
group
result
consecut
admiss
case
exclud
due
miss
data
patient
characterist
compris
median
ci
age
year
sofa
score
apach
ii
score
male
femal
ratio
analysi
egfr
mdrd
ckdepiserumcreatinin
en
ckdepicystatinc
result
significantli
differ
outcom
comparison
mdrdequat
ckdepiserumcreatinineegfr
valu
higher
p
wherea
ckdepicystatinc
valu
lower
p
direct
comparison
ckdepiserumcreatinineegfr
higher
ckdepicystatincegfr
differ
signific
entir
cohort
persist
throughout
kdigo
stage
subgroup
p
kdigo
stage
small
sampl
size
limit
interpret
result
conclus
cohort
use
abovement
mathemat
equat
result
complet
differ
egfr
valu
particularli
new
ckdepiserumcreatinin
ckdepicystatinc
equat
provid
incompar
egfr
valu
although
formula
suppos
precis
remain
question
whether
suffici
reliabl
icuset
introduct
ideal
biomark
earli
diagnosi
septic
acut
kidney
injuri
aki
reflect
renal
damag
cellular
level
aim
studi
assess
compar
role
urinari
cell
cycl
arrest
marker
insulin
like
growth
factor
bind
earli
diagnosi
septic
aki
adult
critic
care
patient
besid
role
mortal
predict
also
evalu
method
singl
center
prospect
cohort
studi
patient
without
aki
admit
medic
intens
care
unit
icu
januari
march
includ
accord
icu
followup
characterist
group
sepsisnon
aki
sepsisaki
nonsepsisnon
aki
control
studi
human
elisa
admiss
daili
collect
serial
urin
sampl
result
one
hundr
eighteen
patient
form
cohort
sepsisnon
aki
sepsisaki
control
group
admiss
urin
predict
septic
aki
develop
sensit
specif
threshold
level
ngml
area
receiv
oper
characterist
curv
auc
impact
sepsi
observ
urin
level
absenc
aki
septic
aki
group
urin
level
continu
increas
upto
day
aki
develop
high
level
suspend
day
continu
ngml
day
aki
predict
mortal
sensit
specif
p
ci
one
signific
predictor
mortal
multivari
analysi
conclus
admiss
urin
level
follow
cours
icu
use
earli
diagnosi
septic
aki
develop
without
affect
sepsi
role
predict
mortal
need
clarif
refer
kashani
k
alkhafaji
ardil
et
al
discoveri
valid
cell
cycl
arrest
biomark
human
acut
kidney
injuri
critic
care
bell
larsson
veng
p
bellomo
r
martensson
j
asses
cell
cycl
arrest
biomark
predict
earli
delay
acut
kidney
injuri
diseas
marker
articl
id
page
http
introduct
establish
categori
risk
develop
sever
acut
kidney
injuri
base
combin
level
ungal
variou
clinic
variabl
method
clinic
retrospect
observ
descript
analyt
studi
icu
medica
sur
clinic
foundat
understood
period
januari
decemb
result
patient
includ
studi
male
femal
mean
age
year
main
caus
admiss
septic
shock
creatinin
level
time
uresi
ungal
signific
differ
probabl
less
cutoff
diagnosi
acut
kidney
injuri
admiss
ng
ml
outcom
sever
acut
kidney
injuri
incom
cutoff
ng
ml
conclus
statist
signific
differ
variabl
except
creatinin
level
urinari
lipocalin
uresi
time
cut
ungal
admiss
outcom
sever
aki
ng
ml
refer
cruz
dn
et
al
intens
care
med
ronco
c
et
al
lancet
ronco
c
et
al
critic
care
introduct
shrunken
pore
syndrom
sp
suggest
egfr
base
cystatin
c
lower
egfr
base
creatinin
ie
egfrcystatin
c
egfrcreatinin
method
preop
plasma
level
cystatin
c
creatinin
measur
patient
undergo
cabg
egfrcystatinc
egfrcreatinin
calcul
use
two
pair
estim
equat
capalmrev
ckdepicystatin
c
ckdepicreatinin
respect
patient
studi
median
followup
time
year
mortal
determin
result
cox
multivari
analysi
demonstr
preop
presenc
sp
independ
predict
poorer
surviv
addit
previous
known
risk
factor
five
year
surviv
patient
mean
ci
surviv
patient
sp
defin
equat
pair
capalmrev
surviv
patient
sp
equat
pair
ckdepicystatin
ccreatinin
conclus
sp
strong
independ
predictor
mortal
refer
grubb
scand
j
clin
lab
invest
introduct
patient
hospit
septic
shock
increas
risk
develop
acut
renal
failur
arf
requir
renal
replac
therapi
rrt
best
delay
start
rrt
matter
debat
new
urin
test
nephrochecktm
valid
correspond
urin
concentr
product
tubular
suffer
marker
associ
risk
develop
arf
within
hour
aim
studi
analyz
capac
urin
predict
absenc
evolut
toward
akin
patient
hospit
septic
shock
present
arf
akin
method
everi
patient
admit
septic
shock
medic
icu
present
arf
akin
within
first
hour
follow
start
catecholamin
prospect
includ
exclus
criteria
pretermin
chronic
renal
failur
chronic
dialysi
anuria
patient
akin
akin
urin
assay
perform
baselin
clinic
biolog
paramet
collect
perform
nephrochecktm
predict
absenc
evolut
toward
akin
level
within
first
hour
test
baselin
measur
evolut
nephrochecktm
baselin
delta
result
fiftyseven
patient
includ
patient
develop
akin
arf
group
akin
patient
reach
level
akin
urin
output
lower
n
akin
versu
akin
mlhkg
p
differ
variabl
baselin
includ
creatininemia
differ
two
group
akin
versu
akin
respect
versu
p
p
median
delta
differ
group
predict
absenc
progress
toward
sensibl
specif
compar
creatininemia
baselin
auc
auc
p
urin
test
superior
assess
risk
differ
diuresi
baselin
auc
p
conclus
nephrochecktm
urin
output
admiss
predict
absenc
progress
akin
toward
akin
level
septic
shock
patient
introduct
acut
kidney
injuri
aki
seriou
complic
hospit
patient
particularli
critic
ill
aki
independ
associ
poor
prognosi
outcom
sepsi
import
caus
aki
pathogenesi
clearli
distinct
nonsept
aki
compar
clinic
cours
outcom
septic
nonsept
critic
ill
patient
worldwid
method
intens
care
unit
icu
invit
particip
voluntarili
intens
care
nation
icon
audit
particip
center
data
prospect
collect
adult
patient
year
admit
icu
period
patient
admit
less
h
routin
postop
surveil
exclud
data
collect
daili
icu
stay
day
followup
outcom
data
hospit
discharg
death
aki
defin
accord
risk
injuri
failur
loss
endstag
rifl
classif
diagnos
first
h
icu
admiss
patient
preexist
chronic
renal
failur
crf
analyz
separ
subgroup
result
studi
popul
compris
patient
admiss
patient
fulfil
sepsi
criteria
develop
aki
compar
nonsept
popul
p
aki
sever
septic
patient
patient
less
like
recov
lower
rilf
categori
compar
nonsept
patient
improv
day
day
vs
p
dialysi
incid
higher
septic
patient
compar
nonsept
patient
vs
p
also
inhospit
mortal
rate
higher
vs
p
increas
septic
nonsept
akif
patient
hospit
mortal
septic
akif
patient
similar
compar
septic
patient
preexist
crf
hr
ci
compar
ci
septic
akif
patient
septic
patient
akir
akii
improv
day
day
admiss
show
similar
mortal
compar
septic
patient
develop
aki
mortal
remain
elev
akif
patient
improv
day
conclus
aki
sepsi
sever
less
like
recov
associ
higher
mortal
compar
nonsept
aki
refer
vincent
jl
et
al
lancet
respir
med
may
introduct
gynaeoncolog
surgeri
involv
patient
popul
elderli
undergo
intraabdomin
surgeri
sometim
tumour
extens
uret
long
anaesthet
surgic
time
extens
blood
loss
factor
highlight
kidney
diseas
improv
global
outcom
kdigo
factor
develop
acut
kidney
injuri
aki
incid
aki
gynaecolog
popul
thought
enhanc
recoveri
surgeri
era
pathway
incorpor
use
goal
direct
fluid
therapi
cardiac
output
monitor
periop
studi
aim
look
incid
aki
introduct
era
pathway
centr
method
retrospect
look
patient
undergo
major
gynaeoncolog
surgeri
introduct
era
pathway
patient
exclus
cohort
use
kdigo
definit
aki
use
patient
preoper
serum
creatinin
baselin
serum
creatinin
admiss
critic
care
unit
taken
day
data
collect
day
main
outcom
studi
incid
aki
pre
post
era
introduct
conting
analysi
use
yate
chisquar
perform
result
singl
centr
cohort
includ
patient
group
introduct
era
pre
era
post
introduct
group
post
era
overal
incid
aki
pre
era
group
post
era
group
statist
differ
day
incid
aki
pre
era
group
post
era
group
pvalu
day
pre
group
post
group
pvalu
analysi
show
statist
differ
incid
aki
pre
post
era
group
day
conclus
incid
aki
cohort
patient
lower
cite
statist
differ
incid
aki
introduct
era
pathway
thu
observ
reduct
incid
aki
introduct
era
pathway
refer
kidney
diseas
improv
global
outcom
acut
kidney
injuri
work
group
clinic
practic
guidelin
kidney
intl
suppl
vaught
aj
et
al
acut
kidney
injuri
major
gynaecolog
surgeri
observ
studi
bjog
septemb
introduct
acut
kidney
injuri
aki
independ
contributor
morbid
mortal
view
evalu
factor
may
associ
develop
aki
hip
knee
arthroplasti
studi
subsequ
effect
aki
length
stay
lo
mortal
method
retrospect
basi
clinic
databas
inform
lower
limb
arthroplasti
elect
tertiari
orthopaed
hospit
analys
time
period
januari
octob
aki
defin
kidney
diseas
improv
global
outcom
kdigo
classif
result
incid
aki
patient
episod
factor
gender
notic
associ
aki
rate
aki
elect
case
compar
urgent
case
revis
surgeri
associ
increas
rate
aki
compar
primari
surgeri
aki
increas
age
rate
aki
patient
age
develop
aki
progress
increas
asa
asa
patient
preoper
anaemia
blood
transfus
increas
risk
aki
respect
patient
develop
aki
postop
anaemia
aki
affect
patient
admit
hdu
patient
admit
hdu
demonstr
rate
aki
patient
aki
mean
lo
day
compar
day
without
aki
patient
aki
mortal
one
year
compar
patient
stage
stage
stage
aki
respect
conclus
incid
aki
much
lower
report
literatur
retrospect
studi
demonstr
rate
aki
elect
orthopaed
surgeri
possibl
may
secondari
routin
postop
admiss
patient
risk
factor
hdu
environ
risk
factor
found
associ
aki
consist
result
previou
studi
even
stage
aki
result
increas
mortal
one
year
interpret
find
limit
confound
earli
recognit
risk
factor
aid
identif
patient
increas
risk
aki
subsequ
preoptimis
normalis
revers
risk
factor
possibl
well
plan
appropri
postop
care
may
reduc
burden
aki
refer
chertow
gm
et
al
j
soc
nephrol
kimmel
l
et
al
clin
kidney
j
gross
jl
et
al
bja
educ
introduct
acut
kidney
injuri
aki
identifi
common
clinic
signific
complic
major
trauma
requir
icu
admiss
method
perform
retrospect
singl
centr
observatori
studi
major
trauma
admiss
royal
london
hospit
adult
critic
care
unit
period
assess
incid
associ
aki
popul
aki
defin
relat
kdigo
definit
use
creatinin
criteria
traumarel
aki
defin
aki
kdigo
creatinin
criteria
occur
seven
day
admiss
absenc
known
baselin
creatinin
admiss
valu
use
result
patient
admit
icu
major
trauma
includ
studi
male
median
age
iqr
median
new
injuri
sever
score
median
icu
admiss
overal
aki
incid
aki
associ
greater
hospit
mortal
vs
p
hospit
length
stay
fig
multivari
logist
regress
account
ill
sever
score
aki
remain
associ
increas
inhospit
mortal
howev
broken
aki
categori
significantli
associ
conclus
acut
kidney
injuri
common
find
critic
ill
patient
major
trauma
associ
greater
ill
sever
rate
death
length
stay
refer
bagshaw
et
al
renal
failur
introduct
major
trauma
patient
chanc
reduc
kidney
function
due
hemorrhag
shock
direct
injuri
studi
aim
evalu
clinic
characterist
risk
factor
acut
kidney
injuri
aki
patient
major
trauma
method
perform
retrospect
cohort
studi
singl
center
among
patient
visit
emerg
depart
januari
decemb
patient
trauma
enrol
patient
divid
two
group
patient
develop
aki
n
n
compar
clinic
data
conduct
multivari
logist
regress
independ
predictor
aki
mortal
result
overal
incid
aki
n
mean
age
year
male
also
initi
intervent
done
embol
n
p
oper
n
p
aki
patient
need
receiv
renal
replac
therapi
independ
risk
factor
associ
traumat
aki
injuri
sever
score
iss
odd
ratio
p
presenc
shock
p
increas
serum
creatin
kinas
ck
p
level
hospit
mortal
higher
aki
group
conclus
develop
aki
associ
sever
damag
organ
perfus
furthermor
aki
patient
trauma
refer
increas
mortal
introduct
demonstr
even
mild
transient
periop
acut
kidney
injuri
associ
significantli
wors
surviv
year
major
surgeri
see
accompani
abstract
howev
confound
effect
major
ill
serum
creatinin
level
may
caus
sever
aki
underestim
recoveri
aki
overestim
method
popul
patient
undergo
major
surgeri
examin
aki
examin
baselin
hospit
discharg
creatininebas
estim
gfr
ckdepi
formula
trajectori
serum
creatinin
patient
hospit
day
surgeri
result
patient
surviv
hospit
discharg
median
durat
hospit
day
iqr
day
patient
postop
aki
hospit
survivor
mean
egfr
rose
significantli
baselin
discharg
p
howev
aki
discharg
egfr
similar
baselin
p
patient
stay
day
surgeri
aki
mean
creatinin
rose
rapidli
eventu
settl
near
baselin
howev
overal
creatinin
fell
progress
five
day
surgeri
baselin
discharg
fig
regress
analysi
higher
discharg
egfr
significantli
correl
longer
hospit
length
stay
p
howev
relationship
exist
baselin
egfr
p
conclus
baselin
reduct
serum
creatinin
major
surgeri
may
confound
abil
identifi
aki
assess
sever
recoveri
importantli
effect
may
pronounc
patient
longer
hospit
admiss
higher
risk
complic
includ
aki
refer
prowl
et
al
clin
j
soc
nephrol
introduct
despit
advanc
critic
care
diagnosi
treatment
incid
acut
kidney
injuri
aki
remain
high
cardiac
surgeri
aki
report
around
need
renal
replac
therapi
aim
character
differ
premorbid
statu
etiolog
intraop
postop
influenc
factor
aki
develop
patient
secondari
outcom
method
singl
center
retrospect
observ
sturdi
aki
determin
acut
kidney
injuri
network
acut
within
h
deterior
renal
function
serum
creatinin
concentr
entir
increas
valu
greater
mgdl
baselin
increment
baselin
patient
divid
group
group
without
aki
patient
group
ii
aki
patient
patient
admiss
databas
record
well
secondari
outcom
measur
result
mean
age
year
report
high
aki
associ
set
aki
group
match
group
respect
age
gender
bodi
mass
index
associ
diabet
hypertens
aki
group
significantli
higher
addit
euro
score
vs
lower
eject
fraction
vs
p
respect
length
ventil
stay
icu
hospit
significantli
higher
aki
group
aki
group
postop
atrial
fibril
vs
p
aki
group
significantli
higher
mortal
vs
group
p
interestingli
aki
promin
asian
group
arab
vs
p
independ
risk
factor
aki
popul
addit
euro
score
cardiopulmonari
bypass
time
postop
low
hemoglobin
postop
white
cell
count
total
blood
loss
conclus
cardiac
surgeri
induc
aki
highli
predomin
prognost
substanti
therapi
target
preoper
anemia
cardiopulmonari
bypass
time
periop
red
blood
cell
transfus
may
display
guard
complic
refer
rosner
mh
okusa
md
acut
kidney
injuri
associ
cardiac
surgeri
clin
j
societi
nephrol
mehta
rl
kellum
ja
shah
sv
molitori
ba
ronco
c
warnock
dg
levin
acut
kidney
injuri
network
akin
report
initi
improv
outcom
acut
kidney
injuri
crit
care
introduct
acut
kidney
injuri
common
complic
major
surgeri
associ
advers
outcom
method
retrospect
studi
major
noncardiac
surgeri
teach
hospit
month
examin
incid
aki
oneyear
followup
aki
defin
kdigo
creatinin
criteria
major
surgeri
defin
inpati
procedur
h
durat
assess
independ
effect
aki
surviv
multivari
cox
proportionalhazard
surviv
model
develop
result
patient
includ
postop
aki
occur
kdigo
stage
stage
stage
patient
develop
aki
significantli
older
lower
baselin
egfr
higher
asa
class
spent
longer
hospit
postop
compar
without
aki
hospit
mortal
occur
patient
develop
aki
postop
compar
p
howev
year
surgeri
patient
develop
postop
aki
die
compar
aki
fig
p
multivari
model
accent
multipl
confound
aki
associ
hazard
ratio
death
year
surgeri
importantli
aki
defin
creatinin
rise
aki
recoveri
remain
associ
ongo
ibcreas
risk
death
one
year
conclus
major
surgeri
patient
demonstr
associ
even
mild
acut
kidney
injuri
increas
risk
death
next
year
introduct
earli
detect
acut
renal
failur
intens
care
unit
import
aspect
determin
diseas
sever
grade
organ
dysfuncion
discharg
patient
intens
care
unit
decreas
mortal
rate
acut
dialysi
qualiti
initi
workgroup
propos
classif
system
acut
kidney
injuri
aki
identifi
rifl
risk
injuri
failur
loss
kidney
function
endstag
kidney
diseas
purpos
studi
assess
acut
renal
failur
develop
intens
care
unit
patient
factor
affect
effect
factor
mortal
via
use
rifl
score
method
age
height
weight
gender
diagnosi
comorbid
diseas
admiss
reason
intens
care
intens
care
stay
record
also
first
day
seventh
day
admiss
intens
care
apach
ii
score
sofa
score
rifl
score
biochem
paramet
albumin
prealbumin
urea
creatinin
cholesterol
level
tricep
thick
waist
circumfer
measur
record
patient
group
aki
nonaki
patient
nonaki
group
oliguria
obviou
creatinin
rise
patient
aki
group
oliguria
obviou
creatinin
rise
aki
group
assess
rifl
score
due
hourli
urin
output
creatinin
rise
seper
three
group
r
risk
injuri
f
failur
result
studi
carri
patient
patient
acut
kidney
group
non
acut
kidney
group
acut
kidney
group
consist
n
r
group
n
group
n
f
group
renal
failur
develop
relat
high
age
short
bodi
height
excess
weight
exist
chronic
diseas
long
intens
care
unit
hospit
period
result
studi
renal
failur
also
relat
high
urea
creatinin
level
low
cholesterol
albumin
prealbumin
level
renal
failur
relat
tricep
thick
measur
intens
care
unit
hospit
stay
mortal
higher
patient
develop
renal
failur
conclus
think
patient
especi
intens
care
unit
high
age
excess
weight
chronic
diseas
high
urea
creatinin
level
low
cholesterol
albumin
prealbumin
level
prone
renal
failur
patient
care
follow
renal
failur
introduct
although
differ
criteria
livekidney
transplant
organ
transplant
programm
world
still
perform
widespread
even
though
develop
tissu
match
immunesupress
protocol
graft
loss
still
import
problem
livekidney
transplant
acut
chronic
allograft
nephropathi
aim
assess
surviv
rate
patient
graft
livekidney
transplant
method
result
livekidney
transplant
year
review
patient
age
gender
tissu
antigen
integr
determin
chronic
reject
primari
graft
failur
rate
record
surviv
rate
graft
patient
month
determin
result
number
kidney
transplant
sourc
organ
transplant
livedonor
mean
age
patient
livekidney
transplant
mean
sd
male
femal
chronic
reject
primari
graft
failur
determin
patient
graft
followup
period
mean
sd
mean
sd
month
respect
mean
surviv
time
patient
month
surviv
rate
month
respect
mean
surviv
time
graft
month
patient
surviv
rate
graft
month
respect
conclus
recent
year
signific
increas
livekidney
transplant
countri
due
inadequt
obtain
organ
cadav
observ
quit
high
patient
graft
surviv
time
low
chronic
reject
incid
livekidney
transplant
patient
although
high
life
qualiti
better
graft
function
livekidney
transplant
compar
cadaverkidney
transplant
cadaverkidney
transplant
increas
introduct
difficult
intub
extub
remain
import
problem
anaesthesia
patient
neck
phlegmon
old
guidelin
airway
flow
fulli
satisfi
anesthesia
procedur
patient
neck
phlegmon
creat
safe
algorithm
intub
extub
patient
method
uncontrol
prospect
cohort
clinic
studi
made
neck
phlegmon
main
group
n
intub
perform
use
fibrobronhoskop
flaplight
laryngoscop
videoadapt
tracheostomi
perform
sedat
deksmedetomidin
infus
control
group
n
intub
made
convent
laryngoscop
earli
tracheostomi
follow
surgeri
sedat
thiopent
na
propofol
result
laryngoscop
flapflight
upgrad
videoadapt
effici
case
difficult
intub
earli
tracheostomi
associ
absolut
risk
mediasten
ci
comparison
patient
without
tracheostomi
dexmedetomidin
effect
method
sedat
reduc
reaction
cardiovascular
system
control
group
postextub
arf
comparison
main
group
postpon
extub
perform
hour
decreas
inflammatori
laryng
edema
trizm
intub
algorithm
evalu
risk
difficult
intub
trizm
stridor
perform
laryngoscopi
classifi
kormacklehan
iiiiv
grade
use
fibrobronchoscop
case
open
mous
cm
unabl
use
fibrobronchoscop
perform
tracheostomi
la
case
ventil
intub
surgeri
airway
exctub
postpon
extub
hr
recommend
sedat
use
dexmedetomidin
infus
rate
mqgkghr
conclus
algorithm
anesthesiologist
action
creat
provid
safe
airway
flow
intra
postop
period
patient
neck
phlegmon
reduc
incid
seriou
intub
fail
intub
mediastin
death
mortal
due
traheostomi
refer
green
lcan
intub
ventil
survey
khowledg
algorithm
difficult
intub
tracheachuev
burov
ne
algorithm
safe
airway
flowclin
introduct
nasal
high
flow
oxygen
nhfo
attract
therapi
acut
hypoxem
respiratori
failur
ahrf
report
comfort
theoret
washout
gener
peep
howev
clinic
efficaci
uncertain
undertook
systemat
review
current
evid
support
use
adult
method
medlin
embas
search
use
term
nasal
highflow
high
flow
oxygen
oxygen
therapi
rct
includ
comparison
made
nhfo
standard
therapi
nhfo
cpap
niv
ahrf
adult
primari
outcom
intub
mortal
report
result
identifi
potenti
relev
studi
rct
met
inclus
criteria
import
differ
patient
group
intervent
outcom
measur
preclud
metaanalysi
signific
differ
intub
rate
mortal
intervent
group
except
frat
demonstr
significantli
reduc
mortal
nhfo
compar
standard
niv
group
lower
intub
rate
post
hoc
analysi
patient
lowest
pf
ratio
conclus
limit
evid
rct
present
support
use
nhfo
rather
convent
therapi
acut
hypoxem
respiratori
failur
adult
studi
patient
risk
requir
invas
ventil
need
refer
jone
rg
respir
care
bell
n
emerg
med
austral
frat
jp
nejm
lemial
v
crit
care
introduct
high
flow
nasal
cannula
hfnc
noninvas
respiratori
support
might
impact
major
clinic
outcom
acut
respiratori
failur
patient
present
preliminari
data
clinic
studi
aim
describ
physiolog
effect
hfnc
differ
flow
rate
method
perform
prospect
random
crossov
studi
acut
respiratori
failur
patient
admit
icu
pao
sub
sub
fio
sub
sub
mmhg
fio
sub
sub
set
obtain
spo
sub
sub
facial
mask
left
unchang
studi
patient
underw
random
step
min
facial
mask
lmin
hfnc
lmin
hfnc
lmin
hfnc
lmin
phase
continu
record
electr
imped
tomographi
eit
data
calibr
spirometri
esophag
pressur
pe
trace
obtain
result
higher
flow
rate
pao
sub
sub
fio
sub
sub
improv
mask
vs
hfnc
vs
hfnc
vs
hfnc
mmhg
p
borg
dyspnea
score
decreas
vs
vs
vs
p
pe
swing
measur
patient
inspiratori
effort
decreas
hfnc
vs
vs
vs
cmh
sub
sub
p
peak
inspiratori
flow
pif
assess
eit
decreas
higher
flow
rate
vs
vs
vs
lmin
p
suggest
decreas
respiratori
drive
interestingli
patient
pif
exceed
flow
deliv
extern
sourc
oxygen
lower
like
indic
higher
discrep
extern
set
alveolar
fio
sub
sub
fig
conclus
hfnc
improv
oxygen
reduc
inspiratori
drive
effort
thu
decreas
risk
respiratori
decompens
optim
flow
rate
hfnc
might
titrat
base
patient
inspiratori
flow
refer
frat
jp
et
al
n
engl
j
med
bodestein
et
al
bmc
pulm
med
introduct
studi
investig
dose
dose
consist
aerosol
deliveri
nasal
high
flow
therapi
nhf
sought
investig
effici
dose
across
two
differ
ga
flow
rate
simul
normal
cystic
fibrosi
cf
breath
salbutamol
use
tracer
aerosol
effici
reliabl
deliveri
aerosol
cf
suffer
noninvas
comfort
mean
deliveri
could
consider
effect
patient
care
method
two
adult
breath
pattern
evalu
use
breath
apparatu
simul
normal
adult
bpm
vt
ie
cystic
fibrosi
adult
bpm
vt
ie
adult
high
flow
nasal
cannula
optiflowtm
fisher
paykel
attach
humidifi
fisher
paykel
set
ml
salbutamol
mgml
nebul
use
vibrat
mesh
nebulis
vmn
aerogen
solo
aerogen
ireland
averag
mass
median
aerodynam
diamet
mmad
measur
use
apparatu
impactor
tracheal
dose
dose
deliv
beyond
trachea
ga
flow
rate
test
lpm
captur
use
absolut
filter
respirgard
baxter
distal
airway
model
n
see
fig
mass
drug
elut
filter
determin
use
uv
spectroscopi
nm
interpol
standard
curv
salbutamol
concentr
result
result
test
present
tabl
time
deliveri
ml
dose
salbutamol
record
approxim
minut
run
result
express
percentag
nomin
dose
place
nebulis
medic
cup
conclus
result
test
perform
normal
cf
simul
adult
ga
flow
rate
lpm
pvalu
respect
indic
set
data
n
normal
distribut
therefor
dose
consist
may
conclud
studi
deliveri
aerosol
adult
high
low
ga
flow
rate
via
nhf
therapi
effici
highli
reproduc
mean
administr
refer
hart
n
et
al
j
respir
crit
care
med
tidden
et
al
eur
respir
j
introduct
endotrach
tube
ett
begin
colon
oral
bacteria
respiratori
pathogen
adher
inner
surfac
use
airway
medix
close
suction
system
amcss
could
effect
reduc
ett
resist
bacteri
burden
biofilm
develop
clinic
pulmonari
infect
score
cpi
goal
studi
evalu
effici
amcss
compar
standard
close
suction
system
method
critic
ill
patient
random
two
group
patient
control
suction
use
kimvent
close
suction
system
kimberli
clark
usa
patient
studi
suction
use
amcss
amcss
biovo
technolog
israel
patient
withdrawn
trial
cpi
calcul
perform
daili
post
extub
resist
ett
measur
use
mass
flow
meter
pressur
transduc
ett
cut
open
longitudin
two
cmlong
hemisect
distal
part
ett
dissect
qualit
quantit
analysi
repres
biofilm
accumul
use
scan
electron
microscopi
sem
analysi
investig
blind
treatment
alloc
result
mean
resist
flow
rate
lmin
lower
studi
group
compar
control
group
vs
differ
signific
accord
mannwhitney
test
cpi
found
lower
studi
group
compar
control
group
vs
proport
subject
cpi
lower
studi
arm
compar
control
differ
signific
accord
mannwhitney
test
tabl
biofilm
stage
lower
studi
group
compar
vs
addit
patient
treat
amcss
time
higher
probabl
lower
biofilm
stage
comparison
control
group
conclus
result
conclud
use
amcss
reduc
resist
cpi
biofilm
format
effect
limit
biofilm
develop
earli
stage
introduct
inflat
endotrach
tube
cuff
form
microfold
enabl
microaspiratoin
test
adequaci
methylen
blue
visual
test
method
porcin
trachea
intub
differ
cuff
shapemateri
barrel
tapper
shape
cuff
made
polyvinyl
chlorid
pvc
polyurethan
poli
test
follow
intub
cuff
fill
air
cuff
pressur
ml
methylen
blue
water
solut
iodin
contrast
iomeron
instil
trachea
protocol
appli
use
ml
syring
instead
trachea
h
visual
confirm
ct
reconstruct
perform
evalu
distal
tracheal
leakag
result
ct
visual
leakag
detect
poli
visual
leakag
confirm
tube
supraglot
suction
leakag
visibl
ct
poli
perform
better
pvc
leak
visual
ct
within
first
hour
cuff
superior
seal
cylindr
model
trachea
poli
perform
better
conclus
poli
cuff
offer
superior
seal
pvc
cuff
regardless
shape
adequ
seal
maintain
h
methylen
blue
compar
confirm
micro
leakag
syring
satisfactori
surrog
actual
trachea
refer
optim
care
design
tracheal
cuff
critic
ill
patient
jailett
et
ann
int
care
introduct
cuffleak
cl
test
postul
use
tool
order
assess
risk
upper
airway
obstruct
uao
extub
howev
current
evid
still
limit
systemat
exclus
patient
receiv
corticosteroid
prospect
trial
limit
knowledg
object
evalu
associ
valu
cl
test
appear
uao
includ
patient
receiv
corticosteroid
detect
associ
risk
factor
method
prospect
observ
studi
gener
mix
icu
maydecemb
daili
screen
patient
consid
readi
wean
medic
team
perform
patient
succeed
spontan
breath
trial
elig
extub
accord
local
protocol
includ
demograph
clinic
data
collect
record
cl
valu
end
success
spontan
breath
trial
prior
extub
appear
uao
need
reintub
reinstitut
mv
record
result
thirtythre
patient
studi
mean
age
year
old
male
patient
receiv
corticosteroid
total
durat
mv
inclus
day
extub
four
patient
develop
uao
requir
reintub
two
case
cl
test
valu
significantli
lower
patient
develop
uao
vs
p
roc
curv
analysi
valu
cl
test
predict
uao
show
auc
ci
p
factor
associ
appear
uao
difficult
intub
vs
p
number
attempt
initi
intub
vs
p
prehospit
intub
vs
p
differ
cormack
mv
day
diamet
endotrach
tube
found
none
patient
receiv
corticosteroid
prior
extub
develop
uao
wherea
among
remain
patient
develop
uao
p
conclus
sampl
appear
uao
extub
associ
significantli
lower
cl
test
valu
studi
requir
order
evalu
use
cl
test
corticosteroid
therapi
prevent
uao
introduct
present
improv
theoret
version
valv
transtrach
ventil
bidirect
manual
respiratori
pump
combin
low
flow
inspir
reduc
ga
suppli
valv
increas
flow
expir
increas
ga
suppli
valv
permit
effect
venturi
effect
effici
expir
low
total
ga
consumpt
method
theoret
perform
valv
model
mathemat
model
test
vitro
standard
valv
variabl
flow
rate
fig
result
shown
increas
flow
expir
valv
would
permit
shorten
expiratori
time
achiev
higher
minut
volum
ie
volum
lmin
ga
higher
compar
ventil
similar
transtrach
cannula
without
variabl
flow
volum
achiev
lmin
variabl
flow
would
provid
shorten
inspiratori
time
effici
expiratori
aid
permit
e
ratio
even
invers
ratio
ventil
conclus
satisfactori
lung
ventil
assur
transtrach
ventil
bidirect
manual
respir
valv
variabl
ga
flow
introduct
longterm
outcom
qualityoflif
qol
patient
requir
prolong
mechan
ventil
pmv
failur
wean
scarc
document
howev
due
improv
respiratori
care
icu
increas
amount
patient
requir
pmv
studi
evalu
longterm
surviv
qol
patient
treat
tracheostomi
difficult
wean
without
need
pmv
icu
discharg
method
retrospect
investig
posticu
trajectori
surviv
patient
admit
medic
icu
tertiari
center
patient
requir
tracheostomi
respiratori
failur
vari
etiolog
difficult
wean
includ
patient
discrimin
requir
ventil
icu
discharg
patient
characterist
affect
surviv
rate
examin
qol
assess
done
survivor
use
short
form
health
survey
sever
respiratori
insuffici
sri
questionnair
result
total
patient
includ
requir
mechan
ventil
icu
discharg
wean
ventil
point
oneyear
surviv
rate
respect
patient
followup
least
five
year
surviv
rate
ventil
wean
patient
ventil
group
surviv
rate
significantli
lower
elderli
p
patient
high
charlson
comorbid
index
p
chronic
kidney
diseas
p
qol
assess
ventil
wean
patient
median
month
respons
rate
respect
overal
qol
score
physic
function
low
group
qol
physic
function
assess
lower
ventil
wean
group
score
social
function
mental
health
less
norm
similar
group
vs
respect
similar
trend
observ
sri
questionnair
conclus
longterm
surviv
patient
select
pmv
tracheostomi
failur
wean
significantli
differ
wean
patient
tracheostomi
suggest
surviv
patient
depend
underli
diseas
ventil
despit
physic
qol
score
low
group
mental
qol
still
accept
introduct
percutan
dilat
tracheostomi
pdt
routin
perform
intens
care
unit
icu
bronchoscopi
guidanc
recent
ultrasound
emerg
potenti
use
tool
assist
pdt
help
identifi
appropri
locat
tracheal
punctur
site
guid
needl
insert
trachea
may
significantli
reduc
procedurerel
complic
method
openlabel
parallel
noninferior
random
control
trial
conduct
compar
ultrasoundguid
pdt
bronchoscopyguid
pdt
mechan
ventil
critic
ill
patient
indic
tracheostomi
primari
outcom
procedur
failur
defin
composit
endpoint
convers
surgic
tracheostomi
associ
use
bronchoscopi
case
ultrasoundguid
pdt
associ
use
ultrasound
case
bronchoscopyguid
pdt
occurr
major
complic
result
total
patient
screen
underw
procedur
patient
ultrasound
group
patient
bronchoscopi
group
procedur
failur
occur
one
patient
ultrasound
group
one
patient
bronchoscopi
group
absolut
risk
differ
group
confid
interv
favor
ultrasound
group
treat
analysi
includ
prespecifi
margin
noninferior
patient
major
complic
group
procedurerel
minor
complic
occur
patient
ultrasound
group
patient
bronchoscopi
group
p
median
procedur
length
vs
minut
p
respect
clinic
outcom
also
differ
group
conclus
ultrasoundguid
pdt
noninferior
bronchoscopyguid
pdt
mechan
ventil
critic
ill
patient
introduct
mani
patient
admit
icu
receiv
tracheostomi
discharg
whit
gener
ward
insuffici
skill
experi
staff
care
tracheostomi
patient
may
lead
suboptim
care
increas
morbid
mortal
tracheostomi
outreach
team
appropri
train
staff
key
improv
qualiti
care
decreas
advers
event
make
decannul
safeti
patient
method
conduct
retrospect
studi
medic
icu
tertiari
care
hospit
stepdown
unit
two
intensivist
team
follow
daili
patient
discharg
tracheostomi
icu
gener
ward
discharg
hospit
train
session
ward
staff
doctor
nurs
nurs
assist
made
tracheostomi
care
everi
week
anal
clinic
epidemiolog
variabl
time
decannul
complic
relat
tracheostomi
decannul
failur
readmiss
mortal
result
februari
octob
total
patient
admit
icu
period
patient
discharg
regular
ward
tracheostomi
tube
place
neurolog
damag
due
head
injuri
ischem
hemorrhag
event
chronic
obstruct
pulmonari
diseas
sever
miopathi
postanox
encephalopathi
guillain
barr
amyotroph
later
sclerosi
patient
high
length
stay
complic
tracheostomi
tracheal
stenosi
granuloma
malacia
solv
readmiss
icu
due
cannula
obstruct
decannul
ward
possibl
patient
none
recannul
surviv
global
mortal
exclud
patient
palli
care
mortal
decreas
caus
death
directli
relat
tracheostomi
conclus
hospit
without
stepdown
unit
high
healthcar
demand
monitor
tracheostom
patient
skill
team
let
decannul
patient
ward
safeti
would
allow
discharg
sooner
kind
patient
icu
therefor
decreas
length
stay
complic
associ
icu
admiss
accordingli
cost
hand
ward
team
detect
earli
complic
solv
creat
safeti
atmospher
patient
famili
staff
charg
introduct
studi
aris
need
implement
therapeut
conduct
appli
tracheostomi
children
prolong
artifici
pulmonari
ventil
last
year
method
patient
includ
studi
group
children
pediatr
icu
institut
mother
child
children
submit
studi
divid
group
group
children
prolong
artifici
pulmonari
ventil
without
tracheotomi
applic
group
children
prolong
artifici
ventil
manag
tracheotomi
appli
result
retrospect
studi
note
follow
children
prolong
artifici
ventil
spent
avg
bedday
classif
diseas
children
requir
intub
prolong
ventil
follow
multipl
develop
abnorm
cs
brain
neuromuscular
disord
cs
bronchopulmonari
chronic
diseas
cs
genet
diseas
cs
septic
condit
cs
develop
abnorm
diaphragm
group
studi
reveal
follow
complic
complic
subcutan
emphysema
cs
pneumomediastinum
cs
lobar
emphysema
cs
suppur
cs
situat
resolv
children
receiv
special
critic
care
protocol
pneumonia
prophylaxi
associ
artifici
ventil
gentl
suction
secret
close
suction
system
cuffinfl
place
oral
hygien
timesday
mandatori
one
also
daili
hydroelectrolit
rebalanc
calcul
individu
energi
need
symptomat
therapi
perform
along
improv
gener
condit
appear
improv
deglutit
reflex
oral
nutrit
semisolid
prepar
recommenc
children
first
day
tracheostomi
applic
cs
nutrit
recommenc
day
togeth
partial
parenter
nutrit
full
resumpt
oral
nutrit
worth
notic
also
signific
decreas
length
stay
artifici
respir
children
day
compar
day
despit
complex
therapeut
effort
due
sever
basic
diseas
group
children
die
group
children
die
conclus
applic
tracheotomi
patient
endotrach
intub
prolong
artifici
ventil
reduc
infant
mortal
rate
group
notic
decreas
durat
treatment
lead
reduct
prime
cost
child
treat
intens
care
unit
introduct
purpos
studi
determin
impact
passiv
humidifi
ph
deliv
aerosol
dose
preval
ph
usag
invas
mechan
ventil
upper
airway
bypass
increas
due
low
cost
eas
use
howev
ph
without
limit
includ
blockag
aerosol
therapi
associ
issu
ph
manufactur
identifi
restraint
use
major
area
develop
bypass
ph
use
develop
smithsmed
hudson
rci
carefus
compani
develop
nonbypass
ph
compat
pall
intersurg
method
nebul
posit
shown
fig
ventil
maquet
oper
condit
vt
ml
e
peep
heat
passov
humidifi
fisher
paykel
heatedwir
circuit
attach
innerdiamet
endotrach
tube
ett
flexicar
absolut
filter
respirgard
baxter
posit
elev
distal
tip
ett
hh
condit
passiv
humidif
condit
ph
precondit
hour
heat
humidifi
condit
vibratingmesh
nebul
aerogen
solo
aerogen
use
nomin
dose
ml
salbutamol
mgml
use
mass
drug
elut
filter
determin
use
uv
spectroscopi
commerci
avail
ph
use
pall
filtatherm
intersurg
compat
airlif
carefus
approv
use
result
result
test
present
fig
result
express
percentag
nomin
dose
recov
filter
valu
use
circuit
b
report
conclus
largest
aerosol
dose
deliv
posit
b
posit
c
aerosol
dose
deliv
compar
ph
place
wye
nebul
posit
deliv
dose
unchang
compar
posit
c
pvalu
suggest
inclus
ph
minim
effect
aerosol
deliveri
refer
campbel
rs
et
al
respir
care
wilk
ar
et
al
anaesthesia
turnbul
et
al
british
journal
anaesthesia
morganhugh
nj
et
al
british
journal
anaesthesia
ari
et
al
respiratori
care
introduct
studi
investig
emit
tracheal
dose
deliveri
vibrat
mesh
nebulis
vmn
jet
nebulis
jn
line
humidifi
nebulis
system
two
differ
nebulis
posit
rel
patient
select
nebulis
type
signific
impact
treat
patient
previou
studi
shown
vmn
deliv
aerosol
convent
jn
method
aerosol
deliveri
perform
evalu
characteris
emit
dose
drug
exit
mouthpiec
tpiec
nebulis
tracheal
dose
drug
deliv
beyond
trachea
ml
dose
salbutamol
mgml
nebulis
tracer
aerosol
use
vmn
aerogen
solo
aerogen
ireland
jn
cirru
intersurg
nebulis
put
inlin
humidifi
nebulis
aquamist
intersurg
system
two
nebulis
posit
distal
proxim
patient
assess
effect
emit
tracheal
dose
deliveri
supplement
ga
flow
rate
lpm
n
tracheal
dose
nebulis
connect
head
model
via
facemask
head
model
connect
breath
simul
bpm
vt
ml
e
drug
collect
absolut
filter
respirgard
ii
baxter
drug
extract
quantifi
use
uv
spectrophotometri
final
pair
ttest
analysi
carri
evalu
differ
test
setup
result
base
result
present
vmn
deliv
highest
emit
dose
distal
lpm
distal
lpm
proxim
lpm
proxim
lpm
attach
setup
supplement
ga
flow
rate
compar
jn
distal
lpm
distal
lpm
proxim
lpm
proxim
lpm
vmn
also
deliv
highest
tracheal
dose
distal
lpm
distal
lpm
proxim
lpm
proxim
lpm
attach
setup
supplement
ga
flow
rate
compar
jn
distal
lpm
distal
lpm
proxim
lpm
proxim
lpm
conclus
result
demonstr
vmn
deliv
significantli
larger
fraction
aerosol
pvalu
emit
tracheal
dose
posit
humidifi
nebulis
patient
circuit
refer
ari
et
al
respir
care
introduct
acut
cardiogen
pulmonari
edema
acp
common
caus
acut
respiratori
failur
non
invas
continu
airway
posit
pressur
cpap
valid
effect
treatment
addit
pharmacolog
therapi
aim
studi
compar
non
invas
pressur
support
ventil
psvniv
cpap
set
patient
method
septemb
novemb
patient
admit
emerg
depart
ed
acp
patient
treat
standard
medic
therapi
addit
patient
treat
cpap
group
treat
nivpsv
group
b
arteri
hemogasanalysi
perform
admiss
minut
begin
ventil
treatment
evalu
ph
lactat
cleareanc
lactat
result
enrol
patient
men
women
median
averag
age
year
baselin
characterist
patient
sistol
blood
pressur
mmhg
diastol
blood
pressur
mmhg
ph
mmhg
lactat
meql
minut
cpap
notic
group
patient
improv
ratio
increas
point
ph
valu
reduct
lactat
cleareanc
group
b
improv
ratio
increas
point
ph
valu
reduct
lactat
cleareanc
patient
requir
endotrach
intub
two
patient
group
minut
cpap
shift
psvniv
increas
conclus
preliminari
result
ongo
trial
shown
better
outcom
patient
affect
acp
treat
psvniv
compar
treat
cpap
lactat
clearanc
improv
ratio
ph
valu
differ
side
effect
two
group
shown
refer
park
random
prospect
trial
oxygen
continu
posit
airway
pressur
bilevel
posit
airway
pressur
face
mask
acut
cardiogen
pulmonari
edema
crit
care
med
scot
twohour
lactat
clearanc
predict
neg
outcom
patient
cardiorespiratori
insuffici
critic
care
research
practic
introduct
noninvas
ventil
niv
commonli
use
first
line
therapi
immunocompromis
patient
acut
respiratori
failur
although
may
appropri
everi
patient
failur
niv
independ
predictor
mortal
delay
endotrach
intub
may
worsen
prognosi
report
center
experi
outcom
patient
activ
haematolog
malign
treat
niv
method
conduct
retrospect
chart
review
consecut
patient
haematolog
malign
admit
mount
sinai
hospit
icu
acut
respiratori
failur
januari
may
initi
treat
niv
bipap
cpap
compar
characterist
patient
success
treat
niv
avoid
endotrach
intub
eti
fail
niv
result
patient
femal
yr
apach
ii
haematolog
malign
treat
niv
acut
respiratori
failur
patient
acut
leukaemia
lymphoma
chronic
leukaemia
multipl
myeloma
myelodysplast
syndrom
aetiolog
respiratori
failur
multifactori
patient
featur
pneumonia
patient
sever
sepsi
septic
shock
pulmonari
oedema
patient
fail
niv
requir
eti
donotintub
dni
order
die
follow
niv
failur
avoid
eti
compar
patient
avoid
eti
fail
niv
like
acut
leukaemia
vs
p
baselin
higher
vs
p
higher
vs
p
vasopressor
use
vs
p
one
patient
diagnost
bronchoscopi
treat
niv
bronchoscopi
within
day
follow
eti
patient
fail
niv
requir
eti
die
icu
overal
icu
mortal
cohort
mortal
conclus
two
third
patient
haematolog
malign
acut
respiratori
failur
requir
eti
follow
niv
failur
high
subsequ
mortal
patient
fail
niv
higher
higher
vasopressor
use
use
niv
may
associ
delay
diagnost
bronchoscopi
introduct
noninvas
ventil
niv
use
welldefin
scientif
evid
acut
decompens
chronic
pulmonari
diseas
acut
pulmonari
edema
niv
also
success
immunosuppress
patient
pulmonari
infiltr
especi
hematolog
pharmacolog
immunosuppress
patient
use
niv
remain
controversi
pneumonia
tuberculosi
flu
acut
respiratori
distress
syndrom
ard
aim
studi
analys
use
niv
infecti
diseas
intensiveintermedi
care
unit
idicu
method
perform
crosssect
studi
adult
patient
need
niv
admit
idicu
exclud
patient
need
niv
chronic
pulmonari
diseas
acut
pulmonari
edema
wean
mechan
ventil
patient
identifi
hospit
databas
subsequ
clinic
record
consult
primari
outcom
result
niv
secondari
outcom
death
predictor
use
appropri
measur
central
tendenc
distribut
statist
test
signific
level
result
includ
patient
male
median
age
major
immunosuppress
patient
human
immunodefici
viru
hiv
infect
count
less
hematolog
neoplasia
chemotherapi
immunosuppress
drug
solid
neoplasia
chemotherapi
median
apach
ii
score
sapsii
score
eight
patient
intub
statu
due
comorbid
frequent
reason
perform
niv
bacteri
pneumonia
follow
pneumocystosi
ard
flu
tuberculosi
median
time
niv
day
niv
success
rate
patient
intub
intub
indic
patient
die
anoth
caus
mortal
rate
found
statist
signific
associ
sever
score
sapsii
apach
niv
result
death
higher
score
associ
failur
niv
death
also
found
patient
hematolog
neoplasia
chemotherapi
higher
rate
failur
niv
death
hiv
infect
associ
death
niv
failur
conclus
use
niv
nowaday
frequent
apart
classic
indic
found
higher
sever
score
hematolog
neoplasia
chemotherapi
associ
unsuccess
niv
howev
niv
use
patient
comfort
measur
introduct
mani
factor
affect
noninvas
ventil
niv
success
investig
data
affect
fragil
niv
outcom
critic
ill
patient
prospect
observ
studi
aim
investig
effect
fragil
applic
result
niv
intens
care
unit
icu
method
includ
patient
year
old
admit
medic
icu
hospit
detect
patient
fragil
clinic
fragil
score
cf
comprehens
geriatr
asses
use
patient
cf
consid
fragil
success
niv
group
nsg
defin
achiev
success
least
two
follow
mmhg
mmhg
ph
improv
respiratori
effort
recoveri
conscious
relationship
entub
fragil
also
assess
applic
problem
defin
cooper
problem
hear
problem
deliriumagit
richmond
agit
sedat
scale
claustrophobia
alzheim
problem
relat
chin
mouth
tooth
leak
lmin
result
includ
patient
underw
niv
two
icu
mean
age
patient
male
mean
apach
ii
score
mean
cf
patient
fragil
cf
patient
nsg
niv
failur
group
nfg
apach
ii
sofa
score
nfg
higher
nsg
nonfragil
patient
cf
vs
p
fiftythre
patient
niv
applic
problem
mean
cf
group
higher
vs
p
use
niv
previous
home
p
apach
ii
p
sofa
p
detect
factor
affect
niv
success
univari
analysi
fragil
patient
cf
significantli
higher
applic
problem
vs
entub
vs
mortal
rate
vs
significantli
lower
niv
succ
rate
vs
p
logist
regress
analys
fragil
independ
risk
factor
niv
failur
conclus
result
show
fragil
associ
niv
applic
problem
failur
icu
increas
niv
failur
risk
time
introduct
metabol
alkalosi
repres
half
acidbas
disturb
hospit
patient
import
know
interact
noninvas
ventil
niv
therapi
hypercapn
respiratori
failur
frequent
diuret
steroid
usag
lot
hypercapn
patient
copd
heart
failur
requir
niv
also
risk
may
caus
hypoventil
mani
reason
niv
failur
studi
defin
extens
reason
niv
failur
investig
hypercapn
respiratori
failur
yet
aim
studi
assess
influenc
niv
success
intens
care
unit
icu
outcom
patient
hypercapn
respiratori
failur
receiv
niv
therapi
method
data
patient
hypercapn
respiratori
failur
treat
niv
screen
retrospect
patient
receiv
asetozolamid
niv
therapi
exclud
studi
investig
frequenc
risk
factor
develop
effect
reduct
rate
niv
icu
hospit
stay
mortal
result
sixti
one
patient
develop
day
group
older
obes
heart
failur
use
loop
diuret
often
group
lenght
niv
icu
hospit
stay
longer
group
nonma
group
respect
arteri
blood
ga
valu
day
ph
mmhg
mmhg
meq
admiss
diagnosi
heart
failur
increas
develop
risk
time
ci
mg
furosemid
dose
determin
cutt
point
develop
auc
p
sensit
specif
durat
niv
significantli
longer
patient
independ
risk
factor
hospit
stay
longer
day
p
conclus
may
seen
high
patient
hypercapn
respiratori
failur
requir
niv
may
caus
increas
risk
longer
hospit
stay
patient
introduct
noninvas
ventil
niv
practic
use
patient
acut
exacerb
copd
aecopd
acut
respiratori
failur
arf
sever
new
mode
niv
current
provid
ventilatori
assist
howev
known
best
one
theoret
neural
adjust
ventilatori
assist
nava
improv
asynchroni
preserv
natur
breath
might
benefit
dynam
hyperinfl
method
pilot
crossov
studi
compar
asynchroni
index
breath
pattern
aecopd
patient
assist
nivp
assist
nivnava
conduct
aecopd
patient
arf
use
nivp
recruit
clinic
stabl
patient
randomli
ventil
nivp
nivnava
minut
switch
mode
washout
period
one
patient
could
enrol
compar
sequenc
breath
pattern
type
asynchroni
electr
diaphragmat
activ
eadi
continu
record
lastminut
period
continu
data
report
median
iqr
mean
sd
compar
use
unpair
ttest
mannwhitney
u
test
result
three
aecopd
patient
alloc
seven
compar
sequenc
nivnava
tend
decreas
asynchroni
index
ps
vs
nava
p
nivnava
significantli
reduc
triggerdelay
td
td
ps
ms
vs
td
nava
ms
p
improv
ineffect
trigger
eventsminut
ps
vs
eventminut
nava
p
moreov
assist
nivnava
tend
deliv
lower
tidal
volum
vt
higher
vt
variabl
mean
vt
mlkg
cv
ps
vs
mean
vt
mlkg
cv
nava
contrast
similar
respiratori
rate
rr
eadi
variabl
observ
rr
minut
ps
vs
minut
nava
eadi
cv
ps
vs
cv
nava
respect
conclus
compar
nivp
nivnava
attenu
asynchroni
especi
ineffect
trigger
aecopd
patient
also
promot
physiolog
breath
pattern
includ
match
neural
trigger
low
vt
high
variabl
refer
terzi
n
piquilloud
l
roze
h
mercat
lofaso
f
delisl
et
al
clinic
review
updat
neural
adjust
ventilatori
assist
report
roundtabl
confer
critic
care
introduct
high
frequenc
ventil
theoret
advantag
manag
ard
howev
high
frequenc
oscillatori
ventil
hfov
improv
outcom
high
frequenc
jet
ventil
hfjv
unlik
hfov
allow
spontan
ventilatori
effort
report
experi
hfjv
patient
sever
hypoxemia
year
period
method
hfjv
monsoon
acutron
medic
system
hirzel
switzerland
superimpos
upon
low
rate
low
volum
ml
simv
patient
requir
fio
sub
sub
peep
cmh
sub
sub
bronchopleur
fistula
candid
hfjv
patient
exclud
air
trap
evid
expiratori
flow
curv
machin
unavail
unit
patient
intratrach
mean
airway
pressur
mawp
measur
continu
paramet
compar
time
use
anova
p
signific
result
patient
receiv
hfjv
male
age
bmi
apach
ii
baselin
bl
vt
peep
peak
pressur
mlkgpbw
cmh
sub
sub
respect
bl
prone
posit
receiv
hfjv
remain
prone
posit
receiv
one
patient
convert
ecmo
patient
wean
ecmo
hfjv
data
shown
first
hour
hfjv
oxygen
improv
significantli
time
point
fig
paco
sub
sub
decreas
p
ph
increas
p
mawp
cmh
sub
sub
p
lactat
mml
p
chang
first
hour
oxygen
improv
patient
hfjv
continu
median
iqr
day
patient
surviv
hospit
discharg
conclus
report
suggest
hfjv
improv
oxygen
without
increas
airway
pressur
reduc
ventil
affect
gener
condit
manifest
lactat
level
prospect
trial
requir
refer
ferguson
nd
et
al
n
engl
j
med
introduct
high
frequenc
oscillatori
ventil
hfov
offer
attract
lung
protect
featur
provid
mean
airway
pressur
minim
tidal
alveolar
pressurevolum
swing
small
trial
suggest
benefit
hfov
two
recent
larg
trial
oscar
oscil
suggest
either
benefit
even
harm
question
generaliz
rais
oscil
enrol
subject
often
shock
mandat
unusu
high
mean
airway
pressur
combin
difficult
manag
center
variabl
expertis
hfov
manag
institut
consider
hfov
experi
retrospect
review
patient
receiv
hfov
us
last
year
method
evalu
patient
receiv
hfov
duke
univers
fortysix
ard
patient
met
oscil
inclus
criteria
data
collect
via
retrospect
chart
review
result
result
compar
oscil
oscar
result
summar
tabl
conclus
despit
limit
studi
retrospect
observ
limit
data
avail
think
lower
hfov
mortal
despit
wors
baselin
oxygen
compar
oscil
oscar
notabl
may
reflect
lower
hfov
mean
airway
pressur
shock
patient
well
experienc
personnel
avail
hour
day
institut
conclud
may
still
role
hfov
sever
ard
patient
properli
select
care
attent
paid
mean
airway
pressur
refer
young
et
al
n
engl
j
med
ferguson
nd
et
al
n
engl
j
med
introduct
multipl
studi
shown
low
tidal
volum
lung
protect
ventil
strategi
may
reduc
pulmonari
complic
nonard
icu
patient
busi
icu
discrep
may
aris
ventil
manag
goal
actual
practic
develop
goaldirect
mechan
ventil
order
set
includ
physicianspecifi
lungprotect
ventil
oxygen
goal
implement
respiratori
therapist
rt
primari
outcom
determin
simpl
respiratori
therapistdriven
order
set
predefin
goal
regard
oxygen
ventil
could
implement
good
complianc
determin
complianc
ardsnet
tabl
secondari
outcom
evalu
durat
mechan
ventil
icu
length
stay
inhospit
icu
mortal
method
evalu
patient
undergo
invas
mechan
ventil
prior
institut
standard
goaldirect
mechan
ventil
order
set
specif
goal
oxygen
tabl
use
ventil
ph
select
provid
subsequ
implement
rt
saw
fit
result
total
uniqu
episod
invas
mechan
ventil
individu
patient
analyz
complianc
new
mechan
ventil
order
set
found
high
mean
ventil
set
compliant
order
differ
order
complianc
implement
statist
signific
mean
vs
p
complianc
ardsnet
tabl
implement
order
set
significantli
greater
median
vs
p
differ
durat
mechan
ventil
icu
length
stay
inhospit
icu
mortal
conclus
standard
mechan
ventil
order
set
physicianspecifi
oxygen
ventil
goal
implement
rt
routin
practic
lungprotect
ventil
implement
good
complianc
improv
adher
ardsnet
tabl
introduct
patient
admit
intens
care
unit
icu
requir
endotrach
tube
ett
intub
mechan
ventil
aim
perform
audit
ventil
regim
critic
ill
patient
admit
whiston
hospit
main
object
evalu
current
manag
ventil
patient
icu
whiston
hospit
comparison
current
local
standard
best
practic
main
emphasi
surround
ibw
ideal
bodi
weight
document
reduct
initi
tidal
volum
tv
tradit
guidelin
method
retrospect
studi
look
sampl
cohort
patient
admit
icu
whiston
januari
end
june
manag
either
pressur
regul
volum
control
prvc
synchronis
intermitt
mandatori
ventil
simv
candid
match
ventil
inclus
criteria
data
sourc
use
icu
subcategori
trust
electron
data
manag
system
icu
electron
chart
system
data
collect
proforma
complet
patient
result
patient
initi
prvc
simv
anthropometr
measur
ulnar
length
actual
height
record
found
patient
admit
record
oppos
local
guidelin
document
ibw
record
optim
tv
base
mlkg
patient
document
ibw
appropri
tv
calcul
commenc
tv
greater
calcul
optim
tv
everi
patient
arteri
oxygen
satur
maintain
patient
met
standard
although
patient
maintain
satur
greater
conclus
summaris
clear
document
relat
ventil
care
lack
despit
clear
section
outlin
icu
admiss
proforma
propos
resolv
issu
would
use
lamin
sheet
includ
patient
ulnar
lengthactu
height
ibw
optim
tv
refer
colledg
n
walker
b
ralston
davidson
principl
practic
medicin
critic
ill
manag
organ
failur
edit
page
churchil
livingston
date
access
introduct
optim
time
wean
mechan
ventil
mv
remain
challeng
critic
ill
patient
studi
look
factor
aid
wean
mv
howev
result
variabl
recent
evid
suggest
lung
ultrasound
lu
predict
success
wean
mv
studi
assess
abil
lung
aerat
score
use
lu
predict
success
wean
critic
ill
patient
method
prospect
observ
nonintervent
studi
perform
gener
icu
larg
univers
hospit
period
month
includ
patient
need
mv
hour
n
elig
spontan
breath
trial
sbt
lu
perform
sbt
lung
aerat
score
calcul
lung
region
point
alloc
accord
worst
ultrasound
pattern
observ
n
normal
lung
pattern
line
multipl
welldefin
b
line
line
multipl
coalesc
b
line
c
consolid
atelectasi
relev
data
collect
patient
includ
demograph
lu
aerat
score
standard
case
report
form
tabl
patient
divid
two
group
group
f
group
base
failur
success
wean
respect
lu
aerat
score
appli
group
assess
predict
wean
failur
result
lung
aerat
score
significantli
higher
patient
group
f
compar
group
p
sensit
specif
fail
extub
lu
score
respect
conclus
lung
aerat
score
use
lung
ultrasound
predict
wean
failur
critic
ill
patient
studi
show
lu
score
good
predict
valu
howev
larger
randomis
control
trial
requir
valid
pilot
studi
refer
conti
g
et
al
intens
care
med
soummer
et
al
critic
care
med
bouhemad
b
et
al
critic
care
med
introduct
clinician
routin
face
challeng
manag
ventilatori
care
wean
process
clinic
cours
ill
almost
mechan
ventil
time
spent
wean
last
decad
automat
ventil
control
ventil
mode
design
help
wean
mechan
ventil
mani
studi
autom
wean
significantli
decreas
wean
time
critic
ill
patient
compar
physician
control
wean
process
conduct
prospect
random
trial
compar
autom
wean
standard
wean
protocol
multidisciplinari
icu
method
april
mar
enrol
critic
ill
adult
requir
hour
mechan
ventil
patient
random
sinc
admiss
consid
avail
smartcar
equip
ventil
evita
xl
unit
smartcar
without
includ
patient
toler
least
hour
pressur
support
pep
equal
less
readi
undergo
spontan
breath
trial
assign
wean
either
smartcar
sc
group
physician
control
wean
accord
local
guidelin
pcw
group
wean
durat
total
durat
mechan
ventil
success
wean
primari
endpoint
result
fortyfour
patient
enrol
group
differ
two
group
concern
age
sex
neurolog
respiratori
histori
diagnosi
sever
studi
entri
wean
durat
total
mechan
ventil
similar
two
group
respect
day
pcw
group
vs
day
sc
group
p
day
vs
day
sc
group
pcw
group
note
one
extub
failur
reintub
sc
group
conclus
although
autom
wean
use
smartcar
show
signific
benefit
patient
concern
durat
mechan
ventil
durat
wean
compar
physiciancontrol
wean
accord
local
protocol
certainli
offer
gain
time
medic
staff
icu
respiratori
physiotherapist
neither
critic
care
specialti
nurs
refer
esteban
et
al
n
engl
j
med
karen
e
et
al
j
respir
crit
care
med
burn
ke
et
al
cochran
databas
syst
rev
introduct
mechan
ventil
mv
therapi
vital
support
use
signific
proport
critic
ill
patient
right
time
succes
discontinu
therapi
challeng
intensivist
ecocardiograph
evalu
diastol
dysfunct
diaphragm
lung
becom
invalu
tool
wean
mv
protocol
especi
pacient
dificult
prolong
wean
mv
propos
mathematich
model
ultrasound
protocol
wean
mv
integr
three
modal
method
base
current
literatur
develop
score
justifi
mathemat
model
base
inequ
result
risk
failur
wean
process
rise
reason
wean
process
suspend
risk
failur
low
wean
process
continu
conclus
use
math
model
decis
make
great
import
set
object
paramet
within
exist
evalu
propos
use
inequ
set
interv
solut
three
point
care
ultrasound
guid
wean
mv
inequ
propos
gener
area
certainti
within
propos
valu
solut
interv
refer
lamia
b
et
al
crit
care
med
matami
et
al
intens
care
med
soummer
et
al
crit
care
med
introduct
aim
assess
diaphragm
ultrasonographi
tool
predict
outcom
wean
method
enrol
intub
patient
admit
intens
care
unit
saint
antoni
hospit
padua
nutriv
nasogastr
tube
place
measur
diaphragm
contractil
transdiaphragmat
pressur
follow
formula
gastric
pressureesophag
pressur
perform
diaphragmat
sonographi
mmode
techniqu
calcul
diaphragm
contract
speed
slope
scdi
curv
provid
diaphragm
contract
inspiratori
phase
spontan
breath
trial
correl
mean
mean
scdi
evalu
use
pearson
method
accord
linear
regress
analysi
result
found
signific
correl
scdi
pearson
coeffici
linear
determin
index
r
shown
fig
conclus
scdi
calcul
trial
spontan
breath
repres
bedsid
standard
reproduc
tool
predict
outcom
wean
refer
eskandar
n
et
al
critic
care
clinic
power
sk
et
al
critic
care
medicin
suppl
bole
jm
et
al
european
respiratori
journal
kim
wy
et
al
critic
care
medicin
introduct
optim
posit
endexpiratori
pressur
peep
acut
respiratori
distress
syndrom
ard
patient
attain
lung
recruit
avoid
overdistens
clinic
challeng
method
titrat
peep
safe
recruit
lung
includ
achiev
adequ
attain
best
complianc
increas
peep
monitor
esophag
manometri
establish
posit
endexpiratori
transpulmonari
pressur
ptp
bedsid
ultrasonographi
avail
use
diagnost
tool
care
critic
ill
patient
preliminari
work
identifi
mark
differ
excurs
dorsal
ventral
diaphragm
lungprotect
tidal
ventil
ard
patient
hypothes
lung
recruit
supin
patient
may
detect
noninvas
increas
dorsal
diaphragmat
excurs
indic
depend
lung
region
may
recruit
adequ
peep
method
proofofconcept
studi
enrol
ard
patient
treat
invas
mechan
ventil
neuromuscular
blockad
supin
posit
measur
ptp
use
esophag
manometri
ventraldors
diaphragm
excurs
use
anatom
mmode
ultrasonographi
appli
peep
chang
set
treat
physician
follow
standard
lung
histori
establish
recruit
maneuv
peep
chang
sequenc
peep
chang
random
subject
use
linear
mix
effect
model
evalu
associ
appli
peep
ptp
dorsal
diaphragmat
excurs
dde
result
accept
ultrasound
imag
diaphragm
excurs
obtain
patient
one
patient
larg
hepat
cyst
preclud
diaphragm
ultrasound
data
subject
exclud
analysi
enrol
mean
sd
pf
ratio
mmhg
mean
baselin
peep
mean
ventral
diaphragmat
excurs
unchang
peep
increas
peep
result
correspond
increas
ptp
dde
p
p
transit
neg
posit
ptp
increas
peep
occur
dde
observ
markedli
increas
conclus
exploratori
studi
suggest
associ
ptp
dde
dorsal
lung
recruit
increas
peep
valid
larger
sampl
ultrasound
evalu
dorsal
diaphragmat
movement
may
noninvas
method
estim
lung
recruit
ard
introduct
puls
oximetri
intens
use
surrog
arteri
oxygen
howev
littl
known
accuraci
daili
icu
practic
disturb
perfus
may
lead
poor
signal
indic
lower
perfus
index
valu
pfi
compromis
accuraci
studi
accuraci
relationship
pfi
method
month
period
patient
retrospect
studi
result
concomitantli
measur
valu
philip
pfi
inotrop
use
ph
map
mechan
ventil
bodi
temperatur
studi
independ
variabl
pfi
valu
categor
low
poor
pfi
intermedi
moder
pfi
reliabl
high
pfi
data
collect
pfi
measur
first
day
admitt
collect
unless
patient
invas
ventil
measur
collect
extub
statist
analysi
linear
correl
valu
assess
pearson
method
mean
differ
assess
use
bland
altman
method
result
statist
analysi
show
overal
correl
r
p
bland
altman
analysi
reveal
limit
agreement
within
gener
mean
show
fig
valu
overestim
valu
case
underestim
wide
rang
pfi
valu
median
rang
found
moder
agreement
slightli
better
agreement
higher
pfi
valu
fig
even
pfi
measur
show
differ
independ
variabl
show
weak
associ
r
except
mechan
ventil
anova
p
conclus
found
clinic
relev
lack
agreement
measur
contrast
gener
expect
exce
measur
pfi
littl
valu
differ
may
great
even
high
good
pfi
valu
concurr
measur
differ
find
may
influenc
daili
practic
adjust
mechan
ventil
measur
introduct
icu
patient
requir
multipl
monitor
input
optim
care
subject
mani
discomfortcaus
intervent
direct
measur
respiratori
effort
nonintub
patient
difficult
clinician
reli
secondari
indic
respiratori
suffici
puls
oximetri
capnographi
signific
limit
clinician
often
resort
use
respiratori
rate
rr
measur
capnograph
use
novel
noninvas
respiratori
volum
monitor
rvm
measur
minut
ventil
mv
tidal
volum
tv
respiratori
rate
rr
assess
abil
rr
quantifi
respiratori
statu
nonintub
patient
method
continu
rvm
capnographi
data
collect
subject
yr
use
impedancebas
rvm
exspiron
capnograph
capnostream
sampl
oralnas
cannula
smart
capnolin
plu
subject
perform
breath
trial
variou
rr
correl
measur
low
mmhg
normal
mmhg
high
mmhg
capnographybas
rr
low
bmin
adequ
bmin
rvmbase
mv
low
lmin
adequ
lmin
evalu
result
comparison
mv
measur
reveal
analyz
epoch
adequ
mv
coincid
normal
time
adequ
mv
coincid
low
low
mv
correspond
either
normal
low
fig
correl
poor
capnograph
rr
measur
normal
coincid
adequ
rr
time
none
low
rr
measur
reveal
high
fig
use
rr
proxi
mv
also
note
low
mv
observ
wide
rang
rr
low
mv
event
captur
low
rr
fig
conclus
studi
confirm
inadequ
proxi
mv
nonintub
patient
rr
poor
proxi
even
wors
proxi
mv
introduct
capnographi
unreli
monitor
respiratori
statu
nonintub
patient
use
noninvas
respiratori
volum
monitor
rvm
provid
accur
measur
minut
ventil
mv
tidal
volum
respiratori
rate
rr
nonintub
patient
compar
relationship
mv
intub
patient
gener
anesthesia
ga
nonintub
patient
spinal
anesthesia
sa
awak
volunt
method
rvm
data
exspiron
respiratori
motion
inc
waltham
collect
patient
group
group
patient
yr
surgeri
ga
group
patient
yr
surgeri
sa
group
volunt
yr
coach
breath
vari
rr
group
data
collect
via
ventil
draeger
apollo
et
tube
group
sampl
nasal
cannula
group
group
data
collect
via
capnograph
covidien
nasal
cannula
deme
regress
quantifi
relationship
mv
sensit
mean
compar
across
cohort
unpair
ttest
result
sensit
significantli
higher
intub
patient
vs
volunt
p
fig
nonintub
patient
sensit
normal
distribut
span
rang
intub
patient
volunt
measur
valu
higher
group
mmhg
vs
mmhg
vs
mmhg
respect
p
fig
measur
normal
distribut
group
conclus
result
show
lack
adequ
sensit
chang
mv
introduc
measur
bia
nasal
cannula
introduct
puls
oximetri
associ
signific
fals
alarm
give
late
notic
respiratori
depress
observ
studi
assess
abil
respiratori
volum
monitor
rvm
noninvas
measur
minut
ventil
mv
tidal
volum
respiratori
rate
captur
respiratori
depress
advanc
low
fewer
fals
alarm
method
rvm
data
collect
patient
age
yr
interv
mv
mvpred
calcul
patient
base
bodi
surfac
area
alarm
condit
min
defin
mv
mvpred
mfanova
use
evalu
differ
clinic
popul
unpair
onesid
ttest
use
compar
measur
across
group
result
alarm
condit
fals
alarm
event
min
occur
patient
fig
rvm
show
desatur
event
patient
motion
high
mv
event
event
fig
true
desatur
event
preced
min
sever
strongli
correl
time
delay
r
p
mfanova
found
differ
demograph
popul
true
desatur
event
vs
fals
alarm
p
ht
wt
age
bmi
sex
length
stay
pacu
true
desatur
group
significantli
longer
vs
p
conclus
studi
show
alarm
pacu
like
fals
mv
monitor
give
advanc
warn
respiratori
depress
fewer
fals
alarm
introduct
edideriv
indic
provid
reliabl
predictor
success
separ
ventil
sbt
perform
better
perform
rsbi
previous
investig
physiolog
studi
relationship
edi
peak
edi
area
curv
pi
index
conclud
pi
index
give
import
inform
balanc
respiratori
drive
respiratori
demand
may
predict
weanabl
clinic
support
level
aim
studi
valid
pi
index
wean
predictor
clinic
ventilatori
support
compar
pi
index
sensit
nava
predict
sbt
success
respect
edi
peak
neuroventilatori
effici
nve
rsbi
method
prospect
enrol
patient
ventil
nava
meet
criteria
sbt
patient
identifi
step
enrol
sub
sub
end
sbt
record
rsbi
edi
peak
two
edideriv
wean
indic
nve
pi
index
sbt
failur
success
defin
accord
clinic
protocol
use
result
patient
complet
sbt
success
extub
patient
fail
sbt
patient
fail
first
wean
step
trial
subgroup
sub
sub
differ
success
failur
f
group
statist
signific
pi
end
sbt
differ
f
group
statist
signific
rsbi
pi
conclus
pi
index
predict
abil
sustain
sbt
ventil
assist
sbt
subgroup
may
repres
group
patient
adequ
assist
classic
indic
nve
abl
predict
inabl
start
sbt
investig
need
understand
whether
pi
index
may
provid
inform
adequaci
assist
nava
ventil
refer
liu
crit
care
bja
dre
icm
muttini
jcc
introduct
opioid
use
decreas
respiratori
drive
caus
opioidinduc
respiratori
depress
oird
challeng
recogn
nonintub
patient
respiratori
rate
rr
alon
use
noninvas
respiratori
volum
monitor
rvm
measur
minut
ventil
mv
tidal
volum
tv
rr
examin
whether
rr
alon
identifi
lowmv
episod
use
defin
oird
postanesthesia
care
unit
pacu
method
written
inform
consent
mv
tv
rr
measur
collect
via
rvm
exspiron
respiratori
motion
waltham
patient
age
yr
bmi
undergo
elect
joint
replac
surgeri
patient
receiv
pca
opioid
pacu
receiv
hydromorphon
mg
receiv
morphin
mg
per
dose
rvm
measur
calcul
segment
minut
first
dose
predict
mv
mvpred
calcul
patient
bsa
lowmv
defin
mv
mvpred
min
lowrr
defin
rr
sensit
specif
analysi
correl
lowrr
lowmv
result
patient
receiv
opioid
lowmv
occur
time
time
dose
importantli
lowrr
coincid
less
lowmv
episod
averag
patient
experienc
lowmv
episod
opioid
rang
durat
min
lowmv
episod
min
opioid
dosag
p
group
low
rr
alarm
set
breathsmin
would
miss
lowmv
episod
yield
sensit
specif
posit
predict
valu
neg
predict
valu
figur
show
plot
pair
mv
rr
measur
conclus
lowrr
measur
alon
provid
insuffici
assess
respiratori
statu
data
suggest
lowmv
primarili
relat
decreas
tv
rr
introduct
although
region
complianc
c
resist
r
vari
consider
differ
lung
region
tradit
pulmonari
function
test
measur
global
valu
overcom
drawback
recent
propos
novel
eitbas
method
estim
region
expiratori
time
constant
tau
abstract
region
valu
compar
global
one
method
ten
intub
patient
hypoxem
hypercapnia
lung
failur
time
constant
estim
global
region
volum
eit
signal
obtain
swisstom
swisstom
switzerland
first
order
exponenti
decay
model
fit
region
global
imped
curv
use
matlab
mathwork
usa
spread
mean
region
valu
depict
fig
compar
one
valu
deriv
global
signal
result
ard
lung
exhal
faster
wherea
copd
lung
slower
latter
reflect
predomin
airway
obstruct
ard
patient
show
minor
region
differ
global
correspond
perfectli
mean
deriv
differ
lung
region
contrast
copd
patient
show
larg
spread
region
valu
nonetheless
mean
region
valu
correspond
well
global
conclus
mean
expiratori
time
constant
deriv
region
eit
signal
similar
one
valu
calcul
global
eit
signal
patient
short
ard
long
expir
time
requir
copd
sign
heterogen
diseas
latter
show
wide
spread
region
valu
introduct
passiv
exhal
show
characterist
exponenti
cours
asymptot
approxim
end
expiratori
lung
volum
describ
v
vinsp
e
r
c
v
lung
volum
time
vinsp
volum
end
inspir
r
resist
c
complianc
lung
product
r
c
call
tau
although
r
c
vari
consider
differ
lung
region
tradit
pulmonari
function
test
provid
global
valu
therefor
recent
propos
novel
method
obtain
region
valu
use
electr
imped
tomographi
eit
approach
challeng
presenc
small
ventil
amplitud
noisi
signal
heterogen
determin
studi
robust
method
intub
patient
hypoxem
hypercapn
respiratori
failur
measur
eit
signal
imag
per
second
use
swisstom
record
consecut
breath
steadi
state
condit
region
breath
breath
valu
fig
estim
fit
exponenti
model
region
curv
valu
within
rang
stem
appropri
fit
curv
consid
therebi
exclud
poorli
ventil
poorli
fit
lung
area
estim
robust
calcul
region
coeffici
variat
cv
breath
standard
deviat
divid
mean
result
mean
median
cv
valu
patient
howev
pixel
show
valu
mainli
lung
boundari
close
poorli
ventil
area
conclus
suggest
approach
calcul
region
expiratori
valu
provid
robust
result
low
coeffici
variat
howev
certain
lung
region
lung
boundari
show
high
variabl
therefor
increas
reliabl
pixel
exclud
futur
calcul
introduct
obstruct
airway
diseas
asthma
copd
increas
number
frequent
lead
sever
exacerb
need
noninvas
invas
mechan
ventil
sever
copd
particular
often
character
inhomogen
ventil
case
mechan
ventil
obstruct
pulmonari
diseas
ard
modern
icu
ventil
provid
accur
measur
pressurevolum
curv
global
region
level
electr
imped
tomographi
eit
contrast
establish
noninvas
tool
measur
region
ventil
aim
studi
calcul
eitbas
pixel
frame
per
second
expiratori
time
constant
tau
imag
pixel
global
one
entir
lung
valid
global
volum
signal
measur
airway
open
method
intub
patient
hypoxem
andor
hypercapn
respiratori
failur
perform
eit
pneumat
volum
measur
swisstom
switzerland
differ
peep
level
record
consecut
breath
steadi
state
condit
breath
frequenc
region
breath
breath
valu
obtain
fit
nonlinear
least
squar
manner
exponenti
function
eit
curv
pixel
algorithm
appli
pneumat
volum
curv
correl
mean
region
eit
measur
result
mean
calcul
region
eit
signal
show
strong
correl
global
calcul
pneumat
volum
signal
breath
pearson
r
patient
sever
copd
typic
show
longer
time
constant
ard
mean
calcul
global
eit
signal
show
strong
correl
global
calcul
pneumat
volum
signal
well
pearson
r
conclus
mean
calcul
region
eit
signal
show
strong
correl
global
pneumat
volum
signal
reflect
eit
valid
method
calcul
global
region
expiratori
time
constant
eit
therefor
provid
first
time
region
breath
breath
measur
airflow
obstruct
may
help
guid
mechan
ventil
especi
obstruct
pulmonari
diseas
introduct
shown
pig
ard
patient
lung
elast
determin
without
esophag
pressur
chang
peep
divid
chang
endexpiratori
lung
volum
deltapeepdeltaeelv
hypothesi
effect
contradirect
forc
expand
rib
cage
recoil
lung
creat
neg
pleural
pressur
persist
also
increas
peepeelv
esophag
pressur
use
surrog
pleural
pressur
ppl
unreli
determin
absolut
endexpiratori
esophag
pressur
extrapleur
effect
measur
aim
present
studi
evalu
effect
expand
rib
cage
absolut
pleural
pressur
chang
peep
step
respiratori
system
model
method
model
recoil
elast
lung
expans
chest
wall
complex
built
fig
lung
elast
could
vari
volum
control
peep
increas
airway
pleural
pressur
measur
deltaeelv
obtain
spirometri
result
peep
increas
endexpiratori
pleural
pressur
increas
first
expir
declin
back
baselin
endexpiratori
transpulmonari
pressur
ptpee
increas
equal
chang
endexpiratori
airway
pressur
deltapeep
deltaptpe
fig
good
correl
transpulmonari
pressur
lung
volum
level
deriv
pawppl
pleural
pressur
transpulmonari
pressur
deriv
lung
elast
calcul
deltapeepdeltaeelv
conclus
endexpiratori
pleural
pressur
remain
unchang
increas
peep
endexpiratori
transpulmonari
pressur
chang
much
peep
lung
complianc
determin
deltaeelvdeltapeep
refer
stenqvist
et
al
acta
anestesiol
scand
lundin
et
al
acta
anesthesiol
scand
introduct
aim
studi
evalu
whether
increas
lactat
pleural
abdomin
effus
use
criterion
differenti
diagnosi
natur
fluid
transud
exud
presenc
pleural
abdomin
effus
frequent
find
patient
icu
intern
medicin
departmentit
possibl
distinguish
transud
exud
light
criteria
pursu
acidbas
assess
fluid
notic
increas
valu
lactat
beyond
blood
rang
case
diagnos
like
exud
calcul
light
criteria
advantag
test
simpl
test
execut
physician
result
avail
within
minut
method
collect
data
patient
clinic
indic
thoracentesi
paracentesisfor
patient
perform
arteri
blood
ga
lactat
total
protein
serum
ldh
dosag
acidbas
assess
lactat
total
protein
ldh
dosag
cytolog
bacteri
cultur
fluidof
everi
patient
calcul
liquidserum
lactat
ratio
order
measur
eventu
present
increas
pleural
abdomin
effusionth
diagnosi
liquid
effus
natur
exud
transud
perform
light
criteriaa
statist
analysi
carri
perform
roc
curv
order
find
best
cutoff
liquidserum
lactat
ratio
predict
presenc
exud
result
patient
male
femal
mean
age
year
periton
effus
pleural
patient
exud
transud
light
criteriaw
perform
roc
curv
predict
presenc
exud
liquid
serum
lactat
ratio
obtain
auroc
best
cutoff
valu
sensit
specif
perform
analysi
pleural
effus
patient
obtanin
auroc
best
cutoff
valu
sensit
specif
conclus
liquidserum
lactat
ratio
seem
promis
tool
predict
presenc
exud
particular
pleural
effus
studi
need
warrant
statement
refer
richard
w
light
n
engl
j
med
vol
namaskel
et
al
thorax
suppl
ii
aananji
et
al
j
emerg
med
smsmith
et
al
journal
clinic
microb
introduct
object
studi
evalu
outcom
patient
admit
intens
care
pulmonari
fibrosi
numer
studi
demonstr
poor
outcom
patient
admit
intens
care
unit
icu
pulmonari
fibrosi
method
computeris
hospit
databas
use
search
patient
admit
icu
east
surrey
hospit
pulmonari
fibrosi
data
analys
use
microsoft
excel
graphpad
softwar
primari
endpoint
surviv
unit
hospit
discharg
result
record
review
met
inclus
criteria
control
group
patient
without
diagnosi
pulmonari
fibrosi
use
comparison
result
show
patient
pulmonari
fibrosi
die
discharg
unit
compar
control
group
p
tabl
similarli
patient
pulmonari
fibrosi
die
hospit
discharg
compar
control
group
p
tabl
conclus
result
studi
consist
previou
find
risk
death
prior
discharg
intens
care
unit
almost
higher
patient
pulmonari
fibrosi
data
present
may
prudent
consid
patient
pulmonari
fibrosi
present
revers
caus
acut
respiratori
failur
may
less
like
benefit
admiss
icu
refer
alhame
fm
sharma
soutcom
patient
admit
icu
acut
exacerb
idiopath
pulmonari
fibrosi
respir
j
bilvet
philit
f
sab
jmoutcom
patient
idiopath
pulmonari
fibrosi
admit
icu
respiratori
failur
chest
introduct
patient
ard
support
ecmo
optim
sedat
analgesia
strategi
unknown
object
character
pharmacolog
practic
highvolum
ecmo
center
describ
sedat
depth
incid
delirium
mobil
popul
method
conduct
retrospect
studi
describ
medic
sed
analges
paralyt
antipsychot
administr
patient
treat
vvecmo
ard
toronto
gener
hospit
record
sedationagit
scale
score
sa
medic
administ
rout
dose
camicu
score
mobil
ecmo
result
interim
adult
male
year
apach
ii
sever
ard
pf
mainli
pulmonari
sepsi
treat
vvecmo
jan
median
durat
vvecmo
day
iqr
hr
post
ecmo
initi
patient
deepli
sedat
sa
receiv
sed
midazolam
propofol
opioid
fentanyl
infus
respect
within
hr
prior
ecmo
discontinu
patient
surviv
ecmo
patient
still
deepli
sedat
time
receiv
sed
infus
vs
intermitt
receiv
opioid
infus
vs
intermitt
hr
post
ecmo
discontinu
patient
reach
light
level
sedat
sa
time
point
still
receiv
sed
infus
vs
intermitt
receiv
opioid
infus
vs
intermitt
receiv
sed
opioid
ecmo
patient
cisatracurium
infus
median
durat
hr
iqr
posit
camicu
score
delirium
haloperidol
quetiapin
primari
antipsychot
use
throughout
ecmo
respect
patient
underw
physic
therapi
within
median
day
start
ecmo
iqr
yet
major
achiev
passiv
rang
motion
bed
ecmo
conclus
patient
ard
deepli
sedat
midazolam
fentanyl
infus
vvecmo
initi
patient
transit
deep
light
level
sedat
around
time
ecmo
discontinu
mani
receiv
sedat
analgesia
via
intermitt
bolu
patient
activ
mobil
ecmo
treatment
introduct
venoven
ecmo
wellestablish
lifesav
measur
patient
sever
acut
respiratori
failur
refractori
convent
therapi
current
accept
definit
guidelin
defin
suitabl
patient
studi
outlin
outcom
patient
refer
criteria
accept
refus
defin
accord
intern
standard
clinic
judgement
aim
characteris
patient
popul
base
whether
refus
accept
ecmo
servic
compar
outcom
categori
method
review
patient
refer
venoven
ecmo
one
nation
centr
month
clinic
paramet
includ
gender
age
work
diagnos
referr
centr
ventil
requir
respiratori
investig
surviv
inform
referr
categor
accord
whether
accept
refus
refus
cohort
substratifi
base
whether
patient
follow
day
referr
result
referr
refus
whilst
accept
servic
remain
transfer
anoth
nation
centr
due
lack
ecmo
bed
studi
centr
mean
age
durat
mechan
ventil
referr
significantli
higher
futil
group
year
day
compar
accept
year
day
year
day
p
futil
group
higher
rate
multiorgan
failur
sever
immunosuppress
gender
bodi
mass
index
lung
injuri
score
degre
hypoxaemia
similar
group
interestingli
patient
well
higher
lung
injuri
score
murray
score
compar
futil
accept
respect
surviv
group
poor
whilst
well
accept
similar
outcom
day
well
die
whilst
futil
surviv
conclus
present
first
report
outcom
patient
refer
accept
vvecmo
context
nation
centralis
referr
system
ident
surviv
day
accept
patient
one
deem
well
warrant
investig
introduct
intern
extracorpor
life
support
organis
elso
publish
ecmo
outcom
score
schmidt
et
al
valid
save
score
use
preecmo
variabl
deriv
elso
dataset
assist
predict
surviv
venoarteri
ecmo
allow
comparison
centr
evalu
outcom
method
patient
receiv
ecl
data
prospect
collat
possibl
save
score
calcul
actual
outcom
compar
provid
qualiti
assur
inform
standardis
mortal
ratio
describ
save
smr
result
ecl
run
patient
patient
receiv
peripher
va
ecmo
case
moribund
convent
intens
care
standard
includ
true
ecpr
case
overal
wean
surviv
wean
die
refus
transfer
destin
vadtranspl
assess
within
va
ecmo
group
ecpr
initi
wean
surviv
savescor
calcul
case
patient
exclud
post
plan
procedur
cardiac
surgeri
emerg
vt
ablat
surviv
mean
age
year
mean
sofa
score
hour
prior
ecmo
cannul
mean
save
score
patient
sever
categori
v
compar
deriv
valid
cohort
studi
predict
surviv
save
score
whilst
observ
surviv
discharg
standard
mortal
ratio
smr
servic
conclus
king
colleg
hospit
ecl
servic
recent
intern
award
elso
perform
excel
recommend
ensur
centr
undertak
benchmark
govern
purpos
recommend
support
centr
impos
restrict
criteria
regard
initi
ecl
moribund
patient
intermac
classif
well
mechan
circulatori
support
destin
therapi
commiss
remain
problem
within
uk
refer
schmidt
et
al
european
heart
journal
introduct
patient
select
venoarteri
extracorpor
membran
oxygen
vaecmo
refractori
cardiogen
shock
particular
earli
recognit
futil
remain
signific
clinic
challeng
previou
case
seri
save
score
focuss
variabl
predict
inhospit
mortal
earli
identif
patient
like
deterior
die
within
hour
despit
vaecmo
attract
paradigm
guid
clinic
decis
make
improv
appropri
resourc
util
method
data
retrospect
collect
record
consecut
patient
support
vaecmo
spectrum
health
januari
octob
base
review
current
literatur
candid
predictor
hmortal
expertli
select
imag
worst
valu
within
hour
prior
ecmo
cannul
consid
model
ridg
regress
use
develop
risk
predict
model
cross
valid
appli
select
optim
tune
paramet
model
discrimin
assess
use
area
receiv
oper
curv
auc
calibr
assess
use
sever
common
indic
result
patient
includ
hmortal
patient
inhospit
mortal
model
demonstr
good
discriminatori
power
auc
bootstrap
ci
good
calibr
arteri
ph
show
strongest
associ
mortal
model
fig
conclus
small
retrospect
cohort
studi
score
preecmo
variabl
predict
mortal
auc
whilst
valid
optimis
larger
cohort
requir
use
preecmo
variabl
correspond
medic
decisionmak
realtim
enhanc
clinic
util
acuteset
refer
schmidt
et
al
european
heart
journal
pavlou
et
al
bmj
aug
introduct
aim
assess
spirometri
valu
month
post
ecmo
ecmo
use
sever
acut
respiratori
failur
refractori
convent
manag
support
entail
ga
exchang
extracorpor
oxygen
allow
lung
rest
underli
patholog
resolv
whilst
prevent
damag
ventil
associ
lung
injuri
knowledg
experi
ecmo
grow
howev
signific
cost
potenti
complic
associ
techniqu
mean
imper
evalu
longer
term
outcom
method
glenfield
hospit
one
five
centr
uk
commiss
nhsengland
provid
respiratori
ecmo
support
adult
ecmo
survivor
invit
follow
clinic
post
ecmo
decannul
undertak
spirometri
roll
seal
forc
expiratori
volum
sec
fvc
forc
vital
capac
pef
peak
expiratori
flowrat
measur
compar
normal
valu
index
patient
age
gender
bodi
mass
index
result
januari
june
patient
attend
followup
clinic
averag
age
year
sd
male
averag
number
day
ecmo
sd
six
patient
unableunwil
undertak
spirometri
leav
patient
data
analysi
mean
fvc
pef
present
predict
standard
deviat
sd
sd
sd
respect
normal
valu
predict
patient
predict
patient
diagnosi
asthma
patient
fvc
valu
predict
indic
moder
sever
restrict
defect
patient
fvc
significantli
longer
time
ecmo
patient
valu
vs
day
p
conclus
ecmo
survivor
demonstr
moderatesever
obstruct
restrict
mix
defect
patient
significantli
longer
ecmo
run
normal
valu
compar
smaller
studi
ecmo
patient
studi
assess
spirometri
convent
treat
ard
patient
month
refer
linden
et
al
act
ana
scand
neff
et
al
chest
masclan
et
al
introduct
low
tidal
volum
ventil
improv
outcom
acut
respiratori
distress
syndrom
may
impair
carbon
dioxid
co
sub
sub
clearanc
extracorpor
carbon
dioxid
remov
ecco
sub
sub
r
control
co
sub
sub
exist
devic
expens
requir
consider
expertis
oper
sinc
co
sub
sub
transport
predominantli
bicarbon
use
dialysi
remov
bicarbon
offer
sever
advantag
approach
limit
bicarbon
replac
problem
howev
contemporari
understand
acidbas
balanc
treat
bicarbon
anion
whose
concentr
depend
strong
ion
differ
sid
hypothesis
novel
dialys
design
remov
bicarbon
maintain
sid
would
lower
co
sub
sub
chang
ph
test
hypothesi
rodent
dialysi
model
compar
dialys
convent
solut
method
spraguedawley
rat
g
anaesthetis
ketamin
xylazin
butorphanol
intub
place
mechan
ventil
femor
jugular
vein
cannul
provid
dialysi
access
ventil
rate
adjust
creat
hypercapnia
dialysi
commenc
dialysi
provid
use
filter
baxter
franc
dialys
construct
bicarbon
present
sid
maintain
blood
gase
test
hourli
istat
abbott
control
dialysi
experi
perform
baxter
franc
data
report
mean
standard
deviat
differ
compar
use
student
ttest
result
use
blood
flow
dialys
flow
rate
mlmin
mean
prefilt
partial
pressur
co
sub
sub
pco
sub
sub
mmhg
wherea
mean
postfilt
pco
sub
sub
mmhg
use
prismasol
mmhg
use
bicarbon
free
dialys
p
remov
bicarbon
significantli
affect
ph
across
dialysi
filter
p
translat
remov
mlmin
co
sub
sub
scale
adult
dialysi
filter
blood
flow
mlmin
equival
remov
mlmin
co
sub
sub
conclus
bicarbon
free
dialysi
solut
design
maintain
sid
lower
pco
sub
sub
postfilt
blood
compar
convent
dialys
maintain
ph
estim
could
remov
mlmin
co
sub
sub
adult
exist
lowflow
ecco
sub
sub
r
devic
remov
mlmin
introduct
purpos
studi
evalu
associ
procalcitonin
plasma
level
first
hour
lung
transplant
lt
earli
oxygen
sever
primari
graft
dysfunct
pgd
icu
mortal
graft
function
one
year
lt
method
prospect
observ
studi
mix
icu
procalcitonin
plasma
level
measur
h
h
h
lt
ltrecipi
includ
prospect
patient
follow
one
year
lt
time
caus
death
record
result
procalcitonin
h
associ
first
h
sever
pgd
h
lt
procalcitonin
h
patient
grade
pgd
differ
patient
grade
pgd
p
pct
level
h
higher
patient
die
p
auc
predict
icumort
procalcitonin
h
h
h
correl
one
year
lt
h
also
correl
fvc
one
year
lt
conclus
higher
level
procalcitonin
h
follow
lt
associ
grade
pgd
h
icu
mortal
procalcitonin
level
h
posttransplant
associ
patient
wors
graft
function
one
year
introduct
acut
respiratori
distress
syndrom
ard
common
complic
nosocomi
pneumonia
np
patient
abdomin
sepsi
aim
studi
investig
new
molecular
biomark
ard
abdomin
sepsi
method
observ
studi
icu
ventil
septic
patient
periton
pancreonecrosi
perform
ard
diagnos
stage
accord
va
negovski
research
institut
criteria
berlin
definit
plasma
surfact
protein
spd
spa
measur
day
immunoenzym
essay
biovendor
usa
patient
treat
accord
intern
guidelin
data
statist
analyz
statistica
anova
present
median
percentil
ngml
p
consid
statist
signific
area
receiv
oper
curv
calcul
result
one
hundr
patient
screen
enrol
studi
accord
inclusionexclus
criteria
patient
assign
group
np
ard
n
year
old
mf
mortal
np
n
year
old
mf
mortal
group
compar
apach
ii
sofa
score
baselin
np
ard
group
spd
higher
point
np
group
plasma
spd
day
ngml
yield
sensit
specif
auc
ci
p
diagnos
ard
np
complex
roc
analysi
spd
pf
ratio
evlwi
mlkg
yield
better
diagnost
accuraci
spd
cutoff
ngml
sensit
specif
auc
ci
p
spa
day
inform
ard
diagnosi
spa
ngml
sensit
specif
auc
ci
p
plasma
spa
significantli
lower
surviv
versu
die
patient
ard
plasma
spa
day
ngml
yield
sensit
specif
predict
mortal
ard
patient
day
icu
stay
auc
ci
p
conclus
thu
abdomin
sepsi
patient
np
ard
new
molecular
biomark
use
ard
diagnosi
spd
prognostif
outcom
spa
introduct
acut
lung
injuri
acut
respiratori
distress
syndrom
aliard
character
tight
junction
tj
barrier
disrupt
chang
composit
integr
claudin
cldn
compon
tj
highli
express
augment
permeabl
lung
parenchyma
although
regul
inflammatori
stimuli
remain
elus
studi
aim
investig
express
regul
tnf
lpsinduc
aliard
mice
method
lung
injuri
induc
intratrach
lp
administr
adult
male
tnf
mice
mice
underw
bronchoalveolar
lavag
bal
sacrif
h
h
lp
administr
histolog
score
ali
assess
lung
tissu
cellular
local
evalu
immunohistochemistri
express
level
verifi
western
blot
result
mice
lung
tissu
follow
lp
administr
immunoreact
distribut
along
alveolar
epithelium
vascular
endothelium
protein
express
level
increas
fold
along
ali
characterist
augment
balf
cellular
protein
content
ali
score
tnf
mice
express
statist
reduc
earli
h
lp
administr
consequ
increas
balf
protein
content
addit
increas
express
observ
upon
h
lp
administr
tnf
biphas
action
express
depend
express
level
conclus
lp
induc
aliard
mice
increas
associ
ali
sever
moreov
tnf
regul
express
tj
permeabl
depend
part
pathway
find
emerg
role
claudin
especi
elucid
pathophysiolog
form
injuri
introduct
adult
respiratori
distress
syndrom
ard
character
breakdown
capillari
integr
lead
leakag
proteinrich
fluid
accumul
inflammatori
cell
within
airspac
bronchoalveolar
lavag
bal
commonli
use
method
obtain
lower
respiratori
tract
sampl
defin
role
cell
inflammatori
respons
ard
howev
need
assess
feasibl
use
rel
noninvas
endotrach
aspir
easp
techniqu
cytolog
studi
lower
respiratori
tract
ard
patient
method
easp
sampl
taken
icu
mechan
ventil
ard
patient
h
admiss
total
cell
countsml
determin
neubauer
chamber
differenti
cell
count
perform
cytospin
prepar
stain
diffquick
result
total
number
cell
ard
easp
sampl
median
cell
viabil
correl
found
neutrophil
count
blood
easp
specimen
p
total
cell
count
tend
lower
within
h
sampl
statist
differ
sampl
time
subject
bacteri
infect
ard
high
neutrophil
percentag
found
percentag
slightli
decreas
macrophag
percentag
trend
higher
ard
patient
posit
bacteri
cultur
compar
neg
one
p
macrophag
neutrophil
percentag
accord
ard
etiolog
report
fig
conclus
easp
analysi
found
increas
neutrophil
bacteri
infect
vs
noninfect
ard
patient
addit
differ
risk
factor
ard
associ
differ
percentag
macrophag
neutrophil
easp
follow
preliminari
find
studi
requir
assess
monitor
easp
cellular
time
could
use
evalu
prognosi
ard
introduct
acut
respiratori
distress
syndrom
ard
common
situat
patient
hospit
intens
care
associ
high
morbid
mortal
rate
manag
alway
great
challeng
intens
care
object
studi
describ
epidemiolog
clinic
profil
patient
ard
surgic
icu
univers
hospit
joseph
ravoahangi
andrianavalona
jra
antananarivo
madagascar
method
studi
twelv
month
led
januari
decemb
surgic
icu
jra
hospit
antananarivo
includ
patient
clinic
radiolog
sign
ard
age
gender
clinic
radiolog
sign
treatment
outcom
patient
consid
result
twentysix
patient
identifi
mean
patient
hospit
intens
care
studi
period
averag
age
year
sex
ratio
f
patient
histori
ethyl
smoke
asthma
particular
experi
case
ard
present
intak
reason
hospit
ard
patient
hemodynam
shock
failur
associ
liver
failur
patient
put
antibiot
treatment
mechan
ventil
mortal
rate
high
context
multipl
viscer
failur
conclus
studi
ard
affect
mainli
young
patient
respiratori
histori
manag
heavi
especi
countri
like
lack
materi
particularli
monitor
mortal
rate
ard
remain
high
current
develop
prone
techniqu
bodi
extra
support
may
improv
ard
mortal
rate
refer
younsuck
koh
updat
acut
respiratori
distress
syndrom
koh
journal
intens
care
eric
kipnissdra
aspect
pratiqu
journe
lillois
anesthesi
reanim
introduct
protect
ventilatori
strategi
ard
lower
tidal
volum
higher
peep
may
benefit
lung
high
peep
may
induc
right
ventricular
rv
dysfunct
may
sever
impair
hemodynam
hypothes
open
lung
recruit
maneuv
follow
maintain
high
peep
may
good
lung
heart
method
includ
ard
patient
pf
mechan
ventil
sedat
paralyz
openlung
protocol
consist
recruit
maneuv
cm
peep
decrement
peep
titrat
find
best
peep
name
openlung
peep
perform
rule
hypovolemia
record
mean
arteri
pressur
map
cardiac
output
co
righttoleft
ventricl
diamet
ratio
rvlv
use
echocardiographi
tricuspid
annular
plane
systol
excurs
taps
aortic
veloc
time
integr
vti
systol
later
rv
annulu
veloc
recruit
maneuv
hour
hour
maneuv
chosen
best
peep
openlung
peep
result
patient
ard
age
sap
includ
median
peep
increas
baselin
p
openlung
peep
increas
p
rvlv
increas
p
peep
return
baselin
valu
p
openlung
peep
taps
decreas
mm
mm
p
peep
return
baselin
mm
openlung
remain
stabl
hour
later
present
pattern
map
drop
mmhg
baselin
mmhg
p
vs
baselin
last
step
recruit
mmhg
openlung
peep
mmhg
hour
later
co
decreas
iqr
iqr
recruit
return
baselin
valu
openlung
peep
iqr
remain
stabl
hour
eject
fraction
unchang
openlung
peep
hour
compar
baselin
valu
conclus
ard
patient
recruit
maneuv
permit
open
lung
increas
pf
appli
high
peep
maintain
lung
open
right
ventricular
function
impair
confirm
good
lung
may
deleteri
heart
introduct
ard
patient
mechan
ventil
recruit
maneuv
may
open
lung
improv
blood
oxygen
maneuv
cardiac
dysfunct
may
occur
decid
analyz
use
speckl
track
effect
recruit
maneuv
left
ventricular
longitudin
strain
lvl
method
includ
ard
patient
mechan
ventil
sedat
paralyz
pf
openlung
protocol
consist
recruit
maneuv
cm
peep
decrement
peep
titrat
find
best
peep
perform
rule
hypovolemia
sever
acidosi
record
clinic
paramet
mean
arteri
pressur
map
heart
rate
hr
well
eject
fraction
ef
use
echocardiographi
mitral
annular
plane
systol
excurs
maps
mmode
echocardiographi
aortic
veloc
time
integr
use
puls
doppler
vti
systol
later
lv
annulu
veloc
use
spectral
tissu
doppler
imag
left
ventricular
longitudin
stress
lvl
use
speckl
track
baselin
recruit
maneuv
minut
maneuv
chosen
best
peep
result
patient
ard
age
sap
pf
lung
complianc
mlmmhg
peep
cm
respiratori
rate
map
mmhg
hr
ef
vti
cm
maps
cm
cm
includ
recruit
peep
hr
increas
map
mmhg
maps
cm
cm
ef
cm
decreas
best
peep
pf
dramat
increas
hemodynam
echocardiograph
doppler
paramet
return
baselin
valu
lvl
baselin
dramat
increas
peep
return
baselin
valu
immedi
recruit
maneuv
left
longitudin
strain
impair
maneuv
sever
apex
vs
conclus
recruit
maneuv
induc
transient
lv
systol
dysfunct
particularli
apex
lv
dysfunct
mayb
due
transient
myocardi
ischemia
disappear
immedi
maneuv
introduct
updat
equip
critic
care
import
improv
practic
chang
new
servic
involv
signific
amount
effort
initi
plan
final
launch
studi
design
evalu
stage
implement
quantifi
time
spent
cost
updat
nitric
oxid
deliveri
servic
nitric
oxid
one
expens
therapi
current
use
hospit
account
euro
per
annum
estim
cost
save
weigh
clinic
risk
cost
implement
new
devic
method
updat
nitric
oxid
deliveri
system
relev
adult
aicu
paediatr
intens
care
unit
picu
cathet
laboratori
theatr
implement
plan
studi
establish
number
hour
cost
stage
use
meet
minut
email
correspond
train
record
work
time
equival
calcul
result
test
equip
trial
new
devic
aicu
picu
carri
clinic
engin
six
month
spent
test
modifi
equip
safe
use
clinic
set
six
month
find
suitabl
patient
time
spent
hour
cost
approv
switch
approv
clinic
practic
committe
meet
division
director
time
spent
hour
cost
develop
cost
model
data
electron
prescrib
system
use
establish
number
patient
hour
treatment
volum
ga
use
financi
year
inform
essenti
calcul
number
cylind
refil
number
consum
requir
cost
rental
machin
cylind
data
present
financ
highlight
potenti
cost
save
switch
deliveri
system
time
spent
hour
cost
contract
servic
level
agreement
new
servic
agre
pharmaci
clinic
engin
procur
compani
agreement
made
number
machin
cylind
held
site
timescal
urgent
deliveri
backup
machin
cylind
annual
servic
requir
sign
director
oper
director
pharmaci
time
spent
hour
cost
train
staff
train
session
nurs
doctor
grade
aicu
amount
hour
time
spent
cost
train
picu
hour
cost
train
cath
lab
theatr
hour
cost
conclus
evalu
shown
switch
new
nitric
oxid
deliveri
system
cost
effect
time
hour
effort
clinic
risk
involv
huge
care
consid
implement
plan
essenti
safe
success
switchov
introduct
acut
pancreat
known
varieti
caus
specif
death
rate
sever
caus
remain
unknown
epidemiolog
studi
acut
pancreat
report
china
europ
includ
statist
analysi
factor
affect
outcom
patient
thu
need
examin
method
present
studi
retrospect
studi
studi
case
sever
acut
pancreat
japanes
facil
januari
decemb
target
case
divid
four
group
gallston
alcohol
idiopath
case
examin
relationship
patient
outcom
caus
variou
type
factor
use
statist
techniqu
result
total
case
sever
acut
pancreat
n
divid
gallston
case
n
alcohol
case
n
idiopath
case
n
case
n
accord
comparison
regard
background
patient
young
men
prone
alcohol
group
comparison
patient
outcom
reveal
signific
statist
differ
rate
administr
earli
enter
nutrit
gallston
alcohol
idiopath
p
mechan
ventil
manag
p
mortal
p
among
four
group
perform
multivari
analysi
death
time
discharg
hospit
develop
infect
odd
ratio
death
time
discharg
hospit
patient
receiv
earli
enter
nutrit
ci
result
show
differ
relationship
among
group
group
causespecif
case
similar
trend
observ
patient
gallston
odd
ratio
develop
infect
patient
alcohol
group
receiv
earli
enter
nutrit
ci
group
ft
indic
tendenc
statist
conclus
result
present
studi
suggest
factor
contribut
improv
outcom
may
differ
accord
caus
sever
acut
pancreat
might
need
examin
tailormad
treatment
sever
acut
pancreat
accord
caus
introduct
sever
liver
failur
common
carri
high
mortal
risk
patient
acut
acuteonchron
liver
failur
extracorpor
liver
support
therapi
eclst
could
one
treatment
option
despit
proven
biochem
efficaci
littl
data
regard
clinic
end
point
show
experi
six
year
icu
method
singlecent
retrospect
observ
studi
enrol
patient
hepat
failur
treat
eclst
novemb
decemb
data
demograph
clinic
characterist
sofa
meld
evalu
excel
graphpad
prism
use
statist
analysi
result
patient
enrol
underw
total
session
men
averag
age
mortal
rate
patient
admit
due
acut
liver
failur
acf
due
acuteonchron
liver
failur
aclf
length
stay
lo
icu
day
hospit
sofa
meld
score
admiss
respect
session
session
p
p
eclst
decreas
total
bilirubin
mgdl
mgdl
p
creatinin
mgdl
mgdl
p
bun
mgdl
mgdl
p
platelet
p
global
mortal
rate
patient
submit
liver
transplant
mortal
rate
wether
mortal
rate
patient
without
liver
transplant
conclus
acf
acfl
high
mortal
rate
without
liver
transplant
although
extracorpor
liver
support
therapi
improv
total
bilirubin
creatinin
bun
nevertheless
valu
extracorpor
liver
support
remain
corrobor
clinic
studi
includ
optim
time
mode
intens
durat
treatment
introduct
acuteonchron
liver
failur
aclf
distinct
syndrom
acut
liver
failur
alf
characteris
acut
decompens
organ
failur
high
shortterm
mortal
sever
novel
measur
consortium
liver
failuresofa
clifsofa
royal
free
hospit
rfh
score
specif
develop
predict
mortal
aclf
howev
valid
assess
alf
aim
studi
compar
perform
mortal
predict
model
alf
aclf
intens
care
unit
icu
set
method
retrospect
data
collect
patient
admit
liver
failur
icu
demograph
clinic
biochem
paramet
record
admiss
icu
main
outcom
death
icu
score
calcul
cliforgan
failur
clifc
shorten
version
clifsofa
clifaclf
includ
age
white
cell
count
rfh
model
endstag
liver
diseas
meld
acut
physiolog
chronic
health
evalu
apach
ii
accuraci
calibr
score
system
assess
use
area
receiv
oper
curv
auroc
goodnessoffit
respect
result
patient
includ
studi
aclf
alf
main
aetiolog
cirrhosi
aclf
group
alcohol
lead
caus
alf
paracetamol
overdos
alcohol
hepat
viral
hepat
aclf
patient
significantli
like
longer
stay
median
vs
day
p
higher
risk
die
vs
gener
score
system
perform
better
alf
auroc
valu
clifof
clifaclf
rfh
meld
apacheii
compar
aclf
auroc
valu
clifof
clifaclf
rfh
apacheii
meld
calibr
model
accept
across
group
except
apacheii
alf
patient
p
conclus
mortal
morbid
higher
aclf
compar
alf
predict
model
develop
aclf
popul
perform
even
better
alf
could
possibl
explain
rel
comorbid
alf
patient
cohort
highest
accuraci
achiev
use
rhf
meld
score
rather
clifsofa
base
measur
refer
r
jalan
et
al
j
hepatol
vol
pp
introduct
known
risk
hemorrhag
patient
chronic
liver
diseas
higher
compar
gener
popul
howev
evid
chronic
liver
diseas
coronari
arteri
diseas
inconclus
investig
diagnosi
coronari
arteri
diseas
patient
chronic
liver
diseas
taiwan
evalu
higher
risk
compar
gener
popul
method
util
sampl
nation
health
insur
claim
databas
contain
one
million
beneficiari
follow
adult
beneficiari
older
year
januari
till
decemb
see
diagnos
coronari
arteri
diseas
identifi
patient
liver
diseas
compar
risk
coronari
arteri
diseas
gener
popul
result
identifi
patient
chronic
liver
diseas
patient
without
control
age
gender
urban
level
socioeconom
statu
diabet
hypertens
hyperlipidemia
malign
heart
failur
atrial
fibril
smoke
obes
peripher
arteri
diseas
charlson
comorbid
index
score
adjust
hazard
ratio
confid
interv
patient
chronic
liver
diseas
subgroup
analys
cirrhot
patient
sever
complic
hazard
ratio
coronari
arteri
diseas
much
lower
compar
gener
popul
result
statist
signific
hazard
ratio
confid
interv
conclus
chronic
liver
diseas
may
associ
decreas
risk
coronari
arteri
diseas
howev
severityeffect
associ
observ
introduct
liver
trasplant
lt
made
hospit
universitario
de
santiago
de
compostela
spain
period
account
lt
perform
spain
case
accord
spanish
liver
transplant
registri
reth
year
experi
review
comparison
acumul
surveil
rate
experi
respect
spanish
data
provid
reth
method
retrospect
descript
studi
case
lt
perform
hospit
universitario
de
santiago
de
compostela
spain
base
local
lt
registr
nation
spanish
registr
reth
result
lt
case
hepatoren
transplant
requir
retransplant
media
lt
ltyear
gender
male
femal
mean
age
year
old
blood
group
predomin
posit
follow
group
posit
frequent
indic
tl
alcoholrel
cirrhosi
follow
idiopath
fulmin
hepat
failur
common
indic
retransplant
hepat
arteri
thrombosi
follow
primari
allograft
dysfunct
mortal
year
frequent
caus
death
recurr
underli
diseas
rate
hepat
c
viru
cirrhosi
follow
bacterialfung
infect
acumul
surveil
rate
year
seri
higher
comparison
overal
data
provid
reth
use
kaplanmei
curv
p
last
five
year
higher
compar
reth
data
period
time
p
acumul
surveil
rate
year
base
lt
indic
fulmin
hepat
failur
group
alcohol
cirrhosi
group
hepat
c
viru
cirrhosi
retransplant
group
acumul
surveil
rate
five
year
conclus
alcoholrel
liver
diseas
hepat
c
viru
hepatocellular
carcinoma
frequent
indic
lt
current
transplant
program
acumul
sirveil
rate
similar
one
found
transplant
program
main
caus
death
recurr
underli
diseas
follow
infecti
cardiovascular
diseas
high
mortal
rate
retransplant
group
lead
care
select
case
introduct
hypothes
diarrhea
lead
intestin
failur
associ
liver
diseas
ifald
critic
ill
risk
factor
liver
injuri
icu
includ
toxic
drug
tpn
etiolog
often
remain
unknown
current
emerg
interest
relat
intestin
failur
liver
injuri
occurr
ifald
mostli
attribut
use
tpn
patient
intestin
failur
recent
data
suggest
interrupt
enterohepat
cycl
also
may
import
caus
diarrhea
induc
nutrient
malabsorpt
may
also
impair
reabsorpt
bile
acid
disturb
gutliv
axi
along
line
reason
diarrhea
may
hitherto
unidentifi
risk
factor
liver
injuri
develop
ifald
method
retrospect
analyz
patient
admit
icu
septemb
februari
marker
liver
injuri
clinic
biochem
paramet
record
day
diarrhea
mlday
develop
median
day
icu
admiss
day
thereaft
patient
without
diarrhea
data
record
day
icu
admiss
day
later
patient
liver
injuri
defin
elev
serum
yglutamyltransferas
alkalin
phosphatas
level
refer
valu
admiss
moment
diarrhea
occur
exclud
patient
remain
analysi
liver
injuri
uni
multivari
analys
perform
identifi
risk
factor
liver
injuri
result
patient
develop
liver
injuri
incid
diarrhea
higher
control
patient
p
multivari
logist
regress
analysi
show
diarrhea
independ
risk
factor
develop
liver
injuri
ci
p
conclus
diarrhea
independ
risk
factor
develop
liver
injuri
icu
support
hypothesi
disturb
livergut
axi
due
diarrhea
bile
salt
malabsorpt
icu
patient
regard
manifest
intestin
failur
potenti
lead
intestin
failur
associ
liver
diseas
futur
research
aim
unravel
mechan
ifald
icu
patient
intervent
limit
malabsorpt
consequ
intestinalhepat
bile
salt
signal
introduct
constip
critic
ill
patient
common
problem
associ
number
signific
complic
includ
prolong
mechan
ventil
increas
length
stay
compromis
intenstin
protect
barrier
difficulti
establish
enter
feed
intens
care
unit
icu
bowel
care
guidelin
specifi
initi
treatment
constip
defin
patient
open
bowel
three
consecut
day
method
retrospect
audit
consecut
icu
patient
twomonth
establish
incid
constip
well
adher
bowel
care
guidelin
patient
exclud
stay
icu
less
three
day
undergon
recent
bowel
surgeri
altern
bowel
care
protocol
eg
encephalopathi
spinal
brain
injuri
patient
data
collect
includ
bowel
care
prescript
rectal
examin
episod
bowel
open
stool
type
result
patient
includ
suffer
period
constip
icu
stay
treatment
patient
bowel
open
three
consecut
day
initi
patient
treatment
strategi
constip
vari
partial
fulli
compliant
guidelin
constip
patient
despit
similar
apach
ii
score
age
across
two
group
incid
patient
least
one
episod
failur
feed
via
enter
rout
occur
higher
proport
constip
patient
compar
nonconstip
patient
conclus
incid
constip
unit
decreas
howev
remain
common
problem
seem
impact
establish
enter
feed
caus
potenti
seriou
complic
critic
care
patient
complianc
guidelin
improv
chang
polici
includ
start
prophylact
lax
unless
contraind
new
admiss
earlier
escal
treatment
continu
educ
promot
new
guidelin
ongo
unit
refer
mostafa
sm
bhandari
richi
g
et
al
constip
implic
critic
ill
patient
br
j
anaesth
masri
abubak
j
ahm
r
prophylact
use
lax
constip
critic
ill
patient
ann
thorac
med
octdec
introduct
phase
angl
pa
obtain
bioelectr
imped
analysi
bia
noninvas
method
measur
alter
electr
properti
biolog
tissu
recognis
object
prognost
marker
diseas
sever
frailti
aim
studi
determin
whether
phase
angl
marker
malnutrit
postop
morbid
low
oper
risk
patient
undergo
cardiac
surgeri
method
prospect
studi
conduct
tertiari
hospit
nutrit
state
cardiac
surgeri
patient
evalu
use
bia
day
schedul
surgeri
appli
select
criteria
low
oper
risk
patient
select
classifi
two
group
accord
pa
valu
low
pa
group
normal
pa
group
correl
low
phase
angl
low
fat
free
mass
index
ffmi
marker
malnutrit
assess
associ
low
phase
angl
advers
postop
outcom
defin
st
postop
risk
evalu
model
analys
impact
low
pa
length
stay
icu
hospit
evalu
result
low
pa
detect
patient
select
group
consist
low
oper
risk
patient
median
euroscor
ii
valu
associ
ffmi
pearson
r
p
low
pa
associ
higher
rate
vs
p
risk
postop
morbid
univari
regress
analysi
p
furthermor
low
pa
persist
independ
factor
multivari
regress
analysi
p
adjust
preoper
risk
factor
postop
morbid
evalu
hospit
length
reveal
tendenc
prolong
hospit
day
rate
vs
p
group
low
pa
conclus
low
preoper
phase
angl
indic
malnutrit
determin
advers
outcom
cardiac
surgeri
research
need
evalu
clinic
applic
phase
angl
accur
identif
malnourish
cardiac
surgeri
patient
introduct
periop
fast
reduc
risk
aspir
gastric
content
risk
weigh
risk
intraop
hypotens
insulin
resist
postop
guidelin
vari
nilbymouthfrommidnight
regim
liber
regim
per
associ
anaesthetist
great
britain
ireland
aagbi
esa
guidelin
wherebi
unlimit
clear
fluid
allow
hour
preoper
method
adult
patient
recruit
prior
theatr
day
surgeri
fast
time
calcul
use
verbal
questionnair
note
anaesthet
start
time
result
patient
exceed
esa
fast
guidelin
solid
fast
greater
hour
elect
procedur
fast
time
liquid
shorter
averag
excess
hour
conclus
patient
irrespect
whether
arriv
day
surgeri
inpati
fast
similar
time
longer
esa
guidelin
patient
famili
well
hospit
staff
awar
current
guidelin
current
protocol
adjust
improv
complianc
refer
esa
guidelin
preoper
fast
european
journal
anaesthesiolog
audit
preoper
fast
elect
surgic
patient
african
academ
medic
center
world
j
surg
introduct
icu
local
great
concern
costbenefit
ratio
earli
enter
nutrit
recommend
case
critic
patient
start
within
h
initi
treatment
hemodynam
stabil
earli
feed
ef
improv
nutrit
outcom
reduc
icu
hospit
death
delay
feed
df
reduc
feed
complic
icu
length
stay
patient
surviv
improv
total
cost
care
reduc
meaning
earli
feed
studi
object
ef
would
influenc
cost
length
stay
final
outcom
icu
hospit
compar
df
method
studi
particular
hospit
icu
bed
esbrazil
critic
patient
nutrit
therapi
indic
enrol
retrospect
studi
group
ef
h
admiss
df
h
compar
lenght
stay
direct
cost
materi
medicin
ga
hospit
fee
outcom
medic
record
extract
mvsystem
epim
softwar
differ
group
studi
use
studentt
independ
sampl
ztest
two
proport
use
assess
outcom
signific
level
confid
interv
result
evalu
patient
male
age
ef
icu
hospit
length
stay
ef
icu
hospit
daili
cost
us
us
ef
icu
hospit
discharg
ef
icu
hospit
death
df
icu
hospit
length
stay
df
icu
hospit
daili
cost
us
us
df
icu
hospit
discharg
df
icu
hospit
death
lenght
stay
cost
hospit
death
statist
differ
ef
receiv
discharg
icu
hospit
p
ef
show
less
icu
death
p
conclus
cost
length
stay
icu
hospit
show
statist
differ
improv
icu
mortal
length
stay
icu
hospit
although
icu
mortal
show
differ
hospit
death
consider
variat
refer
huang
hh
et
al
associ
ill
sever
time
initi
enter
feed
critic
ill
patient
retrospect
observ
studi
nutr
j
may
doig
gs
et
al
earli
enter
nutrit
critic
ill
full
econom
analysi
use
us
cost
clinico
econ
outcom
re
aug
introduct
recent
paper
suggest
energi
expenditur
ee
calcul
ventil
deriv
measur
fix
respiratori
quotient
rqfix
howev
method
introduc
clinic
signific
error
appli
individu
patient
measur
method
unselect
mechan
ventil
patient
ee
measur
indirect
calorimetri
analyz
ee
compar
calcul
use
measur
rqfix
clinic
accept
accuraci
level
set
equat
calcul
ee
shown
tabl
sinc
variat
correspond
rqfix
compar
ee
among
patient
measur
rq
lower
match
higher
rang
statist
analysi
conduct
pair
ttest
ee
bia
determin
mean
differ
kcald
actual
accuraci
rate
group
also
calcul
analys
conduct
spss
statist
version
ibm
usa
result
overal
bia
kcald
present
accuraci
compar
ee
patient
match
level
rq
accuraci
rate
level
bia
clinic
unaccept
patient
lower
higher
rq
tabl
conclus
energi
expenditur
calcul
ventil
deriv
measur
accept
patient
popul
larg
bia
overlook
result
verifi
indirect
calorimetri
ee
deriv
ventil
measur
consid
equal
ee
measur
indirect
calorimetri
refer
stapel
et
al
critic
care
introduct
although
describ
year
ago
refeed
syndrom
remain
understudi
lack
standard
definit
treatment
recommend
aim
systemat
review
provid
evid
regard
standard
definit
incid
rate
time
cours
occurr
associ
advers
clinic
outcom
risk
factor
therapeut
strategi
prevent
treat
condit
method
search
medlin
embas
intervent
observ
clinic
trial
focus
refeed
syndrom
exclud
case
report
review
extract
data
base
predefin
case
report
form
includ
bia
assess
result
potenti
abstract
record
total
patient
includ
final
analysi
includ
intervent
studi
studi
includ
anorex
patient
definit
refeed
syndrom
highli
heterogen
studi
reli
electrolyt
disturb
other
also
includ
clinic
symptom
incid
rate
vari
depend
definit
patient
popul
occurr
mostli
within
first
hour
start
therapi
risk
factor
accord
nice
guidelin
older
age
enter
feed
addit
describ
associ
refeed
syndrom
advers
outcom
remain
unclear
effect
prevent
measur
treatment
algorithm
conclus
although
consensu
regard
risk
factor
time
occurr
refeed
syndrom
wide
variat
definit
report
incid
rate
manag
recommend
prevent
measur
treatment
research
warrant
fill
gap
introduct
particip
epan
trial
chang
protocol
administr
parenter
nutrit
pn
icu
administr
pn
supplement
enter
nutrit
en
case
insuffici
calor
intak
postpon
day
icu
admiss
day
compar
latepngroup
epan
trial
one
except
patient
bmi
less
start
pn
depend
individu
decis
attend
intens
care
physician
protocol
administr
en
glycaem
control
remain
unchang
micronutri
intraven
prescrib
patient
day
icu
admiss
case
inadequ
calor
intak
two
year
implement
new
protocol
conduct
survey
investig
complianc
new
protocol
method
conduct
retrospect
analysi
patient
admit
medic
unit
icu
admit
patient
consid
critic
ill
sinc
receiv
tight
glycaem
control
patient
exclud
analysi
sinc
stay
less
hr
icu
mostli
monitor
purpos
result
patient
receiv
pn
case
pn
start
day
icu
admiss
accord
new
protocol
pn
start
earlier
patient
suffer
haematologicaloncolog
diseas
complic
neutropen
sepsi
bmi
less
alreadi
receiv
pn
ward
sinc
calor
intak
less
calor
target
day
icuadmiss
consid
cutoff
start
pn
old
protocol
patient
would
met
criteria
receiv
pn
accord
protocol
conclus
good
complianc
revis
protocol
pn
start
day
icu
admiss
medic
icu
unit
besid
predefin
except
significantli
reduc
number
patient
receiv
pn
compar
old
protocol
refer
casaer
mp
mesotten
herman
g
wouter
pj
schetz
meyfroidt
g
et
al
earli
versu
late
parenter
nutrit
critic
ill
adult
n
engl
j
introduct
sever
studi
shown
exclus
enter
nutrit
mostli
ineffect
provid
adequ
energi
intak
critic
ill
patient
reason
espen
review
guidelin
attempt
improv
practic
recommend
patient
receiv
less
target
enter
feed
day
consid
parenter
nutrit
aim
studi
evalu
whether
portugues
icu
chang
nutrit
strategi
accord
espen
guidelin
method
observ
prospect
studi
conduct
eleven
portugues
icu
nine
gener
hospit
patient
year
age
older
elig
ventil
length
stay
lo
icu
greater
day
demograph
data
along
energet
intak
first
day
type
nutrit
support
use
collect
select
patient
result
patient
enrol
male
median
age
median
bmi
icu
lo
day
mortal
rate
patient
admit
medic
reason
normal
weight
remain
patient
either
overweight
obes
energi
intak
first
day
kcalkgday
exclud
first
day
rose
nutrit
support
evalu
period
day
day
patient
receiv
nutrit
support
enter
rout
parenter
rout
conclus
energi
need
critic
ill
patient
vari
kcalkgday
studi
larg
proport
portugues
icu
patient
receiv
inadequ
nutrit
recent
random
clinic
trial
support
recommend
less
nutrit
better
howev
uncommon
critic
ill
patient
starv
deleteri
avoid
introduct
appropri
nutrit
deliveri
icu
topic
issu
studi
focus
energi
suppli
enter
parenter
nutrit
studi
also
focus
protein
suppli
studi
also
agre
import
adequ
protein
suppli
gkgday
outcom
aim
studi
evalu
amount
protein
suppli
given
critic
ill
patient
portugues
icu
method
observ
prospect
studi
conduct
eleven
portugues
icu
nine
gener
hospit
patient
year
age
older
elig
ventil
length
stay
lo
icu
greater
day
demograph
data
along
energet
intak
first
day
type
nutrit
support
use
collect
result
patient
enrol
male
median
age
median
bmi
icu
lo
day
mortal
rate
patient
admit
medic
reason
normal
weight
remain
patient
either
overweight
obes
energi
suppli
first
day
kcalkgday
carbohydr
main
sourc
calori
gkgday
lipid
gkgday
proteinamino
acid
administr
gkgday
regard
addit
supplement
besid
artifici
nutrit
impact
overal
energet
intak
propofol
kcal
kgday
amount
glucos
solut
kcal
kgday
conclus
may
safe
conclud
less
calori
better
icu
scientif
recognit
import
protein
grow
although
optim
protein
dose
studi
avail
expert
opinion
support
administ
excess
gkgday
present
portugues
icu
major
critic
ill
patient
receiv
less
half
recommend
protein
intak
introduct
audit
carri
determin
amount
protein
gram
per
kilogram
bodi
weight
per
day
gkgbwd
provid
adult
level
critic
ill
patient
intern
evid
base
guidelin
recommend
gkgbwd
protein
integr
compon
nutrit
therapi
critic
ill
patient
aim
minimis
muscl
wast
method
prospect
audit
carri
bed
level
adult
intens
care
unit
within
univers
teach
hospit
major
trauma
centr
inclus
criteria
includ
patient
enter
fed
exclus
criteria
includ
parenter
nutrit
less
day
enter
nutrit
incomplet
data
protein
provis
measur
gkgbwd
propofol
record
limit
audit
audit
subject
ethic
approv
accord
trust
standard
result
admiss
patient
audit
exclud
patient
includ
within
data
analysi
n
mean
protein
provis
gkgbwd
mean
protein
percentag
deliveri
protein
deficit
becam
pronounc
measur
higher
diseas
specif
recommend
feed
protocol
adher
patient
initi
assess
nutrit
product
met
protein
patient
averag
patient
experienc
hour
enter
nutrit
stoppag
conclus
patient
receiv
mean
gkgbwd
protein
compar
minimum
g
recommend
intern
guidelin
wide
variat
protein
deliveri
patient
group
reason
meet
protein
provis
multifactori
dietitian
expertli
skill
within
mdt
improv
nutrit
care
within
icu
refer
mcclave
sa
martindal
rg
vanek
vw
mccarthi
robert
p
taylor
b
et
al
guidelin
provis
assess
nutrit
support
therapi
adult
critic
ill
patient
societi
critic
care
medicin
sccm
american
societi
parenter
enter
nutrit
aspen
jpen
j
parent
enter
nutr
weij
pj
fundament
determin
protein
requir
icu
current
opinion
clinic
nutrit
metabol
care
introduct
vitamin
defici
commonli
found
hospit
patient
associ
multipl
advers
clinic
event
includ
increas
morbid
mortal
although
condit
also
frequent
found
critic
ill
patient
correl
clinic
outcom
remain
unclear
report
demonstr
preval
vitamin
defici
medic
associ
clinic
outcom
among
medic
critic
ill
patient
thailand
method
prospect
observ
studi
conduct
month
medic
icu
songklanakarind
hospit
demograph
data
clinic
outcom
includ
mortal
ventil
day
icu
hospit
length
stay
collect
serum
oh
measur
within
hour
icu
admiss
oh
level
less
ngml
gener
defin
defici
state
correl
oh
statu
admiss
clinic
outcom
analyz
chisquar
test
student
ttest
pvalu
less
defin
clinic
signific
result
critic
ill
patient
preval
oh
defici
patient
oh
defici
statist
significantli
younger
femal
gender
higher
blood
glucos
level
higher
rate
respiratori
arrest
h
prior
icu
admiss
higher
requir
mechan
ventil
support
oh
defici
significantli
correl
allcaus
mortal
howev
trend
toward
increas
vasopressor
use
higher
rate
icu
infect
longer
hospit
length
stay
among
defici
group
conclus
studi
demonstr
preval
vitamin
defici
thai
critic
ill
popul
high
also
found
significantli
higher
rate
respiratori
arrest
mechan
ventil
depend
defici
group
howev
vitamin
defici
thai
critic
ill
significantli
associ
icu
morbid
mortal
introduct
vitamin
defici
associ
sever
advers
outcom
mainli
outpati
set
object
studi
examin
preval
vitamin
defici
associ
risk
advers
clinic
outcom
larg
prospect
cohort
medic
inpati
method
collect
clinic
data
measur
oh
level
adult
medic
patient
upon
hospit
admiss
follow
day
regress
analys
adjust
age
gender
comorbid
main
medic
diagnosi
perform
studi
effect
vitamin
defici
sever
hospit
outcom
result
includ
patient
oh
level
nmoll
vitamin
insuffici
level
nmoll
sever
defici
vitamin
insuffici
sever
defici
associ
orhr
ci
increas
risk
mortal
increas
length
stay
hr
sever
defici
associ
risk
fall
impair
barthel
index
impair
qualiti
life
associ
remain
robust
multivari
adjust
subgroup
base
gender
age
comorbid
main
diagnos
p
interact
conclus
comprehens
larg
medic
inpati
cohort
vitamin
defici
highli
preval
strongli
associ
advers
clinic
outcom
intervent
research
need
proof
effect
vitamin
supplement
outcom
introduct
last
year
supplement
polyunsatur
fatti
acid
pufa
emerg
therapeut
option
patient
undergo
cardiac
surgeri
due
immunomodulatori
properti
antiarrhythm
action
nonetheless
pauciti
data
support
effect
pufa
treatment
cardiac
surgeri
patient
far
sever
random
control
trial
rct
assess
effect
periop
pufa
prevent
postop
atrial
fibril
poaf
although
efficaci
still
remain
controversi
therefor
conduct
updat
systemat
review
metaanalysi
evalu
effect
periop
oralenter
pufa
intraven
iv
fish
oil
lipid
emuls
relev
clinic
outcom
cardiac
surgeri
patient
method
includ
rct
enrol
adult
patient
undergo
cardiac
surgeri
evalu
oralenter
parenter
pufa
compar
placebo
report
clinic
import
outcom
accord
elig
criteria
origin
studi
abstract
duplic
intens
care
unit
icu
length
stay
lo
primari
outcom
secondari
outcom
incid
poaf
durat
mechan
ventil
mv
hospit
lo
hypothesisgener
subgroup
analysi
perform
identifi
potenti
benefici
treatment
strategi
result
total
rct
n
patient
met
inclus
criteria
data
trial
aggreg
pufa
effect
icu
lo
wmd
ci
p
heterogen
howev
pufa
associ
trend
reduct
poaf
rr
ci
p
p
addit
oralenter
base
trial
pufa
show
tendenc
toward
reduct
poaf
rr
ci
p
p
fig
test
subgroup
differ
overal
poaf
show
trend
p
effect
pufa
mv
day
hospit
lo
conclus
patient
undergo
cardiac
surgeri
supplement
fatti
acid
improv
clinic
outcom
postop
period
introduct
longterm
hospit
patient
intens
care
unit
icu
high
risk
develop
major
depress
syndrom
posttraumat
stress
disord
psd
correl
degre
depress
surviv
patient
incid
depress
psd
three
time
higher
patient
intens
care
compar
gener
popul
precursor
serotonin
use
prevent
depress
patient
method
conduct
random
control
trial
patient
hospit
icu
nonsurgeri
caus
dose
serotonin
level
admiss
day
day
patient
psychiatr
disord
malign
exclud
treatment
drug
interfer
metabol
serotonin
select
patient
randomli
assign
either
receiv
placebo
treatment
first
group
n
receiv
mg
second
group
n
psychiatr
evalu
perform
use
clinicianadminist
posttraumat
stress
disord
scale
result
baselin
signific
differ
record
regard
serotonin
plasma
level
gl
p
age
p
group
first
determin
observ
decreas
serotonin
level
placebo
group
group
p
tvalu
delirium
present
patient
placebo
group
patient
group
day
serotonin
level
lower
placebo
group
compar
treatment
group
p
delirium
absent
latter
mean
end
point
clinicianadminist
posttraumat
stress
disord
scale
higher
placebo
group
compar
treatment
group
p
time
conclus
sever
studi
suggest
depress
increas
mortal
critic
ill
patient
use
antidepress
patient
may
contraind
therefor
becom
altern
therapi
depress
patient
icu
introduct
selenium
essenti
trace
element
antioxid
immunomodulatori
effect
sever
random
control
trial
rct
metaanalys
demonstr
parenter
selenium
may
abl
improv
clinic
outcom
intens
care
unit
icu
patient
new
trial
publish
sinc
last
updat
thu
updat
data
systemat
review
parenter
selenium
singl
strategi
combin
antioxid
micronutri
critic
ill
method
includ
rct
evalu
clinic
outcom
associ
intraven
selenium
singl
combin
strategi
parenter
enter
fed
patient
overal
mortal
primari
outcom
secondari
outcom
infect
icu
length
stay
lo
hospit
lo
ventil
day
subgroup
analys
done
elucid
effect
selenium
mortal
infect
tabl
result
trial
met
inclus
criteria
n
result
trial
report
mortal
aggreg
statist
signific
reduct
mortal
found
rr
ci
p
addit
signific
effect
parenter
selenium
infect
p
effect
iv
selenium
therapi
icu
lo
hospit
lo
ventil
day
result
subgroup
analysi
found
tabl
conclus
parenter
selenium
monotherapi
combin
antioxid
micronutri
effect
overal
mortal
infect
well
icu
lo
hospit
lo
ventil
day
critic
ill
patient
introduct
critic
ill
character
chang
microbiolog
intestin
tract
lead
loss
commens
flora
overgrowth
pathogen
bacteria
probiot
live
nonpathogen
bacteria
colon
intestin
provid
benefit
host
demonstr
probiot
may
abl
reduc
infect
may
influenc
intens
care
unit
icu
last
three
year
differ
random
control
trial
rct
publish
therefor
aim
systemat
review
updat
previou
data
probiot
critic
ill
method
includ
rct
enrol
critic
ill
adult
evalu
probiot
compar
placebo
report
clinic
import
outcom
accord
elig
criteria
origin
studi
abstract
duplic
two
review
overal
infect
primari
outcom
secondari
outcom
overal
mortal
ventilatorassoci
pneumonia
vap
diarrhea
icu
length
stay
lo
hospit
lo
result
total
rct
n
met
inclus
criteria
includ
new
trial
sinc
last
updat
result
trial
report
infect
aggreg
probiot
associ
signific
reduct
infect
rr
ci
p
heterogen
particularli
among
patient
higher
risk
death
rr
ci
p
fig
moreov
probiot
associ
signific
reduct
incid
vap
rr
ci
p
final
probiot
effect
mortal
diarrhea
hospit
lo
conclus
probiot
associ
signific
reduct
overal
infect
well
reduct
incid
vap
refer
petrof
eo
et
al
probiot
critic
ill
systemat
review
trial
evid
crit
care
med
introduct
relationship
diabet
pancreat
cancer
discuss
howev
effect
diabet
poor
control
pancreat
cancer
never
evalu
address
strength
associ
relationship
diabet
pancreat
cancer
method
data
nation
health
insur
beneficiari
util
studi
cohort
consist
diabet
patient
unexpos
subject
among
patient
diabet
admit
hyperglycem
crisi
episod
adult
beneficiari
follow
januari
decemb
evalu
pancreat
cancer
diagnos
cox
regress
model
appli
compar
hazard
adjust
potenti
confound
result
control
age
gender
urban
level
socioeconom
statu
liver
cirrhosi
hypertens
coronari
arteri
diseas
hyperlipidemia
malign
smoke
chronic
obstruct
pulmonari
diseas
obes
histori
alcohol
intox
chronic
renal
insuffici
biliari
tract
diseas
chronic
pancreat
charlson
comorbid
index
score
adjust
hazard
ratio
pancreat
cancer
confid
interv
patient
diabet
patient
histori
hyperglycem
crisi
episod
hazard
ratio
pancreat
cancer
signific
higher
hazard
ratio
confid
interv
conclus
cohort
studi
provid
evid
relationship
diabet
pancreat
cancer
moreov
diabet
hyperglycem
crisi
episod
associ
higher
risk
pancreat
cancer
introduct
hypoglycemia
associ
increas
mortal
critic
ill
patient
aim
studi
assess
glucos
control
intens
care
unit
incid
hypoglycemia
depend
insulin
protocol
method
singlecent
prospect
observ
studi
patient
admit
icu
januari
april
five
day
enrol
data
demograph
clinic
characterist
patient
collect
baselin
blood
glucos
measur
first
day
record
three
insulin
protocol
use
two
use
subcutan
actrapid
insulin
depend
patient
diabet
dp
ndp
intens
protocol
ip
use
iv
insulin
depend
sole
glycem
valu
use
target
valu
mgdl
glucos
valu
mgdl
less
consid
moder
hypoglycemia
mgdl
less
sever
hypoglycemia
spss
use
statist
analysi
result
patient
includ
men
averag
age
year
mortal
rate
patient
nonsurg
diabet
averag
glucos
measur
perform
per
patientday
averag
valu
blood
glucos
level
first
five
day
mgdl
diabet
mgdl
nondiabet
mgdl
depend
protocol
averag
valu
blood
glucos
mgdeal
dp
mgdl
ndp
mgdl
ip
glycem
variabl
mgdl
dp
mgdl
ndp
mgdl
ip
patient
least
episod
moder
hypoglycemia
patient
sever
hypoglycemia
diabet
patient
determin
mgdl
mgdl
nondiabet
mgdl
mgdl
depend
insulin
protocol
incid
moder
hypoglycemia
dp
ndp
ip
sever
hypoglycemia
dp
ndp
ip
conclus
usual
incid
hypoglycemia
higher
diabet
popul
new
target
glycem
control
intens
therapi
incid
hypoglycemia
low
group
contrast
protocol
ndp
better
glycem
control
intens
protocol
introduct
elucid
relationship
sever
diseas
blood
glucos
bg
includ
bg
variabl
consid
signific
determin
bg
target
purpos
studi
analyz
relationship
analysi
fulli
perform
method
one
hundr
forti
nine
patient
glucos
intoler
analyz
week
icu
admiss
studi
item
maximum
valu
sofa
score
sofamax
mean
bg
bgm
standard
deviat
bg
bgsd
bg
measur
basic
everi
hour
insulin
use
bg
mgdl
correl
sofamax
bg
bgm
bgsd
analyz
accord
sofamax
level
result
mortal
patient
sofamax
n
n
n
n
n
n
n
respect
bgsd
linearli
correl
bgm
correl
coeffici
r
sofamax
twodimension
correl
bgm
bgsd
rang
bgm
bgsd
sofamax
less
calcul
twodimension
quadrat
equat
mgdl
respect
twodimension
correl
coeffici
r
sofamax
bgm
accord
sofamax
n
n
n
n
n
n
respect
r
sofamax
bgsd
accord
sofamax
respect
conclus
bg
control
hyperglycemia
one
measur
bring
reduct
bg
variabl
bg
target
consid
obtain
analysi
twodimension
relationship
sever
diseas
bg
possibl
strict
bg
control
effect
sever
moder
sever
patient
consid
result
indic
higher
correl
coeffici
r
sever
patient
glucos
administr
increas
bg
bg
variabl
might
bring
benefici
effect
hypoglycem
patient
also
part
normoglycem
patient
judg
bg
target
list
low
bg
variabl
part
sever
patient
may
relat
lower
variabl
physiolog
activ
analysi
relationship
sever
diseas
bg
base
fine
bg
control
includ
use
artifici
pancrea
consid
link
better
bg
control
outcom
introduct
vari
insulin
protocol
appli
control
blood
glucos
bg
critic
patient
mostli
base
short
act
insulin
consum
lot
manpow
resourc
previou
studi
yield
success
rate
glycem
control
dose
convers
short
act
insulin
dose
mean
differ
mgdl
aim
studi
determin
whether
singl
subcutan
glargin
inject
dose
transit
inferior
continu
regular
insulin
ri
infus
bg
control
critic
ill
patient
inferior
margin
acquir
mean
differ
previou
studi
mgdl
method
elig
particip
admit
critic
care
unit
requir
constant
rate
continu
ri
infus
per
standard
micu
insulin
infus
protocol
consecut
hour
switch
receiv
singl
dose
glargin
insulin
subcutan
total
daili
insulin
requir
calcul
cumul
dose
ri
requir
previou
hour
continu
insulin
infus
discontinu
hour
transit
bg
monitor
everi
hour
follow
hour
studi
termin
discontinu
result
case
includ
case
achiev
good
glycem
control
among
success
subgroup
bg
level
higher
mean
glucos
ri
mgdl
mild
hypoglycemia
event
observ
spontan
resolv
otherwis
among
particip
failur
subgroup
half
develop
hyperglycemia
hour
research
also
found
median
ri
dose
differ
mgdl
among
success
case
mgdl
among
failur
case
conclus
singl
subcutan
glargin
inject
dose
transit
inferior
continu
ri
infus
bg
control
critic
ill
patient
success
rate
higher
pretreat
ri
dose
relat
failur
success
outcom
introduct
target
level
glycemia
critic
ill
patient
fluctuat
sinc
evid
initi
indic
tight
glycem
control
mgdl
lead
lowest
morbid
mortal
howev
subsequ
studi
demonstr
minim
clinic
benefit
combin
greater
morbid
mortal
nowaday
target
glucos
level
approach
mgdl
aim
studi
assess
glucos
control
critic
ill
patient
portugues
icu
evalu
incid
hyperglycemia
hypoglycemia
method
prospect
observ
studi
conduct
eleven
icu
nine
portugues
hospit
six
month
includ
particip
patient
expect
length
stay
lo
icu
day
data
demograph
clinic
characterist
patient
collect
baselin
patient
assign
target
glucos
mgdl
less
blood
glucos
measur
first
day
record
glucos
valu
mgdl
consid
sever
hypoglycemia
result
patient
includ
men
averag
age
icu
lo
day
mortal
rate
patient
nonsurg
diabet
day
hospit
evalu
glucos
measur
perform
averag
per
patientday
averag
valu
blood
glucos
level
first
seven
day
mgdl
diabet
mgdl
nondiabet
nd
mgdl
determin
mgdl
mgdl
mgdl
per
patient
nd
mgdl
nd
conclus
use
target
glucos
level
mgdl
uncontrol
hyperglycemia
avoid
fewer
hypoglycem
episod
diabet
hyperglycem
hypoglycem
event
may
diabet
patient
differ
target
introduct
aim
studi
investig
whether
hyperglycemia
durat
hour
cycl
intraop
first
icu
day
impact
postop
outcom
cardiac
surgeri
method
longrang
observ
studi
carri
depart
januari
june
consist
data
cardiac
surgeri
patient
base
glucos
level
oper
day
hour
patient
divid
group
depend
hour
hyperglycemia
investig
possibl
relationship
durat
hyperglycemia
follow
postop
complic
deep
sternal
wound
infect
acut
kidney
injuri
need
intraven
drip
infus
diuret
solut
renal
replac
therapi
requir
icu
studi
conduct
independ
investig
result
process
statistician
statist
program
spss
result
result
show
tabl
conclus
hyperglycemia
statist
signific
relationship
aki
need
iv
diuret
rrt
requir
studi
hyperglycemia
impact
postop
sternal
wound
infect
introduct
diabet
ketoacidosi
dka
lifethreaten
acut
complic
diabet
present
highaniongap
metabol
acidosi
hyperglycemia
ketonemia
aim
studi
determin
lactat
level
clinic
outcom
dka
patient
admit
medic
intens
care
unit
icu
method
total
thirtyon
patient
admit
medic
icu
tertiari
care
univers
hospit
dka
last
thirti
month
includ
studi
retrospect
hyperlactatemia
defin
serum
lactat
mmoll
result
mean
age
patient
dka
n
men
n
women
twelv
patient
type
diabet
type
mean
serum
lactat
mmoll
patient
elev
serum
lactat
level
mmoll
high
lactat
level
mmoll
correl
found
serum
lactat
level
mortal
length
icu
hospit
stay
besid
lactat
level
correl
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
blood
pressur
serum
glucos
level
conclus
elev
lactat
level
commonli
found
dka
patient
howev
associ
wors
clinic
outcom
diseas
sever
thu
elev
lactat
level
determin
dka
patient
appreci
clinician
defin
highrisk
popul
refer
kitabchi
ae
umpierrez
ge
murphi
mb
et
al
hyperglycem
crise
adult
patient
diabet
consensu
statement
american
diabet
associ
diabet
care
fulop
hoberman
h
rascoff
j
et
al
lactic
acidosi
diabet
patient
arch
intern
med
cox
k
cocchi
mn
salciccioli
jd
et
al
preval
signific
lactic
acidosi
diabet
ketoacidosi
j
crit
care
april
introduct
london
chest
hospit
heart
hospit
merg
st
bartholomew
hospit
becom
bart
heart
centr
receiv
heart
attack
centr
hac
activ
north
central
north
east
london
area
creat
largest
cardiac
intens
care
unit
europ
bed
current
expand
next
year
report
chang
occur
follow
merger
two
hac
servic
adjac
region
data
collect
intens
care
nation
audit
research
centr
icnarc
databas
well
myocardi
ischaemia
nation
audit
programm
minap
method
icnarc
minap
databas
interrog
identifi
number
hac
activationppci
primari
percutan
coronari
intervent
admiss
level
intens
care
compar
data
five
month
follow
merger
may
septemb
month
high
depend
coronari
care
admiss
exclud
inunit
mortal
length
stay
examin
result
express
median
interquartil
rang
iqr
nonnorm
distribut
data
ethic
approv
sought
deem
necessari
result
may
septemb
hac
activ
patient
admit
legaci
site
london
chest
hospit
heart
hospit
follow
merger
increas
patient
hac
activ
legaci
site
mayseptemb
patient
underw
primari
percutan
coronari
intervent
ppci
compar
patient
five
month
postmerg
icnarc
data
collect
heart
hospit
therefor
data
avail
one
legaci
site
itu
admiss
rate
london
chest
observ
compar
new
centr
length
stay
intens
care
increas
follow
merger
median
day
iqr
median
day
iqr
inunit
mortal
decreas
mayseptemb
previou
year
conclus
knowledg
uniqu
situat
three
specialis
london
hospit
merg
produc
one
larg
cardiac
centr
rise
patient
number
yet
fall
ppci
rate
interest
analysi
need
understand
trend
introduct
inhospit
cardiac
arrest
ca
sudden
event
case
result
slow
progress
deterior
patient
aim
studi
systemat
analysi
ca
incid
primari
caus
initi
rhythm
regard
locat
hospit
order
identifi
potenti
obstacl
undertak
prevent
measur
enhanc
outcom
method
inhospit
ca
resuscit
attempt
includ
studi
data
record
accord
utstein
style
templat
inhospit
ca
age
gender
patient
primari
caus
initi
rhythm
locat
ca
record
review
result
result
depict
tabl
conclus
vast
major
ca
occur
area
supervis
cardiolog
depart
togeth
cardio
surgic
ca
cardiolog
relat
ca
percentag
aris
number
ca
ed
riu
also
signific
mean
age
ca
patient
similar
locat
wherea
signific
differ
far
primari
caus
initi
rhythm
analysi
concern
interest
result
merit
studi
larger
number
patient
detail
analysi
relat
paramet
order
conduct
safe
conclus
abl
undertak
prevent
measur
introduct
patient
nosocomi
cardiopulmonari
arrest
cpa
aggrav
clinic
sign
cpa
occur
earli
recognit
sign
quick
treatment
may
reduc
death
rate
patient
examin
background
factor
variou
biomark
patient
resuscit
gener
medicin
ward
method
eighteen
patient
admit
icu
resuscit
gener
medicin
ward
studi
patient
classifi
gfair
prognosi
h
fpgroup
person
patient
surviv
day
gpoor
prognosi
h
ppgroup
person
patient
die
within
day
blood
sampl
drawn
measur
blood
chemistri
sepsisrel
biomark
procalcitonin
presepsin
endotoxin
activ
assay
immedi
icu
admiss
statist
analysi
perform
mannwhitney
utest
chi
squar
test
fisher
test
valu
p
indic
statist
signific
result
underli
diseas
follow
sepsi
acut
respiratori
distress
syndrom
lethal
arrhythmia
ileu
suffoc
amyotroph
later
sclerosi
sudden
unexpect
death
epilepsi
unknown
sofa
score
fpgroup
ppgroup
respect
differ
group
statist
signific
p
score
fpgroup
ppgroup
respect
howev
signific
differ
group
procalcitonin
level
fpgroup
ppgroup
respect
signific
differ
group
level
fpgroup
ppgroup
respect
differ
group
statist
signific
p
eaa
level
ffgroup
wherea
ppgroup
howev
signific
differ
eaa
level
group
conclus
institut
surviv
rate
patient
resuscit
gener
medicin
ward
factor
affect
patient
outcom
sofa
score
howev
could
evalu
durat
cpa
therefor
necessari
examin
futur
introduct
teach
basic
life
support
bl
secondari
school
student
prove
feasibl
much
evalu
conduct
studi
evalu
efficaci
onehour
bl
train
cours
secondari
school
student
method
septemb
june
six
secondari
school
includ
studi
two
receiv
onehour
bl
session
conduct
intensivist
assist
medic
student
session
contain
theoret
lectur
practic
simulationbas
train
use
lowfidel
manikin
laerdal
month
later
train
nontrain
student
assess
use
seriou
game
reproduc
reallif
cardiac
arrest
situat
realtim
simul
softwar
ilumensdassault
system
primari
outcom
time
spent
complet
seriou
game
onset
cardiac
arrest
shock
deliveri
recoveri
secondari
outcom
includ
knowledg
emerg
call
hand
placement
chest
compress
electrod
placement
autom
extern
defibril
result
among
student
assess
seriou
game
receiv
onehour
bl
session
children
age
differ
group
vs
year
old
p
total
game
complet
time
second
train
group
versu
second
nontrain
group
p
fig
knowledg
emerg
call
differ
two
group
train
group
vs
nontrain
group
p
hand
often
properli
place
chest
compress
trainedgroup
vs
p
electrod
autom
extern
defibril
often
properli
place
trainedgroup
vs
p
conclus
onehour
bl
train
session
lowfidel
manikin
improv
significantli
young
student
perform
life
simul
session
introduct
peopl
unrealist
expect
outcom
inpati
adult
cardiopulmonari
resuscit
cpr
conduct
survey
look
clinic
staff
gener
public
percept
knowledg
cpr
compar
local
nation
data
method
public
staff
survey
hospit
gp
surgeri
south
east
london
result
public
knew
cpr
felt
enough
cpr
knowledg
knowledg
appear
influenc
attend
univers
compar
nation
figur
initi
cpr
surviv
public
predict
correct
surviv
rang
accur
see
fig
staff
result
compar
local
hospit
data
hospit
initi
surviv
rate
staff
compar
public
chose
correct
surviv
rang
hospit
b
everi
doctor
underestim
initi
cpr
surviv
figur
nurs
closer
figur
popular
respons
rang
compar
doctor
gp
pessimist
predict
gener
cpr
surviv
rate
nurs
optimist
staff
want
cpr
healthi
drop
chronic
ill
affect
daili
public
figur
respect
peopl
african
origin
less
like
want
cpr
chronic
ill
compar
caucasian
went
univers
like
want
discuss
cpr
doctor
less
survey
attempt
resuscit
dnar
place
conclus
staff
better
predict
initi
cpr
surviv
rate
public
felt
need
knowledg
cpr
popular
learn
modal
onlin
learn
staff
opinion
whether
would
want
cpr
strongli
influenc
presenc
chronic
diseas
caus
daili
impact
refer
ncaa
key
statist
nation
cardiac
arrest
audit
introduct
pediatr
outofhospit
cardiac
arrest
ohca
devast
event
low
surviv
rate
partli
due
lack
bystand
cardiopulmonari
resuscit
cpr
telephon
dispatcherassist
cpr
instruct
tcpr
improv
frequenc
qualiti
bystand
cpr
ohca
adult
support
remain
undevelop
pediatri
aim
assess
effect
new
pediatr
tcpr
protocol
previous
train
untrain
bystand
secondarili
util
ventil
method
adult
cpr
experi
recruit
public
movi
center
among
bachelor
nurs
student
district
volunt
randomli
assign
either
tcpr
tcpr
submit
minut
infant
ohca
scenario
cpr
perform
data
extract
video
infant
manikin
use
laerdal
skillreport
result
volunt
recruit
met
inclus
criteria
distribut
group
train
unguid
group
ung
n
untrain
guid
group
ug
n
train
unguid
group
tng
n
train
guid
group
tg
n
tcpr
increas
significantli
cpr
attempt
ung
group
perform
chest
compress
compar
group
p
overal
cpr
perform
median
time
first
chest
compress
longer
guid
group
p
proport
volunt
manag
deliv
ventil
cpr
higher
p
guid
group
ug
group
tg
group
unguid
group
ung
group
tng
group
tidal
volum
deliv
high
group
fraction
time
requir
give
ventil
signific
higher
guid
group
conclus
tcpr
instruct
potenti
increas
number
perform
bystand
cpr
train
untrain
volunt
mouth
mouth
ventil
respons
major
interrupt
chest
compress
moreov
identifi
overal
tendenc
hyperventil
refer
atkin
dl
et
al
improv
outcom
outofhospit
cardiac
arrest
young
children
adolesc
pediatr
cardiol
stipulant
et
al
implement
alert
algorithm
new
dispatcherassist
telephon
cardiopulmonari
resuscit
protocol
nonadvanc
medic
prioriti
dispatch
system
ampd
emerg
medic
servic
centr
resuscit
goto
et
al
impact
bystand
cardiopulmonari
resuscit
neurolog
outcom
children
cardiac
arrest
prospect
nationwid
cohort
studyj
heart
assoc
introduct
dantrolen
therapeut
drug
patient
malign
hyperthermia
interestingli
dantrolen
antiarrhythm
characterist
might
altern
patient
vt
ventricular
tachycardia
vf
ventricular
fibril
howev
experiment
resuscit
studi
compar
dantrolen
amiodaron
still
miss
aim
studi
evalu
rosc
return
spontan
circul
rate
dantrolen
versu
amiodaron
pig
model
sustain
cardiac
arrest
min
vf
method
ventricular
fibril
induc
anesthet
pig
dantrolen
n
amiodaron
n
salin
n
min
untreat
vf
chest
compress
ventil
start
one
drug
amiodaron
mg
kg
dantrolen
mg
kg
salin
sham
appli
blind
fashion
min
cpr
without
epinephrin
drug
defibril
j
perform
standard
resuscit
includ
mechan
cpr
defibril
accord
protocol
appli
anim
rosc
rate
cardiovascular
well
blood
ga
analysi
cerebr
oximetri
perfus
measur
calcul
experi
result
initi
rosc
rate
anim
dantrolen
group
vs
anim
amiodaron
group
salin
group
howev
persist
rosc
min
followup
shown
anim
dantrolen
group
anim
amiodaron
group
anim
salin
sham
group
howev
result
statist
signific
group
hemodynam
data
cerebr
perfus
well
cerebr
oximetri
compar
survivor
anim
conclus
pharmacolog
effect
dantrolen
compar
amiodaron
regard
rosc
experiment
model
hemodynam
paramet
show
relev
signific
group
futur
studi
evalu
dantrolen
cpr
bundl
approach
includ
epinephrin
postrosc
therapi
protocol
refer
zamiri
n
ramadeen
kusha
hu
x
dantrolen
improv
surviv
ventricular
fibril
mitig
impair
calcium
handl
anim
model
circul
roden
dm
knollmann
bc
dantrolen
better
bacon
treatment
ventricular
fibril
circul
introduct
therapeut
hypothermia
th
improv
short
term
physic
neurolog
outcom
surviv
postarrest
patient
howev
limit
data
long
term
surviv
function
neurolog
outcom
survivor
method
review
databas
post
arrest
patient
undergo
th
surviv
discharg
conscious
glasgowpittsburgh
cerebr
perform
cpc
hospit
hospit
survivor
evalu
life
death
statu
death
date
januari
check
death
certif
nation
registri
system
contact
survivor
rel
phone
mail
schedul
followup
visit
evalu
abil
patient
unabl
visit
assess
function
disabl
phone
interview
use
record
followup
data
function
neurolog
outcom
score
disabl
rate
scale
scale
consist
arous
awar
respons
cognit
abil
selfcar
activ
depend
other
psychosoci
adapt
level
disabl
defin
follow
none
mild
partial
moder
moder
sever
sever
extrem
sever
veget
state
extrem
veget
state
addit
surviv
rate
month
year
discharg
analyz
result
patient
treat
th
patient
surviv
hospit
discharg
seventeen
hospit
survivor
consciou
patient
cpc
discharg
respect
five
pass
away
later
approxim
awak
patient
surviv
month
year
discharg
respect
major
dead
case
die
within
month
sever
function
disabl
score
patient
disabl
score
shown
tabl
onethird
awak
patient
cpc
still
surviv
month
discharg
final
recov
normal
physic
cognit
function
patient
return
normal
function
minim
disabl
conclus
long
term
surviv
rate
consciou
survivor
th
high
hospit
survivor
aliv
longer
month
discharg
good
function
capabl
refer
hall
km
hopkin
k
belleza
cope
dn
disabl
rate
scale
sever
head
trauma
patient
coma
commun
arch
phi
med
rehabil
introduct
kidney
diseas
outofhospit
cardiac
arrest
ohca
previous
incomplet
describ
examin
occurr
chronic
kidney
diseas
ckd
acut
kidney
injuri
aki
ohca
patient
impact
aki
sixmonth
mortal
neurolog
outcom
patient
without
renal
replac
therapi
rrt
method
prospect
cohort
studi
oslo
univers
hospit
oslo
norway
septemb
januari
resuscit
comatos
ohca
patient
admit
intens
care
unit
includ
patient
treat
accord
standard
treatment
protocol
includ
therapeut
hypothermia
hour
ckd
aki
classifi
accord
kidney
diseas
improv
global
outcom
kdigo
guidelin
patient
previous
known
ckd
exclud
detail
analys
main
outcom
sixmonth
mortal
good
neurolog
outcom
defin
cerebr
perform
categori
result
among
includ
patient
male
mean
age
year
previous
known
ckd
develop
aki
aki
patient
consist
aki
stage
aki
stage
aki
stage
overal
sixmonth
outcom
reveal
die
good
neurolog
outcom
compar
kidney
diseas
aki
patient
significantli
increas
mortal
odd
ratio
confid
interv
ci
p
worsen
neurolog
outcom
ci
p
aki
patient
without
rrt
compar
sixmonth
mortal
versu
vs
p
good
neurolog
outcom
vs
p
also
exclud
patient
rrt
withheld
due
futil
conclus
kidney
diseas
occur
half
patient
success
resuscit
ohca
aki
associ
unfavor
sixmonth
mortal
neurolog
outcom
howev
rrt
patient
introduct
avail
clinic
evid
indic
earli
pci
improv
outcom
non
stemi
hospit
cardiac
arrest
ohca
patient
suspect
cardiac
caus
adopt
approach
increas
icu
admiss
region
ppci
center
observ
cohort
studi
analys
icu
servic
depend
ppci
patient
follow
ohca
method
adult
patient
admit
intens
care
unit
april
march
analys
patient
admit
ppci
pathway
follow
ohca
compar
unplan
admiss
studi
period
data
regard
outcom
depend
collect
icnarc
intens
care
nation
audit
research
council
uk
databas
pair
ttest
chi
squar
test
perform
estim
statist
signific
level
result
number
ohcappci
unplan
admiss
studi
period
respect
median
length
icu
stay
significantli
high
ppci
patient
vs
day
p
furthermor
ppci
patient
higher
icnarc
sever
score
vs
p
ppci
patient
significantli
higher
level
depend
evidenc
higher
level
organ
support
vs
organ
p
greater
level
care
vs
day
p
day
ventil
vs
day
p
higher
requir
advanc
cv
support
vs
day
p
signific
differ
dialysi
requir
hospit
length
stay
overal
icu
mortal
rate
higher
ppci
group
vs
p
despit
repres
total
number
patient
admit
studi
period
ppci
patient
account
total
icu
level
bed
day
ventil
day
advanc
cv
day
conclus
overal
patient
undergo
ppci
post
ohca
significantli
greater
level
depend
patient
admit
icu
high
level
depend
need
consid
contempl
expans
pci
servic
non
stemi
ohca
patient
suspect
cardiac
caus
refer
noc
et
al
invas
coronari
treatment
strategi
outofhospit
cardiac
arrest
consensu
statement
eapci
sfl
group
euro
intervent
anthoni
c
et
al
cardiac
catheter
associ
superior
outcom
survivor
hospit
cardiac
arrest
review
metaanalysi
resuscit
introduct
establish
multicent
prospect
cohort
includ
utstein
data
prehospit
treatment
content
data
hospit
arriv
purpos
studi
determin
import
indic
prognosi
patient
return
spontan
circul
rosc
follow
outofhospit
cardiopulmonari
arrest
ohca
develop
best
outcom
predict
model
method
consecut
patient
suffer
ohca
transport
institut
particip
registri
prospect
record
juli
decemb
criteria
inclus
studi
wit
cardiac
arrest
age
greater
year
presum
cardiac
origin
arrest
success
rosc
multivari
logist
regress
mlr
analysi
use
develop
best
predict
model
depend
variabl
favor
outcom
cerebralperform
categori
cpc
poor
outcom
cpc
month
event
explanatori
variabl
use
concern
patient
characterist
resuscit
result
subject
compris
patient
vf
patient
pulseless
electr
activ
pea
asystol
percentag
favor
outcom
vf
peaasystol
import
prognost
indic
favor
outcom
found
mlr
age
p
time
collaps
rosc
trosc
p
base
deficit
p
presenc
bystand
cardiopulmonari
resuscit
p
vf
age
p
trosc
p
base
deficit
p
peaasystol
area
receiveroper
characterist
curv
vf
peaasystol
respect
conclus
model
base
four
select
indic
show
high
predict
valu
favor
outcom
ohca
patient
rosc
introduct
near
infrar
spectrometri
nir
could
use
noninvas
monitor
cerebr
perfus
cardiopulmonari
resuscit
cpr
aim
studi
investig
evalu
nir
cpr
porcin
model
cardiac
arrest
ca
method
pig
gener
anesthesia
mechan
ventil
includ
studi
studi
anim
ventricular
fibril
induc
applic
electr
current
via
pace
wire
min
ca
cpr
initi
use
luca
mechan
devic
min
initi
carhythm
analyz
advanc
life
support
intervent
provid
accord
erc
guidelin
region
cerebr
oxygen
record
resuscit
min
interv
invo
oximet
via
somasensor
electrod
place
pig
head
pig
divid
two
group
depend
return
spontan
circul
ga
rosc
n
gb
rosc
n
ga
gb
compar
phase
baselin
min
cano
flow
min
cpr
initi
thereaft
everi
min
statist
analysi
repeat
measur
anova
use
result
durat
cpr
min
ga
rosc
gb
directli
ca
decreas
record
remain
whole
resuscit
attempt
tabl
statist
differ
studi
group
rosc
remain
decreas
increas
gradual
time
conclus
accord
studi
result
alter
use
identifi
ca
immedi
provid
use
inform
cpr
introduct
new
aha
guidelin
cardiopulmonari
resuscit
recommend
cardiac
compress
perform
sternal
bone
level
bust
point
individu
differ
heart
posit
ratio
realtim
lowoxygen
cerebr
blood
circul
repres
region
cerebr
oxygen
satur
noninvas
quantit
measur
use
near
infraredr
spectroscopi
nir
sensor
place
forehead
higher
absorpt
near
infraredr
ray
occur
lowoxygen
blood
therefor
potenti
enabl
us
monitor
effect
cardiopulmonari
resuscit
purpos
studi
valid
monitor
effect
chest
compress
investig
relationship
arteri
blood
pressur
patient
outofhospit
cardiac
arrest
ohca
method
studi
prospect
observ
studi
conduct
tertiari
emerg
medic
care
center
japan
systol
arteri
pressur
sap
mean
arteri
pressur
map
invas
arteri
pressur
monitor
measur
everi
minut
cardiopulmonari
resuscit
ohca
patient
relationship
absolut
valu
measur
compar
use
two
type
coeffici
correl
within
patient
order
perform
statist
analysi
consid
repeat
measur
taken
singl
patient
result
patient
total
patient
ohca
fulfil
inclus
criteria
studi
patient
final
includ
total
measur
point
patient
point
median
valu
patient
age
year
old
iqr
male
patient
number
patient
wit
time
cardiopulmonari
arrest
two
type
coeffici
correl
arteri
pressur
show
within
patient
f
coeffici
correl
map
ci
coeffici
correl
patient
conclus
correl
map
sternal
chest
compress
patient
ohca
indic
may
use
monitor
cerebr
blood
flow
chest
compress
result
suggest
sternal
chest
compress
monitor
improv
outcom
patient
ohca
introduct
test
eeg
reactiv
standard
procedur
eeg
registr
unconsci
icu
patient
suggest
use
eeg
reactiv
marker
poor
outcom
cardiac
arrest
howev
clearli
defin
protocol
test
reactiv
studi
investig
stimulu
type
effect
evok
cortic
respons
cardiac
arrest
patient
method
prospect
cohort
studi
patient
monitor
continu
eeg
cardiac
arrest
two
dutch
icu
twice
day
strict
stimulu
protocol
includ
five
stimulu
type
order
clap
yell
patient
name
passiv
eye
open
nasal
tickl
sternal
rub
execut
stimulu
appli
time
interv
stimulu
respons
individu
score
reactiv
nonreact
doubt
unscor
eg
much
nois
three
independ
blind
rater
jh
mvp
mtc
reactiv
defin
chang
amplitud
frequenc
eeg
upon
stimul
exclud
muscl
artifact
isoelectr
eeg
exclud
beforehand
stimulu
respons
two
three
rater
agre
includ
analysi
result
stimul
protocol
execut
time
patient
result
independ
rate
stimulu
respons
stimuli
exclud
disagr
rater
intraclass
correl
coeffici
respons
stimuli
patient
found
reactiv
stimulu
induc
eeg
reactiv
often
clap
passiv
eye
open
least
often
induc
eeg
reactiv
conclus
sudden
loud
nois
stimulu
clap
seem
effect
evok
cortic
respons
patient
cardiac
arrest
suggest
integr
stimulu
standard
set
stimuli
test
eeg
reactiv
studi
need
determin
relev
prognost
refer
sandroni
c
et
al
prognost
comatos
survivor
cardiac
arrest
advisori
statement
european
resuscit
council
european
societi
intens
care
medicin
intens
care
med
introduct
serum
concentr
neuronspecif
enolas
nse
establish
highli
specif
predictor
poor
outcom
cardiac
arrest
clear
cutoff
identifi
method
prospect
includ
outofhospit
cardiac
arrest
patient
admit
intens
care
unit
icu
submit
target
temperatur
manag
hour
outcom
assess
accord
cerebr
perform
categori
cpc
icu
discharg
cpc
consid
good
outcom
cpc
poor
outcom
recent
guidelin
suggest
sampl
nse
hour
cardiac
arrest
result
patient
admit
patient
present
good
outcom
patient
present
poor
outcom
accord
cpc
nse
serum
concentr
sampl
day
cardiac
arrest
first
group
nse
valu
mcgl
second
group
nse
valu
mcgl
nevertheless
patient
present
poor
outcom
nse
serum
concentr
mcgl
patient
present
good
outcom
nse
mcgl
fig
observ
great
variabl
nse
valu
patient
poor
outcom
fig
conclus
nse
could
import
biomark
poor
outcom
cardiac
arrest
investig
necessari
clarifi
time
sampl
cut
refer
jerri
p
nolan
et
al
european
resuscit
council
european
societi
intens
care
medicin
guidelin
postresuscit
care
section
european
resuscit
council
guidelin
resuscit
resuscit
l
introduct
encephalopathi
cardiac
arrest
common
caus
coma
requir
intens
care
survivor
certain
malign
electroencephalograph
eeg
pattern
shown
correl
poor
prognosi
neuron
specif
enolas
nse
releas
cardiac
arrest
regard
sever
indic
postanox
neuron
injuri
investig
eeg
find
postcardiac
arrest
patient
correl
find
nse
level
outcom
scale
method
egyptian
patient
resuscit
cardiac
arrest
subject
eeg
nse
measur
glasgow
outcom
scale
go
eeg
data
eeg
monitor
done
within
first
day
admiss
minut
repeat
seventh
day
cardiac
arrest
eeg
classif
day
postarrest
accord
young
et
al
ideltatheta
recordingiitriphas
wavesiiiburstsuppress
pattern
without
epileptiform
activityivalphathetaspindl
pattern
coma
reactiv
vsuppress
gener
microvolt
nse
sampl
day
cardiac
arrest
serum
concentr
nse
measur
use
elisa
techniqu
result
statist
signific
neg
correl
eeg
coma
scale
day
go
p
statist
signific
neg
correl
nse
day
go
p
tabl
statist
signific
posit
correl
eeg
scale
day
neuron
specif
enolas
day
tabl
conclus
postcardiopulmonari
arrest
patient
signific
correl
eeg
coma
scale
glasgow
outcom
scale
certain
malign
eeg
pattern
correl
high
serum
level
nse
good
predictor
poor
outcom
patient
refer
young
gb
mclachlan
rs
kreeft
jh
demelo
jd
electroencephalograph
classif
coma
j
neurol
sci
introduct
report
experi
intens
care
unit
icu
introduc
target
temperatur
manag
ttm
strategi
follow
cardiac
arrest
base
ttm
trial
investig
protocol
includ
pre
postintervent
data
unit
averag
cardiac
arrest
case
month
low
frequenc
given
recent
updat
ttm
evid
concern
temperatur
manag
practic
could
inconsist
outdat
method
case
identifi
retrospect
scottish
nation
icu
audit
databas
patient
diagnosi
cardiac
respiratori
arrest
select
full
case
note
review
baselin
survey
maynovemb
yield
case
set
note
unobtain
data
collect
includ
document
target
temperatur
tt
use
activ
cool
hourli
temperatur
data
first
hour
icu
eventu
outcom
new
ttm
strategi
base
ttm
studi
protocol
introduc
februari
present
local
icu
meet
copi
made
avail
bed
space
staff
refer
subsequ
case
marchseptemb
identifi
method
data
set
collect
total
case
set
note
unobtain
result
baselin
data
indic
consist
ttm
strategi
document
tt
rang
target
document
activ
cool
pyrexi
defin
one
patient
exceed
ttm
target
least
prior
intervent
averag
time
spent
hour
averag
time
hour
follow
intervent
tt
rang
increas
proport
patient
desir
tt
decreas
proport
regrett
still
document
tt
howev
significantli
patient
activ
cool
patient
pyrexi
still
exceed
encouragingli
introduct
protocol
averag
time
spent
hour
reduct
averag
time
hour
reduct
conclus
follow
chang
ttm
recent
year
promis
initi
data
show
introduct
ttm
strategi
small
unit
infrequ
case
achiev
complianc
target
significantli
improv
simpl
intervent
protocol
refer
nielsen
n
et
al
target
temperatur
manag
versu
cardiac
arrest
n
eng
j
med
introduct
regardless
recent
advanc
cardiopulmonari
resuscit
postresuscit
care
patient
die
hospit
stay
outofhospit
cardiac
arrest
ohca
deceas
due
postanox
neurolog
injuri
near
infrar
spectroscopi
nir
provid
inform
region
brain
oxygen
measur
region
cerebr
oxygen
satur
offer
possibl
determin
chang
balanc
oxygen
deliveri
uptak
frontal
lobe
brain
aim
studi
monitor
hour
ohca
patient
target
temperatur
manag
ttm
method
prospect
observ
studi
perform
therapeut
hypothermia
th
hour
follow
rewarm
hour
success
resuscit
ohca
patient
continu
monitor
nir
hour
use
foresighttm
ca
medic
system
branford
ct
usa
cerebr
perform
categori
cpc
scale
use
defin
patient
outcom
day
ohca
cpc
cpc
repres
good
poor
outcom
respect
data
report
mean
sd
student
ttest
perform
appropri
mix
model
creat
analyz
continu
data
time
result
patient
surviv
good
neurolog
outcom
patient
correspond
cpc
score
mean
icu
admiss
survivor
compar
nonsurvivor
p
initi
th
import
decreas
observ
group
lowest
hour
survivor
hour
nonsurvivor
p
follow
progress
increas
toward
baselin
valu
respect
nonsurvivor
regain
baselin
hour
survivor
alreadi
reach
baselin
valu
within
hour
fit
linear
mix
model
signific
time
effect
observ
cours
adjust
age
gender
p
found
nonsurvivor
follow
linear
cours
time
wherea
survivor
could
fit
logarithm
curv
conclus
ttm
follow
ohca
accompani
fluctuat
balanc
oxygen
deliveri
suppli
brain
reflect
chang
moreov
cours
time
significantli
differ
survivor
follow
logarithm
cours
compar
linear
one
nonsurvivor
introduct
therapeut
hypothermia
th
improv
neurolog
outcom
surviv
comatos
patient
rosc
cardiac
arrest
institut
develop
hypothermia
protocol
use
standard
practic
year
aim
evalu
clinic
outcom
patient
undergo
th
analyz
factor
associ
outcom
method
retrospect
review
baselin
characterist
cool
practic
clinic
outcom
postarrest
patient
treat
th
institut
neurolog
statu
measur
cerebr
perform
categori
scale
cpc
surviv
rate
evalu
prognost
factor
good
neurolog
recoveri
surviv
analyz
continu
data
report
median
percentag
chisquar
mann
whitney
u
test
use
compar
data
patient
favor
outcom
unfavor
outcom
result
th
appli
comatos
survivor
includ
survivor
outofhospit
arrest
primari
cardiac
rhythm
major
nonshock
rhythm
median
age
patient
year
overal
patient
surviv
median
hospit
lo
day
nine
survivor
discharg
good
recoveri
eight
patient
sever
disabl
patient
veget
state
free
vasopressor
prognost
factor
good
neurolog
recoveri
p
surviv
p
shorter
time
collaps
rosc
associ
favor
outcom
p
addit
durat
less
hour
rosc
achiev
temperatur
protocol
complet
associ
surviv
p
p
respect
cardiac
rhythm
locat
arrest
target
temperatur
attain
rebound
hyperthermia
age
associ
clinic
outcom
conclus
regardless
cardiac
rhythm
arrest
locat
approxim
post
arrest
patient
th
surviv
survivor
favor
neurolog
outcom
factor
associ
good
recoveri
free
vasopressor
time
collaps
rosc
factor
associ
surviv
free
vasopressor
success
resuscit
time
target
temperatur
less
hour
protocol
complet
refer
alzaga
cerden
varon
j
therapeut
hypothermia
resuscit
introduct
target
temperatur
manag
hospit
cardiac
arrest
remain
recommend
therapeut
approach
australian
resuscit
council
one
top
five
reason
admiss
major
tertiari
australian
intens
care
unit
aim
audit
current
practic
regard
time
target
temperatur
time
target
temperatur
rewarm
practic
method
conduct
retrospect
review
patient
admit
intens
care
unit
return
spontan
circul
rosc
hospit
cardiac
arrest
collect
data
electron
medic
record
system
metavis
analys
use
spss
ethic
approv
obtain
result
patient
achiev
target
temperatur
within
hour
still
achiev
target
within
hour
rosc
maintain
target
hour
target
chosen
degre
patient
rewarm
occur
rate
degre
per
hour
less
patient
despit
find
correl
neurolog
outcom
adher
current
evid
base
recommend
conclus
data
show
unit
unabl
consist
appli
target
temperatur
manag
real
world
practic
accord
evid
base
guidelin
howev
result
advers
outcom
patient
popul
refer
nielsen
n
et
al
target
temperatur
manag
versu
cardiac
arrest
n
engl
j
med
wise
mp
et
al
target
temperatur
manag
outofhospit
cardiac
arrest
certainti
uncertainti
crit
care
nunnal
et
al
target
temperatur
manag
critic
care
report
recommend
five
profession
societi
crit
care
med
nolan
jp
et
al
therapeut
hypothermia
cardiac
arrest
circul
introduct
mild
therapeut
hypothermia
mth
improv
neurolog
outcom
surviv
outofhospit
cardiac
arrest
oohca
tvfv
howev
techniqu
univers
accept
partial
due
technic
difficulti
relat
implement
practic
protocol
present
experi
one
year
sinc
introduct
institut
mth
protocol
test
feasibl
method
cool
comatos
patient
unabl
respond
verbal
command
surviv
oohca
tvfv
sinc
implement
mth
protocol
may
may
pescara
spirito
santo
hospit
secondlevel
hospit
serv
peopl
mth
induc
rosc
intraven
mlkg
ringer
lactat
maintain
icu
admiss
temperatureregul
surfac
devic
arctic
mediv
padova
itali
target
temperatur
rewarm
start
hour
induct
target
devic
pad
left
site
hour
normothermia
achiev
neurolog
sequela
investig
icu
discharg
clinic
evalu
ct
scan
eeg
month
telephon
interview
result
patient
met
protocol
inclus
criteria
male
mean
age
mean
gc
valu
rosc
mth
start
ed
patient
ambul
patient
underw
emerg
coronarographi
mean
core
temperatur
icu
admiss
mean
time
target
temperatur
bradycardia
common
phase
hypokalemia
metabol
acidosi
mean
activ
rewarm
time
mild
hyperkalemia
occur
case
case
hyperthermia
need
pad
reposit
patient
discharg
aliv
free
appar
neurolog
sequela
agit
confus
amnesia
mean
icu
stay
day
month
patient
home
free
neurolog
alter
conclus
studi
point
feasibl
mth
protocol
implement
particular
hospit
set
overcam
difficulti
rapidli
induc
safe
maintain
mth
mix
two
cool
techniqu
time
induct
rewarm
accept
mainten
phase
character
temperatur
stabil
lack
life
threaten
event
clinic
outcom
encourag
refer
bae
ks
et
al
effect
mild
therapeut
hypothermia
good
neurolog
recoveri
outofhospit
cardiac
arrest
accord
locat
return
spontan
circul
nationwid
observ
studi
circul
toma
et
al
perceiv
barrier
therapeut
hypothermia
patient
resuscit
cardiac
arrest
qualit
studi
emerg
depart
critic
care
worker
crit
care
med
introduct
hospit
cardiac
arrest
ohca
patient
treat
target
temperatur
manag
ttm
may
substanti
difficulti
ventil
wean
due
multipl
organ
failur
includ
postttm
neurolog
injuri
abil
predict
clinic
cours
ttm
patient
regard
durat
ventil
import
clinic
decisionmak
safer
extub
plan
earli
tracheostomi
howev
predict
factor
ventil
wean
ttm
remain
unclear
hypothes
wean
difficulti
associ
admiss
resuscit
condit
explor
whether
failur
wean
may
also
predict
admiss
purpos
studi
examin
factor
predict
ventil
wean
difficulti
method
perform
retrospect
cohort
studi
ohca
patient
brought
emerg
room
st
luke
fs
intern
hospit
tokyo
japan
underw
ttm
januari
juli
primari
outcom
day
wean
admiss
intens
care
unit
use
electron
medic
record
collect
patient
characterist
resuscit
condit
examin
data
admiss
character
wean
success
use
descript
statist
relationship
ventil
wean
hospit
resuscit
condit
assess
cox
regress
result
ohca
patient
complet
ttm
median
time
wean
ventil
day
iqr
patient
wean
within
week
admiss
earlier
wean
significantli
associ
age
hr
ci
motor
respons
admiss
hr
ci
though
significantli
associ
wean
ventricular
fibril
asystol
show
trend
toward
earli
later
wean
respect
compar
pulseless
electr
activ
conclus
larg
major
ttm
patient
wean
ventil
within
week
older
age
absenc
motor
respons
admiss
relat
prolong
mechan
ventil
earli
tracheostomi
plan
consid
patient
achiev
ttm
older
show
motor
respons
er
refer
okada
k
ohd
otani
n
ishimatsu
predict
protocol
neurolog
outcom
survivor
outofhospit
cardiac
arrest
treat
target
temperatur
manag
resuscit
introduct
cfo
well
use
detect
pathogenesi
cn
disord
examin
chang
cfo
immunoreact
paraventricular
nucleu
hypothalamu
pvnt
paraventricular
nucleu
thalamu
pvnt
myocardi
infarct
mi
rat
method
infarct
left
ventricl
examin
massoni
trichrom
stain
neuron
degener
damagedeath
examin
day
mi
use
cresyl
violet
cv
fluorojad
b
fj
b
histofluoresc
stain
chang
cfo
immunoreact
examin
immunohistochemistri
cfo
result
averag
infarct
size
left
ventricl
circumfer
mi
neuron
damagedeath
detect
pvnh
pvnt
mi
cfo
immunoreact
cell
hardli
found
nuclei
shamgroup
howev
cfo
cell
increas
nuclei
mi
peak
pvnh
pvnt
day
day
respect
mi
day
mi
cfo
cell
bare
found
nuclei
conclus
result
show
mi
dramat
induc
cfo
immunoreact
pvnt
pvnt
suggest
increas
cfo
express
may
associ
brain
stress
associ
mi
introduct
cerebrovascular
diseas
lead
caus
morbid
mortal
disabl
elev
troponin
level
ai
common
associ
increas
risk
death
cardiac
complic
aim
studi
investig
elev
level
serum
ctni
acut
ischem
stroke
patient
abl
predict
higher
inhospit
mortal
method
retrospect
investig
patient
admit
icu
diagnos
ai
accord
toast
classif
total
patient
hospit
icu
period
brain
ct
mri
use
admiss
sever
neurolog
deficit
score
base
nihss
function
condit
patient
assess
discharg
modifi
rankin
scale
mr
troponin
monitor
day
inclus
criteria
age
ai
less
hour
ctmrt
admiss
troponin
day
exclus
criteria
sah
ich
renal
failur
acut
coronari
syndrom
acut
pe
result
patient
divid
two
groupsdischarg
aliv
die
hospit
averag
age
patient
sd
year
men
age
sd
year
women
sd
year
hospit
mortal
among
patient
patient
discharg
aliv
ctni
investig
day
accord
laboratori
test
result
establish
upper
limit
ctni
mgl
found
higher
level
admiss
day
day
among
patient
high
ctni
hospit
mortal
admiss
day
use
nonparametr
method
compar
median
two
variabl
statist
signific
differ
level
ctni
found
group
die
hospit
first
fifth
day
cut
point
establish
roc
analysi
mgl
third
mgl
area
ci
sensit
method
specif
first
measur
third
fifth
day
conclus
studi
show
increas
level
ctni
patient
ai
die
inhospit
result
gave
us
ground
offer
routin
monitor
ctni
earli
stratif
high
risk
patient
refer
caus
death
kerr
gd
et
al
elev
troponin
stroke
systemat
review
cerb
di
introduct
well
known
neuron
dentat
gyru
dg
hippocampu
resist
short
period
ischemia
hyperthermia
proven
risk
factor
cerebr
ischemia
produc
extens
brain
damag
relat
mortal
rate
aim
studi
examin
effect
hypertherm
condit
h
neuron
death
gliosi
express
sod
antioxid
enzym
gerbil
dg
follow
mintransi
cerebr
ischemia
method
anim
randomli
assign
group
n
sham
group
given
shamoper
normothermia
n
n
ischemia
group
given
mintransi
ischemia
n
h
sham
group
given
shamoper
h
h
ischemia
group
given
mintransi
cerebr
ischemia
h
h
induc
subject
anim
heat
pad
min
oper
result
n
ischemia
group
signific
neuron
death
observ
polymorph
layer
pl
day
ischemiareperfus
h
ischemia
group
neuron
death
also
observ
pl
day
postischemia
degre
neuron
death
sever
n
ischemia
group
addit
examin
gliosi
astrocyt
microglia
use
antigli
fibrillari
acid
protein
gfap
anti
ioniz
calciumbind
adapt
molecul
gfap
glial
cell
much
activ
h
ischemia
group
n
ischemia
group
hand
immunoreact
level
rather
significantli
lower
h
ischemia
group
n
ischemia
group
conclus
brief
basi
find
suggest
cerebr
ischem
insult
hypertherm
condit
bring
sever
neuron
damag
gliosi
polymorph
layer
reduc
express
rather
express
dg
introduct
remot
ischem
post
condit
ripoc
proven
provid
potent
protect
heart
brain
ischemiareperfus
injuri
howev
despit
evid
cerebr
protect
ripoc
compel
ripocmedi
neuroprotect
transient
cerebr
ischem
damag
insult
still
mire
controversi
studi
examin
effect
ripoc
induc
subleth
transient
hind
limb
ischemia
neuron
death
hippocampu
follow
min
transient
cerebr
ischemia
gerbil
method
anim
randomli
assign
sham
ischemia
sham
plu
ripoc
ischemia
ripocgroup
ripoc
induc
three
cycl
min
min
occlusionreperfus
femor
arteri
predetermin
point
time
h
transient
cerebr
ischemia
cv
stain
fj
b
histofluoresc
stain
neun
immunohistochemistri
carri
examin
neuroprotect
ripocmedi
hippocampu
day
ischemiareperfus
result
ischemiagroup
found
signific
loss
pyramid
neuron
stratum
pyramidal
sp
hippocamp
region
day
postischemia
compar
shamgroup
ischemia
ripocgroup
loss
pyramid
neuron
region
day
postischemia
differ
ischemiagroup
conclus
present
find
indic
ripoc
prevent
hippocamp
pyramid
neuron
neuron
death
induc
transient
cerebr
ischemia
introduct
aim
studi
evalu
acut
brain
injuri
abi
correl
brain
death
bd
neurolog
intens
care
unit
nicu
method
dead
patient
abi
nicu
modena
hospit
includ
januari
novemb
data
collect
transplant
regist
donor
action
nation
transplant
servic
result
dead
patient
abi
includ
studi
age
sex
admiss
gc
diagnosi
caus
death
record
mean
age
standard
deviat
sd
progress
increas
period
observ
bd
group
p
male
mean
gc
admiss
among
patient
met
criteria
brain
death
accord
italian
law
admiss
diagnos
cerebr
haemorrhag
patient
anox
coma
brain
trauma
ischem
stroke
brain
cancer
reason
patient
brain
haemorrhag
develop
brain
death
p
fig
anox
brain
injuri
patient
experienc
brain
death
p
fig
conclus
incid
brain
death
higher
patient
admit
nicu
cerebr
haemorrhag
patient
anox
brain
injuri
introduct
imag
brain
septic
shock
patient
show
alter
neurolog
statu
unremark
time
current
studi
provid
find
magnet
reson
imag
brain
septic
shock
method
twenti
patient
septic
shock
brain
dysfunct
symptom
acut
alter
mental
statu
delirium
coma
seizur
focal
neurolog
deficit
median
age
year
apach
ii
sofa
underw
brain
magnet
reson
imag
mri
includ
gradient
echo
fluidattenu
invers
recoveri
flair
diffus
isotrop
imag
map
appar
diffus
coeffici
mri
find
classifi
base
lesion
type
local
blood
withdrawn
simultan
biomark
analysi
neurolog
recoveri
patient
evalu
use
glasgow
outcom
scale
go
discharg
result
none
patient
brain
imag
normal
time
diagnosi
neurolog
alter
includ
mostli
delirium
twelv
patient
show
white
matter
hyperintens
leukoencephalopathi
three
patient
show
ischem
lesion
posterior
revers
encephalopathi
syndrom
find
evid
three
patient
unexpect
find
cerebr
atrophi
relat
age
seen
seven
patient
lesion
correl
diseas
sever
go
unexpect
event
encount
transport
mri
scan
conclus
studi
indic
import
brain
imag
sever
sepsi
septic
shock
mri
import
imag
method
patient
lesion
associ
diseas
sever
poor
outcom
introduct
valproic
acid
vpa
wide
use
antiepilept
drug
known
induc
hepatotox
hyperammonemia
encephalopathi
toxic
side
effect
produc
decreas
carnitin
bloodlevel
valproic
acid
directli
respons
aim
report
demonstr
benefit
lcarnitin
supplement
patient
acut
valproic
acid
intox
patient
chronic
treat
vpa
show
low
level
carnitin
deplet
deposit
therefor
lcarnitin
addit
prove
appropri
method
random
control
trial
conduct
intens
caretoxicolog
unit
clinic
emerg
hospit
bucharest
includ
patient
admit
acut
vpa
poison
vpa
patient
randomli
alloc
group
receiv
standard
therapi
mg
lcarnitin
day
togeth
standard
therapi
day
plasma
level
valproic
acid
ammonemia
determin
everi
six
hour
data
statist
analyz
result
consid
statist
signific
p
result
total
patient
standard
group
lcarnitin
group
accomplish
inclus
criteria
lcarnitin
supplement
result
signific
reduct
ammonemia
vs
moll
determin
hour
level
compar
baselin
p
wherea
paramet
remain
still
high
standard
group
trend
similar
plasma
vpa
level
p
studi
paramet
influenc
gender
correl
age
p
conclus
use
lcarnitin
treatment
vpa
poison
acceler
elimin
vpa
facilit
decreas
ammoniac
plasma
level
therefor
reduc
system
toxic
encephalopathi
risk
control
extent
trial
requir
better
elucid
therapeut
prophylact
role
lcarnitin
manag
vpa
toxic
introduct
eeg
reactiv
report
predictor
outcom
comatos
patient
postanox
encephalopathi
howev
visual
analysi
eeg
reactiv
high
interrat
variabl
time
consum
therefor
analysi
eeg
reactiv
may
benefit
quantit
approach
enabl
automat
interpret
method
prospect
cohort
studi
comatos
icu
patient
continu
eeg
background
pattern
two
dutch
icu
reactiv
auditori
visual
sensori
stimuli
test
follow
strict
protocol
visual
analysi
regard
gold
standard
reactiv
defin
chang
amplitud
frequenc
eeg
stimul
exclud
muscl
activ
stimulu
respons
score
three
independ
expert
jh
mvp
mtc
respons
three
expert
agre
use
data
separ
independ
train
valid
set
spectral
characterist
eeg
stimulu
compar
determin
parametr
nonparametr
method
epoch
second
start
stimulu
analyz
averag
channel
result
train
set
valid
set
stimuli
patient
respect
includ
preval
reactiv
respons
train
set
valid
set
nonparametr
power
spectral
densiti
differ
second
epoch
averag
channel
found
optim
method
automat
analysi
result
sensit
ci
specif
ci
train
set
valid
set
sensit
ci
specif
ci
found
conclus
automat
analysi
eeg
reactiv
base
differ
spectral
characterist
detect
reactiv
research
optim
method
increas
object
eeg
reactiv
test
refer
rossetti
et
al
prognost
cardiac
arrest
hypothermia
prospect
studi
annal
neurolog
rossetti
ao
et
al
prognost
valu
continu
eeg
monitor
therapeut
hypothermia
cardiac
arrest
critic
care
westhal
e
et
al
interrat
variabl
eeg
interpret
comatos
cardiac
arrest
patient
clinic
neurophysiolog
herman
mc
et
al
press
clinic
neurophysiolog
introduct
accur
prognost
model
includ
common
intens
care
sever
score
apach
ii
acut
physiolog
chronic
health
evalu
ii
sap
ii
simplifi
acut
physiolog
score
sofa
sequenti
organ
failur
assess
high
import
qualiti
assur
research
intens
care
aim
studi
investig
use
predict
midterm
mortal
spontan
intracerebr
hemorrhag
ich
whether
score
extra
valu
compar
basic
model
compris
age
level
conscious
method
includ
adult
patient
spontan
ich
treat
finnish
intens
care
unit
icu
nationwid
icu
databas
logist
regress
use
custom
apach
ii
sap
ii
sofa
sixmonth
mortal
predict
creat
refer
model
base
age
glasgow
coma
scale
gc
score
comparison
use
tempor
splitsampl
techniqu
intern
valid
test
model
perform
assess
discrimin
area
curv
auc
calibr
hosmerlemeshow
giviti
calibr
test
result
total
patient
includ
develop
valid
cohort
apach
ii
sap
ii
show
good
discrimin
auc
auc
respect
outperform
refer
model
auc
compar
apach
ii
p
compar
sap
ii
p
sofa
howev
display
significantli
poorer
perform
compar
model
auc
model
show
poor
calibr
p
age
found
particularli
strong
predictor
death
patient
gc
mortal
patient
age
yet
high
patient
age
conclus
apach
ii
sap
iibas
model
show
good
discrimin
poor
calibr
predict
sixmonth
mortal
patient
spontan
ich
treat
icu
perform
simpl
prognost
model
compos
age
gc
compar
complex
score
system
base
result
could
replac
patient
group
refer
knau
wa
et
al
chest
le
gall
jr
et
al
jama
vincent
jl
et
al
intens
care
medicin
introduct
commonest
symptom
nontraumat
subarachnoid
haemorrhag
sah
sudden
onset
sever
headach
emerg
physician
face
signific
diagnost
challeng
condit
headach
repres
ed
attend
sah
account
headach
convent
practic
remain
lumbar
punctur
lp
sampl
analysi
patient
neg
ct
scan
recent
seri
europ
unit
state
demonstr
wide
variat
practic
whether
lp
undertaken
clear
guidanc
lp
omiss
propos
clinic
decis
tool
integr
recent
evid
patient
group
method
search
strategi
includ
medlin
embas
googl
scholar
intern
guidelin
refer
search
well
author
collect
subject
follow
search
string
appli
subarachnoid
haemorrhag
exp
subarachnoid
hemorrhag
exp
sahmp
berri
aneurysmmp
perimesencephal
arterioven
malformationmp
lumbar
puncturemp
cerebrospin
fluid
exp
spinal
tapmp
spinal
lpmp
csfmp
comput
tomographi
exp
ctmp
studi
use
detector
technolog
ctscanner
exclud
result
multipl
risk
factor
identifi
sah
includ
loss
conscious
famili
histori
hypertens
polycyst
kidney
excess
alcohol
intak
smoke
aetiolog
sah
major
patient
aneurysm
circl
willi
ct
sensit
within
elig
studi
rang
largest
studi
prospect
design
includ
patient
report
sensit
ct
perform
within
hour
symptom
onset
recent
work
uk
includ
patient
underw
lp
conclud
lp
low
diagnost
yield
investig
choic
patient
equivoc
lp
find
recurr
symptom
ct
angiographi
conclus
major
patient
present
acut
sever
headach
sah
exclud
neg
ct
scan
seen
hour
onset
imag
report
radiologist
number
patient
delay
present
risk
factor
sah
benefit
ct
angiographi
unless
contraind
find
present
evid
base
clinic
decis
tool
refer
perri
jj
ig
stiell
ml
sivilotti
et
al
sensit
comput
tomographi
perform
within
six
hour
onset
headach
diagnosi
subarachnoid
haemorrhag
prospect
cohort
studi
bmj
p
ref
introduct
aneurism
subarachnoid
haemorrhag
asah
signific
caus
morbid
mortal
throughout
world
primari
goal
treatment
occlus
ruptur
aneurysm
prevent
rebleed
reduc
rate
advers
event
current
guidelin
recommend
surgic
clip
endovascular
coil
perform
earli
feasibl
howev
strategi
may
associ
sever
disadvantag
time
procedur
remain
controversi
aim
studi
evalu
effect
time
invas
treatment
asah
clinic
outcom
method
perform
prospect
observ
cohort
studi
tertiari
univers
hospit
includ
patient
sever
asah
admit
intens
icu
intermedi
postop
care
unit
imcu
tri
earli
endovascular
coil
surgic
clip
period
novemb
octob
analys
demograph
comorbid
apach
ii
score
fisher
hunthess
grade
aneurysm
characterist
type
treatment
time
interv
icu
imcu
admiss
invas
procedur
icu
imcu
hospit
length
stay
outcom
variabl
studi
outcom
mortal
readmiss
reoper
result
total
patient
includ
age
year
old
femal
apach
ii
score
admiss
endovascular
coil
perform
surgic
clip
patient
twentythre
patient
admit
icu
eight
imcu
aneurysm
mainli
anterior
locat
saccular
morpholog
medium
size
mm
fisher
hunthess
grade
occur
frequent
total
patient
coil
clip
die
icu
stay
mean
time
icu
admiss
procedur
perform
shorter
group
survivor
group
day
ci
versu
day
ci
p
correl
time
admiss
procedur
icu
imcu
hospit
length
stay
one
patient
readmit
icu
three
necessari
repeat
new
invas
procedur
conclus
cohort
asah
patient
treat
endovascular
surgic
method
requir
intens
care
found
high
mortal
rate
mainli
relat
earli
procedur
furthermor
specul
find
could
signific
impact
organiz
strategi
cost
save
healthcar
organ
countri
introduct
restrict
red
blood
cell
transfus
rbctx
strategi
advoc
critic
care
popul
whether
standard
practic
appli
aneurysm
subarachnoid
hemorrhag
asah
patient
popul
unclear
aim
describ
transfus
practic
asah
popul
canadian
hospit
includ
hemoglobin
hb
trigger
predictor
rbctx
prepar
transfus
trial
method
multicentr
retrospect
cohort
studi
conduct
four
canadian
academ
tertiari
care
centr
popul
adult
asah
patient
admit
studi
hospit
januari
decemb
patient
identifi
hospit
administr
discharg
record
exist
local
sah
databas
diagnosi
confirm
report
presenc
blood
subarachnoid
space
either
imag
lumbar
punctur
due
ruptur
cerebr
aneurysm
demonstr
angiographi
neuroimag
autopsi
data
collect
train
abstractor
collect
demograph
data
asah
characterist
administr
rbc
transfus
daili
hemoglobin
concentr
major
asah
cointervent
outcom
use
pretest
case
report
form
refer
standard
oper
manual
result
screen
patient
total
asah
includ
studi
mean
age
year
femal
median
present
fisher
grade
iqr
aneurysm
secur
patient
endovascular
coil
surgic
clip
mean
nadir
hemoglobin
gl
occur
median
postadmiss
day
pad
iqr
rbctx
occur
patient
rbctx
rate
vari
across
centr
p
median
unit
rbc
iqr
administ
per
transfus
episod
patient
receiv
median
total
unit
iqr
median
pretransfus
hemoglobin
first
transfus
gl
iqr
vari
substanti
across
centr
gl
p
patient
nadir
hb
gl
receiv
rbctx
compar
hb
nadir
gl
p
univari
predictor
rbctx
increas
age
anterior
circul
aneurysm
lower
present
gc
advanc
fisher
grade
neurosurg
clip
lower
hb
conclus
retrospect
studi
asah
patient
observ
rbctx
uncommon
patient
mostli
reserv
patient
signific
anemia
hb
gl
introduct
littl
publish
anemia
aneurysm
subarachnoid
hemorrhag
asah
aim
describ
diseas
burden
asah
popul
canadian
hospit
preval
incid
moder
anemia
hemoglobin
gl
prepar
transfus
trial
method
multicentr
retrospect
cohort
studi
conduct
four
canadian
academ
tertiari
care
centr
popul
adult
asah
patient
admit
studi
hospit
januari
decemb
patient
identifi
hospit
administr
discharg
record
exist
local
sah
databas
diagnosi
confirm
presenc
blood
subarachnoid
space
either
imag
lumbar
punctur
due
ruptur
cerebr
aneurysm
demonstr
angiographi
neuroimag
autopsi
data
collect
train
abstractor
collect
demograph
data
asah
characterist
daili
hemoglobin
concentr
nadir
hemoglobin
major
asah
cointervent
outcom
use
pretest
case
report
form
refer
standard
oper
manual
result
total
patient
asah
met
studi
elig
criteria
mean
age
year
femal
common
prior
medic
histori
presenc
hypertens
activ
tobacco
smoker
mean
aneurysm
size
mm
occur
anterior
circul
median
present
glasgow
coma
scale
score
fisher
grade
iqr
iqr
respect
aneurysm
secur
patient
endovascular
coil
surgic
clip
moder
anemia
preval
patient
admiss
occur
addit
hospit
nadir
hemoglobin
occur
median
postadmiss
day
pad
iqr
mean
admiss
nadir
hemoglobin
gl
gl
respect
within
first
day
admiss
moder
anemia
occur
patient
median
pad
rbc
transfus
occur
patient
inhospit
mortal
survivor
discharg
hospit
moder
sever
disabl
conclus
moder
anemia
hemoglobin
gl
common
patient
admit
aneurysm
subarachnoid
hemorrhag
less
asah
patient
receiv
rbc
transfus
acut
asah
associ
signific
mortal
morbid
survivor
introduct
nlr
investig
biomark
poor
outcom
variou
condit
prognost
valu
nlr
creactiv
protein
crp
investig
patient
sah
hypothesi
profil
nlr
admiss
hospit
day
could
predict
develop
symptomat
vasospasm
dci
method
retrospect
review
data
consecut
sah
patient
jan
jan
record
demograph
neurolog
examin
radiolog
transcrani
doppler
find
length
stay
lo
icu
mortal
nlr
valu
calcul
admiss
hospit
day
median
compar
group
use
mann
whitney
u
test
multivari
logist
regress
analysi
use
stepwis
backward
method
gener
predict
occurr
symptomat
vasospasm
dci
receiv
oper
characterist
roc
curv
gener
assess
accuraci
nlr
predict
complic
result
cohort
includ
patient
f
median
age
sever
high
patient
respect
fisher
grade
sah
mortal
rate
median
icu
lo
day
asymptomat
vasospasm
notic
patient
symptomat
vasospasm
dci
demonstr
earli
infect
within
first
five
day
notic
median
nlr
icu
admiss
entir
cohort
nlr
decreas
time
median
nlr
day
median
nlr
differ
patient
without
symptomat
vasospasm
vs
p
day
crp
valu
differ
day
patient
earli
infect
show
differ
patient
without
dci
univari
analysi
found
younger
age
fisher
grade
associ
dci
neither
nlr
crp
could
predict
onset
dci
lower
nlr
day
associ
symptomat
vasospasm
univari
analysi
follow
multivari
analysi
younger
age
lower
nlr
day
ci
identifi
risk
factor
symptomat
vasospasm
conclus
nlr
day
vari
presenc
vasospasm
dci
nlr
day
slightli
lower
patient
vasospasm
lower
nlr
day
associ
increas
risk
symptomat
cerebr
vasospasm
introduct
patient
aneurism
subarachnoid
hemorrhag
asah
increas
risk
develop
nosocomi
infect
associ
poor
outcom
aim
studi
describ
infect
incid
featur
asah
patient
evalu
impact
icu
hospit
length
stay
lo
method
retrospect
analyz
data
observ
trial
asah
patient
asah
admit
icu
includ
demograph
clinic
radiolog
microbiolog
data
record
infect
diagnos
accord
current
guidelin
patient
die
within
hour
admiss
exclud
analysi
statist
analysi
perform
use
prism
signific
set
p
valu
result
patient
includ
median
age
year
old
male
aneurysm
locat
anterior
circul
patient
secur
coil
patient
experienc
septic
episod
incid
low
less
sever
world
feder
neurosurgeon
grade
wfn
higher
sever
asah
wfn
p
diagnosi
made
day
admiss
vap
urinari
tract
infect
preval
infect
patient
septic
shock
common
pathogen
haemophilu
influenza
escherichia
coli
pseudomona
aeruginosa
account
infect
multidrug
resist
bacteria
less
icu
hospit
lo
significantli
higher
septic
compar
nonsept
patient
independ
wfn
categori
shown
fig
conclus
icuacquir
infect
common
especi
sever
asah
patient
predominantli
vap
caus
gram
neg
bacteria
infect
caus
longer
icu
hospit
lo
introduct
mechan
ventil
often
necessari
patient
poorgrad
subarachnoid
hemorrhag
sah
supranorm
oxygen
level
frequent
achiev
acut
phase
prehospit
set
intens
care
unit
howev
exact
cerebr
physiolog
effect
normobar
hyperoxia
investig
set
human
cerebr
microdialysi
cmd
uniqu
techniqu
allow
chemistri
extracellular
brain
interstiti
fluid
monitor
continu
patient
bedsid
method
retrospect
analysi
prospect
databas
comatos
patient
sah
monitor
cmd
part
standard
care
relationship
hyperoxia
defin
supranorm
mmhg
least
hour
brain
extracellular
biomark
includ
cmd
lactat
lactatepyruv
ratio
lpr
glutam
examin
acut
phase
first
hour
follow
sah
comparison
group
explor
use
nonparametr
mannwhitney
u
test
signific
set
p
approv
studi
obtain
local
ethic
committe
result
total
match
sampl
consecut
mechan
ventil
poorgrad
sah
patient
median
age
percentil
year
median
wfn
analyz
compar
nonhyperox
sampl
n
hyperoxia
n
associ
higher
cmd
level
lactat
vs
mmoll
lpr
vs
glutam
vs
p
main
cerebr
icp
cpp
system
map
variabl
within
normal
rang
differ
two
condit
conclus
find
comatos
patient
sah
monitor
intracerebr
microdialysi
suggest
hyperoxia
associ
increas
secondari
cerebr
damag
studi
indic
use
supranorm
oxygen
level
mmhg
may
harm
acut
icu
phase
follow
sah
introduct
admiss
intens
care
unit
icu
routin
practic
follow
elect
craniotomi
brain
surgeri
rational
practic
high
risk
surgeri
vital
organ
icu
allow
earli
detect
seriou
complic
howev
sever
studi
shown
mani
patient
requir
minim
icu
intervent
addit
icu
resourc
scarc
costli
intermedi
care
unit
provid
monitor
gener
ward
less
icu
evid
support
benefit
cost
patient
outcom
aim
studi
compar
outcom
patient
underw
elect
craniotomi
admit
intens
intermedi
postop
care
unit
imcu
set
postop
method
conduct
prospect
observ
studi
year
period
novemb
octob
patient
undergon
elect
craniotomi
brain
surgeri
admit
postop
icu
imcu
tertiari
hospit
main
variabl
analyz
includ
demograph
comorbid
asa
apach
ii
score
durat
anesthesia
surgeri
surgic
procedur
diagnosi
icu
imcu
length
stay
studi
outcom
mortal
readmiss
icu
reoper
rate
result
one
hundr
fourteen
patient
includ
studi
mean
age
year
male
sixtyf
patient
asa
ii
class
iii
mean
apach
ii
score
durat
anesthesia
surgeri
min
min
respect
eightytwo
patient
admit
icu
imcu
main
diagnos
supratentori
meningioma
n
glioma
n
infratentori
tumor
n
transsphenoid
resect
pituitari
tumour
n
durat
stay
ci
hour
icu
ci
hour
imcu
group
respect
p
two
patient
admit
icu
die
four
patient
icu
two
imcu
group
readmit
five
patient
icu
two
imcu
patient
reoper
conclus
set
patient
undergo
elect
craniotomi
brain
surgeri
receiv
proper
postop
care
unit
length
stay
shorter
imcu
icu
group
mortal
readmiss
reoper
similar
cost
could
reduc
postop
care
surgeri
provid
intermedi
care
unit
refer
bui
jq
et
al
j
neurosurg
vincent
jl
et
al
crit
care
introduct
everi
realiz
donor
count
save
improv
somebodi
life
aim
studi
analys
patient
receiv
organ
donor
neurocrit
care
method
perform
prospect
followup
studi
patient
transplant
center
transplant
organ
donat
stroke
patient
diagnosi
brain
death
adult
neurocrit
care
unit
subarachnoid
haemorrhag
intracerebr
haemorrhag
ischem
stroke
overal
organ
kidney
liver
retriev
transplant
patient
mean
age
year
result
patient
underw
kidney
transplant
patient
live
year
patient
function
graft
one
patient
primari
afunct
graft
three
patient
reject
occur
month
six
patient
die
kidney
transplant
patient
function
graft
patient
primari
afunct
graft
patient
reject
month
two
patient
liver
transplant
live
year
function
graft
conclus
neurocrit
care
organ
donor
help
patient
live
year
function
patient
kidney
transplant
patient
liver
transplant
introduct
traumat
brain
injuri
tbi
may
affect
pharmacokinet
antiepilept
drug
a
lead
potenti
ineffect
posttraumat
seizur
pt
prophylaxi
levetiracetam
lev
increasingli
util
prophylaxi
pt
recent
studi
suggest
neurocrit
care
patient
may
requir
higher
lev
dose
achiev
therapeut
trough
level
aim
studi
describ
pharmacokinet
lev
earli
less
equal
day
injuri
posttbi
period
evalu
incid
seizur
method
retrospect
chart
review
includ
adult
patient
diagnosi
sever
tbi
least
one
lev
level
drawn
intens
care
unit
icu
admiss
januari
octob
patient
evalu
follow
outcom
lev
trough
level
drawn
steadi
state
lev
dose
regimen
patient
reach
lev
trough
goal
lev
durat
therapi
diagnosi
seizur
hospit
admiss
hospit
icu
length
stay
lo
inhospit
mortal
result
evalu
patient
result
median
lev
trough
iqr
patient
within
trough
goal
goal
goal
subset
patient
two
consecut
lev
level
allow
pharmacokinet
evalu
result
median
maximum
concentr
cmax
minimum
concentr
cmin
volum
distribut
l
halflif
hour
common
mainten
dose
g
twice
daili
patient
follow
g
twice
daili
median
durat
lev
therapi
day
seizur
occur
patient
admiss
major
seizur
occur
first
hour
admiss
median
icu
hospit
lo
day
respect
inhospit
mortal
rate
conclus
major
lev
trough
level
subtherapeut
earli
posttbi
period
despit
aggress
initi
dose
compar
previou
studi
linear
regress
suggest
optim
dose
lev
patient
normal
renal
function
g
everi
hour
research
necessari
determin
impact
augment
renal
clearanc
lev
level
patient
sever
tbi
refer
dewolf
jl
et
al
frontier
neurolog
spencer
dd
et
al
pharmacotherapi
introduct
brainit
databas
contain
physiolog
outcom
data
tbi
patient
aim
identifi
distinct
patient
group
distinguish
trajectori
physiolog
time
use
cluster
analysi
form
data
mine
hypothesis
result
group
would
good
poor
outcom
measur
extend
glasgow
outcom
score
ego
would
indic
physiolog
trajectori
associ
good
poor
prognosi
method
mrec
scotland
approv
use
brainit
data
scientif
purpos
need
inform
consent
waiv
first
clean
databas
left
patient
patient
cluster
base
trajectori
cpp
icp
hr
mean
bp
appli
gener
linear
mix
model
form
cluster
analysi
data
creat
three
algorithm
algorithm
cluster
patient
minutebyminut
physiolog
data
algorithm
use
data
six
outli
patient
remov
algorithm
use
hourbyhour
data
six
outli
patient
remov
algorithm
algorithm
result
cluster
pair
admiss
data
first
gc
outcom
data
measur
ego
result
algorithm
identifi
six
outlier
distinct
extrem
physiolog
trajectori
ego
n
ego
n
ego
n
ego
n
ego
patient
algorithm
separ
cluster
n
ego
algorithm
reveal
three
cluster
n
ego
n
ego
n
ego
similar
physiolog
trajectori
outcom
howev
well
slightli
better
outcom
cluster
ego
older
two
cluster
higher
cpp
mean
bp
conclus
cluster
tbi
patient
base
physiolog
trajectori
possibl
identifi
outlier
distinct
ego
base
minutebyminut
physiolog
model
abl
identifi
group
patient
distinct
outcom
base
hourbyhour
cluster
outlier
remov
refer
brain
group
brain
monitor
inform
technolog
avail
http
wwwbrainiteuabout
access
jain
ak
murti
mn
flynn
pj
data
cluster
review
acm
comput
surv
introduct
chang
pressur
insid
cranium
occur
compart
insid
reach
complianc
limit
chang
point
monitor
second
weak
icp
local
chang
may
gone
wrong
long
icp
reach
alarm
valu
use
electr
bi
realtim
high
sensit
minor
chang
volum
shift
relat
metabol
hs
infus
method
use
four
electrod
bi
cathet
connect
multifrequ
bioimped
measur
devic
smartimpl
ltd
bi
measur
provid
continu
frequenc
hz
khz
data
record
simultan
icp
arteri
pressur
ap
valu
result
ischem
tissu
extravascular
volum
decreas
cytotox
edema
case
microvascular
trauma
damag
vasogen
edema
extracellular
space
expand
fig
administr
hs
monitor
chang
intracellular
extracellular
volum
conclus
bi
fast
rapid
indic
volum
chang
tissu
level
use
method
measur
brain
tissu
statu
icu
indic
hs
administr
result
rebound
effect
refer
dowrick
vivo
bioimped
measur
healthi
ischaem
rat
brain
implic
stroke
imag
use
electr
imped
tomographi
physiol
mea
method
apparatu
determin
condit
biolog
tissu
introduct
aim
evalu
rbc
transfus
frequenc
determin
associ
clinic
outcom
method
conduct
retrospect
multicent
cohort
studi
use
data
nation
trauma
registri
canada
patient
admit
moder
sever
traumat
brain
injuri
one
particip
center
elig
registri
contain
inform
age
gender
trauma
sever
discharg
statu
discharg
disposit
data
discharg
abstract
databas
contain
inform
blood
product
comorbid
intervent
complic
link
ntr
observ
conduct
multivari
robust
poisson
regress
random
effect
center
level
miss
data
handl
multipl
imput
techniqu
result
cours
hospit
stay
patient
ci
receiv
rbc
transfus
among
patient
suffer
traumat
brain
injuri
frequenc
vari
center
femal
gender
age
refer
patient
age
anemia
coagulopathi
sepsi
bleed
hypovolem
shock
presenc
multipl
comorbid
face
thorac
abdomin
spine
lower
extrem
skin
injuri
well
invas
intervent
associ
higher
frequenc
rbc
transfus
trauma
sever
invas
intervent
explain
observ
variat
mortal
complic
discharg
elsewher
home
increas
patient
receiv
rbc
transfus
icu
length
stay
hospit
length
stay
also
longer
patient
receiv
rbc
transfus
stratifi
patient
anem
admiss
show
neither
benefit
disadvantag
outcom
rel
rbc
transfus
similar
result
obtain
stratum
patient
diagnos
sepsi
admiss
conclus
rbc
transfus
common
patient
traumat
brain
injuri
potenti
associ
unfavour
outcom
import
variat
center
observ
highlight
need
stronger
evid
optim
transfus
practic
popul
consid
potenti
impact
rbc
brain
oxygen
popul
rigor
trial
evalu
hb
trigger
transfus
need
introduct
gener
intens
care
unit
icu
noninferior
restrict
transfus
strategi
observ
due
risk
secondari
cerebr
lesion
traumat
brain
injuri
concern
rais
regard
impact
low
hemoglobin
hypoxia
popul
data
remain
scarc
clinic
equipois
persist
method
conduct
cohort
studi
patient
moderatesever
traumat
brain
injuri
admit
icu
level
trauma
center
halifax
data
relat
pretransfus
hemoglobin
level
red
blood
cell
collect
associ
hemoglobin
level
red
blood
cell
transfus
mortal
evalu
use
robust
poisson
model
also
construct
proport
hazard
model
timedepend
variabl
hemoglobin
transfus
evalu
surviv
neurolog
nonneurolog
trauma
complic
well
length
stay
lo
icu
hospit
consid
secondari
outcom
result
includ
patient
male
mean
age
year
third
patient
transfus
icu
stay
n
median
pretransfus
hemoglobin
level
patient
transfus
gl
iqr
gl
iqr
patient
receiv
red
blood
cell
wors
outcom
significantli
frequent
patient
transfus
adjust
model
mortal
rr
ci
neurolog
complic
rr
trauma
complic
rr
icu
lo
geometr
ratio
hospit
lo
geometr
mean
ratio
nonstatist
signific
trend
toward
higher
risk
ratio
unfavor
outcom
follow
transfus
strata
patient
higher
hemoglobin
level
observ
signific
modif
transfus
effect
age
presenc
comorbid
traumat
brain
injuri
sever
observ
conclus
cohort
red
blood
cell
transfus
associ
wors
outcom
patient
traumat
brain
injuri
associ
tend
increas
hemoglobin
level
howev
residu
confound
comorbid
traumat
brain
injuri
sever
possibl
introduct
penetr
gunshot
wound
head
pgwh
associ
high
mortal
morbid
getulio
varga
hospit
public
trauma
center
rio
de
janeiro
high
volum
neurocrit
patient
unusu
number
civil
patient
admit
pgwh
aim
studi
describ
patient
pgwh
admit
intens
care
unit
icu
investig
clinic
characterist
complic
manag
could
relat
better
outcom
set
method
retrospect
assess
hospit
record
everi
patient
pgwh
admit
icu
octob
septemb
exploratori
analysi
clinic
data
imag
result
treatment
complic
outcom
made
primari
end
point
modifi
rankin
scale
hospit
discharg
result
period
studi
patient
admit
icu
pgwh
patient
includ
male
patient
femal
mean
age
year
rang
selfinflict
lesion
pgwh
result
aggress
glasgow
coma
scale
admiss
less
patient
admiss
patient
anisocor
present
shock
associ
bodi
lesion
anoth
gunshot
wound
limb
thorax
mean
sap
rang
mean
apach
ii
rang
ct
scan
find
midlin
shift
patient
singl
lobe
haemorrhag
frontal
pariet
lobe
patient
bleed
one
lobe
six
patient
subarachnoid
intraventricular
hemorrhag
earli
surgic
procedur
made
patient
mainli
decompress
craniectomi
mean
hospit
length
stay
day
rang
day
six
patient
wound
infect
three
infect
site
mortal
rate
entir
group
patient
progress
brain
death
six
patient
discharg
hospit
four
good
outcom
defin
modifi
rankin
score
two
bad
outcom
modifi
rankin
conclus
agreement
previou
report
result
show
surviv
group
mostli
hemodynam
stabl
patient
includ
gc
lower
apach
score
patient
multipl
gunshot
wound
even
nonvit
organ
wors
outcom
introduct
accord
advanc
trauma
life
support
vital
sign
mental
statu
base
excess
serum
lactat
valuabl
paramet
evalu
hemodynam
statu
trauma
patient
studi
examin
role
admiss
blunt
trauma
patient
evalu
valu
admiss
blunt
trauma
patient
respect
intens
care
unit
icu
admiss
rate
length
hospit
stay
method
januari
octob
patient
visit
emerg
room
hospit
due
traumat
injuri
triag
vital
sign
glasgow
coma
scale
gc
sl
check
initi
paramet
also
studi
databas
includ
admiss
length
hospit
stay
mechan
injuri
injuri
sever
score
iss
icu
admiss
admiss
drawn
within
minut
arriv
emerg
room
patient
intracrani
hemorrhag
penetr
injuri
age
year
old
death
arriv
exclud
patient
group
injuri
sever
score
group
ii
iii
iv
result
total
patient
enrol
studi
among
patient
admit
icu
common
caus
icu
admiss
driver
traffic
accid
n
admiss
associ
significantli
icu
admiss
p
area
curv
receiv
oper
characterist
curv
admiss
predict
icu
admiss
also
admiss
odd
ratio
confid
interv
ci
p
iss
ci
p
determin
predictor
icu
admiss
seem
show
weak
correl
iss
r
spearman
admiss
significantli
lower
group
iv
remain
group
conclus
admiss
triag
may
predict
injuri
sever
icu
admiss
blunt
trauma
patient
introduct
previou
studi
found
proadrenomedullin
proadm
inflammatori
blood
marker
provid
addit
prognost
inform
risk
stratif
aim
translat
proadm
cutoff
level
easytous
emerg
depart
ed
triag
algorithm
improv
current
risk
assess
clinic
outcom
predict
medic
patient
method
larg
multin
prospect
observ
studi
switzerland
franc
unit
state
combin
two
proadm
cutoff
valu
fivelevel
ed
risk
assess
tool
manchest
triag
system
mt
riskstratifi
medic
ed
patient
perform
algorithm
test
predict
advers
clinic
outcom
result
use
data
consecut
ed
patient
median
age
year
male
risk
day
mortal
show
stepwis
increas
low
ci
patient
proadm
valu
nmoll
intermedi
ci
proadm
valu
nmoll
nmoll
high
ci
proadm
valu
nmoll
anova
p
combin
initi
ed
triag
mt
proadm
reveal
observ
risk
day
mortal
patient
case
low
prioriti
initi
triag
proadm
valu
nmoll
case
high
prioriti
initi
triag
proadm
valu
nmoll
low
prioriti
patient
overal
day
mortal
ad
proadm
valu
nmoll
rel
risk
reduct
wherea
ad
proadm
valu
nmoll
increas
risk
mortal
four
time
high
prioriti
patient
overal
day
mortal
rel
risk
reduct
ad
proadm
valu
nmoll
doubl
patient
proadm
valu
nmoll
conclus
propos
proadm
base
triag
algorithm
allow
accur
predict
advers
clinic
outcom
medic
ed
patient
high
risk
proof
safeti
efficaci
new
ed
triag
algorithm
intervent
studi
involv
rapid
proadm
pointofcar
measur
mandatori
refer
schuetz
p
et
al
crit
care
p
steiner
et
al
j
emerg
med
press
introduct
simul
train
within
emerg
medicin
grow
variou
peerreview
journal
promot
simul
valuabl
educ
tool
highfidel
mannequin
commonli
use
consider
barrier
remain
particularli
lack
human
interact
suggest
live
patient
pointofcar
simul
teach
seri
could
creat
realist
scenario
develop
nontechn
skill
multidisciplinari
team
addit
studi
shown
curriculum
map
optimis
teach
medic
educ
result
improv
student
satisfact
thu
set
develop
innov
emerg
medicin
pointofcar
simul
programm
use
live
patient
associ
curriculum
map
method
develop
implement
sixmonth
pointofcar
simul
programm
within
royal
cornwal
hospit
emerg
depart
cover
critic
ill
paediatr
major
trauma
present
live
clinic
train
actor
rather
highfidel
mannequin
act
patient
suitabl
weekli
simul
curriculum
map
design
session
detail
specif
curriculum
topic
cover
feedback
collect
emerg
medicin
doctor
use
visual
analogu
scale
questionnair
result
use
curriculum
map
doctor
knowledg
specif
curriculum
learn
increas
increas
percentag
point
state
curriculum
map
usefulveri
use
found
interact
live
patient
posit
learn
experi
state
improv
realism
learn
experi
compar
highfidel
mannequin
felt
live
patient
superior
nontechn
skill
conclus
research
suggest
interact
live
simul
patient
creat
realist
emerg
medicin
simul
provid
opportun
develop
nontechn
skill
within
multidisciplinari
team
appreci
particular
scenario
may
suitabl
approach
comprehens
curriculum
map
context
valu
traine
improv
traine
familiar
curriculum
work
involv
evalu
clinicalpati
outcom
improv
particip
simul
programm
refer
ten
eyck
rp
pediatr
emerg
care
gjerraa
k
tp
acta
anaesthesiol
scand
wong
r
robert
j
bmc
med
educ
introduct
situ
simul
increasingli
recognis
effect
mean
deliv
educ
clinician
within
work
environ
develop
insim
program
novel
situ
simul
program
aim
junior
traine
within
icu
program
focus
develop
clinic
nonclin
skill
traine
improv
multidisciplinari
teamwork
identifi
area
logist
improv
within
unit
method
simul
team
develop
three
simul
scenario
alarm
ventil
massiv
haemorrhag
tracheostomi
emerg
scenario
learn
point
address
clinic
non
technic
skill
involv
structur
debrief
follow
scenario
initi
program
object
deliv
total
simul
includ
junior
medic
nurs
staff
within
scenario
result
total
eight
plan
session
deliv
feedback
scenario
indic
particip
strongli
agre
agre
scenario
use
improv
understand
clinic
subject
strongli
agre
agre
also
strongli
agre
agre
discuss
nonclin
aspect
scenario
use
ask
identifi
one
thing
learnt
scenario
multipl
respond
identifi
nontechn
aspect
import
commun
within
team
situat
awar
close
loop
feedback
number
import
logist
issu
identifi
simul
program
includ
lack
knowledg
content
difficult
airway
trolley
lack
familiar
correct
procedur
activ
hospit
massiv
haemorrhag
protocol
conclus
abl
develop
deliv
situ
simul
program
junior
traine
within
icu
program
well
receiv
increas
junior
traine
understand
confid
deal
number
emerg
scenario
also
help
develop
increas
awar
key
nontechn
skill
situat
final
identifi
number
logist
issu
within
intens
care
unit
address
qualiti
improv
project
refer
walker
st
sevdali
n
mckay
et
al
unannounc
situ
simul
integr
train
clinic
practic
bmj
qual
saf
june
rosen
hunt
ea
pronovost
pj
et
al
situ
simul
continu
educ
health
care
profess
systemat
review
j
contin
educ
health
prof
fall
introduct
cardiac
troponin
test
key
role
diagnosi
prognosi
risk
stratif
acut
coronari
syndrom
ac
util
inappropri
request
creat
heavi
workload
laboratori
staff
increas
cost
health
care
system
unnecessarili
increas
length
stay
cost
patient
aim
studi
make
standard
request
troponin
accur
scientif
without
caus
burden
patient
doctor
laboratori
section
method
total
number
request
serum
troponint
test
emerg
depart
ed
hamad
gener
hospit
review
retrospect
period
start
end
decemb
data
analysi
done
includ
sex
race
age
proper
histori
take
physic
examin
addit
electrocardiograph
ecg
record
necessari
aid
help
make
decis
troponin
request
result
compar
studi
intern
result
result
involv
case
patient
elev
serum
troponint
level
repres
prove
acut
coronari
syndrom
repres
whole
studi
case
cardiac
caus
chest
pain
although
patient
describ
chest
pain
emerg
physician
repres
immedi
challeng
still
conclud
util
troponin
test
increas
workload
cost
conclus
major
chest
pain
complaint
due
ac
noncardiac
chest
pain
second
common
reason
present
ed
account
approxim
percent
visit
worldwid
unnecessari
inappropri
request
serum
troponin
reduc
reduct
request
eas
workload
cut
test
labor
cost
reduc
unnecessari
test
lead
shorten
stay
time
also
benefici
patient
refer
ammann
p
maggiorini
et
al
troponin
risk
factor
mortal
critic
ill
patient
without
acut
coronari
syndrom
j
coll
cardio
ammann
p
fehr
et
al
elev
troponin
sepsi
septic
shock
intens
care
med
pope
jh
selker
hp
acut
coronari
syndrom
emerg
depart
diagnost
characterist
test
challeng
cardiol
clin
introduct
examin
time
emerg
depart
ed
could
influenc
patient
ls
prognosi
door
balloon
time
one
famou
qualiti
indic
relat
patient
ls
outcom
howev
lot
time
qualiti
indic
ed
except
door
needl
time
door
antibiot
time
door
examin
intervent
time
could
qualiti
indic
ed
use
evalu
improv
mainten
ed
aim
develop
real
time
monitor
regist
manag
patient
ls
flow
time
make
new
time
qualiti
indic
ed
monitor
lead
hospit
autom
method
develop
monitor
system
track
patient
ls
flow
show
real
time
big
display
ed
way
logist
system
connect
electron
health
record
ehr
show
time
compon
door
intervent
time
name
time
track
monitor
ttm
ed
result
ttm
system
three
big
appeal
first
show
time
data
per
examin
per
intervent
real
time
help
share
patient
ls
flow
within
medic
staff
would
prevent
mistak
second
time
data
compar
world
standard
time
period
base
qualiti
indic
door
balloon
time
real
time
also
alert
time
ran
past
time
limit
moreov
analyz
relationship
diseas
time
data
ttm
capabl
databas
data
analysi
use
qualiti
comparison
among
patient
l
individu
within
hospit
set
among
hospit
conclus
still
hard
manag
patient
ls
flow
varieti
patient
diseas
ed
although
use
mani
automat
data
accumul
ehr
howev
monitor
could
bring
medic
staff
attent
examin
time
import
introduct
syncop
remain
common
emerg
depart
ed
present
almost
syncop
case
like
caus
reflex
respons
excel
prognosi
unfortun
patient
syncop
discharg
clear
diagnosi
known
elev
risk
morbid
mortal
cardiac
caus
set
develop
focusedechocardiographi
base
algorithm
risk
stratifi
patient
group
method
literatur
search
carri
author
use
medlin
googl
scholar
cochran
collect
intern
guidelin
well
refer
search
search
converg
role
comprehens
echocardiographi
evalu
syncop
parallel
util
focus
echocardiographi
detect
structur
cardiac
diseas
result
patient
syncop
echocardiographi
imag
modal
high
sensit
specif
clinic
signific
structur
diseas
current
guidelin
recommend
formal
echocardiograph
evalu
patient
clinic
suspect
structur
cardiac
diseas
clinic
assess
tool
includ
composit
risk
score
repeatedli
demonstr
poor
identifi
structur
heart
diseas
syncop
event
context
associ
signific
increas
mortal
studi
demonstr
emerg
physician
attain
high
level
profici
echocardiographi
allow
diagnost
evalu
complex
systol
diastol
dysfunct
oper
examin
accur
identif
structur
diseas
focusedechocardiographi
safe
integr
clinic
assess
process
presenc
experienc
oper
yield
find
superior
clinic
assess
alon
conclus
clinic
evalu
laboratori
investig
electrocardiographi
continu
core
investig
patient
syncop
cohort
patient
clear
diagnosi
focussedechocardiographi
appropri
train
oper
offer
addit
safetynet
patient
discharg
without
clear
diagnosi
paper
assimil
find
novel
focusedechocardiographi
base
algorithm
ed
evalu
syncop
refer
da
silva
rm
syncop
epidemiolog
etiolog
prognosi
front
physiol
decemb
soteriad
e
evan
jc
larson
mg
et
al
incid
prognosi
syncop
n
engl
j
med
ref
introduct
realtim
ultrasound
us
guid
studi
aim
determin
rate
pneumothorax
progress
g
cannula
insert
selfventil
swine
model
standard
treatment
suspect
tension
pneumothorax
includ
emerg
insert
larg
bore
cathet
pleural
caviti
wide
accept
practic
includ
cathet
left
insitu
openend
cap
base
quot
dictum
air
significantli
entrain
pleural
space
via
wound
diamet
trachea
method
three
swine
consecut
anaesthetis
use
total
intraven
anaesthesia
remain
selfventil
without
endotrach
intub
time
singl
cannula
bd
venflon
insert
sequenti
second
intercost
space
hemithorax
us
guidanc
realtim
us
use
identifi
develop
pneumothorax
lungpoint
shift
use
track
pneumothorax
expans
within
premap
numer
chest
wall
segment
event
respiratori
distress
air
aspir
cannula
result
insert
uncap
cannula
result
signific
pneumothorax
develop
minut
insert
n
result
lungpoint
move
later
cm
minut
case
minut
swine
observ
develop
signific
tachypnoea
respiratori
rate
show
sign
respiratori
distress
upon
aspir
air
normal
physiolog
restor
aspir
lungpoint
observ
shift
medial
apic
time
confirm
lung
reinflat
upon
replac
cap
monitor
min
subsequ
pneumothorax
physiolog
distress
observ
suggest
expand
pneumothorax
result
air
entrain
via
open
end
cathet
conclus
selfventil
swine
model
insert
uncap
openend
cathet
pleural
space
result
rapid
develop
larg
pneumothorax
data
transfer
human
question
must
rais
leav
openend
cathet
pleural
space
spontan
breath
patient
warrant
studi
refer
committe
trauma
atl
manual
edit
american
colleg
surgeon
greav
porter
prehospit
medicin
arnold
publish
introduct
tea
trolley
train
aim
provid
emerg
intraoss
io
access
teach
time
pressur
hospit
practition
recent
guidelin
advoc
use
emerg
io
access
intraven
access
difficult
batteri
power
devic
like
allow
io
access
within
second
despit
introductori
train
use
io
devic
regular
basi
increas
recognit
lifesav
technic
skill
use
emerg
requir
infrequ
need
regular
practis
prevent
psychomotor
skill
fatigu
method
adopt
novel
techniqu
technic
skill
train
use
initi
difficult
airway
train
train
anaesthet
icu
staff
access
theatr
trolley
convert
mobil
train
trolley
train
devic
tea
cake
trolley
oper
two
anaesthetist
visit
theatr
normal
work
hour
one
anaesthetist
take
care
stabl
patient
theatr
second
deliv
minut
train
session
anaesthet
room
list
anaesthetist
nurseoper
depart
practition
odp
train
includ
devic
locat
practic
aspect
use
follow
tea
cake
questionnair
result
tea
trolley
use
train
mixtur
consult
junior
nurs
odp
report
increas
confid
use
system
found
tea
trolley
use
teach
method
mean
linkert
use
follow
train
particip
correctli
abl
identifi
locat
devic
clinic
area
identifi
correct
anatom
site
io
insert
conclus
utilis
tea
trolley
improv
awar
skill
provid
mobil
train
session
requir
minim
manpow
time
commit
particip
ordinarili
littl
time
practic
transfer
train
approach
could
appli
mani
resuscit
skill
utilis
mani
depart
refer
rcuk
resuscit
guidelin
uk
reiter
et
al
qualiti
cardiopulmonari
resuscit
use
supraglott
airway
intraoss
devic
simul
trial
resuscit
campbel
r
et
al
student
attain
profici
clinic
skill
assess
individu
learn
curv
plo
one
farrel
g
et
al
tea
trolley
difficult
airway
train
anaesthesia
introduct
latrodectu
genu
spider
wide
known
black
widow
characteris
neurotox
venom
worldwid
distribut
purpos
studi
describ
patient
present
clinic
manifest
manag
cours
patient
envenom
black
widow
spider
southern
region
saudi
arabia
method
prospect
observ
case
seri
studi
perform
tertiari
hospit
southern
region
saudi
arabia
one
year
period
adult
patient
histori
envenom
black
widow
spider
includ
record
symptom
physic
sign
laboratori
workup
manag
cours
disposit
patient
came
envenom
black
widow
spider
result
total
subject
particip
studi
patient
male
age
rang
year
median
year
eight
case
black
widow
spider
identif
made
via
descript
spider
time
onset
pain
rang
minut
sting
hour
median
hour
eight
patient
three
asymptomat
three
leg
pain
two
patient
abdomin
pain
one
patient
nausea
vomit
patient
ptosi
sweat
neck
rigid
back
pain
upon
examin
symptomat
patient
red
sting
locat
sign
compart
swell
patient
abdomin
pain
rigid
abdomen
guard
mimick
acut
abdomen
blood
test
includ
white
blood
count
kidney
function
test
coagul
profil
creatin
kinas
result
normal
seven
patient
one
patient
develop
acut
kidney
injuri
although
kidney
function
return
normal
upon
discharg
treatment
symptomat
patient
receiv
analgesia
depend
physician
discret
three
patient
receiv
calcium
glucon
intraven
report
improv
symptom
addit
patient
receiv
tetanu
toxoid
vaccin
four
patient
requir
admiss
discharg
mean
hospit
stay
day
conclus
envenom
black
widow
complex
syndrom
manifest
variou
way
result
variou
outcom
syndrom
gener
selflimit
antivenom
treatment
rare
necessari
patient
signific
pain
improv
admit
observ
possibl
treatment
antivenom
introduct
patient
overdos
intox
admit
icu
hemodynam
respiratori
monitor
impress
mani
patient
monitor
need
intervent
object
studi
estim
incid
mechan
ventil
within
hour
icu
admiss
intox
patient
alreadi
ventil
admiss
icu
method
studi
done
icu
reinier
de
graaf
hospit
delft
hagahospit
hagu
netherland
studi
retrospect
cohort
studi
consecut
patient
admit
either
icu
diagnosi
intox
overdos
mechan
ventil
intub
admiss
need
ethic
approv
waiv
local
ethic
committe
patient
data
collect
regularli
databas
unit
administr
qualiti
improv
purpos
studi
endpoint
mechan
ventil
within
first
hour
icu
admiss
result
studi
period
total
patient
admit
overdos
intox
patient
patient
exclud
sinc
intub
ventil
admiss
characterist
studi
popul
patient
present
tabl
conclus
result
show
small
minor
patient
admit
intox
overdos
ventil
icu
admiss
develop
need
intub
mechan
ventil
next
hour
quarter
patient
admit
gc
subsequ
intub
ventil
first
hr
wherea
patient
admit
gc
need
tracheal
intub
ventil
first
hr
icu
admiss
studi
show
gc
admiss
signific
predictor
need
mechan
ventil
introduct
object
present
survey
identifi
ventilatorassoci
pneumonia
vap
risk
prognost
factor
among
poison
patient
admit
toxicolog
icu
ticu
especi
cn
depress
due
preval
import
vap
main
caus
nosocomi
infect
intens
care
unit
icu
caus
high
mortal
morbid
method
case
control
studi
conduct
loghman
hakim
hospit
march
march
among
poison
patient
mechan
ventil
hour
patient
develop
microbiologicallyconfirm
vap
consid
vap
group
without
vap
defin
control
group
data
collect
age
sex
type
poison
gc
apach
ii
score
length
hospit
stay
previou
antibiot
use
microbi
cultur
trachea
bodi
temperatur
leukocyt
count
patient
outcom
base
type
poison
patient
divid
group
includ
opioid
opium
heroin
methadon
cn
depress
antidepress
benzodiazepin
anticonvuls
pesticid
methanol
mdma
multi
drug
data
express
mean
sd
continu
variabl
frequenc
categor
variabl
logist
regress
use
determin
relationship
risk
factor
vap
result
mean
age
patient
year
probabl
vap
incid
mortal
respect
cn
depress
versu
opioid
odd
ratio
p
apach
ii
odd
ratio
p
hospit
length
stay
odd
ratio
p
independ
risk
factor
vap
apach
ii
score
odd
ratio
p
hospit
length
stay
odd
ratio
p
independ
predictor
vap
mortal
among
patient
common
microorgan
vap
case
methicillinresist
staphylococcu
aureu
mrsa
acinetobact
sp
order
conclus
cn
depress
import
risk
factor
vap
among
poison
patient
hypoventil
due
cn
depress
lead
vap
apach
ii
hospit
length
stay
shown
independ
predictor
vap
mortal
among
patient
seem
patient
short
turn
hospit
would
result
patient
outcom
introduct
solubl
barium
salt
poison
rare
potenti
fatal
caus
sever
hypokalem
paralysi
agreement
adequ
manag
particularli
use
renal
support
present
case
barium
intox
success
treat
hemodiafiltr
result
rapid
clinic
improv
undetect
barium
level
method
case
report
result
male
histori
depress
admit
hospit
emerg
depart
two
hour
voluntari
ingest
nonquantifi
amount
barium
chlorid
patient
procur
purchas
onlin
mean
suicid
attempt
clinic
pictur
consist
vomit
diarrhea
progress
gener
muscl
weak
requir
tracheal
intub
mechan
ventil
subsequ
icu
admiss
sever
hypokalemia
document
minimum
k
mmoll
complic
frequent
ventricular
prematur
beat
prolong
qt
interv
correct
valu
ms
magnesium
sulfat
k
infus
administ
serum
k
remain
low
serum
k
mmoll
barium
level
mmoll
toxic
rang
continu
venoven
hemodiafiltr
cvvhdf
start
result
rapid
decreas
barium
level
normal
serum
k
clinic
improv
ensu
correct
hypokalemia
restor
muscular
function
allow
spontan
ventil
extub
hour
later
barium
persist
undetect
hour
begin
cvvhdf
mmoll
patient
later
transfer
psychiatri
depart
unev
hospit
stay
conclus
limit
publish
data
use
renal
replac
techniqu
acut
barium
intox
associ
quicker
barium
halflif
reduct
clinic
improv
transcellular
k
shift
barium
concentr
impact
muscl
weak
implic
possibl
direct
effect
barium
either
skelet
muscl
neuromuscular
transmiss
patient
present
symptom
typic
sever
barium
intox
nonrespons
k
supplement
clinician
icu
remain
awar
potenti
ingest
unusu
chemic
barium
chlorid
appropri
clinic
context
risk
avail
internet
purchas
may
continu
rise
futur
uniqu
case
add
scanti
exist
evid
literatur
strongli
advoc
use
dyalisi
target
barium
remov
correct
hypokalemia
consent
publish
written
inform
consent
obtain
patient
public
abstract
introduct
central
statist
offic
ireland
cso
report
follow
censu
increas
number
peopl
cycl
work
compar
lead
higher
preval
injuri
hospit
attend
road
safeti
author
rsa
conclud
recent
research
cycl
associ
collis
hypothesis
true
number
cycl
injuri
major
trauma
result
cycl
collis
underreport
place
signific
demand
emerg
depart
ed
intens
care
unit
icu
ireland
method
retrospect
review
patient
cyclingrel
injuri
present
saint
univers
hospit
svuh
januari
decemb
subject
identifi
interrog
maxim
patient
inform
system
use
ed
triag
record
search
keyword
bike
cycl
cyclist
pushbik
bicycl
svuh
particip
trauma
audit
research
network
tarn
data
extract
databas
eg
injuri
sever
score
iss
patient
fulfil
criteria
tarn
result
total
number
cycl
associ
injuri
attend
ed
account
attend
occur
male
mean
age
patient
cyclist
present
follow
road
traffic
collis
involv
least
one
vehicl
wide
spectrum
injuri
upper
limb
injuri
sustain
n
head
injuri
n
facial
injuri
n
patient
includ
tarn
iss
vari
iss
defin
major
trauma
cohort
patient
fulfil
criteria
includ
mortal
injuri
includ
pneumothorac
haemothorac
spinal
fractur
intracrani
haemorrhag
skull
fractur
patient
requir
intens
care
review
patient
admit
icu
conclus
cycl
injuri
result
signific
iss
patient
cohort
sustain
major
trauma
signific
demand
place
ed
injuri
regard
trauma
resuscit
procedur
use
specialis
radiolog
intens
care
involv
cycl
injuri
underreport
ireland
studi
may
help
guid
injuri
prevent
strategi
futur
refer
censu
central
statist
offic
decemb
introduct
burn
combat
usual
repres
injuri
purpos
studi
describ
epidemiolog
characterist
manag
burn
french
militari
oper
method
retrospect
observ
studi
perform
french
casualti
burn
transport
perci
burn
center
medic
treatment
facil
januari
decemb
result
patient
includ
burn
analyz
nonbattl
injuri
mainli
due
mishap
occur
burn
wast
use
fuel
combat
burn
n
explos
relat
improvis
explos
devic
median
total
bodi
surfac
area
burn
major
anatom
region
affect
upper
limb
headneck
hand
battlerel
burn
result
higher
median
injur
sever
score
patient
mechan
ventil
blood
transfus
surgeri
respect
vs
vs
vs
vs
p
combin
burn
injuri
multipl
trauma
occur
n
case
fatal
rate
n
conclus
major
burn
nonbattl
injuri
small
size
access
prevent
battlerel
burn
injuri
anatom
topographi
explain
person
protect
equip
higher
sever
score
due
associ
trauma
mechan
initi
manag
burn
multipl
trauma
remain
attent
prioriti
circul
airway
breath
treatment
either
burn
associ
injuri
may
compromis
combin
presenc
team
approach
essenti
optim
manag
patient
major
burn
requir
hospit
includ
studi
visibl
tip
iceberg
militari
care
provid
familiar
assess
treatment
burn
militari
set
refer
cancio
lc
et
al
j
burn
care
rehabil
kauvar
ds
et
al
j
burn
care
re
dougherti
w
et
al
surg
clin
north
introduct
burn
injuri
amongst
sever
physic
psycholog
insult
patient
experi
morbid
extens
variabl
mortal
studi
repeatedli
confirm
factor
associ
high
mortal
includ
increas
age
extent
burn
presenc
absenc
inhal
injuri
predict
mortal
burn
use
identifi
may
benefit
treatment
initi
treatment
futil
best
interest
patient
object
surveil
studi
evalu
compar
predict
valu
baux
modifi
baux
mbaux
intens
care
nation
audit
research
centr
icnarc
score
overal
outcom
cohort
burn
patient
admit
icu
last
year
method
singl
centr
retrospect
surveil
studi
carri
patient
total
bodi
surfac
area
burn
tbsa
admit
icu
februari
februari
baux
mbaux
icnarc
score
system
compar
data
analysi
perform
use
logist
regress
model
fit
model
assess
use
hosmerlemeshow
coxsnel
nagelkerk
statist
result
patient
admit
icu
burn
injuri
tbsa
none
exclud
studi
patient
die
result
mortal
rate
three
measur
baux
score
highest
valu
found
odd
ratio
surviv
chang
ci
increas
baux
score
one
unit
conclus
data
suggest
baux
score
use
predict
overal
mortal
patient
burn
versu
mbaux
icnarc
score
system
test
utilis
good
discrimin
calibr
mortal
predict
refer
de
roch
r
et
al
epidemiolog
data
cost
burn
injuri
worker
switzerland
argument
immedi
treatment
burn
centr
burn
clark
cj
et
al
mortal
probabl
victim
fire
trauma
revis
equat
includ
inhal
injuri
br
med
j
baux
contribut
l
etud
du
traitement
local
de
brulur
thermigu
etendu
pari
osler
et
al
simplifi
estim
probabl
death
burn
injuri
extend
updat
baux
score
j
trauma
introduct
treatment
intens
care
unit
icu
often
necessit
uncomfort
pain
procedur
patient
throughout
admiss
grow
evid
suggest
chronic
pain
becom
increasingli
recognis
long
term
problem
patient
follow
icu
admiss
intens
care
syndrom
promot
independ
return
employ
in
pire
five
week
rehabilit
programm
patient
caregiv
icu
discharg
glasgow
royal
infirmari
studi
investig
incid
locat
chronic
pain
patient
discharg
icu
classifi
analges
prescrib
accord
world
health
organ
analges
method
in
pire
programm
involv
individu
session
patient
caregiv
physiotherapist
pharmacist
along
intervent
medic
nurs
psycholog
commun
servic
physiotherapist
document
incid
pain
locat
assess
pharmacist
record
analges
medic
prescrib
prior
admiss
clinic
visit
patient
analges
medic
classifi
accord
pain
ladder
zero
three
zero
pain
medic
three
treatment
strong
opioid
data
collect
part
evalu
qualiti
improv
initi
therefor
ethic
approv
waiv
result
data
collect
patient
attend
rehabilit
clinic
median
age
iqr
median
icu
lo
iqr
median
apach
ii
iqr
patient
men
prior
admiss
icu
patient
take
analges
increas
time
clinic
visit
number
patient
step
two
pain
ladder
also
increas
conclus
patient
seen
in
pire
clinic
twothird
state
new
pain
sinc
icu
admiss
despit
increas
number
strength
analges
prescrib
almost
quarter
patient
still
complain
pain
clinic
visit
result
confirm
pain
continu
signific
problem
patient
group
rais
awar
primari
care
incid
chronic
pain
improv
manag
essenti
recoveri
process
follow
icu
admiss
refer
griffith
j
et
al
critic
care
world
health
organ
cancer
pain
relief
guid
opioid
avail
edit
geneva
introduct
despit
develop
avail
effect
analges
procedur
pain
still
underestim
poorli
manag
especi
critic
area
nurs
knowledg
pain
play
signific
role
effect
clinic
decis
make
pain
manag
object
studi
describ
level
knowledg
practic
nurs
pain
manag
well
highlight
possibl
barrier
nurs
face
assess
manag
acut
pain
critic
area
icu
er
method
studi
crosssect
studi
semistructur
questionnair
distribut
nurs
critic
care
area
tertiari
care
hospit
nurs
direct
contact
patient
care
clinic
set
must
provid
pain
assess
manag
patient
measur
investig
like
demograph
data
work
rank
level
educ
year
experi
well
actual
level
knowledg
practic
perceiv
barrier
pain
assess
manag
clinic
work
result
total
nurs
particip
studi
respons
rate
male
femal
nurs
particip
report
document
pain
routin
base
document
assess
document
rare
nurs
particip
alway
agre
patient
statement
pain
nurs
particip
indic
adequ
knowledg
none
nurs
particip
read
guidelin
pain
manag
reason
major
nurs
identifi
work
load
barrier
adequ
pain
manag
identifi
use
sedat
languag
issu
conclus
although
critic
care
nurs
particip
studi
good
exposur
differ
critic
specialti
still
inadequ
pain
manag
signific
level
knowledg
perceiv
barrier
play
major
role
adequaci
pain
manag
practic
hospit
need
improv
refer
batiha
pain
manag
barrier
critic
care
unit
qualit
studi
kizza
b
nurs
knowledg
practic
relat
pain
assess
critic
ill
patient
mulago
hospit
uganda
introduct
criticalcar
pain
observ
tool
cpot
behavior
pain
scale
bp
behavior
pain
assess
unconsci
intens
care
unit
icu
patient
aim
determin
valid
reliabl
cpot
turkish
mechan
ventil
adult
icu
patient
method
prospect
observ
cohort
studi
includ
mechan
ventil
mix
icu
patient
unabl
report
pain
studi
conduct
tertiari
icu
univers
hospit
turkey
obtain
permiss
author
origin
studi
cpot
translat
turkish
languag
valid
perform
accord
report
obtain
senior
intensivist
pain
assess
nonpain
pain
routin
care
procedur
touch
wet
towel
suction
respect
use
cpot
bp
perform
resid
intensivist
concomitantli
test
reliabl
interrat
reliabl
valid
cpot
bp
evalu
result
thirti
three
patient
male
mean
age
mean
apach
ii
score
glasgow
coma
score
equal
less
patient
total
assess
perform
resid
intensivist
record
patient
use
cpot
bp
score
cpot
bp
pain
procedur
significantli
higher
nonpain
procedur
agreement
cpot
bp
pain
nonpain
stimuli
rang
sensit
specif
kappa
valu
agreement
resid
intensivist
pain
nonpain
stimuli
rang
kappa
valu
conclus
turkish
version
cpot
show
good
correl
bp
interrat
reliabl
resid
intensivist
good
studi
show
turkish
version
bp
cpot
reliabl
valid
tool
assess
pain
intub
unconsci
mechan
ventil
critic
ill
patient
use
daili
clinic
practic
refer
gelina
c
et
al
j
crit
care
introduct
assess
manag
pain
sedat
level
patient
mechan
ventil
intens
care
unit
often
challeng
essenti
order
provid
holist
patientcentr
critic
care
aim
audit
evalu
assess
pain
sedat
intens
care
unit
milton
keyn
univers
hospit
nh
foundat
trust
examin
current
clinic
practic
highlight
area
improv
method
guidelin
utilis
formul
audit
criteria
standard
proforma
develop
use
adult
patient
case
mechan
ventil
intens
care
unit
month
period
august
octob
data
code
enter
spreadsheet
analysi
initi
recommend
chang
made
result
patient
case
pain
assess
document
within
hour
admiss
score
utilis
va
initi
pain
assess
score
nurs
staff
selfreport
occur
remain
pain
score
subsequ
evalu
follow
hour
period
mean
number
score
document
n
sedat
score
evalu
utilis
rass
hour
period
mean
number
score
document
n
rang
note
patient
formal
sedat
hold
reason
document
addit
patient
goal
rass
document
daili
ward
round
met
target
rass
conclus
audit
rais
awar
need
improv
assess
pain
sedat
intens
care
unit
result
new
clinic
guidelin
develop
educ
intervent
design
integr
daili
clinic
practic
second
audit
cycl
take
place
refer
gelina
c
chanqu
g
puntillo
k
pursuit
pain
recent
advanc
futur
direct
pain
assess
icu
intens
care
medicin
jackson
dl
proudfoot
cw
cann
kf
walsh
systemat
review
impact
sedat
practic
icu
resourc
use
cost
patient
safeti
critic
care
introduct
underli
diseas
caus
agit
vari
differ
patient
select
sed
agent
made
individu
current
lack
guidelin
sed
use
medic
intens
care
unit
icu
ramathibodi
hospit
prescript
sed
agent
perform
critic
care
pharmacist
patient
care
round
base
appropri
guidelin
patient
data
would
shorten
icu
length
stay
lo
studi
set
investig
impact
pharmacist
intervent
icu
lo
hospit
lo
ventil
day
mortal
medic
intens
care
patient
ramathibodi
hospit
method
beforeaft
studi
medic
icu
total
bed
univers
hospit
conduct
mechan
ventil
patient
receiv
sed
agent
baselin
characterist
activ
problem
apach
ii
use
criteria
match
patient
two
group
retrospect
group
pharmacist
intervent
prospect
group
pharmacist
intervent
medic
chart
review
perform
data
collect
period
retrospect
group
prospect
group
pharmacist
made
intervent
team
select
sed
agent
individu
patient
base
underli
diseas
activ
problem
renal
hepat
function
caus
patient
agit
result
mechan
ventil
patient
prescrib
sed
agent
patient
prospect
retrospect
group
respect
median
durat
icu
lo
reduc
day
retrospect
group
day
prospect
group
p
median
hospit
stay
ventil
day
significantli
differ
two
group
median
hospit
stay
reduc
day
retrospect
group
day
prospect
group
p
ventil
day
day
day
retrospect
prospect
group
respect
p
mortal
remain
unchang
prospect
group
compar
retrospect
group
p
conclus
pharmacist
particip
critic
care
team
result
signific
reduct
durat
icu
stay
hospit
lo
ventil
day
mortal
mechan
ventil
patient
receiv
sedat
refer
barr
j
et
al
clinic
practic
guidelin
manag
pain
agit
delirium
adult
patient
intens
care
unit
crit
care
med
marshal
j
et
al
impact
clinic
pharmacistenforc
intens
care
unit
sedat
protocol
durat
mechan
ventil
hospit
stay
crit
care
med
feb
introduct
agit
syndrom
character
acut
onset
central
nervou
system
dysfunct
identifi
sever
featur
includ
chang
fluctuat
baselin
mental
statu
either
disorgan
think
alter
level
conscious
agit
occur
frequent
critic
ill
patient
intens
care
unit
icu
method
retrospect
studi
waiver
consent
conduct
one
trauma
intens
care
unit
icu
one
year
icu
patient
enrol
studi
classifi
base
agit
statu
depth
sedat
along
ramsey
sedat
scale
rs
glasgow
coma
scale
gc
type
injuri
observ
vital
sign
clinic
evalu
result
one
hundr
two
patient
n
enrol
period
studi
among
patient
forti
six
patient
n
agit
compar
two
group
patient
agit
patient
higher
incid
infect
p
compar
nonagit
patient
addit
signific
differ
type
sedat
use
p
ventil
free
day
p
length
stay
conclus
agit
icu
patient
associ
sever
advers
outcom
includ
prolong
stay
nosocomi
infect
unplan
extub
refer
bay
ej
algas
dl
fear
anxieti
simultan
concept
analysi
nurs
diagnosi
bergbomengberg
haljama
h
assess
patient
experi
discomfort
respir
therapi
bernik
e
mcnabb
de
dialect
inquiri
structur
qualit
research
method
qualit
report
broyl
lm
colbert
tate
ja
swigart
va
happ
mb
clinician
evalu
manag
mental
health
substanc
abus
chronic
pain
condit
intens
care
unit
introduct
aim
observ
retrospect
studi
test
hypothesi
correl
exist
percentag
ventil
patient
develop
vap
vp
use
main
sed
neuromuscular
blockag
agent
index
medic
surgic
icu
serv
commun
hospit
method
januari
decemb
admit
icu
patient
databas
look
percentag
ventil
patient
develop
vap
well
use
follow
agent
item
per
ventil
day
per
ventil
patient
midazolam
amp
mg
propofol
vial
ml
sisatracurium
amp
per
year
use
linear
correl
method
look
linear
slope
correl
coeffici
r
coeffici
determin
linear
regress
method
use
anova
test
look
p
valu
accord
percentag
ventil
patient
develop
vap
use
midazolam
propofol
sisatracurium
result
tabl
conclus
accord
data
statist
signific
correl
detect
percentag
ventil
patient
develop
vap
use
midazolam
propofol
cisatracurium
hand
patient
increas
demand
sed
agent
data
suggest
percentag
ventil
patient
develop
vap
independ
use
main
sed
neuromuscular
blockag
agent
icu
ventil
patient
introduct
sedat
routin
uk
emerg
depart
ed
maintain
improv
qualiti
care
compar
local
practic
nation
intern
standard
standardis
sensit
tool
need
detect
report
advers
event
ae
world
siva
intern
sedat
taskforc
tool
incorpor
physiolog
threshold
clinic
intervent
overal
outcom
grade
ae
minim
sentinel
incorpor
tool
sedat
document
report
effect
detect
document
ae
method
note
patient
undergo
sedat
ed
retrospect
review
document
ae
well
evid
advers
event
formal
record
implement
new
sedat
proforma
incorpor
siva
tool
data
collect
process
repeat
retrospect
result
see
tabl
conclus
siva
tool
highlight
ae
within
ed
gone
unreport
incorpor
improv
awar
document
ae
educ
need
improv
accuraci
report
utilis
tool
facilit
sensit
standardis
data
collect
allow
regular
review
improv
practic
well
comparison
nation
intern
standard
refer
mason
kp
et
al
bja
introduct
sedat
invas
mechan
ventil
mv
intens
care
unit
icu
patient
common
howev
recent
studi
found
increas
sedat
deliveri
advers
affect
mv
patient
outcom
retrospect
audit
length
mv
lomv
sedat
deliveri
christchurch
hospit
icu
calendar
year
carri
method
data
sed
drug
dexmedetomidin
fentanyl
propofol
usag
lomv
collect
hospit
record
total
sed
drug
use
lomv
assess
monthli
compar
year
use
wilcoxon
ranksum
kruskalw
test
zerolag
cross
correl
use
assess
relationship
monthtomonth
trend
lomv
sedat
use
montecarlo
simul
perform
assess
impact
potenti
outlier
month
result
month
remov
without
replac
analysi
repeat
time
standardis
mortal
rate
smr
calcul
year
account
chang
cohort
result
median
interquartil
rang
iqr
lomv
hour
iqr
iqr
iqr
median
lomv
per
patient
significantli
higher
p
hour
vs
hour
median
iqr
total
sed
drug
usag
iqr
mghour
lomv
iqr
iqr
usag
significantli
higher
p
zerolag
crosscorrel
lomv
sedat
usag
per
month
year
indic
rise
trend
well
mirror
addit
shown
fig
mont
carlo
simul
show
trend
increas
sedat
usag
associ
increas
lomv
robust
simul
indic
increas
trend
studi
period
smr
mv
patient
suggest
increas
lomv
due
significantli
ill
mv
cohort
conclus
sed
drug
use
per
ventil
hour
strongli
associ
lomv
increas
metric
last
year
signific
strongli
associ
introduct
sedat
icu
use
sevofluran
via
anaconda
enabl
desir
sedat
level
numer
advantag
propofolmidazolam
base
sedat
patient
sever
ard
inhal
nitric
oxid
improv
oxygen
reduc
right
heart
afterload
therapi
simultan
use
icu
ard
patient
patient
right
heart
failur
ventil
variou
reason
sinc
sevofluran
interact
certain
ga
monitor
eg
quark
rmr
indirect
calorimetri
examin
potenti
ga
read
interact
method
circuit
carefus
anaconda
connect
ventil
tube
ga
concentr
measur
differ
circuit
outlet
ventil
npb
set
vac
ml
bpm
two
sevofluran
concentr
mlh
mlh
three
air
oxygen
test
constant
flow
ppm
result
constant
vac
ventil
constant
flow
inspiratori
concentr
read
show
minim
ns
variat
differ
sevofluran
concentr
administ
similarli
administ
constant
differ
sevofluran
concentr
affect
sevofluran
concentr
read
conclus
coadministr
sevofluran
via
anaconda
affect
ga
analysi
safe
use
sedat
ard
salvag
therapi
refer
mehra
garg
dalvi
pb
taneja
nindra
p
ray
inhal
salvag
therapi
ard
ferrando
c
moreno
j
soro
belda
j
efficaci
safeti
sedat
sevofuran
administ
devic
anaconda
ard
acut
respiratori
distress
syndrom
berlin
definit
jama
introduct
dexmedetomidin
dex
may
spare
sed
use
reduc
delirium
incid
facilit
earlier
extub
therebi
prevent
need
tracheostomi
well
reduc
hospit
expens
howev
pauciti
data
patient
cancer
sought
evalu
clinic
costeffect
drug
set
method
retrospect
review
electron
record
februari
march
conduct
sed
use
ventil
wean
extub
rate
tracheostomi
requir
assess
addit
costanalysi
per
patient
determin
result
twentynin
patient
male
receiv
dex
studi
period
age
rang
year
median
length
stay
day
interquartil
rang
iqr
result
prolong
mechan
ventil
median
day
iqr
nineteen
patient
surviv
icu
discharg
eighteen
patient
requir
tracheostomi
median
durat
day
iqr
dex
use
facilit
sedat
reduct
patient
difficult
wean
manag
agit
delirium
expedit
extubationdecannul
utilis
median
hour
iqr
median
dose
microgramskghr
iqr
deem
improv
defin
outcom
patient
bradycardia
andor
hypotens
observ
patient
within
dex
treatment
almost
half
requir
support
mean
cost
dex
treatment
per
patient
approxim
per
patient
clinic
benefit
cost
offset
reduct
sedat
patient
patient
difficult
manag
agit
agent
well
ventil
wean
earlier
extub
avoid
tracheostomi
patient
conclus
cohort
patient
belong
group
high
mortal
high
length
stay
result
prolong
ventil
associ
difficult
manag
sedat
andor
delirium
studi
evalu
optim
durat
treatment
facilit
deescal
patient
obtain
benefit
refer
curti
j
et
al
propofolbas
versu
dexmedetomidinebas
sedat
cardiac
surgeri
patient
j
cardiothorac
vasc
anesth
thoma
bn
et
al
clinic
econom
impact
substitut
dexmedetomidin
propofol
due
us
drug
shortag
examin
coronari
arteri
bypass
graft
patient
urban
medic
centr
pharmacoeconom
introduct
alcohol
withdraw
patient
increas
risk
ptsd
especi
treat
intens
care
unit
icu
high
bzd
dose
hypothes
dexmedetomidin
addit
bzd
aw
patient
sedat
icu
decreas
ptsd
incid
method
prospect
cohort
studi
conduct
mix
icu
juli
juli
aw
patient
assign
group
group
dexmedetomidin
group
c
control
group
dexmedetomidin
infus
dose
gkgh
prescrib
sedat
aw
symptom
control
bzd
diazepam
mg
antipsychot
haloperidol
mg
prescrib
group
similar
symptomtrigg
local
protocol
posttraumat
stress
disord
diagnos
accord
diagnost
statist
manual
mental
disord
edit
criteria
psychiatrist
use
clinic
interview
within
month
hospit
discharg
result
patient
includ
studi
patient
gr
pateint
grc
posttraumat
stress
disord
diagnosi
month
hospit
discharg
p
followup
patient
grd
grc
diagnos
ptsd
p
month
respect
conclus
dexmedetomidin
addit
basic
aw
therapi
benzodiazepin
antipsychot
may
decreas
risk
ptsd
alcohol
withdraw
patient
icu
refer
parker
sricharoenchai
raparla
schneck
kw
bienvenu
oj
needham
dm
posttraumat
stress
disord
critic
ill
survivor
metaanalysi
crit
care
med
may
introduct
dexmedetomidin
select
agonist
due
uniqu
action
central
nervou
system
wide
use
sed
agent
intens
care
unit
oper
theatr
aim
studi
investig
dexmedetomidin
use
effect
safe
sed
agent
porcin
model
septic
shock
method
pig
gener
anesthesia
mechan
ventil
includ
studi
randomli
assign
one
group
ga
gb
gc
gdeach
group
consist
anim
pig
receiv
continu
infus
propofol
rocuronium
ga
intervent
perform
gb
dexmedetomidin
administ
dose
gc
sepsi
induc
intraven
administr
lp
gd
dexmedetomidin
infus
sepsi
induct
perform
similar
manner
like
gb
gc
respect
studi
paramet
includ
heart
ratehr
mean
systemicmsap
pulmonari
arteri
blood
pressurempap
central
venou
pressurecvp
pulmonari
arteri
occlus
pressurepaop
paramet
record
baselin
everi
min
hr
statist
analysi
repeat
measur
anova
use
result
hr
msap
mpap
valu
depict
follow
tabl
cvp
paop
show
signific
alter
conclus
accord
studi
result
dexmedetomidin
posit
effect
hr
sepsi
induc
pulmonari
hypertens
decreas
msap
similar
studi
anim
septic
nonsept
one
introduct
evid
experiment
studi
suggest
ketamin
may
benefici
analgosed
acut
respiratori
failur
due
bronchospasmolyt
immunomodulatori
effect
howev
limit
data
exist
whether
analgosed
ketamin
safe
use
whether
decreas
requir
respiratori
support
method
period
retrospect
identifi
patient
receiv
ketamin
hypox
respiratori
failur
admiss
critic
care
ketamin
dose
mean
arteri
pressur
heart
rate
blood
biochemistri
ventil
set
sedat
score
record
first
day
ketamin
treatment
complic
delirium
arrhythmia
malabsorpt
feed
document
chest
xray
find
document
day
ketamin
commenc
result
patient
male
femal
includ
mean
age
year
mean
apach
ii
score
die
intens
care
underli
diagnosi
respiratori
failur
includ
copd
sever
asthma
patient
mean
length
stay
critic
care
day
patient
intub
admiss
patient
receiv
control
ventil
day
patient
still
ventil
patient
control
ventil
wean
asb
cpap
simv
ketamin
given
day
day
ketamin
treatment
peak
inspiratori
pressuremax
mmhg
peepmax
mmhg
patient
receiv
intraven
aminophyllin
salbutamol
total
dose
day
mg
decreas
kpa
kpa
lactatemax
decreas
mmoll
mmoll
wherea
phmin
increas
abdomin
distens
observ
patient
fail
absorb
enter
feed
delirium
requir
treatment
haloperidol
seen
patient
patient
xray
chang
consist
infect
patient
posit
microbiolog
result
within
first
day
ketamin
administr
patient
develop
new
onset
af
patient
episod
tachycardia
conclus
ketamin
safe
analgosed
sever
hypox
respiratori
failur
caus
copd
asthma
chest
infect
common
trigger
common
complic
critic
care
constip
delay
gastric
transport
abdomin
distens
delirium
atrial
fibril
frequent
observ
report
critic
ill
patient
introduct
mani
health
profession
believ
lunar
cycl
influenc
incid
psychiatr
present
hospit
research
shown
circalunar
cycl
influenc
object
qualiti
sleep
howev
robust
research
larg
involv
effect
full
moon
emerg
psychiatr
present
fail
find
correl
aim
novel
studi
examin
whether
incid
delirium
intens
care
patient
influenc
lunar
cycl
method
studi
conduct
six
month
gener
intens
care
unit
data
collect
day
full
moon
new
moon
month
hour
delirium
assess
use
confus
assess
method
intens
care
camicu
patient
sedat
assess
cam
icu
exclud
result
data
patient
collect
signific
differ
baselin
characterist
intervent
known
increas
risk
delirium
sed
drug
use
two
group
similar
apart
fact
patient
full
moon
group
receiv
benzodiazepin
vs
haloperidol
vs
statist
differ
incid
delirium
new
moon
camicu
posit
full
moon
group
camicu
posit
conclus
studi
found
associ
incid
delirium
full
moon
intens
care
patient
hypothesis
reason
persist
belief
full
moon
associ
increas
psychiatr
morbid
due
confirm
bia
may
explain
patient
receiv
sed
drug
full
moon
compar
new
moon
refer
wilson
je
tobacyk
jj
lunar
phase
crisi
center
telephon
call
j
soc
psychol
vol
c
l
raison
h
klein
steckler
moon
mad
reconsid
journal
affect
disord
vol
csilla
zita
turanyi
katalin
zsuzsanna
ronai
rezso
zoller
associ
lunar
phase
sleep
characterist
sleep
medicin
vol
varind
parmar
ewa
talikowskaszymczak
emili
down
et
al
effect
fullmoon
definit
psychiatr
emerg
depart
present
isrn
emerg
medicin
introduct
cardiac
surgeri
associ
high
incid
neurolog
complic
includ
stroke
delirium
cognit
impair
involv
mechan
includ
embol
reduc
brain
flow
bypass
data
evalu
impact
cardiac
surgeri
cerebr
autoregul
potenti
relat
neurolog
outcom
aim
prospect
observ
singlecentr
studi
evalu
impact
cardiac
surgeri
dynam
cerebr
autoregul
dca
assess
potenti
associ
postop
delirium
method
adult
euroscor
left
ventricular
eject
fraction
undergo
coronari
arteri
bypass
graft
cabg
surgeri
bypass
includ
cerebr
blood
flow
veloc
cbfv
transcrani
doppler
middl
cerebr
arteri
endtid
infrar
capnograph
blood
pressur
bp
finapr
intraarteri
continu
record
supin
minut
rest
preoper
h
day
surgeri
diagnosi
delirium
perform
use
confus
assess
method
icu
camicu
autoregul
index
ari
estim
cbfv
respons
step
chang
bp
deriv
transfer
function
analysi
use
standard
templat
curv
chang
ari
assess
repeat
measur
anova
result
thirtythre
male
patient
mean
age
year
data
accept
qualitycbfv
step
respons
markedli
differ
fig
correspond
valu
ari
fig
significantli
reduc
compar
p
defin
impair
dca
total
patient
impair
ca
patient
diagnos
patient
impair
dca
compar
normal
dca
fisher
p
patient
impair
dca
delirium
compar
normal
dca
fisher
p
conclus
dynam
cerebr
autoregul
impair
cabg
surgeri
possibl
associ
occurr
postop
delirium
work
need
elucid
underli
mechan
dca
establish
adequ
therapi
introduct
studi
investig
risk
factor
prolong
intens
care
unit
icu
length
stay
lo
elect
surgic
patient
cohort
lo
import
outcom
marker
icu
resourc
consumpt
increas
pressur
use
bed
effici
estim
common
lo
common
icu
patient
group
elect
procedur
patient
identifi
risk
factor
prolong
lo
group
bed
book
prospect
way
could
help
improv
flow
effici
patient
intens
care
bed
method
retrospect
cohort
studi
elect
surgic
patient
stay
icu
king
colleg
hospit
period
data
collect
patient
includ
preoper
immedi
within
hour
postop
physiolog
comorbid
charlson
comorbid
index
cci
calcul
patient
use
specif
algorithm
main
outcom
prolong
lo
defin
lo
greater
equal
percentil
multivari
logist
regress
use
identifi
variabl
significantli
associ
prolong
length
stay
result
multivari
logist
regress
patient
prolong
lo
characteris
renal
diseas
ci
p
high
postop
sodium
ci
p
high
preoper
creactiv
protein
ci
p
low
postop
creactiv
protein
ci
p
cindex
ci
p
analys
univari
relationship
factor
lo
addit
identifi
presenc
anaemia
malign
low
albumin
high
cci
significantli
associ
prolong
stay
valid
signific
multivari
stage
age
chronic
pulmonari
diseas
heart
failur
found
significantli
associ
increas
lo
cohort
conclus
prolong
lo
significantli
associ
sever
measur
patient
characterist
work
would
requir
accur
characteris
risk
factor
valid
similar
risk
factor
could
facilit
prospect
bed
book
dedic
post
anaesthet
care
unit
patient
risk
factor
prolong
lo
instead
admit
directli
gener
icu
postop
introduct
introduct
criteria
system
inflammatori
respons
syndrom
sir
frequent
use
identifi
patient
higher
risk
death
howev
util
sir
recent
question
object
studi
evalu
sir
criteria
might
predict
hospit
mortal
brazilian
cohort
critic
ill
patient
method
method
retrospect
cohort
studi
conduct
privat
tertiari
hospit
hospit
sirioliban
paulo
brazil
extract
relev
inform
adult
intens
care
unit
databas
sistema
comparison
perform
sap
score
model
sir
model
dichotom
variabl
criteria
sir
posit
versu
criterion
sir
neg
ordin
variabl
accord
number
sir
criteria
met
predict
hospit
mortal
model
discrimin
compar
use
area
roc
curv
result
result
januari
decemb
studi
patient
classifi
sir
posit
patient
sir
posit
severili
ill
compar
patient
sir
neg
sap
versu
respect
p
higher
hospit
mortal
rate
vs
respect
p
howev
area
roc
curv
sap
higher
ci
sir
criteria
dichotom
variabl
ic
ordin
variabl
ic
p
comparison
sap
sir
criteria
conclus
conclus
util
sir
criteria
recogn
sever
ill
predict
mortal
cohort
could
observ
introduct
studi
aim
evalu
efficaci
predefin
clinic
biochem
criteria
predict
deterior
follow
hospit
admiss
via
emerg
depart
ed
evalu
util
trigger
involv
imobil
critic
care
outreach
servic
within
hospit
method
patient
randomli
select
king
colleg
hospit
emerg
admiss
note
screen
presenc
nation
earli
warn
score
news
respiratori
rate
transfer
ed
ward
sepsi
hypotens
point
new
acut
kidney
injuri
aki
lactat
metabol
acidosi
blood
ga
analysi
need
high
flow
oxygen
transfer
ed
ward
primari
outcom
measur
mortal
intens
care
unit
icu
admiss
length
stay
associ
propos
criteria
patient
outcom
statist
evalu
result
result
calcul
base
outcom
data
suggest
likelihood
icu
admiss
significantli
increas
news
chisquar
p
new
aki
chisquar
p
need
high
flow
oxygen
transfer
chisquar
p
patient
mortal
significantli
increas
news
chisquar
p
respiratori
rate
chisquar
p
need
high
flow
oxygen
transfer
chisquar
p
detect
metabol
acidosi
blood
ga
analysi
chisquar
p
new
aki
chisquar
p
addit
new
aki
significantli
increas
length
stay
day
p
patient
follow
period
month
current
preliminari
result
reassess
outcom
data
ongo
studi
conclus
news
new
aki
elev
respiratori
rate
metabol
acidosi
high
inspir
oxygen
fraction
requir
signific
predictor
inpati
stay
morbid
could
potenti
use
trigger
earli
critic
care
input
studi
base
larger
patient
sampl
underway
introduct
admiss
follow
elect
surgeri
occupi
admiss
critic
care
unit
ccu
ipswich
hospit
retrospect
studi
show
admiss
result
level
intervent
depend
ccu
bed
pressur
patient
book
elect
postop
admiss
assess
recoveri
room
suitabl
return
gener
ward
purpos
studi
compar
outcom
patient
identifi
high
risk
thu
book
postop
ccu
admiss
therebi
identifi
benefit
ccu
admiss
safe
care
ward
method
retrospect
analysi
ccu
bed
request
undertaken
novemb
april
patient
demograph
comorbid
natur
surgeri
postop
progress
record
comparison
made
admit
ccu
return
gener
ward
result
ccu
bed
request
made
case
admit
ccu
case
return
ward
follow
anaesthetist
intensivist
assess
signific
differ
age
two
group
mean
vs
year
p
signific
differ
comorbid
state
quantifi
use
charlson
comorbid
index
mean
score
vs
p
surgic
special
colorect
patient
like
admit
ccu
overal
length
stay
significantli
longer
admit
ccu
compar
ward
mean
vs
day
p
also
postop
complic
event
patient
vs
event
patient
patient
admit
ccu
requir
subsequ
readmiss
patient
return
ward
admit
ccu
day
postop
thu
ccu
bed
request
result
admiss
level
intervent
conclus
studi
suggest
patient
demograph
comorbid
state
littl
influenc
eventu
postop
care
pathway
patient
cohort
rather
object
assess
recoveri
room
effect
identifi
patient
shorter
length
stay
fewer
postop
complic
recommend
routin
assess
high
risk
patient
recoveri
room
determin
suitabl
admiss
ccu
introduc
proforma
outlin
periop
risk
factor
allow
consist
assess
suitabl
wardbas
care
introduct
obes
one
major
risk
factor
number
chronic
diseas
includ
diabet
cardiovascular
diseas
cancer
obes
chronic
inflammatori
condit
previou
studi
show
obes
patient
sever
infect
found
associ
significantli
lower
mortal
compar
septic
patient
normal
bmi
surgic
critic
ill
patient
whether
obes
confer
protect
effect
clearli
defin
hypothes
surgic
critic
ill
patient
diseas
patholog
differ
septic
medic
patient
may
also
protect
effect
obes
method
conduct
retrospect
cohort
analysi
use
thaisicu
studi
databas
recruit
thai
patient
admit
surgic
intens
care
unit
nine
universitybas
hospit
thailand
patient
whose
bodi
mass
index
bmi
mortal
day
avail
includ
analysi
patient
categor
group
base
bmi
ie
underweight
bmi
normal
bmi
bmi
overweight
bmi
obes
bmi
primari
outcom
mortal
secondari
outcom
incid
system
inflammatori
respons
syndrom
sir
result
patient
patient
classifi
underweight
normal
bmi
overweight
obes
respect
obes
patient
lowest
apach
ii
score
interquartil
rang
iqr
follow
overweight
iqr
normal
bmi
iqr
underweight
iqr
p
among
four
patient
group
obes
patient
lowest
mortal
follow
overweight
normal
bmi
underweight
patient
group
p
obes
patient
also
lowest
incid
sir
follow
overweight
normal
bmi
underweight
patient
p
multivari
analysi
found
everi
one
unit
increas
bmi
associ
lower
risk
hospit
mortal
adjust
odd
ratio
ci
p
adjust
age
gender
apach
ii
sever
score
conclus
demonstr
compar
surgic
critic
ill
patient
lower
bmi
surgic
patient
higher
bmi
significantli
lower
risk
mortal
refer
wacharasint
et
al
crit
care
chittawatanarat
k
et
al
j
med
assoc
thai
introduct
clinic
score
pneumonia
sever
index
psi
recommend
risk
assess
communityacquir
pneumonia
cap
investig
prognost
potenti
nation
earli
warn
score
news
larg
well
defin
cohort
cap
patient
year
followup
method
prospect
follow
cap
patient
previou
swiss
multicentr
trial
primari
outcom
allcaus
mortal
within
year
followup
secondari
outcom
advers
clinic
outcom
defin
intens
care
unit
icu
admiss
complic
empyema
unplan
hospit
readmiss
within
day
use
logist
regress
model
area
receiv
oper
characterist
curv
auc
compar
news
psi
result
sixyear
overal
mortal
n
stepwis
increas
higher
news
categori
mortal
predict
news
show
moder
discrimin
auc
inferior
compar
psi
predict
icu
admiss
news
show
high
discrimin
auc
improv
prognost
accuraci
psi
auc
p
auc
p
news
also
superior
psi
predict
complic
well
predict
rehospitalis
conclus
news
provid
addit
prognost
inform
regard
risk
icu
admiss
complic
therebi
improv
tradit
clinic
risk
score
manag
cap
patient
emerg
depart
set
introduct
concurr
comorbid
increas
risk
sever
infect
greatli
influenc
patient
outcom
studi
evalu
clinic
util
weight
index
comorb
wic
prognost
factor
patient
prolong
acut
mechan
ventil
pamv
ventil
care
hr
method
retrospect
enrol
pamv
patient
admit
mechan
intens
care
unit
icu
pusan
nation
univers
hospit
survivor
defin
patient
surviv
day
icu
admiss
result
median
age
subject
year
rang
male
median
length
stay
icu
hospit
rang
rang
day
respect
icu
hospit
mortal
rate
respect
mortal
rate
icu
admiss
median
wic
rang
signific
differ
wic
nonsurvivor
survivor
p
linear
regress
analysi
reveal
signific
posit
relationship
wic
acut
physiolog
chronic
health
evalu
ii
sequenti
organ
failur
assess
score
admiss
day
p
receiv
oper
characterist
curv
indic
wic
cutoff
valu
area
curv
confid
interv
ci
p
subject
wic
greater
higher
mortal
rate
vs
p
univari
logist
regress
analysi
show
wic
independ
associ
mortal
popul
odd
ratio
ci
p
conclus
studi
wic
use
prognost
indic
mortal
patient
pamv
introduct
mortal
patient
cirrhosi
admit
intens
care
unit
icu
report
high
recent
number
score
system
develop
order
predict
mortal
tertiari
liver
unit
includ
clifsofabas
score
system
royal
free
hospit
rfh
tool
howev
none
valid
patient
admit
gener
icu
aim
studi
valid
new
measur
compar
establish
predict
model
method
data
patient
confirm
cirrhosi
admit
gener
icu
major
univers
hospit
retrospect
collect
medic
record
score
calcul
clifconsortium
organ
failur
score
clifc
shorten
version
clifsofa
clifc
aclf
includ
age
white
cell
count
rfh
model
endstag
liver
diseas
meld
acut
physiolog
chronic
health
evalu
apach
ii
main
outcom
mortal
icu
predict
accuraci
calibr
assess
use
area
receiv
oper
curv
auroc
goodnessoffit
statist
result
patient
identifi
mean
age
year
male
icu
mortal
alcohol
liver
diseas
main
aetiolog
factor
present
patient
patient
admit
icu
gastrointestin
bleed
measur
well
calibr
p
particularli
clifof
p
accuraci
novel
model
gener
superior
establish
score
auroc
valu
clifof
clifaclf
rfh
vs
apacheii
meld
bilirubin
creatinin
platelet
found
independ
predictor
mortal
multivari
logist
model
accuraci
creatinin
alon
higher
predict
model
auroc
p
conclus
rhf
meld
score
best
predict
accuraci
howev
complex
specialis
measur
offer
advantag
predict
mortal
meld
routin
avail
apacheii
score
cirrhot
patient
admit
gener
icu
creatinin
alon
robust
prognost
indic
mortal
simplifi
score
encompass
variabl
may
offer
similar
accuraci
higher
util
refer
e
theocharid
et
al
j
gastroenterol
vol
pp
introduct
admiss
sourc
time
admiss
could
play
role
outcom
pediatr
intens
care
unit
picu
patient
pt
aim
present
studi
investig
admiss
characterist
greek
multidisciplinari
bed
picu
relationship
mortal
discharg
method
retrospect
year
studi
data
collect
demograph
reason
admiss
emerg
admiss
readmiss
comorbid
sourc
admiss
intern
pediatr
intern
surgic
citi
hospit
remot
peripher
hospit
season
admiss
spring
summer
autumn
winter
time
admiss
outofhour
length
stay
lo
outcom
statist
ttest
independ
sampl
chisquar
test
p
result
pt
male
age
mo
mean
sd
median
record
main
reason
admiss
respiratori
failur
postop
care
seisur
head
trauma
coma
polytrauma
sepsi
cardiovascular
accid
mod
miscellan
metabol
lo
day
median
mortal
discharg
age
p
infanc
p
readmiss
p
comorbid
p
season
admiss
p
time
admiss
p
play
role
mortal
contrari
mortal
significantli
relat
sex
male
vs
femal
p
emerg
admiss
vs
p
sourc
admiss
p
reason
admiss
p
intern
pediatr
pt
highest
mortal
follow
citi
hospit
remot
peripher
hospit
intern
surgic
moreov
outcom
wors
mod
mortal
cardiovascular
sepsi
coma
metabol
pt
non
survivor
stay
significantli
longer
vs
day
p
conclus
result
accord
data
attribut
higher
mortal
intern
pt
partial
expect
tertiari
care
hospit
like
season
time
admiss
signific
impact
outcom
indic
high
level
care
even
suboptim
condit
resourc
restrict
happen
holiday
outofhour
admiss
introduct
heart
rate
variabl
hrv
indic
dynam
equilibrium
sympathet
parasympathet
divis
autonom
nervou
system
hypothes
baselin
hrv
variabl
chang
resuscit
may
predict
outcom
critic
ill
method
prospect
observ
studi
perform
inpati
requir
rapid
respons
team
rrt
consult
holter
monitor
serial
measur
physiolog
biochem
data
made
heart
rate
variabl
measur
time
domain
measur
hour
sdnn
asdnn
rmssd
sdann
mean
nn
frequenc
domain
measur
hourli
low
frequenc
vlf
low
frequenc
lf
high
frequenc
hf
lowhigh
ratio
research
ethic
committe
approv
studi
protocol
rac
result
fiftythre
patient
enrol
mean
apach
ii
score
age
year
day
sofa
score
rang
forti
patient
requir
icu
admiss
icu
mortal
rate
hrv
significantli
higher
rrt
consult
stabil
requir
icu
admiss
time
domain
asdnn
vs
p
rmsdd
vs
p
frequenc
domain
meanvlf
vs
p
meanlf
vs
p
meanhf
vs
p
baselin
hrv
significantli
higher
survivor
asdnn
vs
p
rmsdd
vs
p
vs
p
meannn
vs
p
mean
vlf
vs
p
meanlf
vs
p
meanhf
vs
p
survivor
also
demonstr
significantli
larger
increas
hrv
hour
resuscit
deltavlf
vs
p
deltalf
vs
p
conclus
hrv
analysi
appear
power
identifi
outcom
critic
ill
baselin
valu
chang
first
hour
resuscit
accur
predict
need
icu
admiss
surviv
introduct
critic
ill
patient
often
develop
hyperlactatemia
elev
serum
lactat
level
associ
increas
hospit
mortal
howev
epidemiolog
hyperlactatemia
patient
admit
post
anaesthesia
care
unit
pacu
never
studi
previous
method
retrospect
observ
studi
conduct
pacu
univers
hospit
tokyo
japan
januari
decemb
adult
pacu
patient
monitor
arteri
cathet
elect
surgeri
includ
except
patient
lactat
measur
within
hour
pacu
admiss
measur
serum
lactat
level
arteri
blood
sampl
use
pointofcar
devic
studi
patient
divid
three
group
accord
maximum
lactat
level
first
hour
pacu
stay
normal
lactat
mmoll
moder
hyperlactatemia
mmoll
sever
hyperlactatemia
mmoll
primari
outcom
composit
outcom
consist
inhospit
mortal
readmiss
pacu
admiss
icu
emerg
reoper
hospit
stay
result
total
patient
includ
studi
among
patient
patient
normal
lactat
moder
sever
hyperlactatemia
composit
outcom
occur
patient
incid
rate
composit
outcom
increas
serum
lactat
level
elev
normal
moder
sever
normal
vs
moder
p
moder
vs
sever
p
inhospit
mortal
readmiss
pacu
admiss
icu
emerg
reoper
occur
patient
respect
primari
outcom
tend
increas
elev
serum
lactat
level
multivari
logist
regress
analysi
reveal
moder
sever
hyperlactatemia
risk
factor
composit
outcom
odd
ratio
moder
hyperlactatemia
sever
hyperlactatemia
refer
normal
lactat
conclus
incid
hyperlactatemia
pacu
elect
surgeri
although
hyperlactatemia
independ
associ
poor
outcom
sever
hyperlactatemia
similarli
associ
poor
outcom
compar
moder
hyperlactatemia
studi
especi
caus
hyperlactatemia
pacu
clarifi
introduct
sever
sepsi
lifethreaten
multisystem
process
result
signific
morbid
mortal
patient
sever
sepsi
shock
septic
preced
period
physiolog
deterior
evid
suggest
earli
sign
frequent
miss
arteri
blood
ga
abg
analysi
indispens
tool
assess
monitor
critic
ill
patient
icu
critic
care
set
method
crosssect
studi
medic
data
critic
septic
patient
admit
albert
schweitzer
hospit
review
januari
septemb
data
includ
age
gender
sap
iii
score
upon
admiss
sofa
score
arriv
hour
abg
arteri
lactat
level
well
length
stay
inhospit
mortal
rate
collect
logist
regress
model
use
determin
associ
acidbas
disturb
lactat
level
inhospit
mortal
adjust
potenti
confound
factor
result
patient
male
mean
age
year
old
mean
sap
iii
score
point
sofa
score
die
hospit
univari
analysi
show
significantli
higher
risk
mortal
patient
develop
metabol
acidosi
plu
hyperlactatemia
pvalu
multipl
logist
regress
analysi
demonstr
mix
metabol
acidosi
plu
respiratori
acidosi
ci
pvalu
hyperlactatemia
ci
pvalu
patient
acidos
higher
mortal
ph
less
die
ph
less
die
p
p
respect
patient
hyperlactatemia
higher
mortal
arteri
lactat
regular
level
die
arteri
lactat
regular
level
die
p
p
respect
two
signific
predictor
mortal
regardless
confound
variabl
conclus
result
show
critic
septic
patient
initi
metabol
acidosi
hyperlactatemia
signific
predictor
mortal
reinforc
signific
earli
action
restor
tissu
perfus
minim
damag
refer
lactat
ph
blood
ga
analysi
critic
ill
patient
waldau
et
al
acta
anaesthesiol
scand
suppl
introduct
valid
sap
mpmiii
score
larg
contemporari
cohort
patient
admit
brazilian
icu
method
retrospect
multicent
cohort
studi
adult
patient
consecut
admit
icu
hospit
exclud
patient
underw
cardiac
surgeri
invas
cardiac
procedur
readmiss
admit
acut
coronari
syndrom
burn
retriev
clinic
outcom
data
electron
icu
qualiti
registri
epim
monitor
system
includ
estim
mpmiii
sap
score
sap
score
estim
predict
mortal
use
standard
se
latinamerican
la
custom
equat
evalu
model
discrimin
use
area
receiv
oper
characterist
curv
auroc
appli
calibr
belt
evalu
agreement
observ
expect
mortal
rate
calibr
also
calcul
standard
mortal
ratio
smr
model
result
median
age
year
main
reason
icu
admiss
postop
care
sepsi
cardiovascular
neurolog
complic
mechan
ventil
use
admit
patient
vasopressor
dialysi
icu
hospit
mortal
rate
mean
sap
score
point
predict
mortal
rate
sap
se
sap
la
mpmiii
smr
ci
sap
se
sap
la
mpmiii
discrimin
better
sap
model
auroc
mpmiii
auroc
p
calibr
belt
analys
sap
la
overestim
mortal
throughout
risk
class
mpmiii
underestim
uniformli
sap
se
show
relev
deviat
ideal
calibr
conclus
contemporari
larg
cohort
sap
se
accur
predict
outcom
brazilian
patient
refer
fund
idor
cnpq
faperj
endors
bricnet
introduct
previou
studi
assess
relationship
preadmiss
function
statu
fs
mortal
critic
ill
patient
none
assess
impact
fs
result
mortal
predict
model
mpm
hypothes
fs
would
confound
predict
sever
adjust
mortal
method
retrospect
review
prospect
collect
data
includ
patient
admit
bed
intens
care
unit
universityaffili
hospit
abstract
inform
icu
databas
includ
diagnos
apach
ii
score
apii
apach
iv
predict
mortal
apivm
hospit
discharg
statu
prospect
character
patient
fulli
independ
n
partli
depend
live
home
n
live
home
n
stratifi
sever
ill
compar
observ
expect
mortal
ratio
e
creat
multivari
model
assess
independ
effect
fs
mortal
result
younger
like
admit
icu
surgeri
lower
apii
apivm
mortal
p
comparison
impact
fs
confound
predict
mortal
invers
relat
sever
ill
e
mortal
ratio
base
hospit
discharg
statu
apivm
stratifi
sever
ill
apivm
apivm
apivm
apivm
multivari
analysi
demonstr
independ
associ
increas
risk
mortal
compar
ci
respect
p
comparison
conclus
preadmiss
function
statu
independ
associ
risk
mortal
critic
ill
patient
confound
result
mortal
predict
model
especi
patient
less
sever
ill
futur
mortal
predict
model
incorpor
function
statu
design
introduct
studi
identifi
increas
mortal
critic
care
readmiss
patient
discharg
critic
care
hour
method
provid
mortal
readmiss
data
patient
discharg
two
district
hospit
itu
year
discharg
split
night
weekday
weekend
chi
squar
use
calcul
signific
mortal
data
rate
delay
discharg
minut
reason
delay
record
result
hospit
night
discharg
weekday
weekend
night
discharg
mortal
weekday
weekend
weekend
discharg
delay
night
week
hospit
night
discharg
weekday
weekend
night
discharg
mortal
weekday
weekend
daytim
discharg
delay
weekend
night
combin
mortal
data
tabl
p
valu
use
chisquar
group
discharg
delay
four
hour
across
site
delay
due
lack
ward
bed
readmiss
rate
conclus
increas
mortal
night
discharg
note
hospit
higher
rate
night
discharg
higher
rate
delay
discharg
hospit
lower
rate
possibl
demonstr
prompt
discharg
patient
lead
fewer
night
discharg
increas
mortal
discharg
night
highlight
import
avoid
delay
discharg
although
causal
relationship
delay
discharg
night
discharg
mortal
prove
data
add
evid
demonstr
higher
mortal
associ
night
discharg
delay
discharg
contribut
higher
rate
night
discharg
research
requir
explor
refer
edi
et
al
critic
care
introduct
object
identifi
factor
associ
high
mortal
admiss
mix
icu
resourceconstrain
environ
examin
impact
highrisk
admiss
current
admit
around
patient
per
year
mix
gener
univers
hospit
icu
predict
mortal
higher
nation
averag
icnarc
method
retrospect
review
consecut
admiss
analys
exist
icnarc
dataset
togeth
refer
specialti
lead
time
bia
cpr
prior
admiss
logist
regress
use
describ
predict
hospit
mortal
use
age
apach
ii
score
refer
specialti
preadmiss
cpr
subset
admit
postcpr
analys
model
fittest
use
roc
curv
cost
icu
stay
estim
use
mean
durat
stay
current
mean
icu
cost
result
mean
age
rang
median
apach
ii
score
iqr
median
time
hospit
icu
admiss
day
iqr
icu
lo
day
posticu
lo
day
logist
regress
model
use
shown
fig
factor
strongli
associ
mortal
referr
haematolog
oncolog
admiss
cpr
area
roc
patient
admit
cpr
overal
icu
mortal
group
logist
regress
fig
demonstr
strong
associ
mortal
admiss
medic
ward
e
area
roc
estim
icu
cost
per
surviv
hospit
discharg
admit
apach
ii
predict
mortal
admiss
postcpr
refer
haematolog
conclus
referr
haematolog
oncolog
postcpr
independ
associ
poor
outcom
high
cost
per
survivor
result
suggest
need
review
admiss
polici
view
sever
resourc
constraint
bed
shortag
current
experienc
introduct
mortal
one
use
outcom
indic
among
critic
care
patient
depend
sever
variabl
like
comorbid
reason
admiss
sever
diseas
less
attent
direct
time
admiss
discharg
intens
care
unit
icu
may
influenc
hospit
mortal
aim
studi
determin
impact
icu
hospit
mortal
moment
admiss
discharg
intens
care
unit
method
end
develop
prospect
observ
studi
includ
patient
admit
april
novemb
icu
maciel
hospit
montevideouruguay
consid
weekday
monday
thursday
weekend
friday
sunday
nocturn
admiss
defin
pm
result
analyz
patient
median
age
year
sap
ii
valu
point
differ
mortal
icu
found
compar
time
admiss
weekend
vs
weekday
p
ns
time
entri
nocturn
vs
diurnal
p
ns
discharg
day
associ
higher
hospit
mortal
weekend
vs
weekday
p
factor
associ
hospit
mortal
uni
variat
analisi
age
less
year
vs
p
sap
ii
higher
point
vs
p
weekend
discharg
icu
vs
p
copd
vs
p
cardiovascular
comorbid
vs
tracheostomis
patient
vs
p
factor
independ
associ
hospit
mortal
discharg
icu
patient
older
year
ci
discharg
weekend
ci
conclus
studi
show
moment
discharg
independ
associ
hospit
mortal
introduct
investig
impact
organiz
factor
outcom
resourc
use
cancer
patient
admit
larg
sampl
brazilian
icu
method
retrospect
cohort
studi
cancer
patient
solid
hematolog
surgic
medic
admit
icu
locat
gener
hospit
cancer
center
retriev
clinic
outcom
data
electron
icu
qualiti
registri
epim
monitor
system
survey
icu
regard
hospit
icu
structur
organ
staf
pattern
process
care
use
multilevel
logist
regress
analysi
identifi
characterist
associ
hospit
mortal
evalu
effici
resourc
use
use
standard
mortal
rate
smr
resourc
use
sru
base
sap
score
result
icu
mostli
medic
medicalsurg
n
locat
privat
hospit
n
median
number
cancer
patient
per
center
iqr
correspond
icu
admiss
median
sap
score
point
mechan
ventil
mv
use
patient
icu
hospit
mortal
rate
respect
adjust
relev
patient
characterist
age
mv
use
admiss
diagnosi
cancer
type
perform
statu
comorbid
neutropenia
presenc
clinic
pharmacist
icu
ci
number
protocol
daili
meet
oncologist
icu
team
associ
lower
mortal
convers
mortal
higher
icu
hold
train
program
critic
care
number
protocol
meet
oncologist
icu
team
also
independ
associ
effici
resourc
use
low
smr
sru
admiss
icu
cancer
center
compar
gener
hospit
annual
casevolum
impact
mortal
resourc
use
conclus
organiz
aspect
name
implement
protocol
presenc
clinic
pharmacist
icu
close
collabor
oncologist
icu
team
target
improv
mortal
resourc
use
critic
ill
cancer
patient
refer
fund
idor
cnpq
faperj
endors
bricnet
introduct
cancer
grown
steadili
icu
cancer
patient
gradual
improv
treatment
underli
diseas
earlier
diagnosi
effect
treatment
lead
better
prognosi
prospect
number
reach
higher
proport
year
decid
much
admiss
icu
base
question
decid
retrospect
nearli
two
year
evalu
result
hospit
patient
without
cancer
compar
major
clinic
outcom
studi
aim
improv
knowledg
main
clinic
outcom
cancer
patient
icu
larg
privat
hospit
break
paradigm
cancer
patient
may
nonsignificantli
differ
evolut
patient
without
cancer
admit
icu
method
evalu
patient
admit
icu
period
jan
oct
observ
studi
assess
retrospect
data
adult
patient
admit
icu
exclud
termin
separ
two
group
oncolog
diseas
without
oncolog
diseas
divis
group
analyz
comparison
age
sex
sever
score
icu
hospit
length
stay
final
outcom
icu
hospit
data
collect
epim
system
mv
system
tabul
excel
studi
statist
result
group
patient
male
mean
age
icu
stay
hospit
group
male
mean
age
icu
stay
hospit
none
valu
show
signific
studentt
mortal
group
icu
hospit
respect
group
expect
mortal
group
z
test
evalu
two
proport
differ
mortal
icu
group
differ
inhospit
mortal
signific
cancer
patient
conclus
oncolog
patient
outcom
icu
fact
presenc
tumor
obstacl
hospit
icu
refer
parakh
piggin
neeman
mitchel
crispin
p
davi
outcom
haematologyoncolog
patient
admit
intens
care
unit
canberra
hospit
intern
med
j
nov
introduct
palli
oncolog
patient
admit
critic
care
uncommonli
outcom
variabl
often
difficult
predict
sought
observ
intens
care
unit
icu
hospit
outcom
palli
oncolog
patient
relat
demograph
diseas
organ
failur
criteria
method
retrospect
review
electron
databas
note
patient
admit
icu
januari
octob
undertaken
patient
without
formal
palli
diagnosi
diagnosi
haematolog
malign
exclud
demograph
function
statu
current
cancer
treatment
intervent
receiv
palli
care
team
involv
amongst
paramet
collect
sap
ii
apach
ii
score
icu
outcom
record
stata
use
logist
regress
analys
result
patient
identifi
median
iqr
age
year
male
median
iqr
sap
ii
score
patient
inform
avail
metastat
diseas
undergo
palli
chemotherapi
andor
radiotherapi
palli
surgic
intervent
median
iqr
lo
day
patient
die
cc
discharg
hospit
mortal
median
surviv
day
hospit
patient
day
patient
discharg
home
logist
regress
analysi
adjust
age
gender
factor
associ
mortal
icu
discharg
sap
ii
score
ci
p
length
stay
lo
type
palli
treatment
receiv
prior
icu
admiss
metastat
spread
neutropenia
smoke
diabet
statu
highest
record
lactat
hour
prior
icu
admiss
seem
associ
icu
outcom
lack
statist
signific
correl
may
relat
small
sampl
size
conclus
high
sap
ii
score
may
confer
accur
prognost
inform
context
critic
unwel
palli
cancer
patient
overal
icu
mortal
lower
document
previou
work
may
relat
strict
triag
icu
oncolog
team
median
surviv
palli
oncolog
patient
admit
critic
care
remain
poor
refer
soar
et
al
crit
care
nelson
j
et
al
ccm
kress
j
et
al
ccm
introduct
hematooncolog
patient
neutropen
sepsi
septic
shock
grow
concern
oncolog
intens
care
unit
icu
acut
physiolog
chronic
health
evalu
ii
apach
ii
simplifi
acut
physiolog
score
ii
sap
ii
use
predict
prognosi
critic
patient
base
clinic
analyt
criteria
obtain
first
hour
admiss
studi
aim
analys
factor
predict
mortal
cohort
febril
neutropen
fn
patient
haematolog
malign
method
carri
retrospect
studi
evalu
hematooncolog
patient
fn
admit
icu
comprehens
cancer
center
januari
decemb
baselin
clinic
demograph
inform
describ
use
descript
statist
factor
predict
inicu
mortal
identifi
use
univari
logist
regress
variabl
p
valu
includ
multivari
analysi
result
total
patient
includ
analysi
median
age
admiss
year
male
n
baselin
caus
immunosuppress
alogen
stem
cell
transplant
n
recent
chemotherapi
n
sap
ii
apach
ii
score
median
respect
multipl
organ
dysfunct
observ
case
n
singl
frequent
dysfunct
respiratori
n
renal
n
cardiovascular
dysfunct
patient
n
renal
replac
therapi
requir
case
invas
ventil
perform
patient
n
median
durat
hour
median
icu
length
stay
day
inicu
mortal
n
univari
analysi
apach
ii
p
valu
sap
ii
p
valu
renal
dysfunct
p
valu
invas
ventil
iv
p
valu
associ
inicu
mortal
multivari
analysi
apach
ii
remain
statist
signific
p
valu
auc
iv
exact
logist
analysi
conclus
high
apach
ii
score
iv
seem
predict
elev
mortal
risk
icu
patient
fn
haematolog
malign
sap
ii
appear
less
import
predictor
mortal
set
howev
note
score
use
ascertain
prognosi
individu
case
introduct
acut
respiratori
failur
may
complic
cours
patient
hematolog
malign
histor
associ
poor
prognosi
studi
evalu
characterist
outcom
predictor
mortal
patient
hematolog
malign
requir
intub
method
retrospect
studi
patient
hematolog
malign
admit
intens
care
unit
icu
king
abdulaziz
medic
cityriyadh
requir
intub
note
baselin
clinic
characterist
treatment
receiv
icu
differ
outcom
multivari
logist
regress
analysi
perform
evalu
predictor
hospit
mortal
variabl
enter
model
gender
apach
ii
score
admiss
admiss
serum
lactat
inr
septic
shock
noninvas
ventil
intub
renal
replac
therapi
chemotherapi
administr
icu
result
period
patient
hematolog
malign
admit
icu
requir
intub
acut
respiratori
failur
patient
mean
age
year
apach
ii
score
predominantli
male
lymphoma
common
hematolog
malign
follow
acut
leukemia
patient
bone
marrow
transplant
septic
shock
present
patient
icu
admiss
noninvas
ventil
tri
fail
chemotherapi
provid
patient
icu
stay
new
renal
replac
therapi
acut
kidney
injuri
use
patient
hospit
mortal
acut
leukemia
lymphoma
p
death
occur
icu
multivari
analysi
male
gender
odd
ratio
confid
interv
septic
shock
odd
ratio
confid
interv
new
renal
replac
therapi
odd
ratio
confid
interv
independ
mortal
predictor
neither
noninvas
ventil
failur
chemotherapi
icu
stay
associ
mortal
conclus
patient
hematolog
malign
requir
intub
high
mortal
male
gender
septic
shock
renal
replac
therapi
independ
predictor
mortal
introduct
intensivist
clinic
decisionmak
pursu
two
main
goal
patient
decreas
mortal
improv
patientcent
outcom
qualiti
life
function
statu
survivorsw
sought
investig
publish
random
control
trial
rct
explor
patientimport
outcom
critic
ill
patient
method
literatur
search
conduct
medlin
via
identifiy
elig
articl
index
januari
decemb
elig
report
rct
involv
critic
ill
adult
patient
written
english
data
extract
conduct
independ
senior
intensivist
standard
pretest
extract
form
assess
patient
studi
characterist
outcom
primari
secondari
collect
describ
classifi
use
categori
outcom
includ
patientimport
outcom
patientimport
outcom
repres
entiti
mortal
time
patientcent
outcom
assess
icu
discharg
qualiti
life
function
statu
result
articl
retriev
rct
met
inclus
criteria
assess
total
patient
age
year
male
sex
common
topic
mechan
ventil
sepsi
nutrit
among
primari
outcom
patientimport
outcom
mainli
mortal
patientcent
outcom
assess
icu
discharg
function
disabl
qualiti
life
among
secondari
outcom
patientimport
outcom
mainli
mortal
patientcent
outcom
assess
icu
discharg
qualiti
life
function
disabl
neurologicalcognit
perform
handicap
posttraumat
stress
patient
satisfact
ninetysix
rct
report
least
one
patientimport
outcom
either
primari
secondari
outcom
report
least
one
patientcent
outcom
assess
icu
discharg
multivari
analysi
sepsi
topic
ci
rct
jadad
score
ci
like
assess
least
one
patientimport
outcom
conclus
small
percentag
outcom
use
rct
critic
ill
patient
publish
patientimport
outcom
larg
major
mortal
outcom
introduct
alopecia
adult
survivor
critic
ill
previous
well
research
acut
critic
ill
alopecia
minim
concern
icu
team
surviv
primari
aim
recoveri
phase
ill
howev
alopecia
prove
distress
aim
studi
investig
incid
natur
patientreport
alopecia
cohort
critic
ill
survivor
method
singl
centr
qualit
survey
studi
complet
icu
followup
clinic
teach
hospit
wale
patient
discharg
home
least
week
follow
icu
stay
three
day
attend
followup
clinic
invit
complet
survey
survey
adapt
one
use
previou
studi
includ
question
regard
patient
demograph
alopecia
statist
analysi
includ
number
median
iqr
comparison
patient
without
alopecia
made
use
fisher
exact
test
mann
whitney
u
test
due
anonym
survey
wale
rec
confirm
ethic
approv
need
studi
result
survey
complet
patient
attend
clinic
juli
decemb
median
age
year
patient
male
alopecia
report
patient
hair
loss
gradual
patient
sever
hair
loss
cohort
rang
less
locat
hair
loss
vari
patient
one
patient
hair
loss
occur
gradual
one
six
week
posticu
discharg
last
one
seven
month
analysi
signific
differ
found
patient
without
alopecia
demograph
variabl
conclus
limit
research
exist
examin
incid
natur
patientreport
alopecia
adult
survivor
critic
ill
type
amount
locat
hair
loss
vari
patient
studi
main
limit
studi
survey
design
result
lack
inform
regard
potenti
predictor
alopecia
incid
report
studi
howev
suggest
research
warrant
refer
bernstein
gm
crollick
js
hassett
jm
postfebril
telogen
effluvium
critic
ill
patient
crit
care
med
pettignano
r
heard
ml
labuz
md
et
al
hair
loss
extracorpor
membran
oxygen
pediatr
crit
care
med
introduct
south
wale
area
rel
socioeconom
depriv
myriad
wellrecognis
associ
mental
health
problem
patient
mental
health
disord
commonli
admit
icu
direct
consequ
ill
suicid
attempt
due
indirect
consequ
intraven
drug
overdos
drug
addict
result
find
set
ascertain
effect
preexist
mental
health
issu
includ
addict
icu
admiss
method
prospect
studi
design
use
data
collect
admiss
gener
icu
larg
teach
hospit
south
wale
two
month
period
adult
patient
screen
follow
question
admiss
direct
consequ
mental
health
disord
recreat
illicit
psychoact
substanc
use
coexist
mental
health
diagnosi
present
prior
admiss
code
use
defin
mental
health
disord
outcom
studi
includ
inhospit
mortal
ventil
day
length
icu
stay
data
analysi
includ
fisher
exact
mann
whitney
u
test
statist
signific
set
p
ethic
approv
waiv
servic
evalu
result
total
patient
screen
patient
admit
mental
health
disord
patient
direct
consequ
patient
exist
mental
health
problem
patient
mental
health
disord
significantli
younger
control
p
howev
differ
apach
ii
score
signific
differ
mortal
mechan
ventil
day
icu
length
stay
two
group
signific
differ
mortal
rate
patient
admit
direct
consequ
mental
health
disord
control
group
p
conclus
patient
mental
health
problem
appear
wors
outcom
without
mortal
admit
icu
direct
consequ
mental
health
problem
significantli
higher
control
reason
unclear
like
multifactori
futur
multicentr
prospect
studi
plan
wale
investig
nation
impact
mental
health
disord
icu
resourc
introduct
survivor
critic
ill
often
incapacit
form
cognit
psycholog
function
impair
potenti
revers
clinic
condit
year
intens
care
unit
icu
discharg
remain
inadequ
understood
aim
evalu
longterm
cognit
impair
psycholog
morbid
qualiti
life
year
icu
discharg
method
prospect
cohort
studi
survivor
admit
mix
icu
januari
septemb
clinic
evalu
perform
month
year
hospit
discharg
includ
dementia
rate
hospit
anxieti
depress
scale
had
posttraumat
stress
syndrom
inventori
medic
outcom
studi
short
form
euro
qualiti
life
dimens
two
moment
result
studi
period
patient
evalu
outpati
clinic
month
icu
discharg
mean
age
year
reevalu
year
icu
discharg
twelv
patient
present
cognit
impair
percentil
first
evalu
year
p
anxieti
depress
month
present
year
patient
report
anxieti
none
depress
evalu
show
signific
differ
physic
function
vs
p
physic
pain
vs
p
gener
health
vs
p
vital
vs
p
social
function
vs
p
emot
perform
vs
p
mental
health
vs
p
differ
found
physic
perform
vs
p
health
statu
chang
wors
vs
patient
p
evalu
show
vs
p
problem
selfcar
vs
p
usual
activ
vs
p
report
paindiscomfort
vs
p
problem
motil
vs
p
anxietydepress
visual
analogu
scale
month
vs
point
year
p
conclus
cohort
patient
show
increas
cognit
deterior
anxieti
depress
deterior
physic
function
higher
proport
patient
report
health
chang
wors
previou
year
translat
wors
qualiti
life
introduct
icu
ill
sever
score
use
icu
outcom
predict
guidanc
human
financi
resourc
use
applic
sever
ill
score
octagenerian
medic
icu
remain
unclear
method
retrospect
analysi
consecut
octogenarian
admit
micu
perform
calcul
apach
ii
iv
predict
mortal
compar
actual
mortal
actual
predict
length
stay
compar
result
admit
patient
octagenerian
icu
mortal
icu
mortal
younger
patient
p
apach
ii
iv
predict
mortal
thu
overestim
nearli
actual
lo
day
statist
shorter
predict
day
p
conclus
apach
ii
apach
iv
correl
poorli
observ
mortal
appli
octagenerian
micu
discrep
predict
actual
lo
refer
vincent
jl
noreno
r
score
system
critic
ill
critic
care
introduct
advanc
age
associ
increas
ill
sever
lead
increas
mortal
critic
care
requir
although
averag
life
expect
india
year
popul
year
age
icu
major
citi
like
admit
substanti
proport
octagenarian
sinc
icu
outcom
octagenarian
indian
set
known
conduct
retrospect
review
method
retrospect
review
conduct
bed
multidisciplinari
icu
mix
medic
surgic
coronari
care
state
tamilnadu
south
india
data
extract
icu
patient
databas
one
year
period
sept
aug
admiss
period
patient
octagenarian
make
total
admiss
demograph
outcom
octagenarian
compar
rest
icu
admiss
full
avail
apach
period
result
averag
age
octagenarian
admit
icu
year
unlik
rest
admiss
femal
amongst
octagenarian
averag
apach
score
predict
mortal
correl
well
actual
mortal
statist
signific
differ
length
icu
stay
mortal
octagenarian
rest
admiss
number
cardiac
patient
two
group
also
compar
conclus
icu
admiss
octagenarian
compar
western
popul
octagenarian
admit
icu
seem
lower
predict
actual
mortal
indic
less
ill
sever
could
due
combin
patient
factor
healthcar
factor
healthcar
deliveri
locat
cultur
factor
publish
western
data
may
help
discuss
outcom
patient
famili
decis
make
icu
admiss
refer
roch
et
al
longterm
outcom
medic
patient
age
follow
admiss
intens
care
unit
critic
care
ford
pnr
et
al
determin
outcom
critic
ill
octogenarian
surgeri
observ
studi
british
journal
anaesthesia
introduct
brazilian
popul
age
affect
trend
percentag
hospit
intens
care
unit
icu
admiss
attribut
patient
age
year
older
elderli
popul
elderli
quarter
total
popul
advanc
age
associ
increas
sever
acut
critic
ill
admiss
icu
high
risk
death
method
evalu
agespecif
subject
old
retrospect
admit
icu
jan
oct
analyz
clinic
data
subject
divid
two
group
less
greater
equal
year
evalu
major
clinic
outcom
compar
two
group
result
male
averag
length
stay
icu
hospit
show
signific
differ
two
group
mean
sap
differ
group
well
probabl
death
respect
might
expect
mortal
icu
hospit
higher
older
group
signific
accord
z
test
two
proport
conclus
age
affect
length
stay
icu
hospit
elderli
subject
admit
icu
higher
mortal
rate
compar
subject
age
find
rais
question
use
critic
care
end
life
elderli
refer
sim
ys
et
al
mortal
outcom
elderli
patient
year
age
older
admit
icu
respir
care
mar
mb
velasco
et
al
studi
cost
icu
accord
age
group
relat
sap
graviti
stay
outcom
crit
care
suppl
santanacabrera
l
et
al
influenc
age
durat
stay
mortal
patient
remain
intens
care
unit
prolong
time
rev
clin
esp
barc
mar
introduct
compar
younger
patient
octagenerian
experi
higer
shor
longterm
mortal
rate
admiss
rate
last
decad
increas
purpos
studi
evalu
icu
hospit
mortal
mortal
associ
icu
readmiss
method
singl
center
retrospect
studi
tertiari
center
academ
hospit
chart
octagenerian
consecut
admit
medic
icu
analyz
pre
icu
perform
asses
icu
mortal
apach
iv
rate
remiss
hospit
mortal
analyz
result
patient
admit
micu
age
oldest
icu
mortal
among
octagenerian
significantli
higher
compar
younger
patient
mortal
p
none
patient
age
diagnos
sepsi
surviv
icu
inhospit
mortal
octagenerian
patient
readmit
icu
none
surviv
preadmiss
perform
statu
predict
consid
icu
hospit
mortal
conclus
octagenerian
higher
icu
mortal
rate
compar
younger
patient
inhospit
mortal
doubl
readmiss
icu
analyz
period
associ
mortal
pre
icu
perform
statu
independ
risk
factor
mortal
care
evalu
warrant
readmit
elderli
patient
micu
encourag
make
clear
therapeut
plan
icu
discharg
clear
recommend
consid
potenti
icu
readmiss
reintroduc
invas
noninvas
mechan
ventil
vasopressor
commenc
renal
replac
therapi
antibiot
treatment
refer
orsini
j
blaak
c
shamian
b
fonesca
x
salem
chen
yl
assess
util
icu
admiss
octogenarian
age
clinic
experiment
introduct
mani
elderli
patient
admit
intens
care
unit
icu
despit
known
poor
outcom
frequent
patient
prefer
avoid
unnecessari
prolong
life
realiti
expect
attitud
life
support
technolog
intens
care
octogenarian
trial
studi
outcom
elderli
patient
admit
icu
canada
mortal
high
longterm
physic
function
recoveri
also
poor
rais
question
appropri
icu
admiss
group
find
also
carri
signific
econom
implic
use
data
trial
examin
cost
icu
admiss
elderli
factor
affect
cost
potenti
save
reduc
admiss
either
undesir
patient
medic
futil
method
multicentr
prospect
observ
cohort
studi
includ
patient
year
old
admit
canadian
icu
overal
cost
care
per
patient
determin
length
stay
directvari
cost
icu
admiss
use
univari
logist
regress
model
investig
potenti
predict
factor
influenc
cost
includ
patient
outcom
death
vs
surviv
frailti
resid
nurs
home
well
presenc
advanc
direct
exploratori
analysi
perform
illustr
potenti
cost
save
reduc
number
icu
admiss
popul
result
total
patient
year
old
admit
icu
elig
enrol
studi
averag
age
year
median
length
stay
day
icu
day
hospit
mortal
icu
hospit
month
nonsurvivor
median
time
admiss
death
day
enrol
patient
remain
icu
day
die
hospit
year
patient
meaning
recoveri
measur
short
survey
gener
health
statu
includ
physic
mental
health
compon
scale
result
cost
analysi
pend
present
confer
conclus
studi
demonstr
signific
econom
cost
critic
care
elderli
patient
admit
popul
level
care
often
unwant
futil
importantli
expect
illustr
potenti
cost
save
reduc
admiss
crucial
inform
clinic
policymak
decis
introduct
purpos
studi
determin
relationship
acuiti
ill
icu
twoyear
mortal
patient
age
older
data
exist
associ
method
patient
age
older
admit
icu
stoke
mandevil
wycomb
hospit
oct
oct
identifi
month
mortal
evalu
accord
categori
admiss
organ
support
icu
stay
apach
iii
score
result
patient
includ
median
age
rang
patient
die
icu
stay
die
ward
discharg
give
total
hospit
death
month
mortal
respect
medic
patient
highest
acuiti
score
highest
mortal
endpoint
fig
high
apach
iii
score
fig
increas
number
organ
support
correl
shorter
time
icu
admiss
death
p
case
requir
support
organ
patient
none
surviv
hospit
admiss
conclus
almost
half
patient
age
admit
icu
die
discharg
hospit
larg
proport
patient
surviv
month
still
aliv
two
year
high
apach
iii
score
organ
support
associ
higher
mortal
result
suggest
intens
care
benefit
select
patient
age
acuiti
ill
use
indic
longterm
surviv
introduct
intens
care
weak
icuaw
frequent
complic
critic
ill
patient
approxim
incid
diagnosi
clinic
consist
assess
strength
variou
muscl
group
upper
lower
extrem
problem
repres
one
greatest
burden
patient
face
surviv
icu
care
object
assess
incid
identifi
clinic
factor
associ
icuaw
oncolog
center
method
retrospect
collect
data
patient
admit
icu
januari
decemb
review
patient
admit
icu
age
year
mechan
ventil
hour
final
diagnosi
icuacquir
weak
select
predict
factor
icuaw
identifi
use
multivari
logist
regress
analysi
result
patient
includ
develop
icuaw
mean
age
year
femal
median
time
mechan
ventil
hour
patient
solid
tumor
hematolog
malign
glucocorticoid
neuromuscular
block
agent
administ
patient
respect
septic
shock
develop
patient
found
predict
factor
develop
icuaw
pvalu
patient
start
continu
physic
rehabilit
hospit
length
stay
approxim
day
admiss
icu
patient
icuaw
die
day
admiss
icu
patient
icuaw
reevalu
physic
rehabilit
medicin
day
hospit
discharg
signific
improv
note
physic
statu
program
physic
therapi
conclus
icuaw
rel
frequent
problem
septic
shock
found
predict
factor
develop
entiti
earli
mobil
import
intervent
decreas
weak
physic
decondit
critic
ill
patient
refer
kress
j
hall
jicuaw
recoveri
critic
illnessnejm
lipshutz
gropper
macquir
neuromuscular
weak
earli
mobil
icu
anesthesiolog
wiesk
l
et
alimpact
icuaw
posticu
physic
function
followup
studycrit
care
introduct
aim
studi
examin
incid
musculoskelet
problem
ie
pain
weak
decreas
joint
rang
movement
critic
care
patient
post
discharg
post
intens
care
syndrom
pic
wide
use
term
describ
collect
problem
patient
develop
due
stay
intens
care
icu
survivor
found
high
risk
develop
psycholog
problem
physic
problem
intens
care
unit
acquir
weak
icuaw
chronic
pain
method
discharg
patient
icu
attend
week
multidisciplinari
rehabilit
programm
part
qualiti
improv
initi
within
glasgow
royal
infirmari
icu
particip
complet
oneon
musculoskelet
assess
icu
physiotherapist
ethic
approv
waiv
programm
part
qualiti
improv
initi
result
data
collect
patient
attend
programm
median
age
iqr
patient
men
median
icu
length
stay
lo
day
iqr
median
apach
ii
iqr
particip
n
report
new
incid
pain
sinc
discharg
icu
report
lower
limb
pain
report
shoulder
pain
bilater
symptom
report
complain
lower
limb
pain
contrast
shoulder
pain
relat
muscl
weak
particip
present
weak
compar
upper
limb
ul
ul
joint
rang
movement
reduc
particip
reduct
particip
report
numb
ulll
conclus
musculoskelet
problem
especi
shoulder
pain
bilater
pain
weak
remain
signific
problem
survivor
critic
ill
may
implic
regard
fall
risk
exercis
capac
reduc
likelihood
patient
return
work
shoulder
pain
found
one
common
complaint
pain
support
research
contribut
factor
posit
ventil
tube
dialysi
line
central
line
hypothesis
collect
data
help
rais
awar
problem
may
strengthen
case
equip
activ
mobilis
icu
herald
need
increas
understand
downstream
ward
icuaw
refer
battl
et
al
critic
care
griffith
et
al
critic
care
introduct
obes
paradox
critic
ill
refer
better
surviv
higher
bmi
hypothes
fat
mobil
excess
adipos
tissu
critic
ill
provid
energi
effici
exogen
macronutri
could
prevent
lean
tissu
wast
method
centrallycatheter
mous
model
cecal
ligat
punctur
clp
induc
prolong
septic
critic
ill
bodi
weight
composit
muscl
wast
assess
lean
premorbidli
obes
mice
fast
parenter
feed
healthi
mice
lean
n
obes
n
fed
clp
mice
lean
n
obes
n
fast
clp
mice
lean
n
obes
n
muscl
weak
assess
second
mice
experi
examin
ex
vivo
muscl
forc
healthi
mice
lean
n
obes
n
fed
clp
mice
lean
n
obes
n
mice
gener
provid
old
male
mice
ad
libitum
fat
chow
fat
chow
week
prior
septic
insult
also
match
lean
bmi
overweightobes
bmi
prolong
critic
ill
patient
healthi
control
compar
marker
muscl
wast
vastu
laterali
biopsi
n
rectu
abdomini
biopsi
n
well
muscl
weak
quantifi
medic
research
council
sum
score
n
result
five
day
sepsi
reduc
bodi
weight
similarli
lean
obes
mice
fat
loss
obes
p
lean
clp
mice
obes
show
reduc
muscl
mass
p
muscl
protein
content
p
myofib
size
p
muscl
hepat
triglycerid
content
p
irrespect
administ
feed
obes
clp
mice
maintain
normal
maxim
muscl
forc
wherea
lean
clp
mice
maxim
muscl
forc
decreas
p
recov
less
fatigu
p
differ
lean
obes
clp
mice
coincid
sign
effect
hepat
fatti
acid
glycerol
metabol
ketogenesi
obes
also
overweightobes
critic
ill
patient
show
preserv
myofib
size
myofib
size
reduc
lean
patient
p
vastu
laterali
biopsi
p
rectu
abdomini
biopsi
furthermor
fewer
overweightobes
patient
suffer
muscl
weak
assess
day
posticu
admiss
p
conclus
conclus
critic
ill
premorbid
obes
nutrit
facilit
util
store
lipid
attenu
muscl
wast
weak
introduct
aim
studi
evalu
suitabl
physic
outcom
measur
use
critic
care
patient
follow
discharg
icu
survivor
experi
physic
problem
reduc
exercis
capac
intens
care
acquir
weak
nice
guidelin
rehabilit
critic
ill
recommend
use
outcom
measur
howev
provid
specif
guidanc
recent
cochran
review
note
wide
variabl
measur
use
follow
icu
discharg
method
discharg
icu
patient
attend
five
week
multidisciplinari
programm
patient
physic
function
assess
programm
month
month
post
discharg
three
outcom
measur
includ
initi
two
cohort
six
minut
walk
test
increment
shuttl
walk
test
iswt
chosen
use
within
critic
care
follow
set
chester
step
test
cst
wide
thought
good
indic
abil
return
work
one
programm
primari
aim
ethic
approv
waiv
programm
part
qualiti
improv
initi
result
data
collect
initi
patient
attend
programm
n
median
age
iqr
median
icu
lo
day
iqr
median
apach
ii
iqr
men
one
patient
physic
debilit
cst
iswt
could
complet
howev
score
achiev
use
anoth
patient
almost
fail
achiev
level
iswt
subsequ
patient
project
total
n
therefor
test
use
good
interrat
intrarat
reliabl
valid
report
conclus
exercis
capac
measur
achiev
patient
either
iswt
cst
due
sever
physic
debilit
anxieti
posttraumat
stress
disord
depress
common
psycholog
problem
post
discharg
therefor
use
test
bleep
appropri
therefor
appropri
physic
outcom
measur
use
critic
care
patient
post
discharg
refer
nice
guidelin
connolli
et
al
cochran
librari
issu
weisman
et
al
clin
chest
med
jone
et
al
clin
inten
care
volum
issu
introduct
aim
improv
activ
mobilis
intens
care
icu
patient
qualiti
improv
qi
project
icu
patient
return
work
within
one
year
discharg
ongo
physic
psycholog
cognit
problem
icu
discharg
activ
mobilis
shorten
hospit
stay
increas
return
independ
function
reduc
delirium
uk
icu
standard
introduc
direct
minutesday
activ
mobilis
suitabl
patient
method
icu
select
multidisciplinari
md
team
januari
lead
mobilis
qi
project
commit
made
weekli
collect
present
data
use
adept
aim
data
evid
process
team
format
initi
aim
minut
activ
mobilis
daili
suitabl
icu
patient
patient
abl
obey
command
achiev
degre
cardiovascular
stabil
must
musculoskelet
injuri
preclud
mobilis
vasopressor
use
invas
ventil
per
se
barrier
activ
mobilis
agre
form
activ
mobilis
activ
limb
exercis
booklet
exercis
develop
bed
edg
sit
dangl
sit
bed
chair
stand
walk
baselin
data
collect
serial
plan
studi
act
pdsa
cycl
carri
result
baselin
data
march
april
show
daili
mobilis
target
group
perform
improv
median
novemb
maintain
januari
novemb
daili
mobilis
aim
increas
minut
june
minut
octob
saw
reduct
day
ventil
length
stay
septemb
better
reliabl
activ
mobilis
achiev
conclus
result
qi
project
show
md
approach
mobilis
achiev
result
weekli
data
collect
discuss
prove
essenti
advanc
success
extra
resourc
new
fund
help
us
increas
mobilis
time
use
data
success
pdsa
cycl
achiev
success
refer
van
der
schaaf
et
al
journal
rehabilit
medicin
van
der
schaaf
et
al
journal
rehabilit
medicin
schweickert
wd
et
al
lancet
core
standard
intens
care
unit
edit
faculti
intens
care
medicin
introduct
recent
studi
show
icu
survivor
need
mechan
ventil
often
present
neuromuscular
weak
function
impair
icu
acquir
weak
may
develop
even
critic
patient
immobil
day
despit
receiv
support
care
physiotherapi
weak
contribut
poor
outcom
earli
mobil
may
enhanc
function
recoveri
reduc
day
mechan
ventil
shorten
icu
hospit
length
stay
decreas
incid
delirium
improv
surviv
great
part
icu
patient
vasoact
drug
therapi
data
literatur
safeti
mobil
group
therefor
studi
aim
prove
earli
mobil
even
patient
use
low
dose
vasoact
drug
safe
feasibl
method
whe
assign
patient
use
low
dose
vasoact
drug
receiv
daili
session
physiotherapi
icu
length
stay
analyz
toler
exercis
consist
level
mobil
level
passiv
exercis
level
activ
exercis
level
orthostat
posit
walk
hearth
rate
respiratori
rate
peripher
oxygen
satur
map
evalu
moment
physiotherapi
session
immedi
minut
result
patient
follow
novemb
novemb
patient
men
mean
age
vasoact
group
control
group
mean
sap
score
vasoact
group
control
group
p
type
vasoact
drug
norepinephrin
nitroprussid
nitroglycerin
remov
bed
put
seat
posit
patient
vasoact
group
group
complic
statist
signific
exercis
chang
map
major
event
associ
though
increas
dose
vasoact
drug
p
statist
signific
differ
two
group
increas
map
vasoact
group
immedi
mobil
mean
map
mean
dosag
mcgkgmin
norepinephrin
nitroprussid
nitroglycerin
conclus
studi
show
mobil
patient
low
dose
vasoact
drug
therapi
may
possibl
safe
littl
complic
major
chang
map
data
import
encourag
earli
mobil
patient
icu
amelior
outcom
introduct
intens
care
stay
patient
often
chronic
medic
withheld
varieti
reason
new
drug
commenc
patient
often
care
number
differ
medic
team
admiss
potenti
chang
inadvert
continu
intens
care
syndrom
promot
independ
return
employ
in
pire
five
week
rehabilit
programm
patient
caregiv
icu
intens
care
unit
discharg
glasgow
royal
infirmari
within
programm
medic
review
critic
care
pharmacist
provid
opportun
identifi
resolv
pharmaceut
care
issu
also
opportun
educ
patient
caregiv
chang
medic
method
medic
review
identifi
ongo
pharmaceut
care
issu
commun
patient
primari
care
physician
gp
letter
telephon
call
patient
also
encourag
discuss
issu
rais
gp
signific
intervent
classifi
like
clinic
benefit
patient
prevent
seriou
therapeut
failur
result
data
collect
patient
attend
clinic
median
age
iqr
median
icu
lo
iqr
median
apach
ii
iqr
patient
men
pharmacist
made
recommend
includ
relat
drug
withheld
restart
dose
adjust
suggest
occas
new
drug
recommend
made
patient
durat
treatment
new
medic
start
hospit
admiss
clarifi
occas
lastli
advers
drug
effect
report
occas
incorrect
drug
prescrib
occas
intervent
made
consid
moder
high
impact
conclus
pharmacist
identifi
pharmaceut
care
issu
prescrib
medic
half
patient
report
made
awar
alter
prescrib
medic
discharg
therefor
pharmaci
intervent
essenti
part
intens
care
rehabilit
programm
address
medic
relat
problem
provid
educ
ensur
patient
gain
optim
benefit
medic
refer
campbel
aj
et
al
anaesthesia
eijsbroek
h
et
al
j
critic
care
introduct
light
sedat
gain
attent
part
standard
daili
care
intens
care
unit
icu
particularli
earli
mobil
associ
shorter
time
ventil
shorter
icu
length
stay
better
surviv
interact
game
may
challeng
way
engag
patient
rehabilit
program
data
avail
use
interact
game
icu
envirno
part
daili
routin
physiotherapi
although
one
studi
show
safe
method
develop
trolley
wii
devic
easili
use
patient
mobil
chair
addit
use
devic
bedcycl
hypothes
would
associ
increas
motiv
use
bedcycl
patient
result
patient
like
use
wii
devic
particularli
choic
game
made
interest
use
tenni
bowl
box
frequent
use
use
wii
program
daili
mobil
schedul
togeth
physiotherapist
attend
icu
nurs
bedcycl
devic
use
routin
sinc
octob
interest
result
patient
could
choos
environ
want
cycl
around
eg
slot
zeist
wood
use
watercycl
colour
villag
giethoorn
parallel
observ
wii
devic
patient
like
varieti
scene
best
studi
progress
evalu
safeti
well
effect
motiv
patient
use
interact
game
icu
conclus
use
interact
video
game
part
routin
rehabilit
program
icu
environ
feasibl
appear
safe
short
observ
period
interact
game
therapi
may
complement
exist
rehabilit
techniqu
increas
motiv
icu
patient
engag
rehabilit
program
refer
feasibl
observ
safeti
interact
video
game
physic
rehabilit
intens
care
unit
case
seri
kho
damluji
zanni
jm
needham
dm
j
crit
care
apr
introduct
stop
rule
instig
earli
clinic
trial
termin
interim
analysi
show
statist
signific
effect
treatment
part
randomis
control
trial
rct
studi
aim
develop
stop
rule
base
observ
power
signific
differ
mortal
across
rct
arm
studi
method
stop
rule
develop
use
montecarlo
simul
approach
predetermin
control
group
mortal
rate
mc
intervent
group
mortal
rate
mi
stop
rule
determin
bia
mortal
requir
achiev
statist
signific
p
power
result
stop
rule
determin
shown
fig
yaxi
mortal
differ
mdiff
mc
mi
line
denot
stop
rule
differ
mc
exampl
mc
observ
sampl
size
per
arm
mdiff
requir
termin
trial
thu
mi
threshold
trigger
stop
rule
practic
mean
interim
analysi
patient
per
trial
arm
includ
death
control
group
intervent
group
must
observ
death
stop
trial
mi
mc
sampl
size
per
arm
patient
mdiff
figur
approxim
mortal
differ
similar
result
found
ardsnet
trial
compar
lower
tradit
tidal
volum
ventil
ardsnet
trial
found
mortal
differ
versu
signific
patient
per
arm
recruit
trial
earli
termin
trial
trigger
result
valid
stop
rule
design
method
present
studi
conclus
stop
rule
design
method
adapt
twoarm
rct
monitor
probabilist
binari
outcom
approach
design
rct
stop
rule
adjust
particip
cohort
use
local
data
base
desir
studi
characterist
fulfil
ethic
need
statist
justifi
stop
rule
refer
ard
network
nejm
p
introduct
daili
blood
test
long
run
featur
icu
care
regard
essenti
diagnost
tool
medic
staff
howev
risk
iatrogen
anaemia
real
one
signific
cost
method
exist
guidelin
intend
limit
excess
test
stabl
patient
audit
adher
also
record
trend
haematocrit
haemoglobin
identifi
case
iatrogen
anaemia
unit
order
establish
trend
exclud
stabl
post
surgic
patient
limit
elig
patient
unit
day
six
randomli
assign
day
month
period
elig
patient
unit
proforma
fill
retrospect
day
admiss
unit
seven
day
previous
whichev
sooner
presenc
arteri
central
access
also
note
facilit
obtain
sampl
result
obtain
patient
day
worth
data
across
patient
consid
elig
result
demonstr
test
done
requir
importantli
test
carri
deem
clinic
unnecessari
panel
three
icu
physician
order
despit
unit
guidelin
state
otherwis
inpati
cost
carri
unnecessari
blood
test
ad
amount
blood
wast
total
ml
base
figur
averag
volum
unnecessari
blood
taken
patient
per
week
ml
patient
select
central
arteri
line
part
inspect
day
effect
test
taken
daili
anyway
conclus
stop
short
suggest
opt
approach
lab
test
unit
recommend
period
educ
exist
nurs
medic
staff
also
new
traine
intens
care
unit
also
recommend
remov
alter
critic
care
test
set
current
avail
electron
request
system
hope
encourag
critic
think
test
appropri
patient
care
refer
goddard
k
austin
sj
appropri
regul
routin
laboratori
test
reduc
cost
associ
patient
stay
intens
care
unit
critic
care
r
gray
f
baldwin
target
blood
test
icu
may
lead
signific
cost
reduct
critic
care
introduct
signific
track
urin
output
marker
patient
deterior
gener
ward
remain
unclear
aim
explor
util
measur
urin
output
patient
includ
deterior
requir
intens
care
support
cohort
medic
surgic
ward
larg
metropolitan
hospit
australia
note
hospit
program
recognis
respond
deterior
patient
well
embed
includ
modifi
earli
warn
score
track
trigger
respons
method
retrospect
cross
section
analysi
perform
patient
admit
hospit
six
month
time
period
exclud
patient
premorbid
renal
insuffici
requir
dialysi
prior
admiss
patient
would
skew
result
collect
data
urin
output
modifi
earli
warn
score
patient
admit
icu
time
deterior
recognis
respond
patient
length
stay
mortalityal
data
subsequ
analys
use
spss
softwar
ethic
approv
obtain
research
result
ward
patient
urin
output
measur
perform
irrespect
whether
deterior
point
icu
admiss
remain
ward
despit
patient
low
urin
output
record
ward
subsequ
admit
icu
continu
lower
mean
output
first
hour
icu
stay
statist
signific
associ
found
reduct
urin
output
increas
hospit
mortal
mortal
rate
reduc
output
compar
normal
output
patient
subsequ
admit
icu
even
pronounc
correl
deterior
point
requir
icu
admiss
patient
receiv
medic
review
respons
deterior
may
elicit
review
urin
output
monitor
includ
activ
criteria
conclus
research
suggest
urin
output
remain
vital
compon
recognit
deterior
patient
focu
improv
routin
measur
paramet
rather
remov
modifi
earli
warn
scoresmor
reliabl
measur
may
allow
investig
whether
earlier
intervent
base
paramet
may
improv
patient
outcom
refer
acut
med
kidney
int
anaesth
icm
annal
at
introduct
pressur
ulcer
pu
common
seriou
complic
critic
ill
patient
studi
aim
evalu
incid
risk
factor
associ
pu
develop
adult
mix
intens
care
unit
icu
turkey
method
ethic
approv
obtain
prior
start
studi
prospect
cohort
studi
perform
decemb
juli
patient
screen
daili
discharg
death
consecut
period
collect
data
demograph
baselin
variabl
coexist
diseas
serum
albumin
level
reposit
frequenc
presenc
mechan
ventil
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
sequenti
organ
failur
assess
sofa
score
glasgow
coma
score
gc
vasoact
medic
result
total
patient
examin
studi
develop
pu
factor
associ
pu
develop
serum
albumin
level
p
gener
edema
p
mechan
ventil
use
p
sedat
p
gc
p
age
gender
bodi
mass
index
apach
ii
sofa
score
reposit
differ
patient
without
pu
conclus
pressur
ulcer
common
complic
adult
mix
intens
care
unit
potenti
sever
consequ
incid
pressur
ulcer
relat
state
conscious
sedat
mechan
ventilatori
support
presenc
gener
edema
refer
oliveira
costa
ac
sabino
pinho
cp
almeida
do
santo
ad
santo
nascimento
ac
pressur
ulcer
incidandc
demograph
clinic
nutrit
factor
associ
intens
care
unit
patient
nutr
hosp
doi
mehta
c
georg
jv
mehta
wangmo
n
pressur
ulcer
patient
characterist
point
preval
studi
tertiari
hospit
india
base
european
pressur
ulcer
advisori
panel
minimum
data
set
j
tissu
viabil
aug
doi
epub
apr
introduct
increas
number
size
close
icu
alexandria
egypt
met
compar
increas
number
intensivist
consequ
lead
work
overload
neg
impact
patient
intensivist
method
use
inperson
questionnair
consult
inhous
physician
close
icu
alexandria
egypt
obtain
inform
demograph
data
patient
workload
hospit
medic
duti
percept
workplac
teach
environ
result
physician
respond
averag
daili
sd
censu
patient
patient
averag
sd
maximum
servic
size
patient
median
consultantpati
ratio
classifi
icu
unfavour
ratio
icu
icu
favour
ratio
icu
median
inhous
physicianpati
ratio
classifi
icu
unfavour
ratio
unit
icu
favour
ratio
unit
respond
unfavour
ratio
icu
perceiv
significantli
time
constraint
teach
difficulti
burnout
neg
impact
patient
conclus
intensivist
work
unfavour
ratio
icu
frequent
perceiv
overburden
comparison
work
low
ratio
unit
also
high
physicianpati
ratio
may
neg
impact
teach
patient
care
workforc
stabil
refer
ward
ns
read
r
afessa
b
kahn
jm
perceiv
effect
attend
physician
workload
academ
medic
intens
care
unit
nation
survey
train
program
director
crit
care
med
ward
ns
afessa
b
kalispel
r
tisherman
rie
howel
et
alintensivistpati
ratio
close
icu
statement
societi
critic
care
medicin
taskforc
icu
staf
crit
care
med
halpern
na
pastor
sm
oropello
jm
kvetan
v
critic
care
medicin
unit
state
address
intensivist
shortag
imag
specialti
crit
care
med
introduct
reduct
alo
import
effici
indic
icu
hypothes
whether
eicu
creat
impact
qualiti
servic
financi
implic
thereof
method
retrospect
studi
done
tier
citi
hospit
eicu
support
compris
icu
bed
assess
impact
eicu
alo
period
incept
studi
period
octob
april
april
octob
respect
eicu
complet
access
patient
realtim
vital
imag
lab
valu
audiovisu
alert
eicu
support
pertain
patient
manag
clinic
protocol
implement
bundl
complianc
involv
chang
discharg
polici
administr
polici
patient
base
line
demograph
includ
risk
factor
sever
score
allcaus
mortal
day
record
descript
analysi
done
group
comparison
perform
appli
student
test
signific
assum
valu
p
financi
implic
deriv
base
averag
cost
per
icu
bed
per
day
result
total
patient
admit
icu
day
pre
post
eicu
respect
baselin
demograph
patient
profil
two
group
show
statist
signific
differ
mean
apach
ii
smr
standard
mortal
ratio
vs
smr
alo
vs
day
pre
post
eicu
respect
indic
reduct
signific
p
nosocomi
infect
incid
per
thousand
devic
day
post
eicu
came
decreas
financi
impact
reduc
alo
inr
million
signific
compar
eicu
cost
born
unit
inr
million
conclus
eicu
judg
cost
centr
administr
look
case
studi
clear
develop
countri
like
india
cost
effect
also
made
signific
decreas
alo
along
mortal
nosocomi
infect
lead
direct
impact
financi
patient
hospit
mobil
shorter
turnov
help
treat
patient
without
escal
cost
build
new
bed
never
adequ
manpow
resourc
refer
mccarthi
et
al
commit
safeti
ten
case
studi
reduc
harm
patient
common
wealth
fund
april
introduct
deterior
patient
hospit
typic
preced
chang
vital
sign
deterior
detect
base
chang
singl
vital
sign
result
miss
deterior
event
high
fals
alarm
rate
multi
paramet
system
modifi
nation
earli
warn
system
mew
news
use
look
tabl
score
data
multipl
vital
sign
specifi
action
base
score
system
offer
improv
perform
compar
singleparamet
system
creat
physician
consensu
may
make
optim
use
avail
data
explor
use
modern
data
mine
techniqu
deriv
high
perform
multi
paramet
deterior
detect
algorithm
earli
deterior
indic
edi
method
edi
creat
produc
risk
curv
everi
input
featur
everi
featur
valu
map
risk
score
ad
togeth
get
final
score
input
featur
edi
heart
rate
systol
blood
pressur
respir
rate
oxygen
satur
temperatur
age
deriv
valid
edi
collect
data
gener
ward
stay
stay
use
develop
algorithm
test
algorithm
stay
edi
mew
news
calcul
middl
gener
ward
stay
non
deterior
stay
patient
deterior
middl
valu
last
hour
deterior
use
calcul
score
comput
sensit
specif
valu
area
curv
auc
receiv
oper
characterist
curv
score
compar
perform
result
test
abil
edi
mew
news
predict
deterior
defin
patient
death
transfer
higher
level
care
icu
train
dataset
compris
deterior
preval
train
data
auc
valu
edi
news
mew
test
dataset
compris
deterior
preval
auc
valu
edi
news
mew
conclus
edi
develop
use
datadriven
approach
discov
pattern
vital
sign
valu
predict
immin
patient
deterior
base
continuousvalu
risk
curv
sensit
subtl
variat
vital
sign
may
autom
real
time
risk
assess
edi
significantli
improv
perform
commonli
deploy
system
mew
news
make
use
input
paramet
offer
possibl
dropin
solut
reduc
alarm
fatigu
introduct
king
colleg
hospit
one
largest
acut
tertiari
referr
hospit
uk
play
pivot
role
king
health
partner
ahsc
hospit
set
multidisciplinari
enhanc
critic
care
outreach
servic
support
patient
rel
staff
provid
rapid
respons
stabilis
critic
care
followup
outreach
educ
deliv
virtual
critic
care
bed
critic
care
flow
exceed
capac
method
process
hospit
outcom
data
collat
busi
intellig
unit
nation
cardiac
arrest
audit
ncaa
trend
hospit
outcom
cardiac
arrest
analys
use
linear
regress
conting
tabl
result
servic
saw
patient
first
year
repres
hospit
admiss
mean
number
review
per
patient
rang
discharg
patient
undergo
critic
care
intervent
make
clinic
episod
annual
dose
admiss
call
inappropri
exce
minimum
dose
recommend
institut
healthcar
improv
median
time
review
activ
minut
hospit
admiss
acuiti
rose
studi
period
measur
nation
set
metric
reduct
actual
cardiac
arrest
rate
forecast
cardiac
arrest
rate
base
local
histor
ncaa
data
p
signific
differ
trend
expect
vs
observ
death
pre
post
introduct
imobil
servic
p
conclus
high
impact
high
dose
critic
care
outreach
servic
deliv
chang
outcom
difficult
evalu
healthcar
sociocultur
intervent
introduct
icu
bed
scarciti
associ
reduc
probabl
icu
admiss
clear
decis
admit
subject
heurist
bias
impact
greater
cognit
load
method
physician
electron
invit
respond
onlin
questionnair
studi
factori
trial
respond
random
increas
increas
cognit
load
differ
version
vignett
cognit
load
simul
distract
video
sound
timelimit
respons
clinic
vignett
base
real
patient
icu
admiss
request
archetyp
vignett
icu
admiss
refus
defin
base
expert
opinion
six
group
vignett
construct
singl
archetyp
admiss
two
simultan
archetyp
admiss
singl
archetyp
refus
two
simultan
archetyp
refus
singl
nonarchetyp
vignett
group
randomli
present
icu
scarciti
last
bed
avail
nonscarc
set
group
vignett
randomli
present
two
version
consist
multipl
choic
vignett
respond
present
decis
admit
archetyp
case
icu
admiss
elect
surgeri
patient
consist
statu
quo
vignett
last
icu
bed
alreadi
reserv
elect
surgeri
patient
respond
present
two
simultan
icu
request
archetyp
case
icu
admiss
result
physician
log
random
complet
data
complet
rate
lower
cognit
load
group
vs
p
differ
demograph
characterist
cognit
load
impact
proport
case
admit
refus
group
group
vignett
often
refus
admiss
icu
scarciti
set
vs
p
archetyp
vignett
admiss
often
refus
group
multiplechoic
group
statu
quo
vs
p
conclus
impact
cognit
load
respons
result
may
hamper
differenti
dropout
rate
icu
scarciti
associ
increas
refus
patient
icu
admiss
deem
inappropri
refus
patient
icu
admiss
deem
appropri
multiplechoic
bia
impact
statu
quo
bia
inappropri
refus
icu
admiss
refer
sinuff
et
al
crit
care
med
introduct
patient
admit
emerg
depart
ed
intens
care
unit
icu
repres
uniqu
popul
vari
etiolog
ill
exist
descript
analysi
sever
earli
prognosi
diseas
lack
studi
compar
sever
icu
ill
sever
score
acut
physiolog
chronic
health
evalu
apach
ii
simplifi
acut
physiolog
score
sap
ii
sequenti
organ
failur
assess
sofa
score
within
cohort
patient
earli
ed
icu
cours
describ
ill
progress
method
retrospect
review
consecut
patient
admit
ed
icu
academ
referr
center
januari
februari
clinic
demograph
data
collect
calcul
apach
ii
sapsii
sofa
score
initi
ed
arriv
except
sapsii
ed
discharg
first
hour
icu
ttest
use
evalu
differ
score
time
interv
p
repres
signific
result
enrol
patient
averag
year
age
femal
admit
medic
surgic
neurolog
icu
mortal
rate
sofa
apach
ii
sap
ii
result
summar
tabl
comparison
score
ttest
show
signific
increas
ill
sever
ed
arriv
end
first
hour
icu
tabl
conclus
ill
score
sofa
apacheii
sapsii
significantli
increas
hour
icu
admiss
compar
ed
arriv
preliminari
investig
data
provid
insight
expect
progress
ill
icubound
patient
admit
ed
work
need
elucid
prognost
indic
patientcar
factor
introduct
critic
care
cc
servic
increas
demand
publish
guidanc
triag
admiss
may
longer
reflect
current
practic
exercis
toler
clinic
frailti
assess
may
role
assess
patient
pt
refer
cc
aim
establish
impact
frailti
factor
decis
make
process
method
referr
cc
prospect
enrol
review
cohort
data
includ
patient
demograph
measur
acut
physiolog
derang
earli
warn
score
ew
prior
hospit
length
stay
lo
exercis
toler
et
function
depend
statu
canadian
clinic
frailti
scale
ccf
comorbid
logist
regress
analysi
use
assess
factor
influenc
admiss
use
stata
result
express
median
interquartil
rang
odd
ratio
admiss
confid
interv
ci
result
data
collect
pt
refer
cc
novemb
octob
made
hour
admit
median
age
year
male
median
lo
prior
referr
day
median
ccf
met
grade
ew
respect
major
referr
came
medic
specialti
pt
directli
emerg
depart
pt
surgic
specialti
common
comorbid
cardiovascular
pt
diseas
respiratori
pt
diabet
pt
common
referr
reason
sepsi
pt
postop
monitor
account
referr
age
gender
adjust
logist
regress
analysi
ew
per
point
ci
p
ccf
per
point
ci
p
et
yard
ci
p
selfcar
statu
ci
p
housebound
statu
ci
p
influenc
admiss
number
cc
bed
avail
lo
prior
referr
met
grade
conclus
frailti
level
depend
exercis
toler
appear
major
factor
decis
make
regard
admiss
cc
even
adjust
age
factor
may
support
decis
make
allow
object
quantif
function
reserv
refer
acccmsccm
task
forc
ccm
at
ajrccm
lemaguet
p
et
al
icm
may
introduct
demand
critic
care
cc
increas
admiss
may
inappropri
patient
unlik
surviv
consequ
publish
guidanc
may
longer
reflect
current
practic
clinic
frailti
evalu
score
recent
shown
associ
increas
mortal
patient
alreadi
admit
cc
aim
establish
impact
frailti
factor
decis
whether
admit
deterior
hospit
patient
cc
method
unplan
patient
referr
prospect
enrol
review
cohort
data
includ
patient
demograph
acut
physiolog
paramet
prior
hospit
length
stay
lo
canadian
clinic
frailti
scale
ccf
comorbid
logist
regress
analysi
use
assess
factor
influenc
admiss
use
stata
result
express
median
interquartil
rang
odd
ratio
confid
interv
ci
result
june
octob
data
collect
patient
refer
cc
admit
median
age
year
male
median
lo
prior
referr
day
median
sofa
score
ccf
charlson
ageadjust
comorbid
index
caci
respect
unadjust
logist
regress
analysi
age
p
gender
p
lo
p
sofa
score
p
impact
likelihood
admiss
cc
convers
unit
increas
caci
ci
p
ccf
ci
p
caus
decreas
approxim
odd
admiss
respect
age
gender
adjust
multivari
logist
regress
analysi
ccf
retain
abil
predict
admiss
critic
care
per
unit
increas
ci
p
whilst
caci
ci
p
conclus
frailti
appear
major
factor
decis
make
regard
admiss
cc
even
adjust
age
gender
known
comorbid
quantif
frailti
use
ccf
may
valuabl
tool
risk
stratif
resourc
alloc
merit
investig
context
refer
acccmsccm
task
forc
ccm
american
thorac
societi
ajrccm
lemaguet
p
et
al
intens
care
med
may
introduct
intens
care
unit
icu
admiss
triag
perform
routin
icu
develop
develop
countri
often
base
sole
clinic
judgement
could
mask
uneth
prejudic
bia
therefor
develop
object
triag
score
guidelin
appli
individu
patient
discuss
literatur
help
triag
decis
icu
admiss
critic
care
team
assembl
come
instrument
aid
triag
decis
base
societi
critic
care
medicin
sccm
guidelin
sought
evalu
valid
reliabl
instrument
method
algorithm
base
respons
icu
request
form
develop
classifi
patient
four
sccm
prioriti
strata
nine
physician
experi
critic
care
emerg
medicin
evalu
forti
clinic
vignett
reliabl
analyz
correl
algorithmbas
prioriti
surrog
gold
standard
defin
panel
specialist
evalu
valid
analysi
valid
evalu
appli
algorithm
retrospect
sampl
patient
request
icu
admiss
associ
outcom
result
overal
agreement
substanti
weight
kappa
ci
algorithmbas
prioriti
also
correl
prioriti
ascrib
specialist
weight
kappa
ci
subject
assess
appropri
icu
admiss
algorithmbas
prioriti
also
associ
icu
admiss
hospit
mortal
prioriti
hospit
mortal
rate
respect
p
howev
unadjust
analysi
differenti
mortal
benefit
icu
admiss
prioriti
stratum
conclus
icu
admiss
triag
tool
demonstr
good
reliabl
valid
predict
characterist
howev
may
suitabl
standard
practic
yet
sinc
properli
evalu
demonstr
differ
benefit
icu
admiss
justifi
admiss
one
prioriti
stratum
other
prospect
studi
addit
collect
variabl
implement
address
limit
refer
sccm
crit
care
med
sprung
et
al
int
care
med
introduct
ssrisnri
among
commonli
prescrib
drug
patient
admit
critic
care
review
literatur
evid
benefitharm
chronic
use
continu
use
withdraw
guid
clinician
consid
whether
continu
stop
restart
medic
critic
care
method
data
sourc
studi
novemb
identifi
use
prespecifi
search
term
medlin
embas
cochran
central
regist
control
trial
studi
select
abstract
screen
predefin
criteria
fulltext
articl
assess
elig
appli
prespecifi
exclus
criteria
studi
includ
systemat
review
total
patient
one
larg
studi
data
extract
studi
analys
accord
publish
qualiti
criteria
cohort
studi
award
newcastleottawa
score
data
synthesi
low
number
studi
review
heterogen
allow
metaanalysi
narr
review
present
result
found
paper
present
use
evid
five
cohort
studi
one
case
seri
seven
case
report
found
evid
benefit
use
ssrisnri
critic
care
found
evid
increas
morbid
patient
use
ssrisnri
admiss
critic
care
howev
due
inadequ
administr
report
often
unclear
actual
continu
therefor
whether
harm
due
chronic
effect
ongo
use
drug
withdraw
conclus
overal
inadequ
data
draw
firm
conclus
feel
suffici
uncertainti
regard
safeti
util
ssrisnri
critic
care
warrant
random
intervent
studi
continuingwithhold
critic
care
admiss
refer
critic
care
medicin
suppl
chest
apr
gastrointest
endosc
jul
heart
lung
circ
apr
chest
feb
introduct
literatur
lack
brief
specif
valid
instrument
measur
monitor
adapt
cope
hospit
patient
sever
medic
condit
henc
introduc
sick
insight
cope
questionnair
sicq
examin
valid
patientproxi
agreement
method
studi
n
hospit
patient
address
intern
consist
initi
factor
structur
construct
valid
sicq
cope
subscal
brief
cope
ill
cognit
questionnair
utrecht
cope
list
use
compar
measur
test
construct
valid
sicqsubscal
fight
spirit
tough
redefinit
positiv
nonaccept
studi
n
icupati
close
famili
member
icupati
proxi
address
structur
valid
sicq
confirmatori
factor
analys
examin
patientclos
proxi
agreement
correl
blandaltman
plot
analys
result
studi
show
sicq
adequ
intern
consist
clear
initi
factor
structur
adequ
converg
r
diverg
r
construct
valid
studi
show
sicq
good
structur
valid
moder
r
nonaccept
strong
r
fight
spirit
tough
redefinit
positiv
patientclos
proxi
agreement
conclus
overal
sicq
good
psychometr
properti
icu
use
sicq
gain
insight
adapt
cope
style
patient
rate
close
famili
member
introduct
portug
train
intens
care
done
achiev
primari
specialti
chang
propos
creat
primari
intens
care
medicin
icm
specialti
nation
survey
done
determin
intens
care
practition
opinion
train
icm
method
questionnair
sent
intens
care
practition
model
intens
care
train
describ
primari
specialti
direct
entri
follow
primari
medic
qualif
subspecialti
anoth
disciplin
supraspecialti
permit
multidisciplinari
access
rang
base
specialti
result
team
sent
questionnair
obtain
answer
respond
year
male
work
intens
care
year
work
full
time
work
share
schedul
n
dedic
time
icm
primari
specialti
respond
intern
medicin
anaesthesiolog
previou
experi
primari
specialti
initi
intens
care
practic
year
question
ideal
model
n
choos
primari
special
think
train
year
consid
import
common
core
intern
medicin
anaesthesiolog
emerg
medicin
cardiolog
other
remain
train
entir
icm
think
train
dedic
icu
consid
mainli
neuroicu
redicu
support
icm
supraspecialti
n
subspecialti
n
main
reason
point
previou
specialti
facilit
acquisit
icm
knowledg
increas
clinic
autonomi
provid
higher
capac
clinic
judgment
medic
decis
allow
firm
bioethic
knowledg
advantag
multidisciplinari
team
regard
train
program
know
cobatric
project
know
pact
find
useful
technic
compet
found
desir
icm
train
echocardiogram
bronchoscopi
fast
eco
other
undergradu
teach
report
desir
n
conclus
good
respons
rate
less
half
respond
think
icm
primari
specialti
vast
major
think
intens
care
team
compos
consult
differ
specialti
introduct
workrel
stress
accompani
emot
provok
specif
intens
care
unit
icu
well
document
previou
year
highstak
high
stress
environ
icu
health
care
profession
hcp
practic
demand
intellectu
physic
emot
work
engag
operation
posit
workrel
state
mind
character
vigor
dedic
absorpt
aim
studi
explor
influenc
person
resourc
eg
empath
abil
work
engag
among
icu
hcp
method
design
studi
crosssect
survey
studi
among
icu
hcp
ie
intensivist
nurs
erasmu
mc
univers
hospit
netherland
digit
link
questionnair
sent
octob
given
email
address
nurs
mix
icu
nurs
thorac
icu
nurs
cardiac
icu
intensivist
two
remind
sent
work
engag
measur
utrecht
work
engag
scale
includ
item
five
point
likert
item
person
feel
work
addit
item
base
jefferson
scale
physician
empathi
measur
emphat
abil
result
overal
respons
rate
malefemal
ratio
mean
age
respond
year
mean
work
hoursweek
rate
finish
alevel
educ
icu
hcp
score
vigor
higher
dedic
p
lower
absorpt
p
compar
averag
dutch
employe
report
stress
relat
symptom
mental
distanc
sleep
disord
although
icu
hcp
assess
workload
high
compar
emot
burden
score
higher
respect
p
gener
hcp
act
benchmark
empath
abil
icu
hcp
show
equal
score
cognit
compon
compar
lower
score
emot
compon
compar
p
mean
cognit
empathi
posit
correl
vigor
r
although
cognit
emot
empathi
correl
work
engag
conclus
workload
icu
may
high
seem
hard
respond
assum
workload
emot
high
burden
acknowledg
integr
part
icu
work
icu
hcp
understand
patient
rel
remain
certain
distanc
emot
result
studi
suggest
influenc
work
engag
empath
abil
introduct
burnout
rapid
resurg
worldwid
problem
intens
care
unit
icu
practition
particularli
risk
leaderempow
behavior
could
reduc
encount
job
tension
enhanc
work
effect
aim
assess
role
empower
icu
practition
burnout
method
mix
qualit
quantit
methodolog
use
crosssect
descript
survey
case
studi
focus
qatari
icu
anonym
questionnair
survey
present
staff
member
includ
physician
nurs
respiratori
therapist
work
full
time
use
two
main
instrument
maslasch
burnout
scale
mbihss
empower
scale
es
high
burnout
consid
mbihss
score
result
twohundr
healthcar
practition
enrol
mix
medic
surgic
icu
fiftyon
icu
practition
show
high
preval
associ
physician
nurs
respiratori
therapist
equal
present
burnout
associ
p
age
associ
high
burnout
p
gender
empower
significantli
associ
burnout
twotail
test
p
posit
empower
neg
effect
burnout
varianc
specul
practition
burnout
conclus
empower
compon
could
reduc
burnout
within
icu
particular
attent
given
high
burnout
icu
set
refer
lasching
hk
wong
c
mcmahon
l
kaufmann
c
leader
behavior
impact
staff
nurs
empower
job
tension
work
effect
j
nur
maslach
c
jackson
se
leiter
mp
maslach
burnout
inventori
manual
palo
alto
california
ed
introduct
circadian
rhythm
profound
role
harmonis
function
organ
cell
human
bodi
disrupt
rhythm
ie
chronodisrupt
accompani
wide
spectrum
patholog
condit
rhythm
healthi
subject
mainli
orchestr
daili
cycl
light
dark
shown
elev
melatonin
mel
level
peak
dawn
aim
prospect
clinic
studi
examin
rhythm
mel
releas
icu
patient
suffer
continu
light
pollut
method
mechan
ventil
patient
year
without
brain
injuri
enrol
studi
januari
illumin
measur
lux
meter
patient
bodi
serum
mel
level
determin
blood
sampl
measur
took
place
admiss
start
closest
time
point
regular
sampl
period
hour
precis
min
day
blood
sampl
kept
total
dark
clot
centrifug
min
rpm
serum
sampl
place
mel
measur
perform
result
patient
enrol
multidisciplinari
icu
age
year
malefemal
ratio
measurementspati
mel
sampl
analys
mel
illumin
level
summaris
fig
although
illumin
lowest
level
still
lot
higher
physiolog
requir
furthermor
mel
peak
occur
also
miss
repeat
correl
analysi
mel
serum
concentr
illumin
level
show
weak
withinsubject
correl
r
p
still
nonsignific
betweensubject
correl
r
p
conclus
result
indic
circadian
rhythm
desynchron
icu
patient
indic
miss
mel
peak
night
b
poor
correl
illumin
mel
level
c
absenc
normal
rhythm
mel
releas
futur
trial
henc
warrant
test
whether
provid
physiolog
lightdark
condit
could
resynchronis
circadian
rhythm
effect
patient
outcom
refer
hardeland
et
al
progress
neurobiolog
introduct
nois
underestim
problem
icu
attribut
sleep
disturb
delirium
advers
effect
morbid
mortal
critic
ill
patient
recommend
averag
sound
level
dba
achiev
icu
time
averag
sound
level
exceed
dba
report
sinc
nois
also
icu
consid
problem
investig
sound
level
caus
tri
implement
bundl
measur
nois
reduct
method
place
sound
level
meter
amptec
rt
two
place
icu
one
bedsid
twobe
room
one
nurs
station
record
perform
locat
continu
hr
period
simultan
structur
observ
perform
identifi
caus
elev
sound
level
identifi
mean
caus
nois
implement
bundl
measur
nois
reduct
record
observ
repeat
result
averag
sound
level
compar
bedsid
nurs
station
nois
reduct
measur
bedsid
dba
vs
dba
night
dba
vs
dba
daytim
nurs
station
dba
vs
night
dba
vs
dba
daytim
also
differ
incid
sound
level
peak
bedsid
vs
nurs
station
vs
howev
maximum
sound
level
peak
bedsid
significantli
reduc
dba
vs
dba
observ
show
oper
sound
structur
sound
main
caus
nois
icu
particular
icuteam
nurs
doctor
seem
main
contribut
factor
conclus
reduct
nois
icu
complex
multimod
reach
level
seem
feasibl
icu
set
sinc
measur
nois
reduct
temper
peak
averag
sound
level
sinc
icuteam
main
contribut
factor
behaviour
guidelin
play
import
role
nois
reduct
refer
darbyshir
et
al
critic
care
introduct
human
care
critic
patient
bedwash
intern
activ
impact
risk
involv
accident
remov
invas
devic
intens
care
unit
exempt
modifi
bedwash
protocol
order
measur
impact
direct
supervis
profession
nurs
intervent
badwash
relat
incid
accident
remov
invas
devic
method
incid
accident
remov
invas
devic
orotrach
tube
arteri
cathet
central
venou
access
surgic
drainag
indwel
urinari
cathet
review
intens
care
unit
icu
hospit
universidad
de
chile
differ
total
event
bedwash
patient
coordin
continu
medic
educ
nurs
team
emerg
intens
nurs
technician
nurs
auxiliari
modifi
bedwash
protocol
includ
direct
supervis
nurs
intervent
critic
patient
invas
devic
defin
two
period
comparison
incid
rate
analyz
studi
period
kwalli
nonparametr
test
signific
level
p
result
incid
rate
accident
remov
invas
devic
review
icu
databas
nurs
depart
hospit
period
diagnost
describ
event
accident
remov
invas
devic
badwash
rate
adjust
event
per
year
evalu
period
event
report
bedwash
rate
adjust
event
per
year
rate
show
signific
differ
total
event
p
compar
rate
bedwash
event
signific
differ
observ
relat
chang
protocol
p
conclus
decreas
evid
overal
incid
accident
remov
invas
devic
liaison
continu
medic
educ
p
observ
incid
bedwash
period
diagnost
evalu
intervent
p
presenc
nurs
bedwash
decreas
significantli
rate
accident
remov
invas
devic
believ
data
valid
implement
bedwash
protocol
introduct
aim
audit
investig
complianc
critic
care
unit
ccu
applic
depriv
liberti
safeguard
dol
authoris
dol
form
part
uk
mental
capac
act
intend
safeguard
right
patient
lack
mental
capac
whose
freedom
leav
healthcar
environ
potenti
limit
requir
written
applic
local
author
order
gain
permiss
patient
go
care
howev
fact
situat
potenti
appli
patient
ccu
unintend
consequ
legisl
increasingli
appli
critic
ill
patient
result
signific
workload
critic
care
team
local
council
method
search
made
phillip
icip
electron
record
period
dec
sept
number
patient
mental
health
assess
form
complet
declar
lack
capac
detail
search
note
electron
patient
record
epr
made
order
look
retrospect
number
dol
applic
made
comparison
number
requir
result
total
admiss
patient
lack
capac
point
stay
divid
emerg
medic
elect
surgic
emerg
surgic
admiss
respect
patient
retrospect
deem
elig
dol
applic
submit
local
council
reason
authoris
necessari
divid
tracheostomi
relat
chemicalphys
restraint
delirium
best
interest
decis
averag
dol
authoris
necessari
day
local
author
deni
applic
averag
time
identifi
lack
capac
complet
dol
applic
day
conclus
signific
number
patient
admit
ccu
lack
mental
capac
may
risk
liberti
depriv
complianc
rate
may
reflect
way
dol
appli
ccu
local
intervent
routin
precons
streamlin
dol
applic
process
implement
intent
reduc
work
load
improv
rate
complianc
law
refer
crew
et
al
journal
intens
care
societi
volum
introduct
cristal
tool
identifi
elderli
die
patient
hospit
aim
help
avoid
aggress
futil
treatment
initi
appropri
plan
end
life
care
aim
assess
whether
version
modifi
depart
institut
would
help
identifi
elderli
patient
may
benefit
critic
care
method
unplan
critic
care
admiss
patient
age
year
januari
march
retrospect
analys
valid
predictor
short
medium
term
death
chosen
cristal
checklist
assign
score
present
absent
maximum
chronic
kidney
diseas
ckd
previou
myocardi
infarct
abnorm
ecg
present
congest
cardiac
failur
chronic
pulmonari
diseas
cerebrovascular
diseas
dementiacognit
impair
long
term
institutionalis
mental
health
chronic
liver
diseas
solid
tumour
hospit
stay
critic
care
review
previou
hospitalis
past
year
previou
icu
admiss
mark
weight
loss
last
month
frailti
rockwood
scale
sum
score
survivor
nonsurvivor
compar
statist
analysi
perform
via
mannwhitney
u
test
spss
valu
express
median
rang
result
patient
median
age
femal
male
receiv
level
level
care
median
modifi
cristal
score
higher
nonsurvivor
compar
survivor
pvalu
differ
maintain
subgroup
level
survivor
nonsurvivor
pvalu
level
patient
survivor
nonsurvivor
pvalu
conclus
absolut
cristal
score
valu
assess
simplifi
tool
low
across
group
signal
increas
mortal
higher
score
may
suggest
use
inform
treatment
stratif
elderli
critic
ill
patient
identif
appropri
individu
paramet
rel
contribut
toward
overal
score
merit
evalu
refer
cardonamorrel
et
al
bmj
support
palli
care
rockwood
k
et
al
cmaj
introduct
increas
evid
wellstructur
palli
care
initi
form
integr
consult
combin
standard
icu
care
provid
benefit
patient
famili
recent
system
review
suggest
proactiv
palli
care
icu
decreas
hospit
icu
length
stay
method
embark
first
kind
icupalli
collabor
project
singapor
aim
improv
referr
rate
palli
care
patient
wih
poor
prognosi
neurosurg
intens
care
nicu
poor
prognosi
defin
patient
least
one
follow
referr
criteria
hypox
ischaem
encephalopathysever
head
injuri
poor
neurolog
prognosisextens
intracerebralsubarachnoid
haemorrhagelow
present
glasgow
coma
scale
gc
less
multidisciplinari
team
consist
intensivist
neurosurgeon
medic
social
worker
nurs
palli
care
medicin
physician
form
core
team
lead
project
nicu
intervent
includea
structur
screen
tool
easili
avail
nursesa
referr
criteria
agre
upon
involv
care
patientcommun
workshop
conduct
nurs
physician
nicu
broach
end
life
care
issu
familyweekli
palli
round
nicu
discuss
current
case
debrief
previou
patient
refer
result
number
pallait
care
referr
increas
baselin
patient
rel
interview
higher
level
satisfact
overal
medic
care
hospit
day
reduct
icu
stay
patient
refer
palli
care
attend
cost
save
conclus
palli
care
icu
import
part
manag
patient
poor
prognosi
improv
famili
emot
outcom
abd
reduc
icu
length
stay
refer
ipalicu
consensu
group
crit
care
med
introduct
limit
life
support
care
lsc
withdraw
lsc
scarc
studi
intermedi
care
unit
idtcu
report
preval
lsc
limit
patient
medicosurg
intermedi
care
unit
six
month
period
descript
outcom
pattern
lsc
limit
withdraw
patient
method
monocentr
retrospect
observ
studi
idtcu
gener
hospit
data
extract
patient
file
includ
age
gender
admiss
diagnos
knau
index
charlson
comorbid
score
sever
score
sofa
lsc
treatment
idtcu
hospit
mortal
length
stay
lsc
withdrawalfactor
associ
lsc
limit
lsc
determin
univari
multivari
analysi
result
patient
patient
admit
lsc
limit
idtcu
present
higher
chronic
acut
sever
score
unlimit
patient
frequent
admiss
diagnosi
lsc
limit
patient
acut
respiratori
failur
patient
non
invas
ventil
niv
use
frequent
within
popul
hospit
mortal
lsc
limit
patient
high
associ
grow
age
preexist
organ
failur
comorbid
elev
sofa
score
hypoxem
respiratori
failur
withdraw
lsc
proceed
case
frequent
termin
sedat
without
niv
retriev
conclus
patient
limit
lsc
frequent
admit
idtcu
hospit
mortal
high
associ
age
acut
preexist
organ
failur
hypoxem
respiratori
failur
life
support
withdraw
includ
niv
termin
wean
palli
sedat
lsc
limit
hypercapn
patient
appear
safe
treat
niv
high
mortal
sever
patient
rais
question
appropri
care
use
acut
care
resourc
refer
nava
sturani
c
hartl
magni
g
ciontu
corrado
endoflif
decis
make
respiratori
intermedi
care
unit
european
survey
eur
respir
j
nasraway
sa
cohen
il
denni
rc
et
al
guidelin
admiss
discharg
adult
intermedi
care
unit
american
colleg
critic
care
medicin
societi
critic
care
medicin
crit
care
med
mar
introduct
suggest
clinic
deterior
hospit
could
seen
trigger
palli
care
pc
consult
cooccurr
urgent
intens
care
unit
icu
admiss
request
pc
consult
request
analyz
hospit
patient
method
urgent
icu
admiss
palli
care
consult
request
academ
tertiari
hospit
may
may
evalu
patient
analyz
four
differ
group
icu
request
without
palli
care
consult
icunop
icu
request
palli
care
consult
icuandp
compris
patient
palli
care
consult
icu
admiss
request
palbeficu
palli
care
consult
icu
admiss
request
palafticu
result
icu
admiss
request
palli
care
consult
request
former
icu
pal
patient
compar
icunop
older
vs
year
p
sever
diseas
measur
score
vs
p
less
like
admit
icu
vs
p
higher
adjust
hospit
mortal
vs
ci
patient
palbeficu
palafticu
compar
two
group
differ
score
organ
dysfunct
use
artifici
life
support
moment
icu
request
palbeficu
patient
hospit
fewer
day
pc
consult
request
vs
day
p
like
diagnosi
moment
consult
vs
p
present
less
frequent
palli
perform
scale
pp
lower
vs
p
patient
pc
consult
discontinu
palbeficu
group
vs
p
main
reason
discontinu
absenc
indic
exclus
palli
care
vs
p
howev
palbeficu
patient
less
like
admit
icu
vs
p
hospit
mortal
similar
group
vs
p
adjust
sever
ill
conclus
cooccurr
icu
admiss
request
pc
consult
hospit
frequent
pc
consult
icu
request
associ
lower
chanc
icu
admiss
patient
extrem
high
hospit
mortal
despit
differ
time
consult
diagnosi
pp
definit
life
support
limit
data
seem
support
notion
clinic
deterior
hospit
may
seen
opportun
discuss
end
life
goal
introduct
endoflif
eol
decis
make
acut
care
complex
involv
difficult
decis
whether
initi
discontinu
life
support
place
feed
tube
tracheostomi
initi
cardiopulmonari
resuscit
cpr
event
cardiac
arrest
method
critic
care
nurs
suffer
think
perform
procedur
harm
low
efficaci
advocaci
ineffect
prolong
unrecogn
suffer
detriment
lead
disengag
silenc
habitu
silenc
silenc
face
perceiv
wrong
result
perman
deleter
chang
ethic
valu
recent
studi
research
suggest
fals
optim
associ
medic
activ
strong
need
control
death
preval
western
world
ignor
emot
anesthesia
present
us
result
narr
enabl
involv
icu
negoti
mean
critic
care
patient
narr
function
interpret
procedur
allow
divers
person
nursespati
patient
famili
make
sens
critic
care
suppli
theori
instrument
negoti
mean
throughout
process
respect
realiti
limit
care
conclus
effect
practic
medicin
requir
narr
compet
abil
acknowledg
absorb
interpret
act
stori
plight
other
nurs
work
us
everi
day
often
caught
middlean
ethic
unten
posit
attempt
compli
medic
direct
simultan
protect
advoc
patient
refer
practic
expert
critic
care
nurs
situat
prognost
conflict
end
life
catherin
mcbride
robichaux
angela
p
clark
j
crit
care
introduct
evalu
end
life
practis
bed
icu
neuro
intens
care
method
prospect
observ
studi
end
life
decis
made
medic
profession
whether
patient
famili
legal
repres
involv
end
life
decis
result
patient
admit
icu
month
period
patient
die
icu
patient
die
ward
follow
withdraw
die
follow
withdraw
withhold
dead
spontan
cardiac
arrest
brain
deadal
patient
limit
therapi
famili
consensu
autonom
decis
patient
conclus
reason
withdraw
care
either
unrespons
maxim
therapi
irrevers
neurolog
statu
optim
use
resourc
good
practis
optim
care
icu
remain
challeng
consnsu
famili
remain
challeng
despit
good
commun
well
educ
clientelether
still
scope
improv
area
refer
die
digniti
icu
new
eng
journal
june
mcdonagh
jr
elliott
tb
engelberg
ra
et
al
famili
satisfact
famili
confer
endoflif
care
intens
care
unit
increas
proport
famili
speech
associ
increas
satisfact
crit
care
med
introduct
around
death
uk
occur
hospit
give
total
around
respons
confirm
document
death
rest
across
specialti
hospit
doctor
academi
medic
royal
colleg
amrc
releas
consensu
guidelin
aim
standardis
process
guidanc
avail
diagnosi
death
follow
cardiorespiratori
arrest
death
follow
cessat
brainstem
function
diagnosi
transpar
consist
instil
public
confid
process
audit
took
retrospect
look
current
practic
adher
guidelin
method
retrospect
case
note
examin
carri
februari
august
death
observ
whiston
icu
period
doctor
carri
review
involv
process
diagnos
death
order
bia
studi
find
data
collect
entri
made
patient
case
note
compar
recommend
standard
set
within
amrc
guidelin
includ
absenc
heart
breath
sound
central
puls
corneal
reflex
patient
observ
minut
time
date
enter
patient
record
along
namegrad
doctor
result
verif
death
examin
complianc
follow
heart
sound
central
puls
respiratori
effort
observ
minut
absent
case
pain
respons
pupillari
respons
corneal
reflex
time
correct
date
correct
sign
print
name
grade
case
durat
observ
document
mean
time
minut
instanc
practic
fall
line
current
guidelin
conclus
despit
amrc
consensu
guidelin
avail
best
practic
diagnosi
death
remain
great
deal
variat
practic
common
procedur
case
note
examin
met
guidelin
major
observ
patient
long
enough
document
corneal
reflex
furthermor
case
found
document
timed
death
incorrectli
propos
wide
variat
practic
easili
address
introduct
standardis
proforma
complet
sign
clinician
time
verif
refer
wwwonsgovuk
amrc
code
practic
diagnosi
confirm
death
introduct
human
deceas
skin
donor
allograft
repres
suitabl
much
use
tempor
option
skin
cover
follow
kind
skin
injuri
main
advantag
use
includ
dermoprotect
disadvantag
use
includ
limit
abund
donor
avail
surgic
retriv
team
paper
explor
role
skin
procur
perform
intens
care
physician
method
data
skin
procur
perform
modena
hospit
analyz
attend
burn
care
unit
cesena
short
train
plastic
surgeon
usual
perferm
kind
procedur
two
intens
care
physician
abl
perform
skin
retriv
sinc
electr
dermatom
use
remov
skin
retriv
skin
graft
sent
bank
tissu
activ
skin
tissu
bank
current
involv
recoveri
process
storag
distribut
result
human
skin
allograft
obtain
multi
organ
tissu
donor
brain
cardiac
death
nine
year
deceas
donor
skin
allograft
donat
perform
signific
improv
number
skin
procur
observ
introduct
intens
care
physician
surgic
team
fig
qualiti
quantiti
human
skin
allograft
procur
intensivist
compar
procur
plastic
surgeon
conclus
skin
perform
varieti
import
function
human
bodi
deceas
donor
skin
allograft
feasibl
option
save
life
patient
extens
skin
injuri
intensivist
train
human
allograft
procur
implement
donor
pool
refer
c
w
horner
e
crighton
p
dziewulski
challeng
provis
skin
uk
use
human
deceas
donor
skin
burn
care
relat
mass
incid
uk
cell
tissu
bank
doi
jorg
leonvillapalo
moham
eldardiri
peter
dziewulski
use
human
deceas
donor
skin
allograft
burn
care
cell
tissu
bank
doi
introduct
mode
death
pediatr
intens
care
unit
picu
could
differ
differ
popul
institut
set
aim
present
studi
investig
mode
death
singl
center
method
retrospect
death
analysi
multidisciplinari
picu
northern
greec
death
happen
pt
stay
record
data
collect
demograph
reason
sever
score
admiss
treatment
characterist
laboratori
data
appropri
antibiot
defin
pathogen
suscept
least
one
drug
given
least
hour
death
mode
death
classifi
death
due
mod
brain
death
bd
limit
care
dl
p
result
twenti
seven
death
femal
mean
age
mo
record
admiss
eighteen
pt
die
mod
six
bd
three
due
dl
pt
die
mod
significantli
younger
pt
die
due
dl
readmiss
suffer
comorbid
sever
score
lactat
level
admiss
lo
differ
significantli
accord
mode
death
although
signific
time
surround
death
death
posit
blood
cultur
reveal
pt
mod
acinetobact
b
enterobact
c
pseudomona
aer
klebsiella
p
enterococcu
f
candida
non
al
appropri
antibiot
prescrib
conclus
found
mod
main
mode
death
follow
bd
dl
pt
die
mod
like
younger
suffer
comorbid
major
pt
die
mod
inadequ
treatment
result
arriv
quit
late
could
specul
time
process
handl
blood
cultur
result
better
antibiot
coverag
could
lead
better
infect
control
less
progress
mod
death
refer
lee
jk
et
al
pediatr
ten
berg
j
et
al
bmc
pediatr
introduct
organ
donat
euthanasia
perform
least
time
belgium
netherland
often
icu
thousand
undergo
euthanasia
year
unclear
potenti
procedur
donor
pool
method
possibl
obtain
detail
euthanasia
data
dutch
author
belgian
euthanasia
report
analyz
primari
outcom
number
patient
could
donat
least
organ
subgroup
analysi
perform
evalu
number
potenti
donor
per
organ
exclus
base
contraind
donat
within
eurotranspl
region
cancer
exclus
criterion
major
malign
contraind
organ
donat
patient
multipl
patholog
exclud
would
unlik
accept
organ
donor
patient
patholog
exclud
mani
mention
contraind
donat
detail
patholog
lack
subgroup
analysi
patient
renal
diseas
exclud
potenti
kidney
donor
patient
lung
diseas
potenti
lung
donor
within
eurotranspl
region
year
maximum
age
donat
kidney
lung
pancrea
islet
isol
maastricht
categori
deceas
donor
potenti
liver
donor
maximum
age
year
use
whole
pancrea
donor
year
result
obtain
belgian
report
total
potenti
donor
least
suitabl
organ
donat
remain
patient
histori
kidney
diseas
exclud
lead
potenti
kidney
donat
lung
donat
patient
exclud
leav
potenti
lung
donor
patient
year
old
exclud
leav
potenti
liver
donor
whole
pancrea
donat
age
group
year
exclud
result
potenti
pancrea
donor
conclus
first
analysi
belgian
data
euthanasia
order
explor
potenti
organ
donat
euthanasia
euthanasia
case
potenti
suitabl
patient
donat
whether
will
donat
unclear
studi
small
percentag
patient
would
consid
donat
could
mean
increas
donat
belgium
netherland
introduct
abil
commun
well
patient
rel
fundament
clinic
skill
intens
care
medicin
central
good
medic
practic
commun
bedsid
even
patient
unconsci
sedat
may
often
recal
critic
care
survivor
impact
upon
longterm
psycholog
outcom
intens
care
societi
releas
guidelin
provis
intens
care
servic
one
area
highlight
patient
rel
perspect
import
effect
commun
rel
patient
valuabl
time
spent
talk
patient
aim
audit
assess
commun
skill
daili
ward
round
team
leader
normal
call
consult
patient
bedsid
method
observ
studi
compris
daili
ward
round
bed
critic
care
unit
ccu
whiston
hospit
octob
novemb
averag
patient
per
ward
round
record
includ
nonventil
ventil
patient
data
collect
tool
use
assess
whether
consult
lead
ward
round
introduc
explain
role
introduc
rest
team
result
patient
ccu
within
time
period
major
patient
ventil
say
found
consult
introduc
explain
role
introduc
rest
team
seem
signific
differ
commun
consult
ventil
patient
show
introduc
explain
role
introduc
rest
team
conclus
commun
patient
doctor
within
ccu
call
vast
improv
given
evid
mention
imper
strategi
put
place
help
improv
result
found
would
includ
simpl
adjunct
next
bedsid
help
remind
consult
import
effect
commun
worthwhil
reaudit
implement
put
place
see
whether
commun
improv
refer
gauntlett
r
law
continu
educ
anaesthesia
critic
care
pain
commun
skill
critic
care
volum
number
page
young
k
guidelin
provis
intens
care
servic
patient
rel
perspect
section
edit
page
introduct
commun
patient
famili
critic
care
medicin
ccm
complex
challeng
physician
benefit
dedic
commun
teach
although
ideal
model
establish
purpos
develop
assess
impact
commun
skill
curriculum
ccm
fellow
method
survey
includ
multipl
choic
freetext
question
sent
ccm
fellow
staff
physician
nurs
social
worker
institut
result
inform
design
longitudin
commun
skill
curriculum
ccm
fellow
effect
curriculum
assess
trend
clinician
feedback
result
survey
respons
rate
fellow
staff
physician
nurs
social
worker
nonfellow
respond
identifi
fellow
rank
expect
counsel
emot
impact
emerg
situat
fellow
report
least
amount
train
area
least
comfort
address
patient
famili
emot
issu
staff
physician
least
comfort
teach
assess
fellow
capac
address
emot
receiv
least
amount
train
area
nontraine
group
describ
fellow
focu
give
inform
build
rapport
fellow
indic
challeng
may
relat
absenc
prior
relationship
patient
famili
discomfort
talk
death
die
despit
challeng
relat
aspect
commun
topic
greatest
interest
fellow
includ
organ
donat
advers
event
conflict
famili
meet
prefer
learn
method
includ
simul
feedback
clinic
practic
data
guid
develop
commun
skill
curriculum
involv
formal
session
year
structur
feedback
ccm
rotat
formal
session
consist
didact
present
simul
practic
one
formal
session
dedic
basic
principl
commun
incorpor
topicbas
session
form
guid
multidisciplinari
preceptor
provid
feedback
fellow
clinic
practic
also
develop
implement
preliminari
data
indic
fellow
valu
curriculum
feedback
object
curricular
evalu
ongo
conclus
kern
model
valuabl
develop
blend
commun
skill
curriculum
tailor
ccm
fellow
need
curriculum
receiv
favor
introduct
conflict
healthcar
profession
patient
rel
rather
common
intens
care
unit
icu
result
societi
increas
ethnic
divers
conflict
often
involv
actor
differ
ethnocultur
background
howev
known
specif
natur
stafffamili
conflict
multiethn
icu
environ
studi
give
overview
characterist
conflict
famili
member
ethnicminor
group
staff
member
compar
characterist
stafffamili
conflict
gener
method
ethnograph
fieldwork
done
icu
multiethn
urban
hospit
belgium
month
data
collect
negoti
interact
observ
indepthinterview
staff
patient
medic
record
make
note
logbook
data
analyz
via
ground
theori
compar
literatur
stafffamili
conflict
gener
result
known
gener
physician
identifi
situat
less
often
conflictload
rel
suggest
presenc
hidden
conflict
critic
care
howev
studi
multiethn
icu
conflict
found
explicitli
recogn
rel
well
healthcar
profession
visibl
audit
ward
moreov
gener
relativestaff
conflict
tend
center
around
crisi
moment
endoflif
decis
make
patient
death
found
multiethn
icu
conflict
tend
present
variou
care
phase
cur
phase
endoflif
decis
make
noncur
phase
patient
death
concern
broad
spectrum
care
aspect
eg
bedsid
care
activ
seek
second
opinion
easili
assault
core
actor
ident
consequ
endoflif
decis
often
difficult
assign
icu
might
even
problemat
multiethn
context
gener
tension
preend
life
decis
make
phase
might
worsen
conflict
endoflif
decis
make
phase
conclus
icu
stafffamili
conflict
tend
sever
overtli
present
multiethn
context
gener
therefor
urg
develop
specif
effect
stafffamili
conflict
prevent
strategi
multiethn
icu
refer
schuster
ra
et
al
crit
care
med
long
ac
et
al
crit
care
med
visser
et
al
crit
care
doi
introduct
manag
critic
ill
patient
often
challeng
clinician
sedat
unwel
activ
involv
aspect
care
qualiti
care
receiv
patient
also
vari
hospit
locat
turn
influenc
famili
percept
care
provis
famili
member
surrog
patient
monitor
experi
posit
influenc
patient
outcom
aim
studi
identifi
whether
sourc
admiss
critic
care
impact
famili
satisfact
method
prospect
studi
conduct
period
eight
week
critic
care
unit
four
rel
per
patient
prior
discharg
unit
initi
end
life
care
request
fill
modifi
famili
satisfact
survey
fss
icu
questionnair
qualit
respons
obtain
use
likert
scale
transform
numer
data
analysi
result
complet
survey
analys
major
respond
femal
patient
admit
emerg
resuscit
depart
whilst
admiss
inpati
ward
account
patient
admit
emerg
depart
level
satisfact
excel
good
aspect
patient
care
oppos
patient
ward
conclus
result
show
rel
like
satisfi
admit
emerg
depart
inpati
ward
correl
inclus
decisionmak
process
overal
satisfact
time
manner
patient
admit
emerg
depart
resu
well
level
staf
initi
manag
may
account
result
seen
refer
wall
et
al
refin
score
valid
famili
satisfact
intens
care
unit
fsicu
survey
crit
care
med
introduct
sought
evalu
whether
succinct
critic
care
famili
need
inventori
ccfni
valid
survey
may
serv
suitabl
altern
fsicu
undertak
rel
experi
survey
annual
outlin
qualiti
indic
scottish
intens
care
societi
qualiti
improv
group
past
year
complet
fsicu
annual
lengthi
survey
cover
aspect
care
decis
make
fss
previous
valid
larg
uscanadian
studi
recent
famili
report
experi
evalu
free
valid
fsicu
uk
employ
survey
across
differ
icu
approxim
form
complet
method
audit
conduct
across
hospit
trust
week
distribut
ccfni
rel
patient
ituhdu
decis
step
ward
made
includ
section
open
comment
end
survey
result
week
total
survey
complet
select
result
detail
comparison
result
similar
question
fsicu
survey
qualiti
care
ccfni
rel
felt
best
possibl
care
given
patient
almost
time
fsicu
felt
care
receiv
doctor
excel
felt
care
receiv
nurs
excel
commun
ccfni
felt
explan
patient
condit
given
term
could
understand
almost
time
remain
felt
explan
understand
time
fsicu
felt
staff
provid
understand
explan
excel
describ
inform
good
empathi
ccfni
state
staff
member
show
interest
rel
feel
almost
time
time
fsicu
state
icu
staff
excel
show
interest
consider
rel
need
said
staff
good
conclus
result
suggest
rel
satisfi
care
rel
receiv
trust
result
appear
correl
well
fsicu
sever
domain
care
commun
empathi
therefor
propos
ccfni
use
altern
annual
survey
measur
rel
experi
icu
refer
wall
et
al
crit
care
med
azoulay
et
al
j
respir
crit
care
med
introduct
icu
survivor
suffer
persist
physic
psycholog
social
problem
month
year
discharg
critic
care
caregiv
patient
also
suffer
similar
problem
result
innov
peer
support
rehabilit
programm
intens
care
syndrom
promot
independ
return
employ
in
pire
creat
glasgow
royal
infirmari
week
multi
disciplinari
programm
co
facilit
patient
famili
volunt
along
recoveri
trajectori
aim
empow
patient
caregiv
take
control
health
wellb
object
studi
explor
experi
volunt
particip
in
pire
also
sought
identifi
support
requir
volunt
healthcar
profession
involv
project
method
six
depth
semi
structur
interview
undertaken
volunt
patient
famili
member
involv
in
pire
clinic
assist
psychologist
predetermin
topic
guid
utilis
guid
interview
interview
audio
record
transcrib
verbatim
interpret
phenomenolog
analysi
use
analys
transcript
peer
review
undertaken
ensur
credibl
find
result
find
six
key
theme
identifi
interview
social
impact
volunt
share
experi
support
other
person
boundari
support
need
person
gain
import
peer
support
share
understand
particip
need
key
theme
volunt
volunt
describ
need
support
area
confidenti
listen
skill
understand
boundari
conclus
use
peer
volunt
icu
rehabilit
servic
success
within
local
context
larger
scale
research
studi
explor
impact
volunt
icu
survivor
requir
refer
quasim
et
al
employ
social
depend
return
work
intens
care
journal
intens
care
societi
smith
ja
et
al
interpret
phenomenolog
analysi
sage
public
london
hain
kj
et
al
psychosoci
outcom
inform
caregiv
critic
ill
systemat
review
critic
care
medicin
introduct
intens
care
unit
one
stress
place
hospit
rel
expos
mani
factor
may
caus
symptom
anxieti
depress
aim
studi
determin
preval
anxieti
depress
symptom
hour
day
icu
adimss
identifi
factor
associ
symptom
method
rel
patient
admit
nation
burn
center
montevideo
februari
octob
invit
particip
studi
hour
nineti
day
icu
admiss
famili
member
complet
survey
includ
hospit
anxieti
depress
scale
result
rel
repond
survey
hour
day
icu
admiss
repect
preval
anxieti
symptom
hour
day
icu
admiss
respect
symptom
depress
present
rel
third
day
day
icu
admiss
hou
icu
admiss
longer
time
live
patient
associ
anxieti
year
vs
year
p
depress
year
vs
p
moment
higher
total
burn
area
vs
p
associ
depress
factor
associ
anxieti
day
icu
admiss
felt
treatment
inform
incomplet
vs
p
abl
return
work
vs
p
factor
associ
depress
symptom
day
afetr
icu
admiss
abl
return
work
vs
p
conclus
preval
anxieti
depress
among
rel
import
hour
icu
admiss
remain
elev
month
later
studi
show
factor
associ
apear
anxieti
depress
introduct
st
elisabeth
hospit
bed
icu
critic
ill
adult
patient
facilit
famili
centr
care
earlier
year
children
allow
visit
famili
member
icu
object
project
facilit
paediatr
visit
provid
support
relat
distress
need
children
rel
icu
method
practic
aid
develop
caregiv
inform
leaflet
made
practic
inform
parent
subdivid
development
stage
furthermor
creat
book
child
visit
father
icu
pictur
show
children
expect
help
prepar
child
visit
instruct
box
includ
icu
materi
fig
materi
use
give
children
tactil
experi
icu
guidanc
materi
patient
may
die
develop
includ
exampl
littl
box
decor
children
put
memori
token
grief
pedagog
staff
avail
support
parent
children
staff
profound
problem
referr
children
psychologist
hospit
photograph
call
upon
commemor
last
moment
fig
instruct
nurs
doctor
use
materi
guid
children
held
survey
among
staff
inquir
met
need
result
increas
awar
need
children
among
staff
children
parent
welcom
guid
staff
survey
amongst
staff
show
great
appreci
materi
develop
rel
children
die
children
includ
farewel
visit
conclus
child
confront
sick
die
parent
loss
sorrow
inevit
care
giver
bystand
help
parent
guid
children
difficult
time
introduct
found
clear
tendenc
italian
picu
appli
restrict
visit
polici
howev
also
point
formal
process
revis
ward
visit
polici
underway
roughli
half
unit
therefor
carri
new
nation
survey
evalu
issu
italian
picu
method
email
questionnair
sent
head
italian
picu
ask
visit
polici
result
respons
rate
median
daili
visit
time
hour
twenti
per
cent
survey
picu
unrestrict
polici
one
parent
allow
present
day
night
unit
allow
constant
presenc
parent
even
day
children
permit
visit
picu
case
die
patient
picu
extend
visit
hour
increas
number
slot
allow
visitor
gown
procedur
compulsori
visitor
picu
wait
room
famili
member
visitor
provid
unit
thirteen
picu
thirti
recent
revis
ward
visit
polici
conclus
although
italian
picu
persist
tendenc
appli
restrict
visit
polici
find
suggest
revis
current
polici
underway
last
eight
year
percept
chang
favour
liber
visit
italian
pediatr
critic
care
set
despit
mani
object
consid
valid
past
conclus
scientif
basi
limit
famili
presenc
icu
survey
could
contribut
toward
liber
visit
polici
italian
picu
promot
attent
care
patient
hisher
famili
acknowledg
studi
support
associazion
per
il
bambino
nefropatico
milan
itali
refer
giannini
et
al
pediatr
critic
care
med
giannini
et
al
intens
care
med
